2017 Annual Meeting Early Look Program by American Academy of Neurology

g n i t e e M l a u n n A N AA

k o o L y l r Ea

7 1 0 2

y. g o ol r u e N g in c n a v d A

. u o Y g n i c n a Adv

e: dlin Dea ion trat egis ly R Ear

}} Registration }} Advance Program }} Housing

7 201 30, rch Ma

Get your early look at the 2017 Annual Meeting:

ton s o â&#x20AC;˘B 7 1 , 20 8 2 22â&#x20AC;&#x201C; l i r Ap

Discover the All-inclusive Registration Rate Everyoneâ&#x20AC;&#x2122;s Talking About The one registration fee with freedom to move about was an AMAZING improvement to the meeting. ~ 2016 Annual Meeting Attendee z No pre-registration is required for most individual courses z Customize your schedule any way you wantâ&#x20AC;&#x201D; come and go from sessions at your convenience

z Includes expanded experiential learning areas, not-to-be missed social events, and much more

AAN.com/view/AM17

Introduction

Science

Plan Your Meeting Experience �� 6 Experiential Learning Areas �� 8

Meeting Overviews

Preliminary Scientific Schedule �� 140

Highlights Connect at Social Events �� 142

Meeting-at-a-Glance �� 13 Annual Meeting Schedule Saturday, April 22 �� 16 Sunday, April 23 ��17 Monday, April 24 �� 18 Tuesday, April 25 �� 19 Wednesday, April 26 �� 20 Thursday, April 27 �� 21 Friday, April 28 �� 22

Annual Meeting On Demand �� 144

Annual Meeting Information

Annual Meeting Session List by Topic �� 24

General Information ��147 Hotels and Amenities �� 150 Hotel and Reservations �� 152 Travel Information �� 153 69th Annual Meeting Committee Members �� 154 Meeting Information and Contacts �� 156

Course Descriptions by Topic Aging, Dementia, Cognitive, and Behavioral Neurology . . . . . . . . . . . . . 30 Cerebrovascular Disease and Interventional Neurology . . . . . . . . . . . . 37 Child Neurology and Developmental Neurology . . 41 Epilepsy/Clinical Neurophysiology (EEG) . . . . . 44 General Neurology �� 51 Global Health �� 68 Headache �� 68 Infectious Disease �� 73 Leadership University . . . . . . . . . . . . . 75 Movement Disorders �� 80

The 69th AAN Annual Meeting Deadlines-At-A-Glance Late January 2017 Abstract Notifications Available

March 8, 2017 Annual Meeting Hotel Reservation Deadline

MS and CNS Inflammatory Disease . . . . . . . 88

March 30, 2017

Neuro Trauma, Critical Care, and Sports Neurology . . . . . . . . . . . . . . 93

Annual Meeting Early Registration Deadline

Neuromuscular and Clinical Neurophysiology (EMG) . . . . . . . . . 98

Location

Neuro-oncology �� 106

Boston Convention and Exhibition Center

Neuro-ophthalmology/Neuro-otology . . . . . . 108 Neuro-rehabilitation ��115

Headquarter Hotels

Pain and Palliative Care ��118

Renaissance Boston Waterfront Hotel

Practice, Policy, and Ethics �� 120 Research Methodology, Education, and History . . 125 Sleep �� 132

PROGRAM CURRENT AS OF 11/01/16. PROGRAM SUBJECT TO CHANGE.

Westin Boston Waterfront

AAN.com/view/AM17

gives me great pleasure to tell you about our 69th AAN Annual Meeting coming to beautiful, historic Boston. We changed the entire format and feel of the 2016 meeting in Vancouver, with a focus on serving attendees in new and invaluable ways. Attendees took notice, and the excitement in the air was palpable. For 2017, we have further developed this vision and have added even more changes to the program. As always, you can expect top education programming—more than 240 courses led by expert faculty from across the globe covering a wide range of topics—and the most innovative scientific research in the field, with an anticipated 2,800+ abstracts.

Stefan M. Pulst, MD, FAAN Chair, Meeting Management Committee

Value, choice, customization, and innovation. That’s the new Annual Meeting everyone is talking about. I look forward to hearing what you have to say about it when I see you in Boston!

1. 2. 3. 4. 5. 6. 7. 8. 9. 10.

CME: Enough said! Experiential Learning Areas: Sometimes the best learning comes in small packages Plenaries: Prepare to be star struck Boston: Not just a band, and “more than a feeling” Passing of the Presidential Gavel: Neurology’s Olympic Torch Leadership University: Feel like taking over the world Customization: Yes, you can have it your way! Networking: Rub shoulders with your favorite neurologist Opening Party: Just a little get together with thousands of your closest friends Neurobowl®: Because you’re too smart for Jeopardy

What’s New In 2017

Neuroscience in the Clinic Sessions These new sessions will feature a mix of scientists and clinicians actively engaged in lively case discussions to integrate scientific research with clinical application. Scientists will introduce and provide background on a case, including presentation of abstracts, and clinicians will apply the case to a patient. All will come together for audience Q&A.

Expanded Experiential Learning Areas Get ready to experience interactive—and totally flexible—new ways of exploring, engaging, and learning throughout each day of the Annual Meeting. Experiential learning areas will offer a variety of real-world experiences designed to engage you intellectually, emotionally, and socially while serving up fresh ideas to help you personally and professionally. See page 8 for more detailed information.

Exhibit Hall Opening Lunch A special opening lunch on Sunday, April 23, from 11:30 a.m. to 1:30 p.m. will give you a chance to socialize with fellow attendees and preview the latest products and services available in the neurologic industry.

Added Leadership University Offerings Explore how to become an emerging female leader in your organization or learn how to lead by example in promoting personal well-being and resiliency with new course offerings from the AAN’s suite of Leadership University courses. See page 75 for more detailed information.

Best of Science Sessions Platform sessions that will bring together the top four abstracts rated the most important research by our reviewers and lead into the daily Plenary Sessions.

Clinical Discussions Short clinical discussion will give platform sessions a new twist with invited speakers wrapping up the session with clinical application.

Poster Session Neighborhood No more long aisles or rows—we’re clustering topic-related posters together into “neighborhoods” to enhance your discussions and make the posters easier to navigate!

Office of the Future Located inside the Exhibit Hall, this exciting new area will let you experience how an office of the future will look and operate. Reimagine your exam room with the latest ergonomic equipment and cutting-edge technology that engages your patients and encourages shared decision-making—from touch-screen learning to lighting, and everything in-between!

Plan Your Meeting Experience Registration

The 69th AAN Annual Meeting registration site makes planning your week as easy as 1-2-3: 1 2

Register and book your hotel quickly and easily online—enjoy the convenience and value of the single registration rate! Use the convenient pages starting on page 16 » of this book to plan your week, incorporating your favorite education programs, scientific sessions, and other Annual Meeting social and informational events. Show up and experience the excellence of the world’s largest gathering of neurologists.

Ways to Register

Registration Options

Online

Annual Meeting Registration

AAN.com/view/register

The single meeting registration fee is mandatory for all registrants and is determined by AAN member type.

Telephone International: (415) 979-2283

To qualify for the member registration rate, your 2017 membership dues must be paid by April 22, 2017. Failure to do so will result in a balance due.

Registration Deadline: March 30, 2017

Gold Registration

Registrations received after March 30, 2017, will be processed at a higher rate.

Upgrade your meeting registration to include a copy of Annual Meeting On Demand.

US/Canada: (800) 676-4226

Hotel Reservation Deadline: March 8, 2017 For questions go to aanam.cmrushelp.com To obtain a registration form to pay by check, please contact CMR. Registration forms will only be accepted for check payments.

Ways to Save }} Renew your AAN membership or join the AAN for maximum registration savings. Visit AAN.com/view/membership. }} Register by the March 30, 2017, early registration deadline to avoid increased rates after this date.

2017 AAN Annual Meeting Fees Note: All prices in US dollars Early Registration (Before March 30, 2017)

Late Registration (After March 30, 2017)

Early Gold Registration (Before March 30, 2017)

Late Gold Registration (After March 30, 2017)

Students

$199

Senior/Honorary

$399

$245

$335

$444

$534

$420

$570

$619

$769

Junior

Non-neurologist Member Neurologist Member

$720

$980

$1,119

$1,379

Nonmember

$1,220

$1,660

$1,819

$2,259

1 Junior, Intern 2 Researcher, Advanced Practice Provider, Business Administrator

3 Neurologist, Physician Affiliate

2017 AAN Annual Meeting Early Look

What Is Not Included with Additional Information Annual Meeting Registration? Cancelled or Closed Programs While the single registration rate provides an exceptional value, the following few programs are not included, may require a separate registration fee, and are subject to closure due to reaching maximum capacity. For information on pricing please visit AAN.com/view/register. C6 Early Career Research Training Symposium: A Roadmap to Academic Success for Residents and Fellows C7

Neurology MOC Prep Course

C8 Clerkship and Program Directors Leadership Academy

Education programs may be closed due to reaching maximum capacity or cancelled due to insufficient enrollment. In the event of cancellation, registration for the cancelled course will be fully refunded for courses that have a separate registration fee. The AAN is not responsible for airfare, hotel, or other costs incurred by participants in the event of program or registration closure or cancellation.

Cancellations/Refunds of Registration Until March 30, 2017—Refund less $100 administrative fee

C9 Women in Leadership

March 31–April 15, 2017—Refund less $200 administrative fee

C15 Practical Training in Injection Techniques in the Treatment of Headache Disorders Skills Workshop

After April 15, 2017—No refund •• All cancellations must be submitted in writing to aanam. cmrushelp.com or faxed to (415) 293-4071. •• No-shows will not receive a refund. •• Name substitutions are not permitted. •• No refunds will be processed for amounts of $20 or less.

C49 Clinical Uses of Botulinum Toxin for Dystonia Skills Workshop C50 Neuro-ophthalmology and Neurovestibular Exam Lab Skills Workshop C76 Mentoring…Growing the Next Generation of Neurologist C88 Improving Your Leadership Skills: A Practical Approach C89 Neurophysiologic Intraoperative Monitoring Skills Workshop C133 The Most Important Tool in Your Black Bag: Gallup StrengthFinder™ Assessment C135 Neuromuscular Ultrasound Skills Workshop C170 Sports Concussion Skills Workshop I: Event Coverage Skills C171 The Most Important Tool in Your Black Bag: Gallup StrengthFinder™ Assessment: Advanced Workshop C172 EMG Skills Workshop: Basic C185 Sports Concussion Skills Workshop II: Office-based Skills C209 Clinical Usefulness of Botulinum Toxin for Spasticity Workshop C238 Epilepsy Skills Workshop

Special Accommodations Deadline: March 30, 2017 The Boston Convention and Event Center and the AAN strive to accommodate all visitors. Information booths, designated parking, and assisted listening devices are available. If you require special accommodation to attend the Annual Meeting, submit your request while registering online or contact Laurie Dixon no later than March 30, 2017, at ldixon@aan.com or (612) 928-6154. Kosher meals may be provided at any lunch and must be arranged on or before March 30, 2017, through the registration website or by contacting AAN Registration/CMR at aanam.cmrushelp.com, (800) 676-4226, or (415) 979-2283. There is a $50 surcharge per kosher meal. On-site requests cannot be accommodated. There are no refunds for kosher meals.

Group Registration Deadline: March 30, 2017 Group registrations are those in which 10 or more individuals’ fees are paid for with one check or credit card. Special registration instructions are available online AAN.com/view/register or by contacting CMR’s Group Registration at (800) 676-4226 (US/Canada) or (415) 979-2283 (International) or aanam.cmrushelp.com. See page 152 » for housing information.

Fast and easy registration · AAN.com/view/AM17

Experiential Learning Areas

We’re Taking Learning Outside the Traditional Classroom! Live Well: Taking Care of Your Patients Starts with Taking Care of You! Feeling burned out? Get inspired about the importance of taking care of your mental and physical health. From yoga or meditation to important information on eating right and one-on-one mentoring, this area will motivate you to take charge of your well-being.

Scheduled Presentations: Mindful Practice in Neurology: Cultivating Resilience (The Rochester Curriculum) Frederick Marshall, MD Gratitude and Resilience: An Experiential Session Frederick Marshall, MD Physical Exercise and Cognitive Training in Neurology—Application in Aging and Neurodegenerative Disease Ergun Y. Uc, MD Physical Exercise and Cognitive Training in Neurology—Exercise in Stroke A.M. Barrett, MD Diets and Supplements in MS—What’s the Evidence Thus Far? Vijayshree Yadav, MD Integrating Management of Activity and Exercise in Routine Clinical Practice Lisa M. Shulman, MD

Guts and Glory: The Importance of Diet and Exercise in Managing Persons with Multiple Sclerosis Barbara S. Giesser, MD, FAAN Complementary Therapies in Parkinson’s Disease Veronica E. Santini, MD Mastering the Art of Practice: Recapturing the Joy of Neurology—Personal and Professional Balance Jennifer Rose Molano, MD, FAAN, and Heidi B. Schwarz, MD, FAAN Mastering the Art of Practice: Recapturing the Joy of Neurology—Your Organization and Health Care Policy Neil A. Busis, MD, FAAN Meditation: Scientific Overview and Experiential Session Sarah Mulukutla, MD

Yoga (All-levels Vinyasa Sarah Bird Nelson, JD Enhanced Well-being Through Mentoring Joanne L. Smikle, PhD Introduction to Acupuncture I—Conceptual Framework and Mechanism of Action Alexandra Dimitrova, MD Introduction to Acupuncture II—Evidence-based Applications for Acupuncture in the Treatment of Neurologic Conditions Alexandra Dimitrova, MD How Social Relationships Contribute to Healthy Cognitive Aging Joel Salinas, MD, MBA, MSc Integrative Approach to the Management of Chronic Pain Syndromes Jessica Robinson Papp, MD, FAAN

Get ready to experience these interactive—and totally flexible—new ways of exploring, engaging, and learning at this year’s Annual Meeting. Happening every day, these experiential learning areas offer a variety of real-world experiences that will engage you intellectually, emotionally, and socially and offer you fresh ideas to help you personally and professionally.

Navigating Your Career: Choose a Track, Stay on Track, Change Tracks Looking for useful advice for every stage of your career development? One-on-one mentoring and small-group sessions and a lively presentation stage will offer something for everyone: medical students, residents, fellows, junior faculty, senior faculty, and advanced practice providers.

Scheduled Presentations: Choosing a Neurohospitalist Career S. Andrew Josephson, MD, FAAN

Staying on an Academic Clinical Track John Probasco, MD

Choosing a Career in Clinical Practice James C. Stevens, MD, FAAN

Going from Private Practice to Academics Neil A. Busis, MD, FAAN

Being a Great Chief Resident / Advancing Your Leadership Skill: Tips for the Successful Chief Resident Maisha T. Robinson, MD, MS

Research in Residency: How to Choose the Right Project Roy E. Strowd III, MD

Negotiating Jonathan P. Hosey, MD, FAAN Interviewing Skills: Negotiation Allison Brashear, MD, MBA, FAAN Staying on Track: A Career as a Clinical Researcher Rebecca F. Gottesman, MD Interviewing Skills Ralph F. Józefowicz, MD, FAAN Child Neurology—Staying on Track Warren D. Lo, MD

How to Start a Career in Neurology Education Joseph E. Safdieh, MD, FAAN Sleep Health Matters in Neurology—Why We Are Losing Sleep Rachel Marie E. Salas, MD How to Give Feedback Veronica E. Santini, MD What I Learned About Research—An Early Career Perspective Logan D. Schneider, MD

Clinical Research in the Area of Practice, Quality, and Patient Safety Mona Bahouth, MD Choosing Teleneurology as a Career Eric Andersen, MD, PhD

Experiential Learning Areas Education and Publications Station: Knowledge Is Power Are you up-to-date on the latest news and information in the world of neurology? Explore the AAN’s host of top-quality e-learning and other publications offering the very latest science and news in neurology—and valuable CME—like Neurology ® journal, Continuum: Lifelong Learning in Neurology ®, Neurology Today ®, Neurology Now ®, and so much more.

Scheduled Presentations:

(Continued)

Maximize Your Value: Improve Your Neurology Practice Are you employing the best strategies for ensuring the success of your practice? Discover the best business practices for neurology and leave with readily implementable strategies on how to grow and sustain your practice. Get your most pressing questions answered at the daily “Ask the Expert” booth and learn about a variety of topics from quality improvement to demonstrating your value as a neurologist at the presentation stage.

Scheduled Presentations: How EHRs Are a Positive Addition to Practice

Top 10 Ways APPs Can Improve Practice

Integrating Guidelines and Measures into Your EHR

Building an APP Service Model

Telemedicine Beyond Tele-stroke

Using Chronic Care Codes

Top 10 Technologies for Neurology Practice

Gamification of Neurology Education

Hot Topics in Guideline Development

How to Get the Most of Your Annual Meeting Experience

Basics of QI: Using Data to Improve Care

How to Use Continuum® for Resident Education MOC Informational Session Innovative Teaching Tips How to Use an RSS Feed for Your Own Learning What Are Your Patients Reading? Tips for Successful Submission to Neurology®

Administering and Interpreting Patient Reported Outcomes Axon Registry: The Data You Need to Improve Care Using Forms and Clinical Decision Support to Integrate Guidelines and Measures into Your EHR Top 10 Patient Reported Outcomes to Learn and Use APPs as Care Planning Resources for Your Patients Using APPs to Maximize Your Time Telemedicine and APPs

Coding and Reimbursement for APPs Coding for Telemedicine New Technologies for Neurology Practice How to Appeal a Claims Denial What Did We Learn About Neurology Compensation in the Neurology Compensation and Productivity Report? Top 10 Coding Tips for 2017 Improving Patients’ and Families’ Satisfaction and Experiences with Neurologic Care (Two-part Series) Contemporary Ethical Issues Medicare Access and CHIP Reauthorization Act (MACRA) Overview

Research Corner: Moving Neurology Forward Do you know how important research is to the future of neurology? See how it’s making a significant impact on patient care and everyday neurology, discover new and valuable resources to help you move your research forward, and celebrate and congratulate recipients of the 2017 AAN awards.

Scheduled Presentations: Grantwriting 101: Getting Started Building Contracts and Budgets IRB Reviews Your Grant Proposal Was Rejected: Now What? Critiques: Turning Feedback into a Successful Proposal How to Create “Bridge” Funding Loan Forgiveness Programs How to Write a Good AAN Research Program Proposal Congratulations! Your CRTS Was Accepted! Now Make the Most of It Transitioning from AAN Research Program Grant to NIH Funding Are You My Mentor? Finding One, Keeping One, Learning from One, Firing One PCORI—What’s All the Fuss?

NEW! HeadTalks Stage Interested in out-of-the-box learning? Engage in creative and provocative presentations on some of the timeliest topics in neurology. These unique talks will follow a wide variety of formats and include everything from the history of neurologic medicine in Boston to live neuro exams, panel discussions with past AAN presidents, and “ask-the-expert” and interactive style sessions that challenges your creativity.

Scheduled Presentations: Ask Me Anything: Journal Edition Robert A. Gross, MD, PhD, FAAN

NEW! Advocacy to Action: Empowering Patients and Physicians Did you know you can make an impact on the future of neurology through advocacy? Learn how you can get involved and make your voice heard for you, your patients, and the future of neurology. Get inspired to make a difference when you hear directly from AAN member advocates and AAN advocacy staff on initiatives such as BrainPAC, Neurology on the Hill, and the Palatucci Advocacy Leadership Forum. Get inspired to make a difference!

Issues Facing Rural Neurologists Michael Stitzer, MD

Scheduled Presentations:

Neurology and Art David E. Thaler, MD, PhD

Follow the Dollar: BrainPAC Donation to Candidate Contribution

Neurological Exam Tips and Tricks Thomas R. Swift, MD, FAAN; Christopher H. Hawkes, MD, BSc, FRCP Patient Engagement: The Good, the Bad, Is There Any Ugly? Allison L. Weathers, MD, FAAN; Jeffrey R. Buchhalter, MD, FAAN; Daniel B. Hoch, MD, PhD, FAAN; Melissa Yu, MD; Allan Ding Wu, MD Mastering EMG Waveform Recognition Skills in One Hour! Devon I. Rubin, MD, FAAN

AAN Advocacy Priorities How a Bill Becomes a Law: Case Study Lobbyist for a Day Using Social Media Effectively Mock Legislative Visits Advocacy Efforts in Global Health How to Obtain a Grant Finding Time for Advocacy Resident Involvement in Advocacy All content is current as of November 1, 2016. Program subject to change.

OPENING PARTY Sunday, April 23 • 6:00 p.m.–10:00 p.m.

Kick Off the Annual Meeting Everyone’s Talking About with the Party Everyone Will Be Talking About Neurobowl® 6:00 p.m.–8:00 p.m. This popular event, hosted by AAN former president Thomas R. Swift, MD, FAAN, is one of the Annual Meeting’s premier happenings. Neurobowl showcases the best and brightest in neurology competing for the coveted Neurobowl trophy in an entertaining game-show format.

Trinity Irish Dance Company 8:30 p.m.–9:15 p.m. Billed as “everything you expect but nothing you imagine,” Trinity Irish Dance Company quickly dispels whatever notions you may have about Irish dance. The company dazzles audiences with hard-driving percussive power, lightning-fast agility, aerial grace, and the awe-inspiring precision of its dancers that led them to win an unprecedented 17 World Championships for the US and appearances in feature films by Disney, DreamWorks, Touchstone, and Universal and on the Tonight Show.

Live DJ and Dancing 9:15 p.m.–10:00 p.m. Get down with friends and colleagues to some of the most memorable dance tunes spanning the past six decades.

AAN.com/view/AM17

Meeting-at-a-Glance

12:00 p.m. 1:00 p.m. 2:00 p.m.

9:15 a.m.–12:00 p.m.

Education & Science 10:30 a.m.– 12:30 p.m.

5:00 p.m. 6:00 p.m. 7:00 p.m. 8:00 p.m. 9:00 p.m. 10:00 p.m.

Education and Science

Education Education & Science & Science 1:00 p.m.– 3:00 p.m.

1:00 p.m.– 5:00 p.m.

Education & Science 2:00 p.m.– 4:00 p.m.

3:00 p.m. 4:00 p.m.

Clinical Trials Plenary Session

AAN Business Meeting 4:00 p.m.–4:30 p.m.

Hot Topics Plenary Session

1:00 p.m.– 3:00 p.m.

Education and Science

3:30 p.m.– 5:30 p.m.

9:15 a.m.–11:30 a.m.

Education and Science

1:00 p.m.–3:00 p.m.

Education and Science

3:30 p.m.–5:30 p.m.

9:15 a.m.–11:30 a.m.

Education and Science

1:00 p.m.–3:00 p.m.

Education and Science

3:30 p.m.–5:30 p.m.

Education and Science

Frontiers in Neuroscience Plenary Session

Controversies in Neurology Plenary Session

Neurology Year in Review Plenary Session

7:00 a.m.–9:00 a.m.

9:15 a.m.–11:30 a.m.

Education and Science 1:00 p.m.– 3:00 p.m.

9:15 a.m.–11:30 a.m.

Education and Science

3:30 p.m.– 5:30 p.m.

5:00 p.m.–6:30 p.m.

Opening Party

6:00 p.m.–10:00 p.m. 6:00 p.m.–8:00 p.m.

Neurobowl®

8:30 p.m.–10:00 p.m.

Entertainment

Faculty and Trainee Reception 6:00 p.m.– 9:00 p.m.

Education and Science 1:00 p.m.– 3:00 p.m.

Education and Science

3:30 p.m.– 5:30 p.m.

9:15 a.m.–11:30 a.m.

Education and Science 1:00 p.m.– 3:00 p.m.

Education and Science

3:30 p.m.– 5:30 p.m.

Closing Party Happy Hour

Education and Science 6:00 p.m.– 9:00 p.m.

7:00 a.m.–9:00 a.m.

5:30 p.m.–7:00 p.m.

Commitment to Cures 7:00 p.m.–9:30 p.m.

Poster Session VI 8:30 a.m.–5:30 p.m.

11:00 a.m.

Contemporary Clinical Issues Plenary Session

Education and Science

Poster Session V 8:30 a.m.–7:00 p.m.

10:00 a.m.

Presidential Plenary Session

Thur April 27 Fri April 28

Education and Science

Poster Session IV 8:30 a.m.–7:00 p.m.

8:00 a.m.– 5:00 p.m.

7:00 a.m.–9:00 a.m.

Poster Session III 8:30 a.m.–7:00 p.m.

8:00 a.m.– 12:00 p.m.

7:00 a.m.–9:00 a.m.

Exhibit Hall 11:30 a.m.–4:00 p.m.

8:00 a.m.– 10:00 a.m.

Education and Science

Poster Session II 8:30 a.m.–7:00 p.m.

9:00 a.m.

Education Education Education & Science & Science & Science

Wed April 26

Education and Science

Poster Session I 8:30 a.m.–5:30 p.m.

8:00 a.m.

Tue April 25 Run/Walk for Brain Research Education 6:30 a.m.–8:30 a.m. and Science

Exhibit Hall 11:30 a.m.–6:00 p.m.

7:00 a.m.

Mon April 24

Exhibit Hall 11:30 a.m.–3:00 p.m.

Sun April 23

Exhibit Hall 11:30 a.m.–4:00 p.m.

6:00 a.m.

Sat April 22

Saturday, April 22

Sunday, April 23

1:00 p.m.–5:30 p.m.

8:00 a.m.–10:00 a.m.

7:00 a.m.–9:00 a.m.

9:15 a.m.–11:30 a.m.

C1 C2 C3 C4

C23 Using Sleep Medicine to Help Solve

for Dystonia Skills Workshop $ (registration required) C50 Neuro-ophthalmology and Neurovestibular Exam Lab Skills Workshop $ (registration required)

3:30 p.m.–5:30 p.m.

Exhibit Hall

The Neurology of Social Behavior Parkinson’s Disease Update Status Epilepticus Multiple Sclerosis Essentials

8:00 a.m.–12:00 p.m. C5 Resident Basic Science I:

Neuroanatomy—All the Lesions

8:00 a.m.–5:00 p.m. C6 Early Career Research Training

C7 C8 C9

Symposium: A Roadmap to Academic Success for Residents and Fellows (registration required) Neurology MOC Prep Course $ (registration required) L Clerkship and Program Directors Leadership Academy (registration required) L Women in Leadership $ (registration required)

10:30 a.m.–12:30 p.m. C10 Making Sure You Get Paid Under

the New Health Care Laws C11 Neuromyelitis Optica Spectrum Disorders C12 Neuromuscular Junction Disorders I: Myasthenia Gravis, Ocular and MuSK Myasthenia C13 Neurologic Complications of Medical Disease C14 Concussion: From Mechanisms to Management

C24 C25 C26 C27 C28 C29 C30 C31 C32

9:15 a.m.–12:00 p.m.

Presidential Plenary Session 11:30 a.m.–4:00 p.m.

Exhibit Hall

11:30 a.m.–1:30 p.m.

Exhibit Hall Opening Lunch Reception

Techniques in the Treatment of Headache Disorders Skills Workshop $ (registration required)

1:00 p.m.–5:00 p.m. C16 Resident Basic Science II:

C34

C35 C36 C37

C39

C17 How Is Your Patient Really Doing?

C20 C21 C22

C40 C41 C42 C43 C44 C45

Frontotemporal Dementias and Chronic Traumatic Encephalopathy Introduction to Primary Headache Disorders I: Migraine and Other Primary Headaches Including Tension-type, Hypnic, Primary Stabbing, and Nummular Headache Syndromes Deep Brain Stimulation I: Basic Principles and Programming in Movement Disorders Multiple Sclerosis Therapy: Disease-modifying Treatment I Clinical EMG II: Neuromuscular Junction Testing and Quantitative EMG Case Studies: Neurologic Consultations in Cancer Patients I So You’ve Diagnosed Your Patient with a Neuroinfectious Disease, Now What? Practical Pearls in the Treatment and Management of Neuroinfectious Diseases Neurology Update I: Epilepsy, Headache, and Neurologic Infections Clinical Epilepsy II: Considerations Across the Age Span—Pediatrics, Pregnancy, and Elderly Cerebrovascular Disease II: Hemorrhagic Stroke Introduction to Clinical Research and Methods Genomic Neurology Workshop: Developing Practical Knowledge of Tools and Concepts Through Case Studies I Navigating the World of Mobile Health Neuroscience in the Clinic: Neurobiology and Treatment of Disorders of Language and Action

4:00 p.m.–4:30 p.m. AAN Business Meeting

5:00 p.m.–6:30 p.m.

1:00 p.m.–5:00 p.m.

Hot Topics Plenary Session

C46 Resident Basic Science III:

Neuropharmacology C47 L Gender Issues in Leadership C48 L Leadership Challenges in Practice

14 2017 AAN Annual Meeting Early Look

Lewy Body Dementias and Other Parkinsonian Dementias Introduction to Primary Headache Disorders II: Trigeminal Autonomic Cephalalgias and Other Primary Headaches Including New Daily Persistent Headache, Cough, Exercise, and Primary Thunderclap Headaches Deep Brain Stimulation II: Advanced Management in Movement Disorders and Applications Beyond Movement Disorders Multiple Sclerosis Therapy: Disease-modifying Treatment II Clinical EMG III: Nerve Conduction Criteria and Electrodiagnostic Approaches Case Studies: Neurologic Consultations in Cancer Patients II Neurology Update II: Movement, Spine, and Autonomic Neurology Clinical Epilepsy III: Advanced (Status, Beyond AED, Video EEG) Cerebrovascular Disease III: Acute Ischemic Stroke Precision Neurology: The Promise and Perils of Personalized Medicine in the Genomic Era Genomic Neurology Workshop: Developing Practical Knowledge of Tools and Concepts Through Case Studies II Neuroscience in the Clinic: Child Neurology: Neurologic Disorder Through a Lifespan—A Focus on MS

C74 Annual A.B. Baker Program: Focus on Professionalism

Contemporary Clinical Issues Plenary Session 11:30 a.m.–6:00 p.m. 4:30 p.m.–6:00 p.m.

Exhibit Hall Networking Reception

6:00 p.m.–9:00 p.m.

Faculty and Trainee Reception

Conference: Wellness and Burnout During Training

1:00 p.m.–3:00 p.m.

6:00 p.m.–9:00 p.m.

C76 L Mentoring… Growing the Next

C103 Case Studies: Dementia C104 Case Studies: Multiple Sclerosis C105 Test Your Knowledge: A Case-

Trinity Irish Dance Company

DJ Music and Dancing

1:00 p.m.–5:00 p.m.

C55 C56 C57

C60 C61 N2

6:00 p.m.–10:00 p.m.

Opening Party

6:00 p.m.–8:00 p.m. Neurobowl®

8:30 p.m.–9:15 p.m.

9:15 p.m.–10:00 p.m.

Monday, April 24

C88 L Improving Your Leadership Skills:

7:00 a.m.–9:00 a.m.

1:00 p.m.–5:30 p.m.

C62 Mild Cognitive Impairment:

C89 Neurophysiologic Intraoperative

C63 C64 C65 C66 C67 C68 C69 C70 C71 C72 C73

Implications for Clinicians CNS Toxicities ICD-10-CM: How to Optimize for Accurate Diagnosis and Reimbursement Child Neurology I: Pediatric Stroke, MS/Autoimmune Neuro-oncologic Emergencies Infections of the Nervous System I: Diagnostic Testing of Neurological Infections Approach to the Shaky Patient Therapy of Neuromuscular Disease: ALS, Inflammatory Neuropathies and Myopathies, and Myasthenia Gravis Sports Neurology: Enhancing Athletic Performance Hot Topics in Sleep Neurology Gender-specific Care for Neurological Disorders Current Management of Incidental and Asymptomatic Cerebrovascular Lesions

Disease II: Inflammatory Myopathies and Muscle Pathology C99 Therapeutic Temperature Modulation in the ICU C100 Neuro-otology II: Diagnosis and Treatment of Nuanced Causes of Dizziness C101 Drug-induced Neurologic Emergencies C102 Business Strategies for Payer Negotiations and/or How to Go off the Grid

C75 Clerkship and Program Directors

C54

C98 Clinical Approach to Muscle

12:00 p.m.–5:30 p.m.

Generation of Neurologist $ (registration required) C77 Behavioral Neurology I: Network Anatomy of Behavior and Language C78 Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease I C79 Neuroimaging for the General Neurologist I: Brain and Spine C80 Child Neurology II: Epilepsy and Neuromuscular C81 Common Spine Disorders I: Evaluation C82 Infections of the Nervous System II: Neuro-ID Emergencies C83 Hot Topics and Controversies in Parkinson’s Disease C84 Clinical Approach to Muscle Disease I: Muscle Disorders and Rhabdomyolysis C85 Boston City Hospital: The Cradle of American Neurology Part I C86 Neuro-otology I: The Common Peripheral Vestibular Disorders C87 How to Run a Practice: Business Strategies for Neurology Private Practices, Academic Centers, and the Future N3 Neuroscience in the Clinic: Cutting Edge Concussion Data from the NCAA-DoD Grand Alliance

C59

2:00 p.m.–4:00 p.m.

C19

C53

C33 Non-Alzheimer’s Dementia I:

C38

C18

C52

C58

Neuropathology

Patient Reported Scales, Tools and Shared Decision Making Vascular Cognitive Impairment and Dementia: Current Status and Future Neuromuscular Junction Disorders II: Toxins, Lambert-Eaton Syndrome and Less Common Disorders of Neuromuscular Transmission Neurologic Complications of Medical and Surgical Therapies Concussion: Evaluation and Management in the Acute and Chronic Phases It’s a Bird, It’s a Plane, It’s… The Doctor Who Cured my Benign Paroxysmal Positional Vertigo

C51 Non-Alzheimer’s Dementia II:

1:00 p.m.–3:00 p.m.

1:00 p.m.–3:00 p.m. C15 Practical Training in Injection

Difficult Neurologic Cases Child Neurology: A Case-based Approach Cerebellar and Afferent Ataxias: Diagnosis and Management Clinical EMG I: Principles and Practice of NCS and Needle EMG Differential Diagnosis of Neurologic Infections Advances in Neurogenetics Clinical Epilepsy I: Basics Cerebrovascular Disease I: Prevention Advanced Neurologic Coding Emergency Room Neuroophthalmology

C49 Clinical Uses of Botulinum Toxin

A Practical Approach (registration required)

Monitoring Skills Workshop $ (registration required)

3:30 p.m.–5:30 p.m. C90 Behavioral Neurology II: Memory and Praxis

C91 Neuro-rheumatology: C92 C93 C94 C95 C96 C97

Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease II Neuroimaging for the General Neurologist II: Brain and Spine Boston City Hospital: The Cradle of American Neurology Part II Child Neurology III: Headache, TBI/Post-concussion Common Spine Disorders II: Treatment Infections of the Nervous System III: Advanced Topics in Infectious Neurology The Dystonias: Diagnosis, Treatment, and Update on Causes

based Approach to Neuroimaging

C106 Case Studies: Unusual Movement Disorders C107 Case Studies: Unusual Diagnostic and Management of Cases in Neuromuscular Disease C108 Case Studies in the ICU C109 Case Studies: How to Analyze Spells by Video-EEG C110 Case Studies: Challenging Headache Cases

Tuesday, April 25 6:30 a.m.–8:30 a.m.

2017 Run/Walk for Brain Research $ (registration required)

7:00 a.m.–9:00 a.m. C111 Principles of Genomic Medicine:

Clinical Exome Sequencing in Neurologic Disease C112 Stroke in Young Adults and Women C113 Neuroimaging Biomarkers Across the Dementia Spectrum C114 Therapy of Movement Disorders: A Case-based Approach C115 The Burden of Epilepsy: Managing Comorbidities and Quality of Life C116 Multiple Sclerosis Therapy: Symptom Management C117 The Palliative Care Guide in Neurology: Best Practice Guidelines in Communication, Symptom Management, and End of Life Care of Patients with Brain Tumors and Other Life Limiting Neurological Disorders C118 Nystagmus and Saccadic Intrusions Made Simple C119 Management of Migraine and Psychiatric Comorbidities C120 Mastering EMG Waveform Recognition Skills in Just Two Hours!

9:15 a.m.–11:30 a.m.

Clinical Trials Plenary Session 11:30 a.m.–4:00 p.m.

Exhibit Hall 1:00 p.m.–3:00 p.m. C121 Small Fiber Neuropathies: Sensory, Autonomic, and Both I: Focus on Autonomic Nervous System

C122 Neurology Update III:

Neuromuscular, Dementia, and Stroke C123 Myelopathies I: Inflammatory and Vascular Etiologies C124 Unilateral Neglect and Anosognosia: Chalk Talk C125 Nonmotor Manifestations of Parkinson’s Disease I C126 Critical Care EEG Monitoring C127 Neuroendocrine Update: Nuts and Bolts of What You Need to Know C128 Sleep Apnea and Related Disorders Over the Lifecycle: What Neurologists Need to Know C129 Pediatric Neuro-ophthalmology Update C130 Eponymous Women in Neurology I C131 Hot Topics in Headaches and Related Disorders I: Migraine Pathophysiology, Brain Imaging, and Therapeutic Advances C132 Developing the Treatments of Tomorrow I: Taking Molecules from Lab to Human N4 Neuroscience in the Clinic: Zika Virus: The Global Outbreak of a Neurotropic Virus

1:00 p.m.–5:00 p.m. C133 L The Most Important Tool in Your

Black Bag: Gallup StrengthsFinder™ Education Workshop $ (registration required) C134 L Advanced Leadership Training: Life-after-the-Limelights

1:00 p.m.–5:30 p.m. C135 Neuromuscular Ultrasound Skills Workshop $ (registration required)

3:30 p.m.–5:30 p.m. C136 Small Fiber Neuropathies:

Sensory, Autonomic, and Both II: Focus on Sensory Nervous System C137 Neurology Update IV: Multiple Sclerosis, Dizziness, and Autoimmune Encephalopathies C138 Myelopathies II: Symptom Management and Rehabilitation C139 Behavioral Neurology: A Case-based Approach C140 Nonmotor Manifestations of Parkinson’s Disease II C141 Acute and Chronic Clinical Epilepsy Update Explained in 6 Cases C142 Pediatric MS: Diagnosis and Treatment C143 Non-Neuro-oncology: Case-based Palliative Care Throughout the Continuum of Disease C144 Approaching the Management of Common Sleep Disorders: Case-based Review for the Nonsleep Specialist C145 Hot Topics in Neurologic Practice: Managing the Patient Experience in 2017 and Beyond C146 Eponymous Women in Neurology II C147 Hot Topics in Headaches and Related Disorders II: Unusual Headaches, Childhood Headaches, and Obesity C148 Developing the Treatments of Tomorrow II: Clinical Trials in Neurology

C150 Neurological Intensive Care: The

Essentials C151 Neuro-ophthalmology I: Visual Loss, Optic Neuropathies, and Papilledema C152 Clinical Pearls: Learning from Complex Cases—Simple Lessons that Apply to Everyday Problems C153 Alzheimer’s Dementia: Diagnosis and Treatment C154 Autism Spectrum Disorders— What We Know and Where We Are Going C155 Controversies in Stroke Therapy C156 Rehabilitation in Neurology C157 Lumbar Radiculopathy, Lumbar Spinal Stenosis, Low Back Pain, and Failed Back Syndrome

9:15 a.m.–11:30 a.m.

Frontiers in Neuroscience Plenary Session 11:30 a.m.–3:00 p.m.

Exhibit Hall 1:00 p.m.–3:00 p.m. C158 Comprehensive Migraine Education

Program I: Diagnosis, Risk Factors, and Neurobiology C159 Neurological Intensive Care II: From the Brain to the Muscles C160 Neuro-ophthalmology II: Optic Neuritis, Visual Fields, and Anisocoria C161 Bedside Evidence-based Medicine: How to Find and Deconstruct Articles in Order to Take Care of Patients I C162 Continuum ® Test Your Knowledge: A Multiple-choice Question Review I C163 An Introduction to Research in Medical Education C164 Evaluation and Management of Autonomic Disorders I: Autonomic Testing, Failure, and Peripheral Neuropathies C165 Clinical Neurology for Advanced Practice Providers I C166 Circadian Rhythm Disorders: Implications for Neurology C167 Autoimmune Neurology I Basics and Beyond: Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes of the CNS and PNS C168 Neuroimaging for the General Neurologist I: Spine and Peripheral Nerve C169 Core Concepts in Pain Management I: Refractory Neuropathic Pain—Practical Pharmacologics, Advances in Neuromodulation, and a Balanced Look at Cannabinoids C170 Sports Concussion Skills Workshop I: Event Coverage Skills $ (registration required) N5 Neuroscience in the Clinic: Stress and Neurologic Diseases: Effects Through the Neuroendocrine System

1:00 p.m.–5:00 p.m. C171 L The Most Important Tool in Your

Black Bag: Gallup StrengthFinders™ Assessment: Advanced Workshop $ (registration required)

Wednesday, April 26

1:00 p.m.–5:30 p.m.

7:00 a.m.–9:00 a.m.

C172 EMG Skills Workshop: Basic

C149 Low and High Pressure Headache:

Clinical Presentation and Approach to Evaluation and Management

$ (registration required)

3:30 p.m.–5:30 p.m.

9:15 a.m.–11:30 a.m.

C226 How to Integrate Sleep Medicine

C173 Comprehensive Migraine

Controversies in Neurology Plenary Session

C227 Borderlands of Neurology and

1:00 p.m.–3:00 p.m.

of Neuropsychiatric Symptoms in Neurocognitive Disorders C229 Emerging Therapies in Epilepsy C230 Eye Movement Disorders: A Systematic Approach to the Evaluation of Diplopia

Education Program II: Behavioral and Psychological Aspects, Preventative Pharmacology, and Treatment Advances C174 Neurological Intensive Care III: Vascular Diseases C175 Neuro-ophthalmology III: Diplopia, Ocular Motility Disorders, and Nystagmus C176 Bedside Evidence-based Medicine: How to Find and Deconstruct Articles in Order to Take Care of Patients II C177 Continuum ® Test Your Knowledge: A Multiple-choice Question Review II C178 Biomarkers in Dementia C179 Treatments for Drug-resistant Epilepsy: An Update C180 Evaluation and Management of Autonomic Disorders II: Diagnostic Approach and Treatments for Dysautonomia C181 Clinical Neurology for Advanced Practice Providers II C182 Autoimmune Neurology II Advanced: Autoimmune Encephalitis—At the Frontiers of Neuroscience C183 Neuroimaging for the General Neurologist II: Spine and Peripheral Nerve C184 Core Concepts in Pain Management II: Safe Opioid Prescribing— Practical Considerations, Unintended Consequences, and Legal Issues C185 Sports Concussion Skills Workshop II: Office-based Skills $ (registration required) N6 Neuroscience in the Clinic: Functional Recovery in Neurology and Neuroscience

C198 Functional Neurologic Disorders I:

Movement, Non-epileptic Seizures, and MS-like Disorders C199 Clinical EEG II: Focal, Diffuse, and Epileptiform Abnormalities in Adults C200 Therapy in Neurology I: Multiple Sclerosis and Headache C201 Multiple Sclerosis Overview I: Clinical Pearls C202 Higher Cortical Visual Disorders: Case-based Review C203 Hyperkinetic Movement Disorders: Videodiagnosis and Treatment C204 Peripheral Neuropathy II: Diabetic and Inherited Neuropathies C205 Neurologic Complications in Adults with Down Syndrome C206 Neurologic Case Studies in Pregnancy I: Stroke and Headache C207 Severe TBI: From ICU to Rehabilitation C208 A Case-based Approach to Acute CNS Infections C209 Clinical Usefulness of Botulinum Toxin for Spasticity Skills Workshop $ (registration required)

into Your Child Neurology Practice Internal Medicine: Chalk Talk

C228 Assessment and Management

9:15 a.m.–11:30 a.m.

Neurology Year in Review Plenary Session 1:00 p.m.–3:00 p.m. C231 Therapy in Neurology III:

7:00 p.m.–9:30 p.m.

C213 Therapy in Neurology II: Epilepsy

Commitment to Cures

C214 Multiple Sclerosis Overview II:

Neuromuscular Disease and Neuro-infectious Disease C232 Movement Disorders for the General Neurologist II: Tremor, Drug-induced Movement Disorders, RLS, and Ataxia C233 Multiple Sclerosis: A Case-based Approach C234 Sleep for the Practicing Neurologist I: Is it Narcolepsy or Something Else? Diagnostic and Management Challenges in the Central Disorders of Hypersomnolence C235 Neck Pain, Cervical Spinal Stenosis, Cervical Radiculopathy, and Cervical Spondylotic Myelopathy C236 Assessment of Rapidly Progressive Dementias I: Overview, Prion Diseases, and Neurodegenerative Rapidly Progressive Dementia C237 Emergency Neurology I: Evaluation of Coma, Meningitis, and Viral Encephalitis in the Emergency Room N8 Neuroscience in the Clinic: Afferent and Efferent Visual Pathway Manifestations of Neurodegenerative Diseases: Implications for Diagnosis and Treatment

Thursday, April 27

C215 Canalith Repositioning for Benign

1:00 p.m.–5:30 p.m.

7:00 a.m.–9:00 a.m. C186 Chronic Traumatic Encephalopathy: Update

C187 Mitochondrial Disorders in

Neurology C188 Clinical EEG I: Normal EEG, Normal Variants, and How to Avoid Overreading EEGs C189 Cognitive Psychology of Neurologic Errors: Why Do Neurologists Make Errors? C190 Multiple Sclerosis Overview: Basic and Translational Science C191 A Case-Based Approach to Neuro-ophthalmology: What Went Wrong? C192 Paroxysmal Movement Disorders C193 Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies C194 Basic Principles of Brain Tumors: For Practice and for Certification C195 Stroke Team Action Therapy (STAT): Current State of the Art and New Frontiers C196 Emergency and Inpatient Management of Migraine and Other Headache Disorders C197 Interpreting Sleep Study Procedure(s), Data, and Reports: What the Non-sleep Specialist Needs to Know

1:00 p.m.–5:00 p.m. C210 L Being A Resilient Leader:

How Do You Lead the Change?

3:30 p.m.–5:30 p.m. C211 Functional Neurologic Disorders II: Management, CBT, and Inpatient Therapeutic Strategies

C212 Clinical EEG III: Pediatric and Neonatal

and Neuro-oncology Clinical Advances

Paroxysmal Positional Vertigo C216 Balance and Gait Disorders C217 Peripheral Neuropathy III: Genetic Testing and Next Generation Sequencing C218 Cutting Edge Neuro-oncology— Understanding Current Trends C219 Neurologic Case Studies in Pregnancy II: Epilepsy and Neuroophthalmology C220 Memory Disorders: A Case-based Approach C221 Emerging Approaches to Biosensing for the Diagnosis and Management of Neurological Disease N7 Neuroscience in the Clinic: Novel Therapeutic Targets in Critical Care Neurology: Intracerebral and Intraventricular Hemorrhage

Friday, April 28 7:00 a.m.–9:00 a.m. C222 The Global Burden of Neurologic Diseases

C223 Movement Disorders for the

General Neurologist I: Diagnosis and Management of Parkinsonian Disorders C224 Controversies in Multiple Sclerosis Therapy C225 Update on Medical Management of Stroke

C238 Epilepsy Skills Workshop $ (registration required)

3:30 p.m.–5:30 p.m. C239 Therapy in Neurology IV:

Movement Disorders and Cerebrovascular Disease C240 Movement Disorders for the General Neurologist III: Chorea, Dystonia, Myoclonus, Stereotypes, and Tics C241 Update on Endovascular Treatment of Acute Stroke and Cerebrovascular Diseases C242 Sleep for the Practicing Neurologist II: Night Fighting: Sleep Related Hypermotor Epilepsy, Sleepwalking, and Dream Enactment C243 Assessment of Rapidly Progressive Dementias II: Autoimmune Encephalopathies and Infections Presenting as Rapidly Progressive Dementia C244 Emergency Neurology II: Consultations in the General ICU C245 Now You See It, Now You Know It—Pathognomonic Neuroophthalmology Findings

5:30 p.m.–7:00 p.m.

Closing Party Happy Hour

Annual Meeting Mobile App Now Available Tap into the meeting from anywhere and start planning your 2017 experience: • View and customize your program schedule • Access program syllabi and slide materials • Access program evaluations • Find room locations • Get hotel information • Access information about Boston Available for iPhone®, iPad®, or Android® Sponsored by:

AAN.com/view/app

Saturday, April 22 8:00 a.m.–10:00 a.m. C1 C2 C3 C4

The Neurology of Social Behavior ��30 Parkinson’s Disease Update ��80 Status Epilepticus ��44 Multiple Sclerosis Essentials ��88

8:00 a.m.–12:00 p.m. C5

Resident Basic Science I: Neuroanatomy—All the Lesions ��125

8:00 a.m.–5:00 p.m. C6

C7 C8 C9

Early Career Research Training Symposium: A Roadmap to Academic Success for Residents and Fellows (registration required) ��126 Neurology MOC Prep Course $ (registration required) ��51 L Clerkship and Program Directors Leadership Academy (registration required) ��75 L Women in Leadership $ (registration required) ��76

10:30 a.m.–12:30 p.m. C10 Making Sure You Get Paid Under the C11 C12 C13 C14

New Health Care Laws ��120 Neuromyelitis Optica Spectrum Disorders ��88 Neuromuscular Junction Disorders I: Myasthenia Gravis, Ocular and MuSK Myasthenia ��98 Neurologic Complications of Medical Disease ��51 Concussion: From Mechanisms to Management ��93

16 2017 AAN Annual Meeting Early Look

1:00 p.m.–3:00 p.m. C15 Practical Training in Injection Techniques

in the Treatment of Headache Disorders Skills Workshop $ (registration required) ��68

1:00 p.m.–5:00 p.m. C16 Resident Basic Science II: Neuropathology ��126

2:00 p.m.–4:00 p.m. C17 How Is Your Patient Really Doing? C18 C19 C20 C21 C22

Patient Reported Scales, Tools and Shared Decision Making ��121 Vascular Cognitive Impairment and Dementia: Current Status and Future ��30 Neuromuscular Junction Disorders II: Toxins, Lambert-Eaton Syndrome and Less Common Disorders of Neuromuscular Transmission ��99 Neurologic Complications of Medical and Surgical Therapies ��52 Concussion: Evaluation and Management in the Acute and Chronic Phases ��94 It’s a Bird, It’s a Plane, It’s… The Doctor Who Cured my Benign Paroxysmal Positional Vertigo ��108

4:00 p.m.–4:30 p.m.

AAN Business Meeting 5:00 p.m.–6:30 p.m.

Hot Topics Plenary Session

Sunday, April 23 7:00 a.m.–9:00 a.m. C23 Using Sleep Medicine to Help Solve C24 C25 C26 C27 C28 C29 C30 C31 C32

Difficult Neurologic Cases ��132 Child Neurology: A Case-based Approach ��41 Cerebellar and Afferent Ataxias: Diagnosis and Management ��80 Clinical EMG I: Principles and Practice of NCS and Needle EMG ��99 Differential Diagnosis of Neurologic Infections ��73 Advances in Neurogenetics ��52 Clinical Epilepsy I: Basics ��45 Cerebrovascular Disease I: Prevention ��37 Advanced Neurologic Coding ��121 Emergency Room Neuro-ophthalmology ��109

9:15 a.m.–12:00 p.m.

Presidential Plenary Session 11:30 a.m.–4:00 p.m.

Exhibit Hall

11:30 a.m.–1:30 p.m. NEW Exhibit Hall Opening Lunch Reception

1:00 p.m.–3:00 p.m. C33 Non-Alzheimer’s Dementia I: Frontotemporal C34

C35 C36 C37 C38 C39

C40 C41 C42 C43 C44 C45 N1

Dementias and Chronic Traumatic Encephalopathy ��30 Introduction to Primary Headache Disorders I: Migraine and Other Primary Headaches Including Tension-type, Hypnic, Primary Stabbing, and Nummular Headache Syndromes ��69 Deep Brain Stimulation I: Basic Principles and Programming in Movement Disorders ��80 Multiple Sclerosis Therapy: Disease-modifying Treatment I ��88 Clinical EMG II: Neuromuscular Junction Testing and Quantitative EMG ��99 Case Studies: Neurologic Consultations in Cancer Patients I �� 106 So You’ve Diagnosed Your Patient with a Neuroinfectious Disease, Now What? Practical Pearls in the Treatment and Management of Neuroinfectious Diseases ��73 Neurology Update I: Epilepsy, Headache, and Neurologic Infections ��53 Clinical Epilepsy II: Considerations Across the Age Span—Pediatrics, Pregnancy, and Elderly ��45 Cerebrovascular Disease II: Hemorrhagic Stroke ��38 Introduction to Clinical Research and Methods ��127 Genomic Neurology Workshop: Developing Practical Knowledge of Tools and Concepts Through Case Studies I ��53 Navigating the World of Mobile Health ��121 Neuroscience in the Clinic: Neurobiology and Treatment of Disorders of Language and Action

1:00 p.m.–5:00 p.m. C46 Resident Basic Science III: Neuropharmacology ��127 C47 L Gender Issues in Leadership ��77 C48 L Leadership Challenges in Practice ��77

1:00 p.m.–5:30 p.m. C49 Clinical Uses of Botulinum Toxin for Dystonia

Skills Workshop $ (registration required) ��81 C50 Neuro-ophthalmology and Neurovestibular Exam Lab Skills Workshop $ (registration required) ��109

3:30 p.m.–5:30 p.m. C51 Non-Alzheimer’s Dementia II: Lewy Body Dementias C52

C53 C54 C55 C56 C57 C58 C59 C60 C61 N2

and Other Parkinsonian Dementias ��31 Introduction to Primary Headache Disorders II: Trigeminal Autonomic Cephalalgias and Other Primary Headaches Including New Daily Persistent Headache, Cough, Exercise, and Primary Thunderclap Headaches ��69 Deep Brain Stimulation II: Advanced Management in Movement Disorders and Applications Beyond Movement Disorders ��82 Multiple Sclerosis Therapy: Disease-modifying Treatment II ��89 Clinical EMG III: Nerve Conduction Criteria and Electrodiagnostic Approaches ��100 Case Studies: Neurologic Consultations in Cancer Patients II ��106 Neurology Update II: Movement, Spine, and Autonomic Neurology ��54 Clinical Epilepsy III: Advanced (Status, Beyond AED, Video EEG) ��46 Cerebrovascular Disease III: Acute Ischemic Stroke ��38 Precision Neurology: The Promise and Perils of Personalized Medicine in the Genomic Era ��128 Genomic Neurology Workshop: Developing Practical Knowledge of Tools and Concepts Through Case Studies II ��54 Neuroscience in the Clinic: Child Neurology: Neurologic Disorder Through a Lifespan

6:00 p.m.–10:00 p.m.

Opening Party ��142 6:00 p.m.–8:00 p.m. Neurobowl®

8:30 p.m.–9:15 p.m. Trinity Irish Dance Company

9:15 p.m.–10:00 p.m. DJ Music and Dancing

Fast and easy registration · AAN.com/view/AM17 17

Monday, April 24 7:00 a.m.–9:00 a.m. C62 Mild Cognitive Impairment: Implications for Clinicians ��31 C63 CNS Toxicities ��55 C64 ICD-10-CM: How to Optimize for Accurate C65 C66 C67 C68 C69 C70 C71 C72 C73 C74

Diagnosis and Reimbursement ��122 Child Neurology I: Pediatric Stroke, MS/Autoimmune ��42 Neuro-oncologic Emergencies ��107 Infections of the Nervous System I: Diagnostic Testing of Neurological Infections �� 74 Approach to the Shaky Patient ��82 Therapy of Neuromuscular Disease: ALS, Inflammatory Neuropathies and Myopathies, and Myasthenia Gravis ��100 Sports Neurology: Enhancing Athletic Performance ��94 Hot Topics in Sleep Neurology ��132 Gender-specific Care for Neurological Disorders ��55 Current Management of Incidental and Asymptomatic Cerebrovascular Lesions ��38 Annual A.B. Baker Program: Focus on Professionalism ��128

9:15 a.m.–11:30 a.m.

Contemporary Clinical Issues Plenary Session 11:30 a.m.–6:00 p.m.

Exhibit Hall

4:30 p.m.–6:00 p.m. NEW Exhibit Hall Networking Reception

12:00 p.m.–5:30 p.m. C75 Clerkship and Program Directors Conference:

Wellness and Burnout During Training ��128

1:00 p.m.–3:00 p.m. C76 L Mentoring… Growing the Next Generation of Neurologist $ (registration required) ��77

C77 Behavioral Neurology I:

Network Anatomy of Behavior and Language ��32

C78 Neuro-rheumatology: Neurological Manifestations

C87 How to Run a Practice: N3

Business Strategies for Neurology Private Practices, Academic Centers, and the Future ��122 Neuroscience in the Clinic: Cutting Edge Concussion Data from the NCAA-DoD Grand Alliance

1:00 p.m.–5:00 p.m. C88 L Improving Your Leadership Skills:

A Practical Approach (registration required) ��78

1:00 p.m.–5:30 p.m. C89 Neurophysiologic Intraoperative Monitoring

Skills Workshop $ (registration required) ��46

3:30 p.m.–5:30 p.m. C90 Behavioral Neurology II: Memory and Praxis ��32 C91 Neuro-rheumatology: C92 C93 C94 C95 C96 C97 C98 C99 C100 C101 C102

Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease II ��90 Neuroimaging for the General Neurologist II: Brain and Spine ��57 Boston City Hospital: The Cradle of American Neurology Part II ��57 Child Neurology III: Headache, TBI/Post-concussion ��42 Common Spine Disorders II: Treatment �� 115 Infections of the Nervous System III: Advanced Topics in Infectious Neurology �� 74 The Dystonias: Diagnosis, Treatment, and Update on Causes ��83 Clinical Approach to Muscle Disease II: Inflammatory Myopathies and Muscle Pathology ��101 Therapeutic Temperature Modulation in the ICU ��39 Neuro-otology II: Diagnosis and Treatment of Nuanced Causes of Dizziness �� 110 Drug-induced Neurologic Emergencies ��58 Business Strategies for Payer Negotiations and/or How to Go off the Grid ��123

6:00 p.m.–9:00 p.m.

of Systemic Inflammatory and Autoimmune Disease I ��89

Faculty and Trainee Reception

Brain and Spine ��56

6:00 p.m.–9:00 p.m.

C79 Neuroimaging for the General Neurologist I:

C80 Child Neurology II: Epilepsy and Neuromuscular ��42 C81 Common Spine Disorders I: Evaluation �� 115 C82 Infections of the Nervous System II: Neuro-ID Emergencies ��74

C103 Case Studies: Dementia ��32 C104 Case Studies: Multiple Sclerosis ��90 C105 Test Your Knowledge: A Case-based Approach to Neuroimaging ��58

C83 Hot Topics and Controversies in Parkinson’s Disease ��82 C84 Clinical Approach to Muscle Disease I: Muscle

C106 Case Studies: Unusual Movement Disorders ��83 C107 Case Studies: Unusual Diagnostic and Management

C85 Boston City Hospital:

C108 Case Studies in the ICU ��95 C109 Case Studies: How to Analyze Spells by Video-EEG ��46 C110 Case Studies: Challenging Headache Cases ��70

Disorders and Rhabdomyolysis ��100 The Cradle of American Neurology Part I ��56

C86 Neuro-otology I:

The Common Peripheral Vestibular Disorders �� 110

18 2017 AAN Annual Meeting Early Look

of Cases in Neuromuscular Disease ��101

Tuesday, April 25 6:30 a.m.–8:30 a.m.

2017 AAN Run/Walk for Brain Research $ (registration required) ��142

7:00 a.m.–9:00 a.m. C111 Principles of Genomic Medicine: C112 C113 C114 C115 C116 C117

C118 C119 C120

Clinical Exome Sequencing in Neurologic Disease ��58 Stroke in Young Adults and Women ��39 Neuroimaging Biomarkers Across the Dementia Spectrum ��33 Therapy of Movement Disorders: A Case-based Approach ��83 The Burden of Epilepsy: Managing Comorbidities and Quality of Life ��47 Multiple Sclerosis Therapy: Symptom Management ��90 The Palliative Care Guide in Neurology: Best Practice Guidelines in Communication, Symptom Management, and End of Life Care of Patients with Brain Tumors and Other Life Limiting Neurological Disorders ��107 Nystagmus and Saccadic Intrusions Made Simple �� 110 Management of Migraine and Psychiatric Comorbidities ��70 Mastering EMG Waveform Recognition Skills in Just Two Hours! ��102

9:15 a.m.–11:30 a.m.

Clinical Trials Plenary Session 11:30 a.m.–4:00 p.m.

Neuroscience in the Clinic: Zika Virus: The Global Outbreak of a Neurotropic Virus

1:00 p.m.–5:00 p.m. C133 L The Most Important Tool in Your Black Bag:

Gallup StrengthsFinder™ Education Workshop $ (registration required) ��78 C134 L Advanced Leadership Training: Life-after-the-Limelights ��79

1:00 p.m.–5:30 p.m. C135 Neuromuscular Ultrasound

Skills Workshop $ (registration required) ��102

3:30 p.m.–5:30 p.m. C136 Small Fiber Neuropathies: Sensory, Autonomic, and

Both II: Focus on Sensory Nervous System ��103

C137 Neurology Update IV: Multiple Sclerosis, Dizziness,

and Autoimmune Encephalopathies ��59

C138 Myelopathies II:

Symptom Management and Rehabilitation �� 116

C139 Behavioral Neurology: A Case-based Approach ��34 C140 Nonmotor Manifestations of Parkinson’s Disease II ��84 C141 Acute and Chronic Clinical Epilepsy Update C142 C143

Exhibit Hall

C144

1:00 p.m.–3:00 p.m.

C145

C121 Small Fiber Neuropathies: Sensory, Autonomic, and C122 C123 C124 C125 C126 C127 C128 C129 C130 C131 C132

Both I: Focus on Autonomic Nervous System ��102 Neurology Update III: Neuromuscular, Dementia, and Stroke ��59 Myelopathies I: Inflammatory and Vascular Etiologies �� 115 Unilateral Neglect and Anosognosia: Chalk Talk ��33 Nonmotor Manifestations of Parkinson’s Disease I ��84 Critical Care EEG Monitoring ��47 Neuroendocrine Update: Nuts and Bolts of What You Need to Know ��59 Sleep Apnea and Related Disorders Over the Lifecycle: What Neurologists Need to Know ��133 Pediatric Neuro-ophthalmology Update �� 111 Eponymous Women in Neurology I ��129 Hot Topics in Headaches and Related Disorders I: Migraine Pathophysiology, Brain Imaging, and Therapeutic Advances ��71 Developing the Treatments of Tomorrow I: Taking Molecules from Lab to Human ��130

C146 C147 C148

Explained in 6 Cases ��48 Pediatric MS: Diagnosis and Treatment ��91 Non-Neuro-oncology: Case-based Palliative Care Throughout the Continuum of Disease �� 118 Approaching the Management of Common Sleep Disorders: Case-based Review for the Non-sleep Specialist ��133 Hot Topics in Neurologic Practice: Managing the Patient Experience in 2017 and Beyond ��123 Eponymous Women in Neurology II ��130 Hot Topics in Headaches and Related Disorders II: Unusual Headaches, Childhood Headaches, and Obesity ��71 Developing the Treatments of Tomorrow II: Clinical Trials in Neurology ��131

Fast and easy registration · AAN.com/view/AM17 19

Wednesday, April 26 7:00 a.m.–9:00 a.m. C149 Low and High Pressure Headache: C150 C151 C152 C153 C154 C155 C156 C157

Clinical Presentation and Approach to Evaluation and Management ��71 Neurological Intensive Care: The Essentials ��95 Neuro-ophthalmology I: Visual Loss, Optic Neuropathies, and Papilledema �� 111 Clinical Pearls: Learning from Complex Cases—Simple Lessons that Apply to Everyday Problems ��60 Alzheimer’s Dementia: Diagnosis and Treatment ��34 Autism Spectrum Disorders—What We Know and Where We Are Going ��43 Controversies in Stroke Therapy ��39 Rehabilitation in Neurology �� 116 Lumbar Radiculopathy, Lumbar Spinal Stenosis, Low Back Pain, and Failed Back Syndrome �� 119

9:15 a.m.–11:30 a.m.

Frontiers in Neuroscience Plenary Session 11:30 a.m.–3:00 p.m.

Exhibit Hall

1:00 p.m.–3:00 p.m. C158 Comprehensive Migraine Education Program I:

Diagnosis, Risk Factors, and Neurobiology ��72

C159 Neurological Intensive Care II:

From the Brain to the Muscles ��96

C160 Neuro-ophthalmology II: C161 C162 C163 C164 C165 C166 C167 C168 C169

C170

Optic Neuritis, Visual Fields, and Anisocoria �� 112 Bedside Evidence-based Medicine: How to Find and Deconstruct Articles in Order to Take Care of Patients I �� 124 Continuum ® Test Your Knowledge: A Multiple-choice Question Review I ��60 An Introduction to Research in Medical Education ��131 Evaluation and Management of Autonomic Disorders I: Autonomic Testing, Failure, and Peripheral Neuropathies ��103 Clinical Neurology for Advanced Practice Providers I �� 124 Circadian Rhythm Disorders: Implications for Neurology ��133 Autoimmune Neurology I Basics and Beyond: Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes of the CNS and PNS ��61 Neuroimaging for the General Neurologist I: Spine and Peripheral Nerve ��61 Core Concepts in Pain Management I: Refractory Neuropathic Pain—Practical Pharmacologics, Advances in Neuromodulation, and a Balanced Look at Cannabinoids �� 119 Sports Concussion Skills Workshop I:

20 2017 AAN Annual Meeting Early Look

Event Coverage Skills $ (registration required) ��96 Neuroscience in the Clinic: Stress and Neurologic Diseases: Effects Through the Neuroendocrine System

1:00 p.m.–5:00 p.m. C171 L The Most Important Tool in Your Black Bag: Gallup

StrengthFinders™ Assessment: Advanced Workshop $ (registration required) ��79

1:00 p.m.–5:30 p.m. C172 EMG Skills Workshop: Basic $ (registration required) ��104

3:30 p.m.–5:30 p.m. C173 Comprehensive Migraine Education Program II: C174 C175 C176 C177 C178 C179 C180 C181 C182 C183 C184 C185 N6

Behavioral and Psychological Aspects, Preventative Pharmacology, and Treatment Advances ��72 Neurological Intensive Care III: Vascular Diseases ��96 Neuro-ophthalmology III: Diplopia, Ocular Motility Disorders, and Nystagmus �� 112 Bedside Evidence-based Medicine: How to Find and Deconstruct Articles in Order to Take Care of Patients II �� 124 Continuum ® Test Your Knowledge: A Multiple-choice Question Review II ��61 Biomarkers in Dementia ��34 Treatments for Drug-resistant Epilepsy: An Update ��48 Evaluation and Management of Autonomic Disorders II: Diagnostic Approach and Treatments for Dysautonomia ��104 Clinical Neurology for Advanced Practice Providers II ��125 Autoimmune Neurology II Advanced: Autoimmune Encephalitis—At the Frontiers of Neuroscience ��62 Neuroimaging for the General Neurologist II: Spine and Peripheral Nerve ��62 Core Concepts in Pain Management II: Safe Opioid Prescribing—Practical Considerations, Unintended Consequences, and Legal Issues ��120 Sports Concussion Skills Workshop II: Office-based Skills $ (registration required) ��97 Neuroscience in the Clinic: Functional Recovery in Neurology and Neuroscience

7:00 p.m.–9:30 p.m.

Commitment to Cures $ (registration required)

Thursday, April 27 7:00 a.m.–9:00 a.m. C186 Chronic Traumatic Encephalopathy: Update ��35 C187 Mitochondrial Disorders in Neurology ��63 C188 Clinical EEG I: C189 C190 C191 C192 C193 C194 C195 C196 C197

Normal EEG, Normal Variants, and How to Avoid Over-reading EEGs ��48 Cognitive Psychology of Neurologic Errors: Why Do Neurologists Make Errors? ��63 Multiple Sclerosis Overview: Basic and Translational Science ��91 A Case-Based Approach to Neuro-ophthalmology: What Went Wrong? �� 113 Paroxysmal Movement Disorders ��85 Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies ��104 Basic Principles of Brain Tumors: For Practice and for Certification ��108 Stroke Team Action Therapy (STAT): Current State of the Art and New Frontiers ��40 Emergency and Inpatient Management of Migraine and Other Headache Disorders ��73 Interpreting Sleep Study Procedure(s), Data, and Reports: What the Non-sleep Specialist Needs to Know ��134

9:15 a.m.–11:30 a.m.

1:00 p.m.–5:00 p.m. C210 L Being A Resilient Leader:

How Do You Lead the Change? ��79

3:30 p.m.–5:30 p.m. C211 Functional Neurologic Disorders II:

Management, CBT, and Inpatient Therapeutic Strategies ��65

C212 Clinical EEG III: Pediatric and Neonatal ��49 C213 Therapy in Neurology II: Epilepsy and Neuro-oncology ��65 C214 Multiple Sclerosis Overview II: Clinical Advances ��92 C215 Canalith Repositioning for Benign Paroxysmal Positional Vertigo �� 113 C216 Balance and Gait Disorders ��86 C217 Peripheral Neuropathy III: Genetic Testing and Next Generation Sequencing ��105 C218 Cutting Edge Neuro-oncology—Understanding Current Trends ��108 C219 Neurologic Case Studies in Pregnancy II: Epilepsy and Neuro-ophthalmology ��65 C220 Memory Disorders: A Case-based Approach ��35 C221 Emerging Approaches to Biosensing for the Diagnosis and Management of Neurological Disease ��66 N7 Neuroscience in the Clinic: Novel Therapeutic Targets in Critical Care Neurology: Intracerebral and Intraventricular Hemorrhage

Controversies in Neurology Plenary Session 1:00 p.m.–3:00 p.m. C198 Functional Neurologic Disorders I:

Movement, Non-epileptic Seizures, and MS-like Disorders ��63 C199 Clinical EEG II: Focal, Diffuse, and Epileptiform Abnormalities in Adults ��49 C200 Therapy in Neurology I: Multiple Sclerosis and Headache ��64 C201 Multiple Sclerosis Overview I: Clinical Pearls ��92 C202 Higher Cortical Visual Disorders: Case-based Review �� 113 C203 Hyperkinetic Movement Disorders: Videodiagnosis and Treatment ��85 C204 Peripheral Neuropathy II: Diabetic and Inherited Neuropathies ��105 C205 Neurologic Complications in Adults with Down Syndrome ��43 C206 Neurologic Case Studies in Pregnancy I: Stroke and Headache ��64 C207 Severe TBI: From ICU to Rehabilitation �� 117 C208 A Case-based Approach to Acute CNS Infections ��75 C209 Clinical Usefulness of Botulinum Toxin for Spasticity Skills Workshop $ (registration required) ��85

Fast and easy registration · AAN.com/view/AM17 21

Friday, April 28 7:00 a.m.–9:00 a.m. C222 The Global Burden of Neurologic Diseases ��68 C223 Movement Disorders for the General Neurologist I:

Diagnosis and Management of Parkinsonian Disorders ��86

C224 Controversies in Multiple Sclerosis Therapy ��93 C225 Update on Medical Management of Stroke ��40 C226 How to Integrate Sleep Medicine into Your Child Neurology Practice ��135

C227 Borderlands of Neurology and Internal Medicine:

Chalk Talk ��66

C228 Assessment and Management of Neuropsychiatric

Symptoms in Neurocognitive Disorders ��36 C229 Emerging Therapies in Epilepsy ��50 C230 Eye Movement Disorders: A Systematic Approach to the Evaluation of Diplopia �� 114

9:15 a.m.–11:30 a.m.

C236 Assessment of Rapidly Progressive Dementias I:

Overview, Prion Diseases, and Neurodegenerative Rapidly Progressive Dementia ��36 C237 Emergency Neurology I: Evaluation of Coma, Meningitis, and Viral Encephalitis in the Emergency Room ��97 N8 Neuroscience in the Clinic: Afferent and Efferent Visual Pathway Manifestations of Neurodegenerative Diseases: Implications for Diagnosis and Treatment

1:00 p.m.–5:30 p.m. C238 Epilepsy Skills Workshop $ (registration required) ��50

3:30 p.m.–5:30 p.m. C239 Therapy in Neurology IV:

Movement Disorders and Cerebrovascular Disease ��67

Neurology Year in Review Plenary Session

C240 Movement Disorders for the General Neurologist III:

1:00 p.m.–3:00 p.m.

C241 Update on Endovascular Treatment of Acute Stroke

C231 Therapy in Neurology III:

Neuromuscular Disease and Neuro-infectious Disease ��67 C232 Movement Disorders for the General Neurologist II: Tremor, Drug-induced Movement Disorders, RLS, and Ataxia ��87 C233 Multiple Sclerosis: A Case-based Approach ��93 C234 Sleep for the Practicing Neurologist I: Is it Narcolepsy or Something Else? Diagnostic and Management Challenges in the Central Disorders of Hypersomnolence ��135 C235 Neck Pain, Cervical Spinal Stenosis, Cervical Radiculopathy, and Cervical Spondylotic Myelopathy �� 117

Chorea, Dystonia, Myoclonus, Stereotypes, and Tics ��87

and Cerebrovascular Diseases ��41 C242 Sleep for the Practicing Neurologist II: Night Fighting: Sleep Related Hypermotor Epilepsy, Sleepwalking, and Dream Enactment ��136 C243 Assessment of Rapidly Progressive Dementias II: Autoimmune Encephalopathies and Infections Presenting as Rapidly Progressive Dementia ��37 C244 Emergency Neurology II: Consultations in the General ICU ��98 C245 Now You See It, Now You Know It—Pathognomonic Neuro-ophthalmology Findings �� 114

5:30 p.m.–7:00 p.m.

Closing Party Happy Hour ��142

22 2017 AAN Annual Meeting Early Look

Annual Meeting Edition Planning for the 2017 AAN Annual Meeting—and earning 10 FREE self-assessment CME credits—has never been easier: Pre-test

Annual Meeting

Post-test

Take pre-test by

Attend Annual Meeting

Take post-test by

April 22, 2017

April 22–28, 2017

An AAN Member Exclusive—FREE to Members! AAN.com/view/NeuroSAEAM

July 29, 2017

Annual Meeting Session List by Topic AGING, DEMENTIA, COGNITIVE, AND BEHAVIORAL NEUROLOGY C1 The Neurology of Social Behavior ��30 C18 Vascular Cognitive Impairment and Dementia: Current Status and Future ��30

C33 Non-Alzheimer’s Dementia I: Frontotemporal

Dementias and Chronic Traumatic Encephalopathy ��30 Neuroscience in the Clinic: Neurobiology and Treatment of Disorders of Language and Action C51 Non-Alzheimer’s Dementia II: Lewy Body Dementias and Other Parkinsonian Dementias ��31 C62 Mild Cognitive Impairment: Implications for Clinicians ��31 C77 Behavioral Neurology I: Network Anatomy of Behavior and Language ��32 C90 Behavioral Neurology II: Memory and Praxis ��32 C103 Case Studies: Dementia ��32 C113 Neuroimaging Biomarkers Across the Dementia Spectrum ��33 C124 Unilateral Neglect and Anosognosia: Chalk Talk ��33 C139 Behavioral Neurology: A Case-based Approach ��34 C153 Alzheimer’s Dementia: Diagnosis and Treatment ��34 C178 Biomarkers in Dementia ��34 C186 Chronic Traumatic Encephalopathy: Update ��35 C202 Higher Cortical Visual Disorders: Case-based Review �� 113 C205 Neurologic Complications in Adults with Down Syndrome ��43 C207 Severe TBI: From ICU to Rehabilitation �� 117 C220 Memory Disorders: A Case-based Approach ��35 C228 Assessment and Management of Neuropsychiatric Symptoms in Neurocognitive Disorders ��36 C236 Assessment of Rapidly Progressive Dementias I: Overview, Prion Diseases, and Neurodegenerative Rapidly Progressive Dementia ��36 C243 Assessment of Rapidly Progressive Dementias II: Autoimmune Encephalopathies and Infections Presenting as Rapidly Progressive Dementia ��37

CEREBROVASCULAR DISEASE AND INTERVENTIONAL NEUROLOGY C30 C42 C59 C73

Cerebrovascular Disease I: Prevention ��37 Cerebrovascular Disease II: Hemorrhagic Stroke ��38 Cerebrovascular Disease III: Acute Ischemic Stroke ��38 Current Management of Incidental and Asymptomatic Cerebrovascular Lesions ��38 C99 Therapeutic Temperature Modulation in the ICU ��39 C112 Stroke in Young Adults and Women ��39 C155 Controversies in Stroke Therapy ��39 24 2017 AAN Annual Meeting Early Look

C195 Stroke Team Action Therapy (STAT): Current State of

the Art and New Frontiers ��40 C225 Update on Medical Management of Stroke ��40 C241 Update on Endovascular Treatment of Acute Stroke and Cerebrovascular Diseases ��41

CHILD NEUROLOGY AND DEVELOPMENTAL NEUROLOGY C24 Child Neurology: A Case-based Approach ��41 N2 Neuroscience in the Clinic: Child Neurology: Neurologic Disorder Through a Lifespan

C65 Child Neurology I: Pediatric Stroke, MS/Autoimmune ��42 C80 Child Neurology II: Epilepsy and Neuromuscular ��42 C94 Child Neurology III: Headache, TBI/Post-concussion ��42 C112 Stroke in Young Adults and Women ��39 C129 Pediatric Neuro-ophthalmology Update �� 111 C142 Pediatric MS: Diagnosis and Treatment ��91 C154 Autism Spectrum Disorders—What We Know and Where We Are Going ��43

C205 Neurologic Complications in Adults with Down

Syndrome ��43 C226 How to Integrate Sleep Medicine into Your Child Neurology Practice ��135 C244 Emergency Neurology II: Consultations in the General ICU ��98

EPILEPSY/ CLINICAL NEUROPHYSIOLOGY (EEG) C3 Status Epilepticus ��44 C29 Clinical Epilepsy I: Basics ��45 C41 Clinical Epilepsy II: Considerations Across the C58 C89 C109 C115 C126 C141 C179 C188 C199

Age Span—Pediatrics, Pregnancy, and Elderly ��45 Clinical Epilepsy III: Advanced (Status, Beyond AED, Video EEG) ��46 Neurophysiologic Intraoperative Monitoring Skills Workshop $ (registration required) ��46 Case Studies: How to Analyze Spells by Video-EEG ��46 The Burden of Epilepsy: Managing Comorbidities and Quality of Life ��47 Critical Care EEG Monitoring ��47 Acute and Chronic Clinical Epilepsy Update Explained in 6 Cases ��48 Treatments for Drug-resistant Epilepsy: An Update ��48 Clinical EEG I: Normal EEG, Normal Variants, and How to Avoid Over-reading EEGs ��48 Clinical EEG II: Focal, Diffuse, and Epileptiform Abnormalities in Adults ��49

C212 Clinical EEG III: Pediatric and Neonatal ��49 C229 Emerging Therapies in Epilepsy ��50 C238 Epilepsy Skills Workshop $ (registration required) ��50

GENERAL NEUROLOGY C7 C13 C20

C23 C28 C31

C40 C44 C57 C60 C61 C63 C72

C78 C79 C85 C92 C93 C101 C105 C111

C122

Neurology MOC Prep Course $ (registration required) ��51 Neurologic Complications of Medical Disease ��51 Neurologic Complications of Medical and Surgical Therapies ��52 Hot Topics Plenary Session Using Sleep Medicine to Help Solve Difficult Neurologic Cases ��132 Advances in Neurogenetics ��52 Advanced Neurologic Coding ��121 Presidential Plenary Session Neurology Update I: Epilepsy, Headache, and Neurologic Infections ��53 Genomic Neurology Workshop: Developing Practical Knowledge of Tools and Concepts Through Case Studies I ��53 Neurology Update II: Movement, Spine, and Autonomic Neurology ��54 Precision Neurology: The Promise and Perils of Personalized Medicine in the Genomic Era ��128 Genomic Neurology Workshop: Developing Practical Knowledge of Tools and Concepts Through Case Studies II ��54 CNS Toxicities ��55 Gender-specific Care for Neurological Disorders ��55 Contemporary Clinical Issues Plenary Session Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease I ��89 Neuroimaging for the General Neurologist I: Brain and Spine ��56 Boston City Hospital: The Cradle of American Neurology Part I ��56 Neuroimaging for the General Neurologist II: Brain and Spine ��57 Boston City Hospital: The Cradle of American Neurology Part II ��57 Drug-induced Neurologic Emergencies ��58 Test Your Knowledge: A Case-based Approach to Neuroimaging ��58 Principles of Genomic Medicine: Clinical Exome Sequencing in Neurologic Disease ��58 Clinical Trials Plenary Session Neurology Update III: Neuromuscular, Dementia, and Stroke ��59

$ = Additional Fee Required L = Leadership University

C127 Neuroendocrine Update:

Nuts and Bolts of What You Need to Know ��59 C137 Neurology Update IV: Multiple Sclerosis, Dizziness, and Autoimmune Encephalopathies ��59 C145 Hot Topics in Neurologic Practice: Managing the Patient Experience in 2017 and Beyond ��123 C152 Clinical Pearls: Learning from Complex Cases— Simple Lessons that Apply to Everyday Problems ��60 Frontiers in Neuroscience Plenary Session C162 Continuum ® Test Your Knowledge: A Multiple-choice Question Review I ��60 C167 Autoimmune Neurology I Basics and Beyond: Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes of the CNS and PNS ��61 C168 Neuroimaging for the General Neurologist I: Spine and Peripheral Nerve ��61 N5 Neuroscience in the Clinic: Stress and Neurologic Diseases: Effects Through the Neuroendocrine System C177 Continuum ® Test Your Knowledge: A Multiple-choice Question Review II ��61 C182 Autoimmune Neurology II Advanced: Autoimmune Encephalitis—At the Frontiers of Neuroscience ��62 C183 Neuroimaging for the General Neurologist II: Spine and Peripheral Nerve ��62 C187 Mitochondrial Disorders in Neurology ��63 C189 Cognitive Psychology of Neurologic Errors: Why Do Neurologists Make Errors? ��63 C190 Multiple Sclerosis Overview: Basic and Translational Science ��91 Controversies in Neurology Plenary Session C198 Functional Neurologic Disorders I: Movement, Non-epileptic Seizures, and MS-like Disorders ��63 C200 Therapy in Neurology I: Multiple Sclerosis and Headache ��64 C206 Neurologic Case Studies in Pregnancy I: Stroke and Headache ��64 C211 Functional Neurologic Disorders II: Management, CBT, and Inpatient Therapeutic Strategies ��65 C213 Therapy in Neurology II: Epilepsy and Neuro-oncology ��65 C219 Neurologic Case Studies in Pregnancy II: Epilepsy and Neuro-ophthalmology ��65 C221 Emerging Approaches to Biosensing for the Diagnosis and Management of Neurological Disease ��66 C222 The Global Burden of Neurologic Diseases ��68 C227 Borderlands of Neurology and Internal Medicine: Chalk Talk ��66 Neurology Year in Review Plenary Session C231 Therapy in Neurology III: Neuromuscular Disease and Neuro-infectious Disease ��67

Fast and easy registration · AAN.com/view/AM17 25

Annual Meeting Session List by Topic C237 Emergency Neurology I: Evaluation of Coma,

Meningitis, and Viral Encephalitis in the Emergency Room ��97 C239 Therapy in Neurology IV: Movement Disorders and Cerebrovascular Disease ��67 C244 Emergency Neurology II: Consultations in the General ICU ��98

GLOBAL HEALTH

Diagnostic Testing of Neurological Infections ��74 C82 Infections of the Nervous System II: Neuro-ID Emergencies ��74 C96 Infections of the Nervous System III: Advanced Topics in Infectious Neurology ��74 N4 Neuroscience in the Clinic: Zika Virus: The Global Outbreak of a Neurotropic Virus C208 A Case-based Approach to Acute CNS Infections ��75

C222 The Global Burden of Neurologic Diseases ��68

HEADACHE

C15 Practical Training in Injection Techniques in the

C34

C47 C48 C76

C52

C110 C119 C131 C147 C149 C158 C173 C196

Treatment of Headache Disorders Skills Workshop $ (registration required) ��68 Introduction to Primary Headache Disorders I: Migraine and Other Primary Headaches Including Tension-type, Hypnic, Primary Stabbing, and Nummular Headache Syndromes ��69 Introduction to Primary Headache Disorders II: Trigeminal Autonomic Cephalalgias and Other Primary Headaches Including New Daily Persistent Headache, Cough, Exercise, and Primary Thunderclap Headaches ��69 Case Studies: Challenging Headache Cases ��70 Management of Migraine and Psychiatric Comorbidities ��70 Hot Topics in Headaches and Related Disorders I: Migraine Pathophysiology, Brain Imaging, and Therapeutic Advances ��71 Hot Topics in Headaches and Related Disorders II: Unusual Headaches, Childhood Headaches, and Obesity ��71 Low and High Pressure Headache: Clinical Presentation and Approach to Evaluation and Management ��71 Comprehensive Migraine Education Program I: Diagnosis, Risk Factors, and Neurobiology ��72 Comprehensive Migraine Education Program II: Behavioral and Psychological Aspects, Preventative Pharmacology, and Treatment Advances ��72 Emergency and Inpatient Management of Migraine and Other Headache Disorders ��73

C88 C133 C134 C171 C210

MOVEMENT DISORDERS C2 Parkinson’s Disease Update ��80 C24 Child Neurology: A Case-based Approach ��41 C25 Cerebellar and Afferent Ataxias: Diagnosis and Management ��80

C35 Deep Brain Stimulation I:

INFECTIOUS DISEASE

C49

C27 Differential Diagnosis of Neurologic Infections ��73 C39 So You’ve Diagnosed Your Patient with a

C53

Neuroinfectious Disease, Now What? Practical Pearls in the Treatment and Management of Neuroinfectious Diseases ��73 C67 Infections of the Nervous System I: 26 2017 AAN Annual Meeting Early Look

Clerkship and Program Directors Leadership Academy (registration required) ��75 Women in Leadership $ (registration required) ��76 Gender Issues in Leadership ��77 Leadership Challenges in Practice ��77 Mentoring… Growing the Next Generation of Neurologist $ (registration required) ��77 Improving Your Leadership Skills: A Practical Approach (registration required) ��78 The Most Important Tool in Your Black Bag: Gallup StrengthsFinder™ Education Workshop $ (registration required) ��78 Advanced Leadership Training: Life-after-the-Limelights ��79 The Most Important Tool in Your Black Bag: Gallup StrengthFinders™ Assessment: Advanced Workshop $ (registration required) ��79 Being A Resilient Leader: How Do You Lead the Change? ��79

C68 C83

Basic Principles and Programming in Movement Disorders ��80 Clinical Uses of Botulinum Toxin for Dystonia Skills Workshop $ (registration required) ��81 Deep Brain Stimulation II: Advanced Management in Movement Disorders and Applications Beyond Movement Disorders ��82 Approach to the Shaky Patient ��82 Hot Topics and Controversies in Parkinson’s Disease ��82

C97 The Dystonias:

Diagnosis, Treatment, and Update on Causes ��83 C106 Case Studies: Unusual Movement Disorders ��83 C114 Therapy of Movement Disorders: A Case-based Approach ��83 C125 Nonmotor Manifestations of Parkinson’s Disease I ��84 C140 Nonmotor Manifestations of Parkinson’s Disease II ��84 C192 Paroxysmal Movement Disorders ��85 C203 Hyperkinetic Movement Disorders: Videodiagnosis and Treatment ��85 C209 Clinical Usefulness of Botulinum Toxin for Spasticity Skills Workshop $ (registration required) ��85 C216 Balance and Gait Disorders ��86 C223 Movement Disorders for the General Neurologist I: Diagnosis and Management of Parkinsonian Disorders ��86 C232 Movement Disorders for the General Neurologist II: Tremor, Drug-induced Movement Disorders, RLS, and Ataxia ��87 C240 Movement Disorders for the General Neurologist III: Chorea, Dystonia, Myoclonus, Stereotypes, and Tics ��87

MS AND CNS INFLAMMATORY DISEASE C4 Multiple Sclerosis Essentials ��88 C11 Neuromyelitis Optica Spectrum Disorders ��88 C36 Multiple Sclerosis Therapy:

Disease-modifying Treatment I ��88 C54 Multiple Sclerosis Therapy: Disease-modifying Treatment II ��89 C78 Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease I ��89 C91 Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease II ��90 C104 Case Studies: Multiple Sclerosis ��90 C116 Multiple Sclerosis Therapy: Symptom Management ��90 C142 Pediatric MS: Diagnosis and Treatment ��91 C190 Multiple Sclerosis Overview: Basic and Translational Science ��91 C201 Multiple Sclerosis Overview I: Clinical Pearls ��92 C214 Multiple Sclerosis Overview II: Clinical Advances ��92 C224 Controversies in Multiple Sclerosis Therapy ��93 C233 Multiple Sclerosis: A Case-based Approach ��93

NEURO TRAUMA, CRITICAL CARE, AND SPORTS NEUROLOGY C14 Concussion: From Mechanisms to Management ��93 C21 Concussion: Evaluation and Management in the

C32 Emergency Room Neuro-ophthalmology ��109 C70 Sports Neurology:

Enhancing Athletic Performance ��94 Neuroscience in the Clinic: Cutting Edge Concussion Data from the NCAA-DoD Grand Alliance C108 Case Studies in the ICU ��95 C126 Critical Care EEG Monitoring ��47 C150 Neurological Intensive Care: The Essentials ��95 C159 Neurological Intensive Care II: From the Brain to the Muscles ��96 C170 Sports Concussion Skills Workshop I: Event Coverage Skills $ (registration required) ��96 C174 Neurological Intensive Care III: Vascular Diseases ��96 C185 Sports Concussion Skills Workshop II: Office-based Skills $ (registration required) ��97 C207 Severe TBI: From ICU to Rehabilitation �� 117 N7 Neuroscience in the Clinic: Novel Therapeutic Targets in Critical Care Neurology: Intracerebral and Intraventricular Hemorrhage C237 Emergency Neurology I: Evaluation of Coma, Meningitis, and Viral Encephalitis in the Emergency Room ��97 C244 Emergency Neurology II: Consultations in the General ICU ��98

NEUROMUSCULAR AND CLINICAL NEUROPHYSIOLOGY (EMG) C12 Neuromuscular Junction Disorders I: Myasthenia

Gravis, Ocular and MuSK Myasthenia ��98

C19 Neuromuscular Junction Disorders II: Toxins, LambertC26 C37 C55 C69 C84 C98 C107

Eaton Syndrome and Less Common Disorders of Neuromuscular Transmission ��99 Clinical EMG I: Principles and Practice of NCS and Needle EMG ��99 Clinical EMG II: Neuromuscular Junction Testing and Quantitative EMG ��99 Clinical EMG III: Nerve Conduction Criteria and Electrodiagnostic Approaches ��100 Therapy of Neuromuscular Disease: ALS, Inflammatory Neuropathies and Myopathies, and Myasthenia Gravis ��100 Clinical Approach to Muscle Disease I: Muscle Disorders and Rhabdomyolysis ��100 Clinical Approach to Muscle Disease II: Inflammatory Myopathies and Muscle Pathology ��101 Case Studies: Unusual Diagnostic and Management of Cases in Neuromuscular Disease ��101

Acute and Chronic Phases ��94

$ = Additional Fee Required L = Leadership University

Fast and easy registration · AAN.com/view/AM17 27

Annual Meeting Session List by Topic C120 Mastering EMG Waveform Recognition Skills

in Just Two Hours! ��102 C121 Small Fiber Neuropathies: Sensory, Autonomic, and Both I: Focus on Autonomic Nervous System ��102 C135 Neuromuscular Ultrasound Skills Workshop $ (registration required) ��102 C136 Small Fiber Neuropathies: Sensory, Autonomic, and Both II: Focus on Sensory Nervous System ��103 C164 Evaluation and Management of Autonomic Disorders I: Autonomic Testing, Failure, and Peripheral Neuropathies ��103 C172 EMG Skills Workshop: Basic $ (registration required) ��104 C180 Evaluation and Management of Autonomic Disorders II: Diagnostic Approach and Treatments for Dysautonomia ��104 C193 Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies ��104 C204 Peripheral Neuropathy II: Diabetic and Inherited Neuropathies ��105 C217 Peripheral Neuropathy III: Genetic Testing and Next Generation Sequencing ��105

NEURO-ONCOLOGY

C118 Nystagmus and Saccadic Intrusions Made Simple �� 110 C129 Pediatric Neuro-ophthalmology Update �� 111 C151 Neuro-ophthalmology I: Visual Loss, Optic Neuropathies, and Papilledema �� 111

C160 Neuro-ophthalmology II:

Optic Neuritis, Visual Fields, and Anisocoria �� 112 C175 Neuro-ophthalmology III: Diplopia, Ocular Motility Disorders, and Nystagmus �� 112 C191 A Case-Based Approach to Neuro-ophthalmology: What Went Wrong? �� 113 C202 Higher Cortical Visual Disorders: Case-based Review �� 113 C215 Canalith Repositioning for Benign Paroxysmal Positional Vertigo �� 113 C230 Eye Movement Disorders: A Systematic Approach to the Evaluation of Diplopia �� 114 N8 Neuroscience in the Clinic: Afferent and Efferent Visual Pathway Manifestations of Neurodegenerative Diseases: Implications for Diagnosis and Treatment C245 Now You See It, Now You Know It—Pathognomonic Neuro-ophthalmology Findings �� 114

NEURO-REHABILITATION

C56 Case Studies:

C81 Common Spine Disorders I: Evaluation �� 115 C95 Common Spine Disorders II: Treatment �� 115 C123 Myelopathies I: Inflammatory and Vascular Etiologies �� 115 C138 Myelopathies II:

C66 C117

C156 Rehabilitation in Neurology �� 116 C157 Lumbar Radiculopathy, Lumbar Spinal Stenosis, Low

C38 Case Studies:

Neurologic Consultations in Cancer Patients I ��106

C194 C218

Neurologic Consultations in Cancer Patients II ��106 Neuro-oncologic Emergencies ��107 The Palliative Care Guide in Neurology: Best Practice Guidelines in Communication, Symptom Management, and End of Life Care of Patients with Brain Tumors and Other Life Limiting Neurological Disorders ��107 Basic Principles of Brain Tumors: For Practice and for Certification ��108 Cutting Edge Neuro-oncology—Understanding Current Trends ��108

NEURO-OPHTHALMOLOGY/ NEURO-OTOLOGY C22 It’s a Bird, It’s a Plane, It’s… The Doctor Who Cured C32 C50 C86 C100

my Benign Paroxysmal Positional Vertigo ��108 Emergency Room Neuro-ophthalmology ��109 Neuro-ophthalmology and Neurovestibular Exam Lab Skills Workshop $ (registration required) ��109 Neuro-otology I: The Common Peripheral Vestibular Disorders �� 110 Neuro-otology II: Diagnosis and Treatment of Nuanced Causes of Dizziness �� 110

28 2017 AAN Annual Meeting Early Look

Symptom Management and Rehabilitation �� 116

Back Pain, and Failed Back Syndrome �� 119 N6 Neuroscience in the Clinic: Functional Recovery in Neurology and Neuroscience C207 Severe TBI: From ICU to Rehabilitation �� 117 C235 Neck Pain, Cervical Spinal Stenosis, Cervical Radiculopathy, and Cervical Spondylotic Myelopathy �� 117

PAIN AND PALLIATIVE CARE C15 Practical Training in Injection Techniques in the C81 C95 C117

C143

Treatment of Headache Disorders Skills Workshop $ (registration required) ��68 Common Spine Disorders I: Evaluation �� 115 Common Spine Disorders II: Treatment �� 115 The Palliative Care Guide in Neurology: Best Practice Guidelines in Communication, Symptom Management, and End of Life Care of Patients with Brain Tumors and Other Life Limiting Neurological Disorders ��107 Non-Neuro-oncology: Case-based Palliative Care Throughout the Continuum of Disease �� 118

C157 Lumbar Radiculopathy, Lumbar Spinal Stenosis, Low

Back Pain, and Failed Back Syndrome �� 119 C169 Core Concepts in Pain Management I: Refractory Neuropathic Pain—Practical Pharmacologics, Advances in Neuromodulation, and a Balanced Look at Cannabinoids �� 119 C184 Core Concepts in Pain Management II: Safe Opioid Prescribing—Practical Considerations, Unintended Consequences, and Legal Issues ��120 C235 Neck Pain, Cervical Spinal Stenosis, Cervical Radiculopathy, and Cervical Spondylotic Myelopathy �� 117

Personalized Medicine in the Genomic Era ��128

C74 Annual A.B. Baker Program: Focus on Professionalism ��128 C75 Clerkship and Program Directors Conference: Wellness and Burnout During Training ��128

C85 Boston City Hospital:

The Cradle of American Neurology Part I ��56

C93 Boston City Hospital: C130 C132

PRACTICE, POLICY, AND ETHICS

C145

C10 Making Sure You Get Paid Under the New Health

C146 C148

C17 C31 C45 C48 C64 C87 C102 C143 C145 C161 C165 C176 C181

Care Laws ��120 How Is Your Patient Really Doing? Patient Reported Scales, Tools and Shared Decision Making ��121 Advanced Neurologic Coding ��121 Navigating the World of Mobile Health ��121 L Leadership Challenges in Practice ��77 ICD-10-CM: How to Optimize for Accurate Diagnosis and Reimbursement ��122 How to Run a Practice: Business Strategies for Neurology Private Practices, Academic Centers, and the Future ��122 Business Strategies for Payer Negotiations and/or How to Go off the Grid ��123 Non-Neuro-oncology: Case-based Palliative Care Throughout the Continuum of Disease �� 118 Hot Topics in Neurologic Practice: Managing the Patient Experience in 2017 and Beyond ��123 Bedside Evidence-based Medicine: How to Find and Deconstruct Articles in Order to Take Care of Patients I ��124 Clinical Neurology for Advanced Practice Providers I ��124 Bedside Evidence-based Medicine: How to Find and Deconstruct Articles in Order to Take Care of Patients II ��124 Clinical Neurology for Advanced Practice Providers II ��125

RESEARCH METHODOLOGY, EDUCATION, AND HISTORY C5

Resident Basic Science I: Neuroanatomy—All the Lesions ��125 C6 Early Career Research Training Symposium: A Roadmap to Academic Success for Residents and Fellows (registration required) ��126 C16 Resident Basic Science II: Neuropathology ��126 C43 Introduction to Clinical Research and Methods ��127 C46 Resident Basic Science III: Neuropharmacology ��127

C60 Precision Neurology: The Promise and Perils of

$ = Additional Fee Required L = Leadership University

C163 C189

The Cradle of American Neurology Part II ��57 Eponymous Women in Neurology I ��129 Developing the Treatments of Tomorrow I: Taking Molecules from Lab to Human ��130 Hot Topics in Neurologic Practice: Managing the Patient Experience in 2017 and Beyond ��123 Eponymous Women in Neurology II ��130 Developing the Treatments of Tomorrow II: Clinical Trials in Neurology ��131 An Introduction to Research in Medical Education ��131 Cognitive Psychology of Neurologic Errors: Why Do Neurologists Make Errors? ��63

SLEEP C23 Using Sleep Medicine to Help Solve

Difficult Neurologic Cases ��132

C71 Hot Topics in Sleep Neurology ��132 C128 Sleep Apnea and Related Disorders Over the

Lifecycle: What Neurologists Need to Know ��133

C144 Approaching the Management of Common Sleep

Disorders: Case-based Review for the Non-sleep Specialist ��133 C166 Circadian Rhythm Disorders: Implications for Neurology ��133 C197 Interpreting Sleep Study Procedure(s), Data, and Reports: What the Non-sleep Specialist Needs to Know ��134 C226 How to Integrate Sleep Medicine into Your Child Neurology Practice ��135 C234 Sleep for the Practicing Neurologist I: Is it Narcolepsy or Something Else? Diagnostic and Management Challenges in the Central Disorders of Hypersomnolence ��135 C242 Sleep for the Practicing Neurologist II: Night Fighting: Sleep Related Hypermotor Epilepsy, Sleepwalking, and Dream Enactment ��136

Fast and easy registration · AAN.com/view/AM17 29

Course Descriptions

Aging, Dementia, Cognitive, and Behavioral Neurology

AGING, DEMENTIA, COGNITIVE, AND BEHAVIORAL NEUROLOGY

Saturday, April 22, 2017

Topic: Aging, Dementia, Cognitive, and Behavioral Neurology

8:00 a.m.–10:00 a.m.

The Neurology of Social Behavior

Topic: Aging, Dementia, Cognitive, and Behavioral Neurology Director: Bradford Dickerson, MD, Boston, MA Program Description: Over the past decade, we have seen remarkable advances in our knowledge of social cognitive and affective neuroscience. Our understanding of the neural circuits underpinning socioemotional behaviors such as empathy, self-awareness, warmth, and reading others’ intentions is more precise than ever before. Faculty will provide an overview of how specific neural networks normally function to support social behavior, and will show how this new information can improve our ability to understand the kinds of neurologically based behavioral dysfunction that result from disease and injury. Disturbances of socioemotional behavior in clinical neurology will be discussed using data from patients with diseases that particularly impair social functions, such as frontotemporal dementia, autism, ADHD, sociopathy, and Williams syndrome. Upon Completion: Participants should be able to understand that social behavior and cognition rely on specific neurologic systems in the brain, have a sense of the basic organization and general neuroanatomy of social behavior, and be aware of specific neurologic conditions that particularly impair social functioning. Lecture/Faculty: }} Social Cognitive and Affective Function: Behavior and Brain Systems Bradford Dickerson, MD, Boston, MA }} Social Cognition and Behavior in Neuropsychiatric Disorders Elizabeth Finger, MD, FAAN, London, ON, Canada }} Case Discussions Faculty Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist

30 2017 AAN Annual Meeting Early Look

C18

2:00 p.m.–4:00 p.m.

Vascular Cognitive Impairment and Dementia: Current Status and Future

Director: Larry B. Goldstein, MD, FAAN, FAHA, Lexington, KY Program Description: Faculty will provide an overview of clinical science-related vascular cognitive impairment and dementia. An introduction to the overall status and challenges in the field will be followed by a review of current diagnostic strategies and treatment and potential future approaches. This program will conclude with a general summary and time-permitting case discussions. Upon Completion: Participants should be able to discuss diagnostic challenges, and current and possible future approaches to VCI/dementia. Lecture/Faculty: }} Vascular Cognitive Impairment/Dementia: Setting the Stage Larry B. Goldstein, MD, FAAN, FAHA, Lexington, KY }} Assessment and Diagnosis of Patients with Suspected VCI/ Dementia David S. Knopman, MD, FAAN, Rochester, MN }} Current and Future Management of Patients with VCI/ Dementia Gregory A. Jicha, MD, PhD, Lexington, KY Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist Sunday, April 23, 2017

C33

1:00 p.m.–3:00 p.m.

Non-Alzheimer’s Dementia I: Frontotemporal Dementias and Chronic Traumatic Encephalopathy

Topic: Aging, Dementia, Cognitive, and Behavioral Neurology Director: Gil Dan Rabinovici, MD, San Francisco, CA Program Description: Frontotemporal dementia (FTD) and chronic traumatic encephalopathy (CTE) represent important, likely underdiagnosed, causes of neurodegenerative dementia. FTD is as common as Alzheimer’s disease (AD) in patients presenting with an early-onset dementia (under age 65), whereas CTE is increasingly recognized through autopsy in individuals exposed to repetitive mild traumatic brain injury (through contact sports, military exposures, and other highrisk endeavors) who present with neurobehavioral decline. Faculty will present a case-based approach to introduce the diverse clinical

Upon Completion: Participants should be able to apply up-to-date clinical criteria and current evidence to diagnose and treat DLB, MSA, PSP, and CBS.

This program complements C51: Non-Alzheimer’s Dementia II: Lewy Body Dementias and Other Parkinsonian Dementias, but covers independent topics.

Lecture/Faculty: }} Alpha-synucleinopathies: Parkinson’s, Lewy Body, and Multiple System Atrophy Bradley F. Boeve, MD, Rochester, MN }} Tauopathies: Progressive Supranuclear Palsy and Corticobasal Degeneration Anthony E. Lang, MD, FAAN, Toronto, ON, Canada Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Psychiatrist, Geriatrician

Upon Completion: Participants should be able to apply up-to-date clinical criteria and diagnostic tools to classify the different subtypes of FTD, to identify individuals at risk for CTE, and to differentiate FTD and CTE from AD. Improving clinical diagnosis and in vivo prediction of molecular pathology is critical in preparation for emerging disease-specific therapies for these disorders. Lecture/Faculty: }} Frontotemporal Dementia and Primary Progressive Aphasia Gil Dan Rabinovici, MD, San Francisco, CA }} Chronic Traumatic Encephalopathy Andrew E. Budson, MD, Boston, MA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Psychiatrist Sunday, April 23, 2017

C51

3:30 p.m.–5:30 p.m.

Non-Alzheimer’s Dementia II: Lewy Body Dementias and Other Parkinsonian Dementias

Topic: Aging, Dementia, Cognitive, and Behavioral Neurology Director: Gil Dan Rabinovici, MD, San Francisco, CA Program Description: Occasionally lumped as “Parkinson’s Plus” syndromes, Lewy body disease (DLB), multiple systems atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal syndrome (CBS) are associated with distinct clinical and pathological features, differential responses to dopamine therapy, and differential sensitivity to neuroleptics and other agents. Furthermore, in addition to the movement disorder, all these diseases are associated with cognitive, behavioral, and systemic symptoms that provide unique challenges for clinicians and caregivers. Faculty will provide a case-based approach to introduce the clinical characteristics of these disorders and provide up-to-date recommendations on clinical management, as well as an update on biomarker development and advances in unraveling the pathophysiology and developing disease-specific therapeutics. This program complements C33: Non-Alzheimer’s Dementia I: Frontotemporal Dementias and Chronic Traumatic Encephalopathy, but covers independent topics.

$ = Additional Fee Required L = Leadership University

Monday, April 24, 2017

C62

7:00 a.m.–9:00 a.m.

Mild Cognitive Impairment: Implications for Clinicians

Topic: Aging, Dementia, Cognitive, and Behavioral Neurology Director: David J. Gill, MD, Rochester, NY Program Description: The diagnosis of mild cognitive impairment (MCI) often represents prodromal Alzheimer’s disease or other dementia. However, diagnosis, prediction of outcome, and treatment of patients with mild cognitive impairment presents many challenges. Faculty will address the diagnosis, pathophysiology, role of biomarkers, and treatment of mild cognitive impairment. The upcoming revision of the AAN Practice Parameter for MCI will be reviewed and a number of cases will be presented to illustrate controversies and management issues. Upon Completion: Participants should be able to understand the basic biology of MCI and be familiar with the recommended diagnostic strategy, appropriate use of biomarkers, and management of patients with MCI. Lecture/Faculty: }} Overview of Mild Cognitive Impairment Faculty }} Mild Cognitive Impairment: Prediction of Progression and Treatment David J. Gill, MD, Rochester, NY Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

Fast and easy registration · AAN.com/view/AM17 31

Aging & Dementia

presentations of these disorders, and provide an update on biomarker development and advances in understanding the genetic and molecular underpinnings of these disorders.

Course Descriptions Monday, April 24, 2017

C77

1:00 p.m.–3:00 p.m.

Behavioral Neurology I: Network Anatomy of Behavior and Language

Topic: Aging, Dementia, Cognitive, and Behavioral Neurology Director: Maria Gorno Tempini, MD, PhD, San Francisco, CA Program Description: Identification of structure-function relationships in the brain has been an important goal of behavioral neurology. Many new methodologies, studying both healthy controls and neurologically impaired individuals, have recently provided new insights into the networks of brain regions that underlie specific tasks or functions. Faculty will illustrate the contributions of a variety of modalities toward understanding the neural correlates of behavior and language functions. A cognitive neuroscience perspective will inform discussion of the component processes and brain systems subserving these behaviors. An efficient approach to the evaluation of patients with cognitive and behavioral disorders, including dementia and stroke, will be reviewed. This program complements C90: Behavioral Neurology II: Memory and Praxis, but covers independent topics. Upon Completion: Participants should be able to describe strengths and weaknesses of a variety of approaches (e.g., neuroimaging methods) toward identifying structure-function relationships; be able to describe some recent insights into the neural bases of executive function, social behavior, speech and language; be able to describe the component processes of these cognitive abilities using a contemporary cognitive neuroscience perspective; and should increase their sophistication in understanding the neurobehavioral assessment of patients with behavioral and cognitive neurologic disorders, including dementias. Lecture/Faculty: }} Network Anatomy of Behavior Faculty }} Network Anatomy of Speech and Language Maria Gorno Tempini, MD, PhD, San Francisco, CA Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist

Aging, Dementia, Cognitive, and Behavioral Neurology Monday, April 24, 2017

C90

3:30 p.m.–5:30 p.m.

Behavioral Neurology II: Memory and Praxis

Topic: Aging, Dementia, Cognitive, and Behavioral Neurology Director: Maria Gorno Tempini, MD, PhD, San Francisco, CA Program Description: Identification of structure-function relationships in the brain has been an important goal of behavioral neurology. Many new methodologies, studying both healthy controls and neurologically impaired individuals, have recently provided new insights into the networks of brain regions that underlie specific tasks or functions. Faculty will illustrate the contributions of a variety of modalities toward understanding the neural correlates of memory and praxis. A cognitive neuroscience perspective will inform discussion of the component processes and brain systems subserving these behaviors. An efficient approach to the evaluation of patients with cognitive and behavioral disorders including dementia will be reviewed. This program complements C77: Behavioral Neurology I: Network Anatomy of Behavior and Language, but covers independent topics. Upon Completion: Participants should be able to describe strengths and weaknesses of a variety of approaches (e.g., neuroimaging methods) toward identifying structure-function relationships; be able to describe some recent insights into the neural bases of memory and praxis; be able to describe the component processes of these cognitive abilities using a contemporary cognitive neuroscience perspective; should increase their sophistication in understanding the neurobehavioral assessment of patients with behavioral and cognitive neurologic disorders, including dementias and stroke. Lecture/Faculty: }} Memory: Systems, Abilities, and Deficits Faculty }} Two Routes to Skilled Action in the Healthy and Damaged Brain Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist Monday, April 24, 2017

6:00 p.m.–9:00 p.m.

C103 Case Studies: Dementia Topic: Aging, Dementia, Cognitive, and Behavioral Neurology Director: Neill R. Graff-Radford, MD, FAAN, Jacksonville, FL Program Description: Faculty will discuss the presentation, diagnosis, and management of a variety of dementing disorders. There will be a number of examples of 32 2017 AAN Annual Meeting Early Look

Upon Completion: Participants should be able to recognize the presentation, diagnosis, and management of a variety of common and uncommon dementing disorders and receive an update on new breakthroughs in the field. Participants should become more aware of the treatable causes of dementia. Lecture/Faculty: }} Numbness, Memory Loss, and Hearing Loss Neill R. Graff-Radford, MD, FAAN, Jacksonville, FL }} A Treatable Cause of MCI Ronald C. Petersen, PhD, MD, Rochester, MN }} Memory Loss and Abnormal Movements Jody Corey-Bloom, MD, PhD, La Jolla, CA }} Walking and Memory Difficulty Neill R. Graff-Radford, MD, FAAN, Jacksonville, FL }} Behavioral and Gait Changes Jody Corey-Bloom, MD, PhD, La Jolla, CA }} An Unusual Case Ronald C. Petersen, PhD, MD, Rochester, MN }} Audience Cases and Other Faculty Cases Jody Corey-Bloom, MD, PhD, La Jolla, CA Neill R. Graff-Radford, MD, FAAN, Jacksonville, FL Ronald C. Petersen, PhD, MD, Rochester, MN Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 3 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist Tuesday, April 25, 2017

7:00 a.m.–9:00 a.m.

C113 Neuroimaging Biomarkers Across the Dementia Spectrum

Topic: Aging, Dementia, Cognitive, and Behavioral Neurology Director: Liana Apostolova, MD, FAAN, Indianapolis, IN Program Description: Faculty will update clinicians on the newest vivo methods to detect AD pathology in the brain; review all major modalities for imaging of neurodegenerative disorders and their applications in the clinic and research; discuss barriers to using amyloid radiotracers in the diagnostic evaluation of Alzheimer’s and mild cognitive impairment, and ongoing efforts to overcome these barriers; and cover how these new biomarkers can help us understand the heterogeneity of neurodegeneration, and help us improve therapeutic outcomes. $ = Additional Fee Required L = Leadership University

Upon Completion: Participants should be able to understand the role imaging methods play in the evaluation of neurodegenerative diseases; gain knowledge of the specific imaging biomarker signatures of the major classes of neurodegenerative diseases; understand how biomarkers can be used in conjunction with clinical findings to refine the differential diagnosis; understand how biomarkers may be used in the future to facilitate targeted therapies; and understand the barriers for using amyloid imaging in clinical settings, and the ongoing approaches to rectify those barriers. Lecture/Faculty: }} Updates on the Clinical and Research Use of Magnetic Resonance Imaging in Neurodegenerative Disorders Liana Apostolova, MD, FAAN, Indianapolis, IN }} The Role of Functional Neuroimaging in the Evaluation of Patients with Cognitive/Behavioral Impairment or Dementia Bradford Dickerson, MD, Boston, MA }} Towards Molecular Diagnosis: Clinical Applications of Amyloid and Tau PET Imaging Gil Dan Rabinovici, MD, San Francisco, CA Core Competencies: Medical Knowledge, Patient Care, SystemsBased Practice Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Tuesday, April 25, 2017

1:00 p.m.–3:00 p.m.

C124 Unilateral Neglect and Anosognosia: Chalk Talk

Topic: Aging, Dementia, Cognitive, and Behavioral Neurology Director: Kenneth M. Heilman, MD, FAAN, Gainesville, FL Program Description: Disorders of attention, such as spatial and personal neglect, as well as unawareness of disability (anosognosia), are both terribly disabling disorders that can be caused by stroke, degenerative diseases, trauma, tumor, and other diseases. Faculty will discuss the means by which these two disorders can be assessed, their pathophysiology, and some of the means by which these disorders can be treated and managed. Upon Completion: Participants should be able to learn the means of evaluating patients for spatial and personal attentional disorders such as neglect and anosognosia; understand the diseases that may cause these disorders and the brain mechanisms that may account for these disorders; and learn about possible treatment and management of these disorders. Lecture/Faculty: }} Neglect Kenneth M. Heilman, MD, FAAN, Gainesville, FL

Fast and easy registration · AAN.com/view/AM17 33

Aging & Dementia

treatable dementias. Sample cases will be presented and the audience will be encouraged to discuss controversial aspects of the diagnosis and management of these cases. Participants are encouraged to suggest cases of their own prior to the course by contacting Neill R. Graff-Radford, MD, FAAN, at graffradford.neill@mayo.edu.

Course Descriptions }} Anosognosia Kenneth M. Heilman, MD, FAAN, Gainesville, FL Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Neurospychologist, Occupational and Physical Therapist, Psychiatrist, Advanced Practice Provider Tuesday, April 25, 2017

3:30 p.m.–5:30 p.m.

C139 Behavioral Neurology:

A Case-based Approach

Topic: Aging, Dementia, Cognitive, and Behavioral Neurology Director: A. M. Barrett, MD, FAAN, West Orange, NJ Program Description: Accurate diagnosis and appropriate treatment in behavioral neurology requires the development of specialized localization skills, similar to other subspecialties in neurology. Clinical cases of cognitive and behavioral decline will be presented as though in the clinical setting using actual patient video, with course participants guiding the clinical history and focused exam, generating a differential diagnosis, reviewing relevant data, and formulating a treatment plan via the audience response system. Faculty will highlight salient features in the cases and describe important techniques in the history and exam to optimize time spent with similar patients. Current evidence regarding diagnostic tools, accuracy of diagnosis, and treatments will also be discussed. Cases will represent atypical, non-Alzheimer’s dementia and dementia accompanying other neurological disorders. Upon Completion: Participants should be familiar with evaluation and differential diagnosis in behavioral neurology, including bedside mental status screening, neuroimaging, and genetic testing in patients who present for evaluation of cognitive decline. Lecture/Faculty: }} Case 1: Presentation Mario F. Mendez, MD, PhD, FAAN, Los Angeles, CA }} Case 2: Presentation Faculty Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist

Aging, Dementia, Cognitive, and Behavioral Neurology Wednesday, April 26, 2017

7:00 a.m.–9:00 a.m.

C153 Alzheimer’s Dementia:

Diagnosis and Treatment

Topic: Aging, Dementia, Cognitive, and Behavioral Neurology Director: Beau M. Ances, MD, PhD, MS, Saint Louis, MO Program Description: Knowledge in the area of dementia is rapidly evolving. Faculty will present the clinical and molecular biology of Alzheimer’s disease; an overview of frontotemporal dementia and dementia with Lewy bodies; rapidly progressive dementia; chronic traumatic encephalopathy; dementia from clinical, neuropsychological, neuroimaging, and fluid biomarker perspectives; and dementia management. This program complements C178: Biomarkers in Dementia, but covers independent topics. Upon Completion: Participants should be able to appreciate the differential diagnosis of dementia; the appropriate role of neuropsychology, neuroimaging, and molecular biomarkers in supporting the diagnosis; and the management of dementing illnesses. Lecture/Faculty: }} Alzheimer’s Dementia: Diagnosis and Treatment Beau M. Ances, MD, PhD, MS, Saint Louis, MO Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Wednesday, April 26, 2017

3:30 p.m.–5:30 p.m.

C178 Biomarkers in Dementia Topic: Aging, Dementia, Cognitive, and Behavioral Neurology Director: Beau M. Ances, MD, PhD, MS, Saint Louis, MO Program Description: Knowledge in the area of dementia is rapidly evolving. Faculty will present an overview of the clinical and biological changes seen with Alzheimer’s disease; frontotemporal dementia; dementia with Lewy bodies; rapidly progressive dementia; and vascular dementia from clinical, neuropsychological, neuroimaging, and molecular (including cerebrospinal fluid) biomarker perspectives. This program complements C153: Alzheimer’s Dementia: Diagnosis and Treatment, but covers independent topics. Upon Completion: Participants should gain an understanding of the differential diagnosis of dementia; the appropriate role of neuropsychology, neuroimaging, and molecular biomarkers that supports a particular diagnosis; and the management of dementing illnesses.

34 2017 AAN Annual Meeting Early Look

Thursday, April 27, 2017

7:00 a.m.–9:00 a.m.

C186 Chronic Traumatic Encephalopathy: Update Topic: Aging, Dementia, Cognitive, and Behavioral Neurology Director: Andrew E. Budson, MD, Boston, MA Program Description: Chronic traumatic encephalopathy is increasingly recognized as a cause of memory loss in addition to mood and behavior issues. Faculty will present up-to-date information regarding epidemiological, clinical, cognitive, pathological, and imaging aspects of this disorder. Upon Completion: Participants should be able to identify patients in their practice with chronic traumatic encephalopathy; the changes in cognition, mood, and behavior that result; and understand the underlying pathology and its imaging correlates. Lecture/Faculty: }} Clinical Aspects of Chronic Traumatic Encephalopathy Andrew E. Budson, MD, Boston, MA }} Pathology of Chronic Traumatic Encephalopathy Ann C. McKee, MD, Boston, MA }} Imaging of Chronic Traumatic Encephalopathy Faculty }} Current Clinical Research in Chronic Traumatic Encephalopathy Robert Stern, PhD, Boston, MA Core Competency: Medical Knowledge Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

$ = Additional Fee Required L = Leadership University

Thursday, April 27, 2017

1:00 p.m.–3:00 p.m.

C202 Higher Cortical Visual Disorders: Case-based Review

Topics: Neuro-ophthalmology/Neuro-otology; Aging, Dementia, Cognitive, and Behavioral Neurology Director: Sashank Prasad, MD, Boston, MA See complete course description on page 113 » Thursday, April 27, 2017

1:00 p.m.–3:00 p.m.

C205 Neurologic Complications in

Adults with Down Syndrome

Topics: Child Neurology and Developmental Neurology; Aging, Dementia, Cognitive, and Behavioral Neurology Director: Seth M. Keller, MD, Lumberton, NJ See complete course description on page 43 » Thursday, April 27, 2017

1:00 p.m.–3:00 p.m.

3:30 p.m.–5:30 p.m.

C220 Memory Disorders:

A Case-based Approach

Topic: Aging, Dementia, Cognitive, and Behavioral Neurology Director: David A. Wolk, MD, Philadelphia, PA Program Description: Memory loss is almost certainly the most common presenting cognitive complaint encountered by neurologists and internists in clinical practice. However, the underlying cognitive impairment may be quite disparate, reflecting the multiple memory systems that can dysfunction. Even within a particular type of memory (e.g., episodic memory), qualitative differences in the nature of the impairment may be due to disruption of different underlying component processes. As these systems and subprocesses have unique functional neuroanatomical underpinnings, identification has localizing value which ultimately assists in determining the etiology. Faculty will present cases to highlight practical approaches to the history and examination to make these distinctions and discuss use of ancillary studies and available therapeutic interventions. Fast and easy registration · AAN.com/view/AM17 35

Aging & Dementia

Lecture/Faculty: }} Biomarkers in Alzheimer’s Disease Beau M. Ances, MD, PhD, MS, Saint Louis, MO }} Biomarkers in Frontotemporal Dementia and Dementia with Lewy Body Faculty }} Biomarkers in Rapidly Progressive Dementia Gregory S. Day, MD, MSc, St. Louis, MO }} Biomarkers in Vascular Dementia Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

Course Descriptions Upon Completion: Participants should develop a framework for the evaluation of patients with memory disorders with a particular focus on discriminating different types of memory failures and their implication for the underlying brain “lesion“ and diagnosis. Lecture/Faculty: }} Differential Diagnosis of Episodic Memory Failures: Case Presentations Andrew E. Budson, MD, Boston, MA }} Clinical Assessment of Memory Loss: Case Presentations David A. Wolk, MD, Philadelphia, PA Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, NonNeurologist Friday, April 28, 2017

7:00 a.m.–9:00 a.m.

C228 Assessment and Management of Neuropsychiatric Symptoms in Neurocognitive Disorders

Topic: Aging, Dementia, Cognitive, and Behavioral Neurology Director: Daniel Kaufer, MD, FAAN, Chapel Hill, NC Program Description: This course will outline practical, systematic approaches to assessing and managing neuropsychiatric symptoms in neurocognitive disorders. Neuropsychiatric symptoms reflect cerebral dysfunction across a wide range of cortical and subcortical networks. They represent core features of dementia with Lewy bodies and behavioral variant frontotemporal degeneration, and may be prominent comorbidities in Alzheimer’s disease and other neurocognitive disorders. Faculty will review the spectrum of neuropsychiatric disturbances seen in neurocognitive disorders, discuss practical clinical assessment techniques based on informant report, and outline a systematic approach to management including pharmacological and nonpharmacological interventions. Faculty will review case vignettes encouraging audience participation in highlighting interventional approaches to common neuropsychiatric symptoms such as apathy, agitation, anxiety and mood symptoms, delusions and hallucinations, motor hyperactivity and repetitive behaviors, and vegetative signs. The target audience is clinical providers who manage patients with neurocognitive disorders in out-patient and residential care facilities. Upon Completion: Participants should be able to efficiently identify and assess common neuropsychiatric symptoms; develop a systematic approach to formulating a flexible, comprehensive treatment plan; select appropriate pharmacological therapies for specific target symptoms to ensure safety, improve quality of life, and minimize patient and

36 2017 AAN Annual Meeting Early Look

Aging, Dementia, Cognitive, and Behavioral Neurology caregiver distress; better understand possible iatrogenicity and minimize risks associated with polypharmacy; and become familiar with behavioral modification techniques and utilize community resources for caregiver education and support. Lecture/Faculty: }} Phenomenology, Classification, and Assessment Faculty }} Pharmacological and Non-Pharmacological Management Faculty }} Clinical Cases Faculty Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement, Professionalism Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider Friday, April 28, 2017

1:00 p.m.–3:00 p.m.

C236 Assessment of Rapidly Progressive

Dementias I: Overview, Prion Diseases, and Neurodegenerative Rapidly Progressive Dementia

Topic: Aging, Dementia, Cognitive, and Behavioral Neurology Director: Michael D. Geschwind, MD, PhD, San Francisco, CA Program Description: Rapidly progressive dementia (RPD) can be challenging to diagnose. The differential diagnosis is broad and includes many potentially reversible conditions. As many RPD are treatable if treated early, quick diagnosis is important. Through presentation of common and challenging cases, faculty will review the differential diagnosis of RPD, the approach, and management strategies. This session will focus on prion and other neurodegenerative disorders. This program complements C243: Assessment of Rapidly Progressive Dementias II: Autoimmune Encephalopathies and Infections Presenting as Rapidly Progressive Dementia, but covers independent topics. Upon Completion: Participants should be familiar with the differential diagnosis of prion and other neurodegenerative disease causes of RPD and the clinical presentation and evaluation of the more common conditions. Lecture/Faculty: }} Approach to Rapidly Progressive Dementia and Clinical Overview of Prion Diseases Michael D. Geschwind, MD, PhD, San Francisco, CA

Friday, April 28, 2017

3:30 p.m.–5:30 p.m.

CEREBROVASCULAR DISEASE AND INTERVENTIONAL NEUROLOGY Sunday, April 23, 2017

C30

7:00 a.m.–9:00 a.m.

Cerebrovascular Disease I: Prevention

Topic: Cerebrovascular Disease and Interventional Neurology Director: Larry B. Goldstein, MD, FAAN, FAHA, Lexington, KY

C243 Assessment of Rapidly Progressive

Program Description: Faculty will cover specific, rotating topics related the prevention of a first or recurrent stroke, including lifestyle modifications, statins, carotid revascularization, and anticoagulants. There will be ample time for discussion and questions.

Topic: Aging, Dementia, Cognitive, and Behavioral Neurology

This program complements C42: Cerebrovascular Disease II: Hemorrhagic Stroke and C59: Cerebrovascular Disease III: Acute Ischemic Stroke, but covers independent topics.

Dementias II: Autoimmune Encephalopathies and Infections Presenting as Rapidly Progressive Dementia

Director: Michael D. Geschwind, MD, PhD, San Francisco, CA Program Description: Rapidly progressive dementia (RPD) can be challenging to diagnose. The differential diagnosis is broad and includes many potentially reversible conditions. As many RPD are treatable if treated early, quick diagnosis is important. Through presentation of common and challenging cases, faculty will review the differential diagnosis of RPD, the approach, and management strategies. This session will focus on infectious and autoimmune (mostly antibody-mediated) causes of RPD. This program complements C236: Assessment of Rapidly Progressive Dementias I: Overview, Prion Diseases and Neurodegenerative Rapidly Progressive Dementias, but covers independent topics. Upon Completion: Participants should be familiar with the differential diagnosis of infectious and non-prion neurodegenerative disease causes of RPD. They should understand the clinical presentation and be able to evaluate for the more common causes of RPD. Lecture/Faculty: }} Infectious Causes of Rapidly Progressive Dementia Allen J. Aksamit, Jr., MD, FAAN, Rochester, MN }} Autoimmune and Antibody-mediated Causes of Rapidly Progressive Dementia Jeffrey Marc Gelfand, MD, MAS, San Francisco, CA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

$ = Additional Fee Required L = Leadership University

Upon Completion: Participants should be able to recommend appropriate lifestyle changes for stroke prevention, select patients for treatment with a statin, discuss risks and benefits of carotid revascularization for stroke prevention, and identify patients with atrial fibrillation who would benefit from treatment with warfarin or a novel oral anticoagulant and choose appropriate reversal strategies. Lecture/Faculty: }} Introduction and the Importance of Lifestyle Larry B. Goldstein, MD, FAAN, FAHA, Lexington, KY }} Statins for Primary and Secondary Stroke Prevention Larry B. Goldstein, MD, FAAN, FAHA, Lexington, KY }} Carotid Revascularization for Stroke Prevention Seemant Chaturvedi, MD, FAAN, FAHA, Miami, FL }} Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation Karen L. Furie, MD, Providence, RI Core Competency: Medical Knowledge Teaching Style: Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

Fast and easy registration · AAN.com/view/AM17 37

Aging & Dementia

}} Non-prion Neurodegenerative Diseases Presenting as Rapidly Progressive Dementia Bradley F. Boeve, MD, Rochester, MN Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

Course Descriptions Sunday, April 23, 2017

C42

1:00 p.m.–3:00 p.m.

Cerebrovascular Disease II: Hemorrhagic Stroke

Topic: Cerebrovascular Disease and Interventional Neurology Director: Philip B. Gorelick, MD, MPH, FAAN, Grand Rapids, MI Program Description: Hemorrhagic stroke is an important cause of morbidity and mortality. This course will focus on intraparenchymal hemorrhage (IPH) and aneurysmal subarachnoid hemorrhage (SAH). Course participants will become familiar with basic diagnostic and management recommendations for IPH and SAH, up-to-date guidance statements, and the role of endovascular therapies and new clinical trial data for the diagnosis and management of IPH and SAH. This program complements C30: Cerebrovascular Disease I: Prevention and C59: Cerebrovascular Disease III: Acute Ischemic Stroke, but covers independent topics. Upon Completion: Participants should be able to discuss key diagnostic and management recommendations for IPH and SAH, discuss key scientific guidance recommendations for diagnosis and management of IPH and SAH, and discuss the role of endovascular therapies and recent clinical trial data in diagnosis and management of IPH and SAH. Lecture/Faculty: }} Evidence-based Diagnosis and Management of Intraparenchymal Hemorrhage Venkatesh Aiyagari, MD, Dallas, TX }} Evidence-based Diagnosis and Management of Aneurysmal Subarachnoid Hemorrhage Sean D. Ruland, MD, Maywood, IL }} Aspirin: Benefits and Bleeding Risks Philip B. Gorelick, MD, MPH, FAAN, Grand Rapids, MI Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Pharmacist, Advanced Practice Provider Sunday, April 23, 2017

C59

3:30 p.m.–5:30 p.m.

Cerebrovascular Disease III: Acute Ischemic Stroke

Topic: Cerebrovascular Disease and Interventional Neurology Director: Philip B. Gorelick, MD, MPH, FAAN, Grand Rapids, MI Program Description: Stroke is the fifth leading cause of death and a major cause of adult morbidity. Recent advances in acute ischemic stroke (AIS) management 38 2017 AAN Annual Meeting Early Look

Cerebrovascular Disease and Interventional Neurology have led to new opportunities to reduce acute stroke morbidity and mortality. In this course we provide an evidence-based update of AIS management via a case-based approach. Case-based principles of AIS diagnosis and management will be illustrated by leading experts in the field who will highlight proper use of intravenous alteplase (tPA) and other medical therapies, and endovascular interventions. This program complements C30: Cerebrovascular Disease I: Prevention and C42: Cerebrovascular Disease II: Hemorrhagic Stroke, but covers independent topics. Upon Completion: Participants should be able to discuss proper application of evidencebased guidance for administration of intravenous alteplase (tPA) in acute ischemic stroke (AIS), discuss proper application of evidencebased guidance of other key medical therapies in AIS, and discuss proper application of endovascular interventions in AIS. Lecture/Faculty: }} Use of of Intravenous Alteplase in Acute Ischemic Stroke Louis R. Caplan, MD, FAAN, Boston, MA }} Case Examples of Evidence-based Application of Endovascular Therapy in Acute Ischemic Stroke Tudor G. Jovin, MD, Pittsburgh, PA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Pharmacist, Advanced Practice Provider Monday, April 24, 2017

C73

7:00 a.m.–9:00 a.m.

Current Management of Incidental and Asymptomatic Cerebrovascular Lesions

Topic: Cerebrovascular Disease and Interventional Neurology Director: Seemant Chaturvedi, MD, FAAN, FAHA, Miami, FL Program Description: In the past 10 years, the rate of neuroimaging has soared. Included in this category is both brain and neurovascular imaging. The increase in imaging has led to marked increase in the number of identified patients with asymptomatic or incidental neurovascular conditions. At the current time, there exists considerable controversy in the management of unruptured aneurysms and AVMs. In addition, the surgical treatment of asymptomatic carotid stenosis is receiving renewed scrutiny due to advances in medical therapy. Faculty will review the evaluation and management of these asymptomatic neurovascular conditions. Upon Completion: Participants should become aware of the most recent clinical trial and population-based data pertaining to asymptomatic neurovascular conditions, such as unruptured aneurysms and AVMs, and asymptomatic carotid stenosis; as well as gain an appreciation for which treatments are potentially cost-effective. Participants should also become familiar with new clinical trials related to these conditions.

Monday, April 24, 2017

C99

3:30 p.m.–5:30 p.m.

Therapeutic Temperature Modulation in the ICU

Topic: Cerebrovascular Disease and Interventional Neurology Director: Stephan A. Mayer, MD, New York, NY Program Description: Therapeutic temperature modulation (TTM) is an essential therapy for minimizing brain injury in the ICU. Faculty will review the latest technology, data, and protocols for TTM in the treatment of hypoxicischemic brain injury after cardiac arrest, elevated intracranial pressure, and neurogenic fever; how to minimize complications from TTM; and describe the implications of TTM on prognostication after severe brain injury. Upon Completion: Participants should be able to know when TTM is indicated and when it is not, employ ICU-based protocols and algorithms for the safe and efficient application of TTM, and understand the impact of TTM on neurological recovery and prognostication. Lecture/Faculty: }} How to Cool in the ICU Neeraj Badjatia, MD, Baltimore, MD }} TTM for Cardiac Arrest Stephan A. Mayer, MD, New York, NY }} TTM for Fever Control David M. Greer, MD, FAAN, New Haven, CT }} TTM for Trauma and ICP Neeraj Badjatia, MD, Baltimore, MD }} Emerging Indications: Stroke and Status David M. Greer, MD, FAAN, New Haven, CT }} Prognostication in the Era of TTM Stephan A. Mayer, MD, New York, NY Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

$ = Additional Fee Required L = Leadership University

Tuesday, April 25, 2017

7:00 a.m.–9:00 a.m.

C112 Stroke in Young Adults and Women Topics: Cerebrovascular Disease and Interventional Neurology; Child Neurology and Developmental Neurology Director: Aneesh B. Singhal, MD, FAAN, Boston, MA Program Description: Faculty will review the incidence, risk factors, mechanisms, outcomes, and long-term impact after stroke in young adults and women. The program will focus on ischemic stroke and cerebral venous sinus thrombosis. Special emphasis will be given to cerebral arteriopathies such as dissection, vasculitis and the reversible cerebral vasoconstriction syndromes, as well as hormonal risk factors, and the unique multi-disciplinary needs of young adults and women with stroke. Upon Completion: Participants should be able to promptly recognize stroke in the young, develop cost-effective diagnostic strategies, deliver appropriate evidence-based acute and preventive treatment, and effectively manage the long-term consequences of stroke in young adults and women. Lecture/Faculty: }} Introduction and Epidemiology Aneesh B. Singhal, MD, FAAN, Boston, MA }} Cerebral Arteriopathies Aneesh B. Singhal, MD, FAAN, Boston, MA }} Hormones and Hypercoagulable States Cheryl Bushnell, MD, MHS, Winston Salem, NC Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Wednesday, April 26, 2017

7:00 a.m.–9:00 a.m.

C155 Controversies in Stroke Therapy Topic: Cerebrovascular Disease and Interventional Neurology Director: Steven R. Messé, MD, FAAN, FAHA, Philadelphia, PA Program Description: The management of patients with acute ischemic stroke and strategies for stroke prevention continue to evolve rapidly. Keeping abreast of advances in the field is a challenge. Several recent clinical trials will have substantial impact on stroke therapy. However, some published data are conflicting, and there are numerous remaining questions, leading to controversy regarding optimal management. Faculty will present a succinct, up-to-date, evidence-based approach to the comprehensive management of acute cerebral infarction and long-term vascular risk reduction. When an approach is unclear or unproven, faculty will discuss their experience with particular Fast and easy registration · AAN.com/view/AM17 39

Cerebrovascular

Lecture/Faculty: }} Approach to Unruptured Aneurysms and AVMs Roberta Novakovic, MD, Dallas, TX }} Approach to Asymptomatic Carotid Stenosis Seemant Chaturvedi, MD, FAAN, FAHA, Miami, FL }} Illustrative Cases Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider

Course Descriptions strategies. Presentations will provide concise, useful information that may be directly applied to the participant’s practice. Discussions will include common yet challenging scenarios in stroke management. The session will provide ample opportunity for participants to ask questions or present their own cases to the faculty. Upon Completion: Participants should be knowledgeable about the optimal management of acute cerebral infarction, including patient selection for thrombolytic treatment, endovascular therapy, and surgical interventions; and develop a logical framework for implementing various long-term vascular risk reduction strategies, including selection of antithrombotic agents, lipid modifiers, antihypertensive therapies, and revascularization procedures. Lecture/Faculty: }} Controversies in Acute Stroke Steven R. Messé, MD, FAAN, FAHA, Philadelphia, PA }} Controversies in Stroke Prevention Tanya N. Turan, MD, FAAN, Charleston, SC }} Questions and Cases Faculty Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Thursday, April 27, 2017

7:00 a.m.–9:00 a.m.

C195 Stroke Team Action Therapy (STAT):

Current State of the Art and New Frontiers

Topic: Cerebrovascular Disease and Interventional Neurology Director: Antonio Culebras, MD, FAAN, FAHA, Syracuse, NY Program Description: With the accumulation of clinical data and mounting experience, the frontiers of mechanical thrombectomy are in a process of expansion fueled by robust data from recent clinical trials. The 6-6-6 rule (NIHSS minimum 6; onset 6 hours or less; ASPECTS 6 or higher) has become convention but the optimal neuroimaging modality remains under question and there are clinical variations such as very old age, wakeup-stroke, pregnancy, and others that require further exploration. PFO is a common finding in patients admitted for management of acute stroke. When PFO is associated with other vascular risk factors or with cardiac anomalies including a right-to-left shunt, uncertainties regarding therapeutic management to prevent recurrent stroke become a disquieting issue. Using a Case Discussion format faculty will present a challenging case, discuss recommendations and present scientific evidence supporting the recommendations to implement optimal acute Stroke Team Action Therapy (STAT). 40 2017 AAN Annual Meeting Early Look

Cerebrovascular Disease and Interventional Neurology Upon Completion: Participants should become familiar with the expanding frontiers of mechanical thrombectomy in acute stroke and learn about the new guidelines for prevention of recurrent stroke in patients with PFO. Lecture/Faculty: }} Introduction Antonio Culebras, MD, FAAN, FAHA, Syracuse, NY }} Frontiers of Mechanical Thrombectomy in Acute Stroke Faculty }} Therapeutic Management of Recurrent Stroke in Patients with PFO and Additional Vascular Risk Factors Steven R. Messé, MD, FAAN, FAHA, Philadelphia, PA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider Friday, April 28, 2017

7:00 a.m.–9:00 a.m.

C225 Update on Medical Management of Stroke Topic: Cerebrovascular Disease and Interventional Neurology Director: Natalia Sana Rost, MD, FAAN, Boston, MA Program Description: For patients presenting with signs and symptoms of acute stroke, the window for diagnosis and intervention is narrow and treatment options are often limited. This program will address the challenges in management of acute stroke and provide the essential skill set for rapid clinical decision-making based on the latest advances in cerebrovascular disease. Faculty will outline critical milestones in the management timeline of acute stroke and resources necessary to deliver best practices in stroke care. Upon Completion: Participants will be familiar with the latest advances in medical management of acute stroke including: best practices in selecting patients for thrombolytic and antithrombotic agent use; management of fluctuating neurological exam and hyperacute stroke complications; referral for early endovascular and surgical interventions; and resources (such as TeleStroke and advanced neuroimaging) to guide precision-diagnosis and management options that are known to improve stroke outcomes. Lecture/Faculty: }} The Hyperacute Stroke: All That On-call Neurologists Need to Know Natalia Sana Rost, MD, FAAN, Boston, MA }} Beyond Thrombolytics: Medical Management of Acute Stroke and Its Early Complications Jose Biller, MD, FAAN, FACP, FAHA, Chicago, IL }} Difficult Decision-making in Acute Stroke: Tools and Resources for Management of Unstable Patients Natalia Sana Rost, MD, FAAN, Boston, MA

Friday, April 28, 2017

3:30 p.m.–5:30 p.m.

C241 Update on Endovascular Treatment of Acute Stroke and Cerebrovascular Diseases

Topic: Cerebrovascular Disease and Interventional Neurology Director: Dileep R. Yavagal, MD, FAAN, Miami, FL Program Description: Endovascular therapy has recently become the standard of care in conjunction with IV tPA for acute ischemic stroke. This case- and evidence-based course will review this landmark advancement and its implementation. Faculty will also review rapid advances that have occurred in endovascular therapy to treat several other cerebrovascular disorders (CVD). Most notably, faculty will review data that have accrued since the landmark RCTs for endovascular mechanical thrombectomy in 2015. They will review how to organize stroke systems of care for maximizing access in our communities. Furthermore, faculty will review several new devices and recent clinical trial data available for endovascular treatment of hemorrhagic CVD, including aneurysms, AVMs, and Dural AVFs. The latest consensus and ongoing trials in the controversial area of carotid stenting and intracranial stenting will also be discussed in detail. Upon Completion: Participants will be able to discuss the application of mechanical thrombectomy in AIS as the new standard of care. They will be able to review the latest endovascular techniques for aneurysms, AVMs, and dural AVFs, their indications for application in patients, and scientific evidence from latest clinical trials. Participants will also be able to discuss how to tailor application of neuroendovascular therapies in individual case scenarios. Lecture/Faculty: }} Mechanical Thrombectomy: What Have We Learned Since the Landmark Trials? Dileep R. Yavagal, MD, FAAN, Miami, FL }} Selection of Patients and Devices for Mechanical Thrombectomy Faculty }} Advances in Embolization of Intracranial Aneurysms, AVMs, and Dural AVFs Thanh Ngoc Nguyen, MD, Boston, MA }} Update on Carotid and Intracranial Stening Dileep R. Yavagal, MD, FAAN, Miami, FL

$ = Additional Fee Required L = Leadership University

Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement, Professionalism, Systems-Based Practice Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Nurse, Advanced Practice Provider

CHILD NEUROLOGY AND DEVELOPMENTAL NEUROLOGY Sunday, April 23, 2017

C24

7:00 a.m.–9:00 a.m.

Child Neurology: A Case-based Approach

Topics: Child Neurology and Developmental Neurology; Movement Disorders Director: Elaine C. Wirrell, MD, Rochester, MN Program Description: The field of child neurology is changing rapidly. Faculty will provide an evidence-based update on recent advances in our understanding of the pathophysiology, diagnostic strategies, and therapies for various neurologic disorders in children, using cases to facilitate discussion. Upon Completion: Participants should be able to identify and implement new breakthroughs in the field of child neurology that impact day-to-day practice, and be able to locate and use new practice guidelines to inform medical decision-making. Lecture/Faculty: }} Child Neurology: Autoimmune Cases Jan-Mendelt Tillema, MD, Rochester, MN }} Child Neurology: Cerebrovascular Cases Faculty }} Child Neurology: Epilepsies and Paroxysmal Disorders Elaine C. Wirrell, MD, Rochester, MN Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Child Neurologist, Advanced Practice Provider

Fast and easy registration · AAN.com/view/AM17 41

Cerebrovascular

}} Special Cases in Acute Stroke: Challenging the Norm Jose Biller, MD, FAAN, FACP, FAHA, Chicago, IL Core Competencies: Interpersonal and Communication Skills, Practice-Based Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist

Course Descriptions Monday, April 24, 2017

C65

7:00 a.m.–9:00 a.m.

Child Neurology I: Pediatric Stroke, MS/Autoimmune

Topic: Child Neurology and Developmental Neurology Director: Marc C. Patterson, MD, FAAN, FRACP, Rochester, MN Program Description: This program focuses on disorders that are frequent and well recognized in adults, but which may be missed and undertreated in children. Stroke in neonates and children is less common than in adults, and its causes and presentations vary. Better diagnostic techniques and standardized treatment protocols have been developed, and will be described. Multiple sclerosis and other immune mediated disorders also occur in children; recent advances in understanding and management of these conditions will be reviewed. This program complements C80: Child Neurology II: Epilepsy and Neuromuscular, and C94: Child Neurology III: Headache, TBI/Postconcussion, but covers independent topics. Upon Completion: Participants should be able to recognize the presentations and etiology of stroke, MS, and autoimmune disorders throughout childhood, and recommend and interpret appropriate investigations and implement data-driven management strategies. Lecture/Faculty: }} Stroke in Children Faculty }} Multiple Sclerosis and Autoimmune Disorders Jan-Mendelt Tillema, MD, Rochester, MN }} Metabolic Mimics of Stroke and Immune-mediated Disorders Marc C. Patterson, MD, FAAN, FRACP, Rochester, MN Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Monday, April 24, 2017

C80

1:00 p.m.–3:00 p.m.

Child Neurology II: Epilepsy and Neuromuscular

Topic: Child Neurology and Developmental Neurology Director: Marc C. Patterson, MD, FAAN, FRACP, Rochester, MN Program Description: Epilepsy is a common cause of disability in children. Mechanisms of this family of disorders are being elucidated using molecular and electrophysiological tools and will be described, as will the application of these advances is improving diagnosis and offering 42 2017 AAN Annual Meeting Early Look

Child Neurology and Developmental Neurology new approaches to management. Similar approaches have likewise improved our understanding of neuromuscular disease in children, leading to improved diagnosis and management. Key advances will be presented. This program complements C65: Child Neurology I: Pediatric Stroke, MS/Autoimmune and C94: Child Neurology III: Headache, TBI/Postconcussion, but covers independent topics. Upon Completion: Participants should be able to describe current approaches to diagnosis and management of epilepsy and neuromuscular disease in children, and relate these to advances in basic science. Lecture/Faculty: }} Epilepsy in Children and Adolescents Faculty }} Neuromuscular Disease Faculty Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Monday, April 24, 2017

C94

3:30 p.m.–5:30 p.m.

Child Neurology III: Headache, TBI/Post-concussion

Topic: Child Neurology and Developmental Neurology Director: Marc C. Patterson, MD, FAAN, FRACP, Rochester, MN Program Description: Headache is one of the most frequent presenting complaints in neurologic and general pediatric practice. The physiological basis of headache is becoming better understood in line with advances in genomics. In parallel, the natural history of childhood headache, particularly chronic headache, is better defined. A broad range of treatment options are now available for children afflicted with headache and will be reviewed. Traumatic brain injury and concussion is increasingly recognized as a significant cause of disability in children and adults. The current understanding of these disorders and their management will be reviewed. This program complements C65: Child Neurology I: Pediatric Stroke, MS/Autoimmune, and C80: Child Neurology II: Epilepsy and Neuromuscular, but covers independent topics. Upon Completion: Participants should be able to diagnose and classify common and less frequent headaches and devise an effective management strategy. They should also be familiar with the current understanding of traumatic brain injury and concussion and be comfortable managing these disorders in children and adolescents.

Tuesday, April 25, 2017

7:00 a.m.–9:00 a.m.

1:00 p.m.–3:00 p.m.

3:30 p.m.–5:30 p.m.

Wednesday, April 26, 2017

7:00 a.m.–9:00 a.m.

C154 Autism Spectrum Disorders—What We Know and Where We Are Going

Topic: Child Neurology and Developmental Neurology Director: Frances E. Jensen, MD, Philadelphia, PA Program Description: Faculty will emphasize the clinical application of the DSM-5 for the diagnosis of ASD, identification of genetic disorders with ASD and how to test for these, the utility of diagnosing epilepsy in this population, and what AEDs are useful. Upon Completion: Participants should be able to understand how to apply the DSM-5 criteria in diagnosing ASD, recognize some specific genetic disorders associated with ASD and how to test for these, and know which epilepsy syndrome are associated with ASD and which AEDs are useful and tolerated in patients with ASD. Lecture/Faculty: }} Autism Spectrum Disorders—What We Know and Where We Are Going Frances E. Jensen, MD, Philadelphia, PA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider Thursday, April 27, 2017

1:00 p.m.–3:00 p.m.

C205 Neurologic Complications in

Adults with Down Syndrome

Topics: Child Neurology and Developmental Neurology; Aging, Dementia, Cognitive, and Behavioral Neurology Director: Seth M. Keller, MD, Lumberton, NJ Program Description: Neurologic complications in adults with Down syndrome (DS) are very common. Years ago individuals with Down syndrome often did not survive into adulthood, but with advances in health care and disability rights, many are now becoming seniors. Advancing age brings the expected age-related decline in function as well as disease. Neurologic complications including gait dysfunction, tremors, seizures, and dementia all become significant health complications which often have a tremendous impact on quality of life, activities of daily living, as well as their effects on families and support organizations that care for these individuals. This program will bring together experts in the field who will be able to educate and train the health care provider in being able to reduce the burden of disease, improve satisfaction of care, and provide a model to others.

$ = Additional Fee Required L = Leadership University

Fast and easy registration · AAN.com/view/AM17 43

Child Neurology

Lecture/Faculty: }} Episodic Migraine and Episodic Syndromes Associated with Migraine Faculty }} Chronic Migraine and Other Daily Headache Disorders Kenneth J. Mack, MD, PhD, FAAN, Rochester, MN }} Traumatic Brain Injury and Concussion Faculty Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement Teaching Style: Case-Based CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist

Course Descriptions Upon Completion: Participants should be familiar with the demographics of aging over time in those with DS; discuss the issues involved with aging parents and community supports; describe how seizures manifest in those aging with DS; explain how gait dysfunction develops in those aging with DS; and recognize how early onset Alzheimer’s disease occurs in those with DS. Lecture/Faculty: }} Transitioning of Care Nicole Tara Baumer, MD, Boston, MA }} The Aging Brain: Cognitive Dysfunction and Decline Ira T. Lott, MD, Mission Viejo, CA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Self Advocate, Family Member, Support Staff, DD Supervisor, Advanced Practice Provider Friday, April 28, 2017

7:00 a.m.–9:00 a.m.

C226 How to Integrate Sleep Medicine

into Your Child Neurology Practice

Topics: Sleep; Child Neurology and Developmental Neurology Director: Suresh Kotagal, MD, FAAN, Rochester, MN See complete course description on page 135 » Friday, April 28, 2017

3:30 p.m.–5:30 p.m.

C244 Emergency Neurology II:

Consultations in the General ICU

Topics: Neuro Trauma, Critical Care, and Sports Neurology; Child Neurology and Developmental Neurology; General Neurology Director: Jose I. Suarez, MD, Cleveland, TX See complete course description on page 98 »

44 2017 AAN Annual Meeting Early Look

Epilepsy/Clinical Neurophysiology (EEG)

EPILEPSY/CLINICAL NEUROPHYSIOLOGY (EEG) Saturday, April 22, 2017

8:00 a.m.–10:00 a.m.

Status Epilepticus

Topic: Epilepsy/Clinical Neurophysiology (EEG) Director: Frank W. Drislane, MD, FAAN, Boston, MA Program Description: While generalized convulsive status epilepticus (GCSE) is relatively easily diagnosed, recognition of nonconvulsive SE is often poor, especially in medically and neurologically ill patients in ICUs. Diagnosis of SE requires knowledge of many clinical syndromes. This course will review many different etiologies and presentations of status epilepticus (SE), including convulsive, nonconvulsive, and myoclonic SE—each of which must be evaluated and treated differently. There will be plenty of information on the proper interpretation of EEGs in the diagnosis of SE, including during prolonged EEG monitoring in the ICU. Management of SE has become more complicated than simply choosing ‘the’ drug for convulsive SE. Detailed description will be given of the remarkably varied treatments that are emerging for the most refractory SE cases. Upon Completion: Participants should be able to diagnose status epilepticus in urgent and unusual presentations; integrate clinical and EEG findings to make a correct diagnosis; recognize and treat cases of nonconvulsive status, avoiding both under-recognition and over-treatment; have a command of the utility and practicalities of EEG monitoring in the management of SE in very ill ICU patients; and utilize several more “aggressive“ treatments effectively for the most refractory SE cases. Lecture/Faculty: }} Nonconvulsive and Unusual Forms of Status Epilepticus Frank W. Drislane, MD, FAAN, Boston, MA }} Use and Interpretation of EEG Monitoring for Seizures and Status Epilepticus in the ICU Faculty }} Treatment of Refractory Status Epilepticus Stephan Schuele, MD, FAAN, Chicago, IL Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

C29

7:00 a.m.–9:00 a.m.

Clinical Epilepsy I: Basics

Topic: Epilepsy/Clinical Neurophysiology (EEG) Director: Tracey A. Milligan, MD, FAAN, Boston, MA Program Description: Faculty will comprehensively cover aspects of diagnosing and managing patients with seizure disorders; review the new ILAE classification scheme, Epilepsy Quality Measures, and the primary goals of accurate diagnosis and selection of appropriate first-line medications; address common psychiatric comorbidities; review the latest advances in each topic discussed; emphasize issues most useful to clinical practice by using a case-based approach; and use video case presentations to illustrate the differential diagnosis of seizure-like events and how to classify seizures. This program complements C41: Clinical Epilepsy II: Considerations Across the Age Span—Pediatrics, Pregnancy and Elderly and C58: Clinical Epilepsy III: Advanced (Status, Beyond AED, Video EEG), but covers independent topics. Upon Completion: Participants should be able to efficiently and thoroughly evaluate a patient presenting with seizures, accurately apply the latest approved classification system for epilepsy, choose appropriate first-line treatments, and recognize and know how to evaluate common psychiatric comorbidities. Lecture/Faculty: }} Is Epilepsy the Diagnosis? Case Studies and Videos Tracey A. Milligan, MD, FAAN, Boston, MA }} Psychiatric Co-morbidities: What All Neurologists Need to Know in the Management of the Seizure Disorder Andres M. Kanner, MD, Miami, FL }} Individualizing AED Choices Jacqueline French, MD, FAAN, New York, NY Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

$ = Additional Fee Required L = Leadership University

Sunday, April 23, 2017

C41

1:00 p.m.–3:00 p.m.

Clinical Epilepsy II: Considerations Across the Age Span— Pediatrics, Pregnancy, and Elderly

Topic: Epilepsy/Clinical Neurophysiology (EEG) Director: Barbara C. Jobst, MD, FAAN, Lebanon, NH Program Description: Faculty will comprehensively address specific aspects of epilepsy care across the age span. This includes recognition and treatment of childhood epilepsy syndromes, with considerations for special testing, such as early genetic testing. Women’s health issues in seizure care, especially during pregnancy, will inform about the risks and benefits of medical and surgical treatments. Birth control options for patients with epilepsy will be discussed. The elderly are another distinct patient population. The distinction between epileptic and non-epileptic events is particularly important in this age group. Declining cognition and the effects of anti-epileptic medications and their interactions will be discussed. Illustrative cases will complement the course. This program complements C29: Clinical Epilepsy I: Basics and C58: Clinical Epilepsy III: Advanced (Status, Beyond AED, Video EEG), but covers independent topics. Upon Completion: Participants should be able to efficiently and thoroughly evaluate a patient presenting with seizures while considering special age-related aspects of care. Participants should be informed about diagnosis and treatment of common childhood epilepsy syndromes, be able treat and advise women in the reproductive age appropriately, and be informed about special aspects of epilepsy care in the elderly. Lecture/Faculty: }} Diagnosis and Treatment of Pediatric Epilepsy Lily Wong-Kisiel, MD, Rochester, MN }} Pregnancy and Reproductive Health in Patients with Epilepsy Page B. Pennell, MD, Boston, MA }} Epilepsy in the Elderly: Special Considerations Barbara C. Jobst, MD, FAAN, Lebanon, NH Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

Fast and easy registration · AAN.com/view/AM17 45

Epilepsy (EEG)

Sunday, April 23, 2017

Course Descriptions Sunday, April 23, 2017

C58

3:30 p.m.–5:30 p.m.

Clinical Epilepsy III: Advanced (Status, Beyond AED, Video EEG)

Topic: Epilepsy/Clinical Neurophysiology (EEG) Director: Tobias Loddenkemper, MD, Boston, MA Program Description: Faculty will review and discuss complicated aspects of diagnosing and treating patients with epilepsy with a focus on tertiary aspects. The recognition of acute repetitive seizures and status epilepticus in their various forms, from subtle to convulsive, will be discussed in detail. Management options will be reviewed in various settings, including in the home, the emergency room, inpatient, and the intensive care unit. The latest definition for drug resistant epilepsy will be discussed and how to apply it to an individual patient. Therapeutic options beyond antiepileptic drugs will be reviewed in detail, including diet, devices, surgery, and marijuana. Faculty will review the latest advances in each topic discussed. Issues most useful to clinical practice will be emphasized by using a case-based approach. Video case presentations will be used to illustrate different seizure types in an engaging manner with the audience. This program complements C29: Clinical Epilepsy I: Basics and C41: Clinical Epilepsy II: Considerations Across the Age Span—Pediatrics, Pregnancy and Elderly, but covers independent topics. Upon Completion: Participants should be able to recognize when a patient meets criteria for acute repetitive seizures, status epilepticus, and drug resistant epilepsy. Participants should be able to know the latest therapeutic approaches to these patients in a variety of settings from home, to outpatient clinic, and in the hospital. Participants should recognize when to consider treatments in addition to AEDs and which ones to consider given a specific patient seizure type and clinical scenario. Participants will become more familiar with classifying seizures through video presentations. Lecture/Faculty: }} Acute Repetitive Seizures and Status Epilepticus Tobias Loddenkemper, MD, Boston, MA }} Beyond AEDs—Surgery, Devices, Diet, or Marijuana? Elson L. So, MD, FAAN, Rochester, MN }} Name that Seizure: Video Case Presentations William O. Tatum, IV, DO, FAAN, Tampa, FL Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Neurointensivist, Advanced Practice Provider

46 2017 AAN Annual Meeting Early Look

Epilepsy/Clinical Neurophysiology (EEG) Monday, April 24, 2017

C89

1:00 p.m.–5:30 p.m.

Neurophysiologic Intraoperative Monitoring Skills Workshop $ (registration required)

Topic: Epilepsy/Clinical Neurophysiology (EEG) Director: Gloria Galloway, MD, FAAN, Columbus, OH Program Description: This workshop will include didactic discussion and case studies supplemented in some cases by demonstrations of basic intraoperative neurophysiologic monitoring techniques used in clinical practice. Discussion will include Somatosensory, Motor and EMG and Peripheral Nerve monitoring. Upon Completion: Participants should be able to have a basic understanding of the various evoked potential modalities used in intraoperative neurophysiologic monitoring cases. Lecture/Faculty: }} Review of Somatosensory Evoked Potentials in IOM Aatif M. Husain, MD, Durham, NC }} Review of Motor Evoked Potentials in IOM Ronald G. Emerson, MD, FAAN, New York, NY }} EMG and Peripheral Nerve Monitoring Gloria Galloway, MD, FAAN, Columbus, OH }} Skills Sessions / SEPS Aatif M. Husain, MD, Durham, NC }} Skills Sessions / BAER Alan D. Legatt, MD, PhD, FAAN, Bronx, NY Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive CME Credits: 4 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Technologists Monday, April 24, 2017

6:00 p.m.–9:00 p.m.

C109 Case Studies:

How to Analyze Spells by Video-EEG

Topic: Epilepsy/Clinical Neurophysiology (EEG) Director: Amy Z. Crepeau, MD, Phoenix, AZ Program Description: Spells can be difficult to diagnosis in children and adults, as both epileptic and non-epileptic causes need to be considered. Video EEG is often necessary to provide a definitive diagnosis. This course will use a case-based approach to evaluating seizure semiology, and the differential diagnosis of seizure-like spells, using video EEG as a guide.

Lecture/Faculty: }} Seizure Semiology Faculty }} Evaluation of Pediatric Spells in the EMU Tobias Loddenkemper, MD, Boston, MA }} Evaluation of Adult Spells in the EMU Amy Z. Crepeau, MD, Phoenix, AZ Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive, Audience Participation, Video Examples CME Credits: 3 Recommended Audience: Trainee, General Neurologist, NonNeurologist Tuesday, April 25, 2017

7:00 a.m.–9:00 a.m.

C115 The Burden of Epilepsy:

Managing Comorbidities and Quality of Life

Topic: Epilepsy/Clinical Neurophysiology (EEG) Director: Gregory D. Cascino, MD, FAAN, Rochester, MN Program Description: This program will address the cognitive, neurologic, and psychiatric disorders associated with epilepsy, and the socio-economic consequences of the disease. The adverse effects of the therapy will also be considered. The comorbidity of epilepsy may be progressive and impair the patients’ quality of life. In selected individuals these disorders may be more significant that the seizure activity. The burden of epilepsy is not well understood by many neurologists, and not addressed adequately in the evaluation and treatment of people with epilepsy. Upon Completion: Participants should become familiar with the current recommendations for the evaluation and treatment of comorbid conditions that occur in people with epilepsy including language and cognitive disorders, behavioral problems, depression, and complications of treatment. Clinical pearls to screen patients for significant mood disorders that may be associated with suicide will be provided. The risks, prevalence, and possible prevention of sudden unexplained death in epilepsy (SUDEP) will be presented. Lecture/Faculty: }} Medical Knowledge, Patient Care Terence John O’Brien, MBBS, Victoria, Australia }} Cognitive and Psychiatric Issues Associated with Seizure Disorders Kimford J. Meador, MD, FAAN, Palo Alto, CA $ = Additional Fee Required L = Leadership University

}} SUDEP and Medical Issues Related to Seizures Jeffrey R. Buchhalter, MD, FAAN, Calgary, AB, Canada Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Tuesday, April 25, 2017

1:00 p.m.–3:00 p.m.

C126 Critical Care EEG Monitoring Topics: Epilepsy/Clinical Neurophysiology (EEG); Neuro Trauma, Critical Care, and Sports Neurology Director: Aatif M. Husain, MD, Durham, NC Program Description: This course will review important aspects of continuous EEG (cEEG) monitoring in critically ill patients. This will include a review of the frequency with which seizures are detected in this patient population. Additionally, faculty will present information about the appropriate patient type to monitor and how long to monitor. Interpretation of cEEG monitoring can be significantly different than interpreting other types of EEG data, and faculty will explain how to recognize artifacts and differentiate them from seizures, as this is a frequent source of errors and misinterpretation. The significance of many EEG patterns is uncertain in this patient population, and faculty will review this pattern and present nuanced interpretation of these patterns, as well as cover quantitative analysis programs frequently used in analyzing cEEG data along with various ways to evaluate cEEG data quantitatively. Upon Completion: Participants should be able to recognize appropriate patients who may benefit from cEEG monitoring, appreciate the nuanced interpretation of cEEG data and differentiate artifacts from cerebral activity, and recognize the value and limitations of quantitative analysis of cEEG and apply this to their practice settings. Lecture/Faculty: }} ICU EEG Monitoring: Why, When, and for Whom Aatif M. Husain, MD, Durham, NC }} EEG Patterns in the ICU Suzette M. LaRoche, MD, FAAN, Asheville, NC }} Quantitative EEG for Seizure Identification Nicholas Scott Abend, MD, Philadelphia, PA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider

Fast and easy registration · AAN.com/view/AM17 47

Epilepsy (EEG)

Upon Completion: Participants should be able to understand the basic technical requirements for performing video EEG monitoring and indications for referring patients. In addition, they will be able to recognize various seizure semiological features that assist with localization, and outline non-epileptic seizure mimics.

Course Descriptions Tuesday, April 25, 2017

3:30 p.m.–5:30 p.m.

C141 Acute and Chronic Clinical Epilepsy Update Explained in 6 Cases

Topic: Epilepsy/Clinical Neurophysiology (EEG) Director: Joseph I. Sirven, MD, FAAN, Phoenix, AZ Program Description: Faculty will use a “headline news” approach to highlight important epilepsy clinical information, and a rapid fire, multi-topic case-based approach with video to provide salient pithy updates on numerous epilepsy topics. Topics will include new treatments, and when to use them; how to manage seizure emergencies; the evidence base for the risks and benefits of cannabis in epilepsy patients; how to approach decisions on devices and diagnosing; and treating immune causes of epilepsy. Upon Completion: Participants should be able list or identify all currently available medication and device treatments for epilepsy; understand the management of acute seizure emergencies; know when to consider immune-based diagnoses and treatments for epilepsy, as well as surgical interventions; know how to counsel on driving laws for epilepsy; and understand where current thought stands on cannabis for epilepsy. Lecture/Faculty: }} Cases Matthew T. Hoerth, MD, Phoenix, AZ Joseph I. Sirven, MD, FAAN, Phoenix, AZ Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Pharmacist, Psychologist, Advanced Practice Provider Wednesday, April 26, 2017

3:30 p.m.–5:30 p.m.

C179 Treatments for Drug-resistant Epilepsy: An Update

Topic: Epilepsy/Clinical Neurophysiology (EEG) Director: Ellen J. Bubrick, MD, Boston, MA Program Description: Epilepsy is a common neurologic disorder, and up to a third of patients suffer from drug-resistant disease. This course will define this patient population using the most current classification system, and then focus on available treatment options including surgical resection, devices, and other non-traditional approaches. The discussion of surgery will be broken down into indications for resection with and without invasive monitoring, intracranial monitoring techniques (e.g., subdural electrodes vs. stereoEEG), and the use of laser ablation. The 48 2017 AAN Annual Meeting Early Look

Epilepsy/Clinical Neurophysiology (EEG) devices section will cover good candidates for vagal nerve stimulators as well as when to consider responsive neuro-stimulation, and current data on the latter. Other available treatments including data on diet therapies and cannabinoids will briefly be discussed. Upon Completion: Participants should be able to identify patients with drug-resistant epilepsy, become familiar with current treatment options for this patient population, and know when to refer these patients for surgery or other treatment options. Lecture/Faculty: }} Drug-resistant Epilepsy: What Is It? Who Has It? How to Treat It? Ellen J. Bubrick, MD, Boston, MA }} Surgical Management of Drug-resistant Focal Epilepsy Gregory D. Cascino, MD, FAAN, Rochester, MN }} Case Studies in Surgical Epilepsy Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Thursday, April 27, 2017

7:00 a.m.–9:00 a.m.

C188 Clinical EEG I:

Normal EEG, Normal Variants, and How to Avoid Over-reading EEGs

Topic: Epilepsy/Clinical Neurophysiology (EEG) Director: Selim R. Benbadis, MD, Tampa, FL Program Description: Faculty will provide an overview of the principles underlying the practice of clinical EEG. The presentations will emphasize aspects that are crucial to reading EEGs in clinical practice. Specific topics will be common normal patterns, normal variants that are commonly overinterpreted, artifacts, and guidance on how to generate meaningful EEG reports. This program complements C199: Clinical EEG II: Focal, Diffuse, and Epileptiform Abnormalities in Adults and C212: Clinical EEG III: Pediatric and Neonatal, but covers independent topics. Upon Completion: Participants should be able to distinguish normal pattern form abnormalities; avoid common pitfalls, such as misinterpretation of artifacts and normal variants; and generate quality reports. Lecture/Faculty: }} Over-reading EEGs and the Myth of “Phase Reversals” Selim R. Benbadis, MD, Tampa, FL }} Artifacts and How to Avoid Overcalling Them Susan T. Herman, MD, FAAN, Boston, MA

Thursday, April 27, 2017

1:00 p.m.–3:00 p.m.

C199 Clinical EEG II: Focal, Diffuse, and

Epileptiform Abnormalities in Adults

Topic: Epilepsy/Clinical Neurophysiology (EEG) Director: Susan T. Herman, MD, FAAN, Boston, MA Program Description: This course provides a thorough review of the practice of clinical EEG, including routine EEG in adults and children, long-term ambulatory and video-EEG monitoring in epilepsy, and EEG in critically ill patients. In Clinical EEG II, faculty will discuss common indications for EEG studies, and the relative yield of different EEG types for diagnosis and management of epilepsy, encephalopathy, and coma. Topics will include EEG abnormalities caused by focal brain lesions, EEG in dementia and encephalopathy, techniques to increase the yield of epileptiform activity, identification of interictal and ictal epileptiform patterns, and EEG findings in common and uncommon epilepsy syndromes. Multiple examples of focal abnormalities, diffuse abnormalities, and interictal and ictal EEG patterns will be presented. The session will end with interactive review of unknown EEG samples. This program complements C188: Clinical EEG I: Normal EEG, Normal Variants, and How to Avoid Over-reading EEGs and C212: Clinical EEG III: Pediatric and Neonatal, but covers independent topics. Upon Completion: Participants should be able to appropriately order EEG studies in the diagnostic evaluation of neurologic disorders in adults, avoiding inappropriate use of EEG. Identify normal and abnormal EEG patterns in adults and the elderly; correctly interpret focal and diffuse EEG abnormalities in patients with epilepsy, focal brain disorders, and diffuse brain disorders; select the best EEG type in the diagnostic evaluation of epilepsy; identify interictal and ictal epileptiform patterns in adults in outpatient, inpatient, and ICU settings; and correctly interpret focal and generalized epileptiform patterns to aid in seizure and epilepsy syndrome classification.

$ = Additional Fee Required L = Leadership University

Lecture/Faculty: }} Focal and Diffuse Abnormalities in Adults Susan T. Herman, MD, FAAN, Boston, MA }} Interictal and Ictal Abnormalities in Adults Katherine H. Noe, MD, PhD, Phoenix, AZ }} EEG Unknowns Susan T. Herman, MD, FAAN, Boston, MA Katherine H. Noe, MD, PhD, Phoenix, AZ Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Advanced Practice Provider Thursday, April 27, 2017

3:30 p.m.–5:30 p.m.

C212 Clinical EEG III:

Pediatric and Neonatal

Topic: Epilepsy/Clinical Neurophysiology (EEG) Director: Susan T. Herman, MD, FAAN, Boston, MA Program Description: This course will provide a thorough review of the principles underlying the practice of clinical EEG, including routine EEG in adults and children, long-term ambulatory and video-EEG monitoring in epilepsy, and EEG in critically ill patients. Faculty will present abnormal EEG in neonates and children. Topics will include normal maturation of EEG patterns from the neonatal period through adolescence. The session will build on information from Clinical EEG II by highlighting diffuse and focal abnormalities specific to pediatric EEG, and interictal and ictal epileptiform patterns seen in neonates and children. Multiple examples of focal abnormalities, diffuse abnormalities, and interictal and ictal EEG patterns will be presented. The session will end with interactive review of unknown EEG samples. This program complements C188: Clinical EEG I: Normal EEG, Normal Variants, and How to Avoid Over-reading EEGs and C199: Clinical EEG II: Focal, Diffuse, and Epileptiform Abnormalities in Adults, but covers independent topics. Upon Completion: Participants should be able to appropriately order EEG studies in the diagnostic evaluation of neurologic disorders in neonates and children, avoiding inappropriate use of EEG; identify normal and abnormal EEG patterns in pediatric patients; correctly interpret focal and diffuse EEG abnormalities in patients with epilepsy, focal brain disorders, and diffuse brain disorders; select the best EEG type in the diagnostic evaluation of epilepsy; identify interictal and ictal epileptiform patterns in neonates and children in outpatient, inpatient, and ICU settings; and correctly interpret focal and generalized epileptiform patterns to aid in seizure and epilepsy syndrome classification.

Fast and easy registration · AAN.com/view/AM17 49

Epilepsy (EEG)

}} Normal EEG and the Range of Normal John M. Stern, MD, FAAN, Los Angeles, CA }} How to Write EEG Reports Selim R. Benbadis, MD, Tampa, FL }} Discussion, Questions and Answers, and Show-and-Tell Faculty Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, EEG Technologist

Course Descriptions Lecture/Faculty: }} Normal and Abnormal EEG in Neonates and Children Tammy Tsuchida, MD, PhD, Washington, DC }} Interictal and Ictal EEG in Neonates and Children Tobias Loddenkemper, MD, Boston, MA }} EEG Unknowns Tobias Loddenkemper, MD, Boston, MA Tammy Tsuchida, MD, PhD, Washington, DC Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Advanced Practice Provider Friday, April 28, 2017

7:00 a.m.–9:00 a.m.

C229 Emerging Therapies in Epilepsy Topic: Epilepsy/Clinical Neurophysiology (EEG) Director: Daniel Friedman, MD, New York, NY Program Description: Despite the availability of over 20 anti-seizure drugs, about 30 percent of people with epilepsy cannot achieve complete seizure control on available therapy, and many more experience side-effects of their treatment. Treatment gaps also exist in the management of status epilepticus; many patients fail to respond to first- or second-line treatments. This program will review some of the latest advances in the medical and surgical treatment of epilepsy. Faculty will provide the latest information about the potential efficacy and safety of cannabinoids for epilepsy treatment to help clinicians have evidence-based discussions with patients and family as medical cannabis becomes more widely available. Faculty will also discuss advances in surgical approaches that are less invasive than traditional epilepsy surgery and could increase the number of patients who can benefit from this approach. Finally, we will discuss novel treatments for status epilepticus that may improve patient outcomes in this neurologic emergency. Upon Completion: Participants should be able to have greater understanding of the current evidence to support the safety and efficacy of various cannabinoids for epilepsy treatment as well as potential interactions with anti-seizure drugs. Participants will also become familiar with new approaches to surgical treatment of epilepsy including laser ablation, stereotactic radiosurgery, and ultrasound-based therapies; learn about the evidence supporting these new modalities and which patients may be appropriate these new options; and understand new treatments for status epilepticus, including out-of-hospital therapies and strategies for management of refractory status epilepticus. Lecture/Faculty: }} Update on Cannabinoids for Epilepsy Daniel Friedman, MD, New York, NY 50 2017 AAN Annual Meeting Early Look

Epilepsy/Clinical Neurophysiology (EEG) }} Minimally and Non-invasive Surgical Treatments for Focal Epilepsy Jerry J. Shih, MD, FAAN, La Jolla, CA }} New and Emerging Treatments for Status Epilepticus Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider Friday, April 28, 2017

1:00 p.m.–5:30 p.m.

C238 Epilepsy Skills Workshop $ (registration required)

Topic: Epilepsy/Clinical Neurophysiology (EEG) Director: William O. Tatum, IV, DO, FAAN, Tampa, FL Program Description: In an era of technology, an often-lost art in the diagnosis and treatment of epilepsy involves recognizing the importance of a hands-on approach to patient care. This workshop will use a case study approach within small group-dedicated workstations. The goal is to facilitate practical learning that will enhance the ability to extract clinical information regarding an accurate seizure and epilepsy diagnosis for the purposes of optimizing personalized treatment. Topics that will be addressed include EEG interpretation, video EEG monitoring, childhood epilepsy syndromes, seizure emergencies, and outpatient clinical medical and surgical decision-making that is designed to optimize quality care in epilepsy. An emphasis on clinical pearls gleaned from the history, physical examination, and diagnostic evaluation will provide the foundation for treatment selection. Faculty will emphasize skills pertaining to common errors, misinterpretation, gaps, and pitfalls using case studies, protocols that involve a Sim-man in the status epilepticus portion of the workshop, and a hands-on demonstration of neuromodulation. Groups will be limited to 20 attendees to permit a focused individualized approach to guide the evaluation process of patient management depicting common scenarios by an expert faculty facilitator. Upon Completion: Participants should be familiar with the essential skills required for effective emergency management of seizures in the hospital and at the bedside. Identifying commonly misdiagnosed EEG patterns, typical semiologies necessary to make accurate diagnoses will be appreciated. Addressing common chief complaints of patients with seizures and epilepsy who present to the outpatient clinic will be attained. Attendees will be able to apply new definitions and terminology to patients with seizures, and will be able to integrate newer forms of treatment including new antiseizure drugs, formulations, surgical techniques and neuromodulation into the treatment regimens of both the pediatric and adult patien with epilepsy.

GENERAL NEUROLOGY Saturday, April 22, 2017

8:00 a.m.–5:00 p.m.

Neurology MOC Prep Course $ (registration required)

Topic: General Neurology Director: Ericka P. Simpson, MD, Houston, TX Program Description: This program is intended to provide information to help neurologists prepare for their Maintenance of Certification (MOC) exam. Invited speakers who have taken and passed the recertification examination will cover areas of neurology that are both heavily weighted on the ABPN examination and those areas that have recently been added to the examination, including interpersonal and communication issues, systems-based practice issues, diagnostic procedures, and neurorehabilitation. In addition, representatives from the ABPN and AAN will discuss new requirements for admission to the MOC examination and enrollment in the Continuous Maintenance of Certification (C-MOC) after recertification. The program will incorporate pre-test questions for each presentation to assist attendees in identifying areas that require focused study. Presentations and syllabus materials will be provided and include resources for ongoing study and review. This course has been approved by the ABPN to provide 6.5 Selfassessment CME credits. Upon Completion: Participants should be able to identify areas of neurology that require more focused study and review in preparation for the recertification examination; self-assess knowledge after completion of the educational program to further focus study and review; and $ = Additional Fee Required L = Leadership University

demonstrate improved competency and performance in clinical practice and patient outcomes based upon application of new and reviewed information derived from the educational program in their clinical practice, as well as for successful recertification and continued maintenance. Attendees will be provided information regarding the new requirements for MOC examination admission and continuing maintenance of examination including completion of CME credits, self-assessment activities, and completion of an Improvement in Medical Practice (PIP) unit. Lecture/Faculty: }} Movement Disorders Eugene C. Lai, MD, PhD, Houston, TX }} Dementia, Disease of Aging, and Cognitive Neurology Eugene C. Lai, MD, PhD, Houston, TX }} Headache and Pain Amaal J. Starling, MD, Phoenix, AZ }} Epilepsy/Sleep Katherine H. Noe, MD, PhD, Phoenix, AZ }} Demyelinating/CNS Inflammatory Disease George J. Hutton, MD, Houston, TX }} Neuromuscular Disorders Vern C. Juel, MD, FAAN, Durham, NC }} Stroke/Vascular Neurology, Critical Illness, Trauma, and Neuro-infection Faculty }} Ethics, Systems-based Practice, Interpersonal Communication, and Neuro-rehabilitation Joseph S. Kass, MD, JD, FAAN, Houston, TX Core Competency: Medical Knowledge Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 6.5 Recommended Audience: General Neurologist, Specialist Neurologist, Advanced Practice Provider Saturday, April 22, 2017

C13

10:30 a.m.–12:30 p.m.

Neurologic Complications of Medical Disease

Topic: General Neurology Director: Sara E. Hocker, MD, Rochester, MN Program Description: The interface of neurology and medicine is vast and much of the overlap is uncommonly encountered by an individual physician who may encounter, for example, only a single case of Whipple’s disease once in his/her career. Faculty will present an update of the interface of neurology and medicine in 75 minutes, followed by a 45-minute in-depth overview of the neurologic complications of cardiac and aortic disease. This program complements C20: Neurologic Complications of Medical and Surgical Therapies, but covers independent topics. Fast and easy registration · AAN.com/view/AM17 51

Epilepsy (EEG)

Lecture/Faculty: }} Breakout Session: EEG Interpretation Elizabeth Waterhouse, MD, FAAN, Richmond, VA }} Breakout Session: Video-EEG Monitoring Joseph F. Drazkowski, MD, FAAN, Phoenix, AZ }} Breakout Session: Epilepsy Clinic William O. Tatum, IV, DO, FAAN, Tampa, FL }} Breakout Session: Intensive Care Unit Matthew T. Hoerth, MD, Phoenix, AZ Joseph I. Sirven, MD, FAAN, Phoenix, AZ }} Breakout Session: Pediatric Epilepsy Raj D. Sheth, MD, FAAN, Jacksonville, FL Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation, Simulation CME Credits: 4 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Neurosurgeon, Pediatric Neurologist

Course Descriptions

General Neurology

Upon Completion: Participants should be able to recognize “update issues“ as they pertain to areas of overlap between internal medicine and neurology, and be able to recognize neurologic complications of cardiac and aortic disease, including complications from cardiac arrhythmias, patent foramen ovale, endocarditis, cardiac tumors, and aortic aneurysm and/or dissection. Lecture/Faculty: }} Overview of the Interface of Neurology and Medicine Neeraj Kumar, MD, Rochester, MN }} Neurologic Complications of Cardiac and Aortic Disease James P. Klaas, MD, Rochester, MN Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

Sunday, April 23, 2017

Saturday, April 22, 2017

Program Description: Continuing advances in genetics have led to greatly accelerated gene discovery in neurologic disorders, improving diagnosis, providing new mechanistic insights, and identifying therapeutic targets. Faculty will highlight recent technological advances and discoveries impacting the entire spectrum of neurologic diseases. In-depth focus topics will include the genetics of movement disorders and the genetics of inherited and acquired myopathies. Faculty will cover critical areas in neurogenetics, encompassing a broad spectrum of neurologic disorders that differ in their clinical manifestation, age of onset, neuroanatomical susceptibilty, and genetic mechanism. Faculty will also cover important ethical and methodological issues concerning genetic testing for neurogenetic disorders, challenges in data interpretation, and translation of neurogenetics into clinical practice. Upon Completion: Participants should obtain a broad overview of neurogenetic advances, familiarity with available tools in diagnostics, current understanding of disease mechanisms underlying hereditary developmental and degenerative neurologic disorders, treatment strategies, and expert opinions on practical and still-evolving approaches to neurogenetic disorders. Lecture/Faculty: }} Overview: Genetic Discoveries and Technological Advances Across Neurology Matthew Harms, MD, New York, NY }} Focus Topic I: Genetic Advances in Movement Disorders Christine Klein, MD, Luebeck, Germany }} Focus Topic II: The Genetics of Inherited and Acquired Myopathy Namita Goyal, MD, Orange, CA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist

C20

2:00 p.m.–4:00 p.m.

Neurologic Complications of Medical and Surgical Therapies

Topic: General Neurology Director: Sara E. Hocker, MD, Rochester, MN Program Description: Neurologic complications of medical and surgical therapies frequently are major sources of morbidity for patients admitted to the hospital. Drug therapies, critical care, and cardiac surgeries and procedures in particular are major sources of neurologic complications. Faculty will review specific neurologic complications of drug therapies, intensive care, and cardiac surgeries and procedures. This program complements C13: Neurologic Complications of Medical Disease, but covers independent topics. Upon Completion: Participants should be able to identify neurologic syndromes resulting from commonly used drugs; recognize neurologic syndromes commonly associated with intensive care; and have an approach to the evaluation of altered mental status, abnormal movements, or focal deficits following cardiac surgeries or procedures. Lecture/Faculty: }} Neurologic Complications of Cardiac Surgeries and Procedures Sara E. Hocker, MD, Rochester, MN }} Neurologic Complications of Critical Care Christopher Lawrence Kramer, MD, Chicago, IL }} Neurologic Complications of Drug Therapies Sara E. Hocker, MD, Rochester, MN Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider 52 2017 AAN Annual Meeting Early Look

C23

7:00 a.m.–9:00 a.m.

Using Sleep Medicine to Help Solve Difficult Neurologic Cases

Topics: Sleep; General Neurology Director: Bradley V. Vaughn, MD, FAAN, Chapel Hill, NC See complete course description on page 132 » Sunday, April 23, 2017

C28

7:00 a.m.–9:00 a.m.

Advances in Neurogenetics

Topic: General Neurology Director: Matthew Harms, MD, New York, NY

C31

7:00 a.m.–9:00 a.m.

Advanced Neurologic Coding

Topics: Practice, Policy, and Ethics; General Neurology Director: Peter D. Donofrio, MD, FAAN, Nashville, TN See complete course description on page 121 » Sunday, April 23, 2017

C40

1:00 p.m.–3:00 p.m.

Neurology Update I: Epilepsy, Headache, and Neurologic Infections

Topic: General Neurology Director: Joseph E. Safdieh, MD, FAAN, New York, NY Program Description: One of the primary goals of the AAN is to help its members stay upto-date on the latest developments in the diagnosis and management of neurologic disorders. This course will provide updates on epilepsy, headache, and neurologic infections. This program complements C57: Neurology Update II: Movement, Spine, and Autonomic Neurology, C122: Neurology Update III: Neuromuscular, Dementia, and Stroke, and C137: Neurology Update IV: Multiple Sclerosis, Dizziness, and Autoimmune Encephalopaties. The topics in the Neurology Update programs do not overlap and the four Update programs can provide a comprehensive update of all major fields in neurology. Upon Completion: Participants should have knowledge of the most current recommendations for the diagnosis, management, and therapy of patients with the disorders discussed, and be able to put recent developments in context to provide optimal patient care. Lecture/Faculty: }} Update in Epilepsy Faculty }} Update in Headache Christopher J. Boes, MD, FAAN, Rochester, MN }} Update in Neurologic Infections Kenneth L. Tyler, MD, FAAN, Aurora, CO Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

$ = Additional Fee Required L = Leadership University

Sunday, April 23, 2017

C44

1:00 p.m.–3:00 p.m.

Genomic Neurology Workshop: Developing Practical Knowledge of Tools and Concepts Through Case Studies I

Topic: General Neurology Director: Jeffery M. Vance, MD, PhD, Miami, FL Program Description: This program will introduce genomic databases that neurologists can use in their own practices. Team-based learning (TBL) will allow participants to work together using online genomics tools to answer practical clinical questions in a case-based format. Participants will receive instructional materials prior to the workshop. This flippedclassroom model allows more classroom time for performance-based, as opposed to purely knowledge-based, learning. A brief pre-lecture will ensure participants understand the important concepts to proceed to the TBL activity. Teams will answer case questions related to practical issues in ordering and interpreting genomic testing. Attendees should bring their laptops or tablets to enable hands-on experience using websites relevant to their practice. This program complements C61: Genomic Neurology Workshop: Developing Practical Knowledge of Tools and Concepts Through Case Studies II, but covers independent topics. However, attendees are strongly encouraged to attend both Part I and Part II of this course. Upon Completion: Participants should be able to list the factors that help determine which patients are appropriate candidates for neuro-genomic testing; determine, using online tools, the clinical significance of a genetic variant related to diagnosing and treating neurologic disease; describe key aspects of informed consent for genomic analyses; describe the process of next-generation sequencing data analysis; and describe the benefits and limitations of integrative genomic analyses for patients with neurologic disease, including managing incidental findings. Lecture/Faculty: }} Team Teaching Exercises Richard Haspel, MD, PhD, Boston, MA Jeffery M. Vance, MD, PhD, Miami, FL Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Interactive, Audience Participation, Team Learning CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist

Fast and easy registration · AAN.com/view/AM17 53

General Neurology

Sunday, April 23, 2017

Course Descriptions Sunday, April 23, 2017

C57

3:30 p.m.–5:30 p.m.

Neurology Update II: Movement, Spine, and Autonomic Neurology

Topic: General Neurology Director: Joseph E. Safdieh, MD, FAAN, New York, NY Program Description: One of the primary goals of the AAN is to help its members stay upto-date on the latest developments in the diagnosis and management of neurologic disorders. This course will provide updates on movement disorders, spine disorders, and autonomic neurology. This program complements C40: Neurology Update I: Epilepsy, Headache, and Neurologic Infections, C122: Neurology Update III: Neuromuscular, Dementia, and Stroke, and C137: Neurology Update IV: Multiple Sclerosis, Dizziness, and Autoimmune Encephalopathies. The topics in the Neurology Update programs do not overlap and the four Update programs can provide a comprehensive update of all major fields in neurology. Upon Completion: Participants should have knowledge of the most current recommendations for the diagnosis, management, and therapy of patients with the disorders discussed, and be able to put recent developments in context to provide optimal patient care. Lecture/Faculty: }} Update in Movement Disorders Claire Henchcliffe, MD, PhD, FAAN, New York, NY }} Update in Spine Disorders J. D. Bartleson, MD, FAAN, Rochester, MN }} Update in Autonomic Neurology Roy L. Freeman, MD, Boston, MA Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Sunday, April 23, 2017

C60

3:30 p.m.–5:30 p.m.

Precision Neurology: The Promise and Perils of Personalized Medicine in the Genomic Era

Topics: Research Methodology, Education, and History; General Neurology Director: Peter K. Todd, MD, PhD, Ann Arbor, MI See complete course description on page 128 »

54 2017 AAN Annual Meeting Early Look

General Neurology Sunday, April 23, 2017

C61

3:30 p.m.–5:30 p.m.

Genomic Neurology Workshop: Developing Practical Knowledge of Tools and Concepts Through Case Studies II

Topic: General Neurology Director: Jeffery M. Vance, MD, PhD, Miami, FL Program Description: This program seeks to provide neurologists with knowledge of genomic databases that they can use in their own practices. Teambased learning (TBL) will allow participants to work together using online genomics tools to answer practical clinical questions in a casebased format. Participants will receive instructional materials prior to the workshop. This flipped-classroom model allows more classroom time for performance-based, as opposed to purely knowledge-based, learning. A brief pre-lecture will ensure participants understand the important concepts to proceed to the TBL activity. Teams will answer case questions related to practical issues in ordering and interpreting genomic testing. Attendees should bring their laptops or tablets to enable hands-on experience using websites relevant to their practice. This program complements C44: Genomic Neurology Workshop: Developing Practical Knowledge of Tools and Concepts Through Case Studies I, but covers independent topics. However, attendees are strongly encouraged to attend both Part I and Part II of this course. Upon Completion: Participants should be able to list the factors that help determine which patients are appropriate candidates for neuro-genomic testing; determine, using online tools, the clinical significance of a genetic variants related to diagnosing and treating neurologic disease; describe key aspects of informed consent for genomic analyses; describe the process of next-generation sequencing data analysis; and describe the benefits and limitations of integrative genomic analyses for patients with neurologic disease, including managing incidental findings. Lecture/Faculty: }} Team Teaching Exercises Richard Haspel, MD, PhD, Boston, MA Jeffery M. Vance, MD, PhD, Miami, FL Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Interactive, Audience Participation, Team Learning CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist

C63

7:00 a.m.–9:00 a.m.

CNS Toxicities

Monday, April 24, 2017

C72

Topic: General Neurology Director: Neeraj Kumar, MD, Rochester, MN Program Description: New drugs of abuse are emerging at an alarming rate as manufacturers of “legal high“ products use chemicals to replace those that are banned. Many of these drugs (bath salts, spice, molly) are touted as legal, perceived as safe, and in many cases difficult to detect on standard drug screens. The industrial use of metals resulting in occupational exposure continues to engender public and scientific interest. Over-the-counter medications may be associated with neurotoxicity. Use of biologics like TNF alpha-inhibitors and various monoclonal antibodies may be accompanied by neurological side effects. CNS toxicities are seen in context of antineoplastics, antiepileptics, analgesics, anesthetics, and antimicrobials. Syndromes such as posterior reversible encephalopathy syndrome (PRES), neuroleptic malignant syndrome (NMS), reversible cerebral vasoconstriction syndrome (RCVS), and serotonin syndrome result from commonly used medications. This course will cover the topic of CNS toxicities in a case-based format with a focus on recent developments. Upon Completion: Participants should have a clear understanding of how to diagnose and treat CNS disorders that may accompany heavy metal toxicity, illicit drug use and those that occur as an adverse effect of prescribed medications. Lecture/Faculty: }} Pharmaceuticals Eoin P. Flanagan, MBBCh, Rochester, MN }} Drugs of Abuse Neeraj Kumar, MD, Rochester, MN }} Syndromes Eoin P. Flanagan, MBBCh, Rochester, MN }} Metals Neeraj Kumar, MD, Rochester, MN Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist

7:00 a.m.–9:00 a.m.

Gender-specific Care for Neurological Disorders

Topic: General Neurology Director: Jennifer Graves, MD, PhD, San Francisco, CA Program Description: Neurologic disease may have different manifestations in men and women. Reproductive considerations may further impact therapeutic choices. In this course, we will highlight key considerations in gender-based care for neurologic diseases in both didactic and casebased presentations. Upon Completion: Participants should be familiar with the most common known genderbased considerations in neurologic disease evaluation and treatment. While updates in sex-based research will be included, the course will be focused on pragmatic clinical approaches and recommendations. Lecture/Faculty: }} Gender-based Care Considerations in Multiple Sclerosis Jennifer Graves, MD, PhD, San Francisco, CA }} Neuroendocrine Considerations in the Treatment of Men and Women with Epilepsy Cynthia L. Harden, MD, New York, NY }} Gender-based Care in Neurovascular Disease and Headache Faculty }} Sex Differences in Neurodegenerative Diseases Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Monday, April 24, 2017

C78

1:00 p.m.–3:00 p.m.

Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease I

Topics: MS and CNS Inflammatory Disease; General Neurology Director: Jeffrey Marc Gelfand, MD, MAS, San Francisco, CA See complete course description on page 89 »

$ = Additional Fee Required L = Leadership University

Fast and easy registration · AAN.com/view/AM17 55

General Neurology

Monday, April 24, 2017

Course Descriptions Monday, April 24, 2017

C79

1:00 p.m.–3:00 p.m.

Neuroimaging for the General Neurologist I: Brain and Spine

Topic: General Neurology Director: Jennifer McVige, MD, Amherst, NY Program Description: Neuroimaging is a critical tool to aid in the diagnosis and prognosis of neurologic conditions. Up-to-date information on these imaging advances is essential for neurologists who are continuously being scrutinized by payors who demand cost effective, but appropriate care of patients. The faculty will discuss imaging modalities, approaches to reading images, common causes, and differential diagnoses. The course will cover neuroanatomy of brain MRI/CT as it relates to pediatric and adult interpretation of MR imaging of the brain, cognitive disorders, and suprasellar lesions. This program complements C92: Neuroimaging for the General Neurologist II: Brain and Spine, but covers independent topics. Upon Completion: Participants should be able to understand how to identify important anatomy when reading MRI/CT brain and spine, be familiar with ordering appropriate imaging modalities and sequences, and identify neurologic disorders on imaging sequences. Lecture/Faculty: }} Anatomical Guide to Interpret MR Imaging of the Brain Bela Ajtai, MD, Amherst, NY }} Neuroimaging of Cognitive Disorders John Allen Bertelson, MD, Austin, TX }} Pituitary and Suprasellar Lesions Laszlo Mechtler, MD, FAAN, FASN, Buffalo, NY Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement, Systems-Based Practice Teaching Style: Case-Based, Didactic, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Monday, April 24, 2017

C85

1:00 p.m.–3:00 p.m.

Boston City Hospital: The Cradle of American Neurology Part I

Topics: General Neurology; Research Methodology, Education, and History Director: Steven A. Sparr, MD, FAAN, Bronx, NY Program Description: The Neurological Unit at Boston City Hospital has been called the Cradle of American Neurology. From the time it was established by Stanley Cobb in the 1920s until Boston City Hospital ceased to exist as an independent entity in 1997, the Unit remained at the 56 2017 AAN Annual Meeting Early Look

General Neurology forefront of the development of neurology as a specialty both in terms of scientific advancement and training of generations of neurologists who assumed leadership roles throughout the country. Among the accomplishments of the faculty were: the discovery of the first effective anticonvulsant (phenytoin) using an animal model of epilepsy, the development of the multichannel EEG, the birth of child neurology as a discipline, the rebirth of behavioral neurology as a subspecialty, the development of the EMG as a physiological probe into the peripheral nervous system, and the elucidation of the neuropathology of stroke, autism, and many other conditions. The history of the Neurological Unit is best told through consideration of the colorful personalities who formed the faculty and their many contributions to our field. In this course we will focus on the careers of H. Houston Merritt, Tracy Putnam, Derek Denny-Brown, Raymond D. Adams, C. Miller Fisher, Frederick and Erna Gibbs, Paul Yakovlev, Thomas Kemper, Norman Geshwind, Albert Galaburda, Alexandra Adler, and others who shaped the Unit and were shaped by it. This program complements C93: Boston City Hospital: The Cradle of American Neurology Part II, but covers independent topics. Upon Completion: Participants will become familiar with the development of the modern academic neurology training program which combined scientific research with clinical care of patients; achieve a better understanding of the origins and early development of technologies such as EEG and EMG, which remain important tools in neurological practice; and become familiar with classic methods of clinico-anatomic correlation and neuropathology as techniques that established the foundation of neurology as a clinical and scientific discipline. Lecture/Faculty: }} In the Beginning: The Creation of the Neurological Unit at Boston City Hospital David M. Dawson, MD, FAAN, Boston, MA }} The Birth and Development of Epilepsy in Boston Frank W. Drislane, MD, FAAN, Boston, MA }} Tuesday Rounds with Derek Denny-Brown Thomas D. Sabin, MD, FAAN, Waban, MA }} Raymond D. Adams and C. Miller Fisher: From the Microscope to the Ward Louis R. Caplan, MD, FAAN, Boston, MA Core Competency: Medical Knowledge Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, NonNeurologist, Advanced Practice Provider

C92

3:30 p.m.–5:30 p.m.

Neuroimaging for the General Neurologist II: Brain and Spine

Topic: General Neurology Director: Jennifer McVige, MD, Amherst, NY Program Description: Neuroimaging is a critical tool to aid in the diagnosis and prognosis of neurologic conditions. Up-to-date information on these imaging advances is essential for neurologists who are continuously being scrutinized by payors who demand cost effective, but appropriate care of patients. The faculty will discuss imaging modalities, approaches to reading images, common causes, and differential diagnoses. The course will cover neuroanatomy of brain MRI/CT as it relates to pediatric and adult cases of congenital disorders, outpatient concerns, and ER critical care emergencies. This program complements C79: Neuroimaging for the General Neurologist I: Brain and Spine, but covers independent topics. Upon Completion: Participants should be able to understand how to identify important anatomy when reading MRI/CT brain and spine. They should be familiar with ordering appropriate imaging modalities and sequences, and identify neurologic disorders on imaging sequences. Lecture/Faculty: }} Congenital Anomalies of Pediatric Neuroimaging Jennifer McVige, MD, Amherst, NY }} Imaging of Patients with Headache and Other Common Outpatient Complaints: When, Why, What? Dara G. Jamieson, MD, New York, NY }} Emergency and Critical Care Neuroimaging Joshua P. Klein, MD, PhD, FANA, FAAN, Boston, MA Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement, Systems-Based Practice Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Monday, April 24, 2017

C93

3:30 p.m.–5:30 p.m.

Boston City Hospital: The Cradle of American Neurology Part II

exist as an independent entity in 1997, the Unit remained at the forefront of the development of neurology as a specialty both in terms of scientific advancement and training of generations of neurologists who assumed leadership roles throughout the country. Among the accomplishments of the faculty were: the discovery of the first effective anticonvulsant (phenytoin) using an animal model of epilepsy, the development of the multichannel EEG, the birth of child neurology as a discipline, the rebirth of behavioral neurology as a subspecialty, the development of the EMG as a physiological probe into the peripheral nervous system, and the elucidation of the neuropathology of stroke, autism, and many other conditions. The history of the Neurological Unit is best told through consideration of the colorful personalities who formed the faculty and their many contributions to our field. In this course we will focus on the careers of H. Houston Merritt, Tracy Putnam, Derek Denny-Brown, Raymond D. Adams, C. Miller Fisher, Frederick and Erna Gibbs, Paul Yakovlev, Thomas Kemper, Norman Geshwind, Albert Galaburda, Alexandra Adler, and others who shaped the Unit and were shaped by it. This program complements C85: Boston City Hospital: The Cradle of American Neurology Part I, but covers independent topics. Upon Completion: Participants will become familiar with the development of the modern academic neurology training program which combined scientific research with clinical care of patients; achieve a better understanding of the origins and early development of technologies such as EEG and EMG, which remain important tools in neurological practice; and become familiar with classic methods of clinico-anatomic correlation and neuropathology as techniques that established the foundation of neurology as a clinical and scientific discipline. Lecture/Faculty: }} The Early Development of Child Neurology at Boston City Hospital N. Paul Rosman, MD, FAAN, Boston, MA }} Norman Geschwind and the Rebirth of Behavioral Neurology Kenneth M. Heilman, MD, FAAN, Gainesville, FL }} Anatomy and Neuropathology at Boston City Hospital Jeremy D. Schmahmann, MD, FAAN, Boston, MA }} The Cocoanut Grove Nightclub Disaster of 1942: Alexandra Adler’s Seminal Work on Visual Agnosia and PTSD Steven A. Sparr, MD, FAAN, Bronx, NY Core Competency: Medical Knowledge Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

Topics: General Neurology; Research Methodology, Education, and History Director: Steven A. Sparr, MD, FAAN, Bronx, NY Program Description: The Neurological Unit at Boston City Hospital has been called the Cradle of American Neurology. From the time it was established by Stanley Cobb in the 1920s until Boston City Hospital ceased to $ = Additional Fee Required L = Leadership University

Fast and easy registration · AAN.com/view/AM17 57

General Neurology

Monday, April 24, 2017

Course Descriptions Monday, April 24, 2017

3:30 p.m.–5:30 p.m.

C101 Drug-induced Neurologic Emergencies Topic: General Neurology Director: Sara E. Hocker, MD, Rochester, MN Program Description: Drugs can result in a variety of neurologic emergencies. Neurologic emergencies may result from drugs administered in the hospital or from neurotoxic effects of environmentally significant effects of environmentally significant chemical hazards, manufactured drugs, and naturally occurring compounds. Faculty will review specific complications of drug therapies encountered in the intensive care unit, drug induced movement disorders, and neurotoxicology emergencies. Upon Completion: Participants should be able to evaluate, diagnose, and treat neurologic emergencies resulting from drugs administered in the hospital or from neurotoxic effects of environmentally significant effects of environmentally significant chemical hazards, manufactured drugs, and naturally occurring compounds. Lecture/Faculty: }} Drug-induced Disorders Seen in the ICU Sara E. Hocker, MD, Rochester, MN }} Drug-induced Movement Disorder Emergencies Faculty }} Neurotoxicology and Neurologic Emergencies Michel Toledano, MD, Rochester, MN Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Monday, April 24, 2017

6:00 p.m.–9:00 p.m.

C105 Test Your Knowledge:

A Case-based Approach to Neuroimaging

Topic: General Neurology Director: Joseph C. Masdeu, MD, PhD, FAAN, Houston, TX Program Description: Neuroimaging places in the hands of neurologists powerful tools for clinical diagnosis and patient management. In this activity, attendees will have an opportunity to test and improve their knowledge of neuroimaging by attending an explanation on how to read brain imaging studies; comparing their responses to those of the group and panel when reviewing different neuroimaging cases; and reviewing carefully a set of different neuroimaging cases discussed by the faculty.

58 2017 AAN Annual Meeting Early Look

General Neurology Upon Completion: Participants should be able to describe an organized approach to reading neuroimaging studies, as well as helpful imaging clues to identify on imaging the diagnosis of common and unusual disorders. Lecture/Faculty: }} Neuroimaging Cases I Joseph C. Masdeu, MD, PhD, FAAN, Houston, TX }} A Checklist for Neuroimaging James G. Smirniotopoulos, MD, Silver Spring, MD }} Neuroimaging Cases II Joshua P. Klein, MD, PhD, FANA, FAAN, Boston, MA }} Neuroimaging Cases III Joseph C. Masdeu, MD, PhD, FAAN, Houston, TX }} Neuroimaging Cases IV Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 3 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist Tuesday, April 25, 2017

7:00 a.m.–9:00 a.m.

C111 Principles of Genomic Medicine: Clinical Exome Sequencing in Neurologic Disease

Topic: General Neurology Director: Brent L. Fogel, MD, PhD, FAAN, Los Angeles, CA Program Description: Faculty will discuss the concept of genomic medicine and its use in clinical practice. Available diagnostic testing designed to comprehensively assess the human genome for disease-causing mutations will be discussed (i.e., clinical exome sequencing). Types of mutations identified will be described and presented in the context of their role in neurogenetic disease. The indications for the clinical use of this technology will be discussed for various common neurologic diseases (e.g., movement disorders, epilepsy, neurodevelopmental disorders, metabolic disease). Ethical challenges, including informed consent, appropriate genetic counseling, the reporting of incidental findings, and the detection of variants of unknown significance will be discussed and strategies presented to resolve such issues. Expected results from such testing will be discussed and strategies presented for effective clinical interpretation. Upon Completion: Participants should be able to understand the principles of genomic medicine and the basics of common genomic diagnostic testing methodologies (e.g., clinical exome sequencing); effectively educate, counsel, and consent patients and their families regarding genomic diagnostic testing; understand, interpret, and communicate genomic diagnostic testing results to patients; and appreciate the ethical challenges inherent in genomic medicine and identify strategies to address them in clinical practice.

Tuesday, April 25, 2017

1:00 p.m.–3:00 p.m.

C122 Neurology Update III:

Neuromuscular, Dementia, and Stroke

Topic: General Neurology Director: Barney J. Stern, MD, FAAN, Baltimore, MD Program Description: This course will provide updates on the diagnosis and management of stroke, neuromuscular disorders, and dementia. This program complements C40: Neurology Update I: Epilepsy, Headache, and Neurologic Infections, C57: Neurology Update II: Movement, Spine, and Autonomic Neurology, and C137: Neurology Update IV: Multiple Sclerosis, Dizziness, and Autoimmune Encephalopathies. The topics in the Neurology Update programs do not overlap and the four update programs can provide a comprehensive update of all major fields in neurology. Upon Completion: Participants should be able to be aware of the current developments in the diagnosis, management, and treatment of patients with stroke, neuromuscular disorders, and dementia and be able to put recent developments in context to provide optimal patient care. Lecture/Faculty: }} Neuromuscular Disorders Justin Y. Kwan, MD, Baltimore, MD }} Dementia Gregory S. Day, MD, MSc, St. Louis, MO }} Stroke Scott B. Silverman, MD, Boston, MA Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Didactic CME Credits: 2 $ = Additional Fee Required L = Leadership University

Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Tuesday, April 25, 2017

1:00 p.m.–3:00 p.m.

C127 Neuroendocrine Update:

Nuts and Bolts of What You Need to Know

Topic: General Neurology Director: Alison M. Pack, MD, New York, NY Program Description: Neuroendocrine axes affect the presentation and treatment of neurological diseases. Through review of the neuroendocrine anatomy and humoral relationships, faculty will discuss the effects of the neuroendocrine system on epilepsy, multiple sclerosis, headaches, stroke, and trauma. Upon Completion: Participants should be able to understand how neuroendocrine anatomy and humoral relationships influence the presentation and treatment of epilepsy, multiple sclerosis, headaches, and trauma. Lecture/Faculty: }} Neuroendocrine Axes: Hypothalamus, Pituitary, and Beyond Karen Klahr Miller, MD, Boston, MA }} Epilepsy, Antiepileptic Drugs, and Neuroendocrine Effects Alison M. Pack, MD, New York, NY }} Neuroendocrine Effects on Multiple Sclerosis Riley Bove, MD, San Francisco, CA }} Neuroendocrine Effects on Headache Michael A. Rogawski, MD, PhD, Sacramento, CA }} Neuroendocrine Effects of Traumatic Brain Injury Gary M. Abrams, MD, FAAN, San Francisco, CA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Tuesday, April 25, 2017

3:30 p.m.–5:30 p.m.

C137 Neurology Update IV:

Multiple Sclerosis, Dizziness, and Autoimmune Encephalopathies

Topic: General Neurology Director: Barney J. Stern, MD, FAAN, Baltimore, MD Program Description: This course will provide updates on the diagnosis and management of multiple sclerosis, dizziness, and autoimmune encephalopathies. This program complements C40: Neurology Update I: Epilepsy, Headache, and Neurologic Infections, C57: Neurology Update II: Fast and easy registration · AAN.com/view/AM17 59

General Neurology

Lecture/Faculty: }} The Use of Clinical Exome Sequencing in the Diagnosis of Neurologic Disease Brent L. Fogel, MD, PhD, FAAN, Los Angeles, CA }} Medicolegal and Ethical Issues in Clinical Exome Sequencing Faculty }} Case Presentations and Examples of Clinical Interpretation of Exome Sequencing Results Brent L. Fogel, MD, PhD, FAAN, Los Angeles, CA Hane Lee, PhD, Los Angeles, CA Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Genetic Counselor, Advanced Practice Provider

Course Descriptions Movement, Spine, and Autonomic Neurology, and C122: Neurology Update III: Neuromuscular, Dementia, and Stroke. The topics in the Neurology Update programs do not overlap and the four Update programs can provide a comprehensive update of all major fields in neurology. Upon Completion: Participants should have knowledge of the most current recommendations for the diagnosis, management, and therapy of patients with the disorders discussed, and be able to put recent developments in context to provide optimal patient care. Lecture/Faculty: }} Multiple Sclerosis Daniel Harrison, MD, Baltimore, MD }} Dizziness Daniel R. Gold, DO, Baltimore, MD }} Autoimmune Encephalopathies David R. Benavides, MD, PhD, Baltimore, MD Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Tuesday, April 25, 2017

3:30 p.m.–5:30 p.m.

C145 Hot Topics in Neurologic Practice: Managing the Patient Experience in 2017 and Beyond

Topics: Practice, Policy, and Ethics; General Neurology; Research Methodology, Education, and History Director: Richard J. Caselli, MD, FAAN, Scottsdale, AZ See complete course description on page 123 » Wednesday, April 26, 2017

7:00 a.m.–9:00 a.m.

C152 Clinical Pearls:

Learning from Complex Cases—Simple Lessons that Apply to Everyday Problems

Topic: General Neurology Director: S. Andrew Josephson, MD, FAAN, San Francisco, CA Program Description: The successful busy clinical practice of neurology is dependent upon insightful and efficient bedside diagnostic clinical skills. Faculty will share their clinical experiences and observations in an interactive format to enhance and enrich the neurologist’s ability to make

60 2017 AAN Annual Meeting Early Look

General Neurology effective and correct diagnoses with a goal on improving patient outcomes. Upon Completion: Participants should be able to enhance and enrich their ability to make effective and correct clinical diagnoses using bedside clinical observations and thus improving patient outcomes. Lecture/Faculty: }} Pearls from the Inpatient Setting...Mysteries and Surprises S. Andrew Josephson, MD, FAAN, San Francisco, CA }} Neuromuscular Medicine: Pearls and Pitfalls Robert M. Pascuzzi, MD, FAAN, Indianapolis, IN }} Cases Martin A. Samuels, MD, MACP, FAAN, Boston, MA Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Professionalism Teaching Style: Case-Based, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Wednesday, April 26, 2017

1:00 p.m.–3:00 p.m.

C162 Continuum® Test Your Knowledge:

A Multiple-choice Question Review I

Topic: General Neurology Director: Steven L. Lewis, MD, FAAN, Chicago, IL Program Description: This course will use case-based, multiple-choice questions and brief faculty expert discussions to help neurologists stay current in clinical practice. Using the audience response system, faculty will engage participants in clinical problem solving and use multiple-choice questions from recent issues of Continuum: Lifelong Learning in Neurology ® as a springboard for discussion of timely and important topics in headache and movement disorders. This course has been approved by the ABPN to provide 2 Selfassessment CME credits. This program complements C177: Continuum ® Test Your Knowledge: A Multiple-choice Question Review II, but covers independent topics. Upon Completion: Participants should be able to increase and refresh their knowledge of headache and movement disorders through presentation of common and not-so-common clinical problems, as well as learn to work through difficult clinical presentations both logically and successfully. Lecture/Faculty: }} Headache David W. Dodick, MD, Phoenix, AZ }} Movement Disorders Susan Fox, MD, Toronto, ON, Canada

Wednesday, April 26, 2017

1:00 p.m.–3:00 p.m.

C167 Autoimmune Neurology I Basics and

Beyond: Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes of the CNS and PNS

Topic: General Neurology Director: Maarten Jan Titulaer, MD, PhD, Rotterdam, Netherlands Program Description: Recent years have been very exciting for autoimmune neurology: many new diseases have been discovered, providing possibilities to treat patients previously considered untreatable. Faculty will describe the full range of neural autoantibodies and their relevant clinical disorders (neurological, psychiatric, neuropediatric, and oncological), from encephalitis to the neuromuscular junction; including clinical pearls aiding diagnosis of autoimmune and paraneoplastic neurologic disorders, also covering differential diagnosis, investigations, and treatment. This course will cover the basics, and go somewhat beyond, but be less advanced than the Autoimmune Neurology II course. Although both courses stand alone, overlap is minimized, and physicians are encouraged to complete both courses. This program complements C182: Autoimmune Neurology II Advanced: Autoimmune Encephalitis—At the Frontiers of Neuroscience, but covers independent topics. Upon Completion: Participants should be able to understand the autoantibody nomenclature; recognize autoimmune neurologic disorders; know the neurologic and cancer associations of the autoantibodies; know the pitfalls in antibody testing; know the appropriate oncological evaluations for paraneoplastic neurologic disorders; and know some treatment regimens for autoimmune neurologic disorders. Lecture/Faculty: }} Introduction—Overview of Autoimmune Neurology Maarten Jan Titulaer, MD, PhD, Rotterdam, Netherlands }} Classical Paraneoplastic Neurological Disorders Andrew McKeon, MD, Rochester, MN }} Autoimmune Disorders of the Peripheral Nervous System Eric Lancaster, MD, PhD, Philadelphia, PA }} Autoimmune Encephalitis—The Cell Surface and Synaptic Antibodies Josep O. Dalmau, MD, PhD, Barcelona, Spain Core Competencies: Medical Knowledge, Patient Care, Practice$ = Additional Fee Required L = Leadership University

Based Learning and Improvement Teaching Style: Case-Based, Didactic, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist Wednesday, April 26, 2017

1:00 p.m.–3:00 p.m.

C168 Neuroimaging for the General Neurologist I: Spine and Peripheral Nerve

Topic: General Neurology Director: Joshua P. Klein, MD, PhD, FANA, FAAN, Boston, MA Program Description: This program is designed to increase clinician comfort and competence in reviewing neuroimaging studies of the spine and peripheral nerves to provide a practical and systematic approach that will allow for recognition of degenerative and vascular conditions. This program complements C183: Neuroimaging for the General Neurologist II: Spine and Peripheral Nerve, but covers independent topics. Upon Completion: Participants should be able to systematically review images of the spine and detect degenerative and vascular abnormalities. Lecture/Faculty: }} Approach to Spine Imaging, Including Degenerative Disease, and Trauma Joshua P. Klein, MD, PhD, FANA, FAAN, Boston, MA }} Vascular Imaging of the Spine Ashutosh P. Jadhav, MD, Pittsburgh, PA Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Neurology Allied Practitioner, Advanced Practice Provider Wednesday, April 26, 2017

3:30 p.m.–5:30 p.m.

C177 Continuum® Test Your Knowledge: A Multiple-choice Question Review II

General Neurology

Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement, Professionalism Teaching Style: Case-Based, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

Course Descriptions questions from recent issues of Continuum: Lifelong Learning in Neurology ® as a springboard for discussion of timely and important clinical topics in neuro-oncology and multiple sclerosis. This course has been approved by the ABPN to provide 2 Selfassessment CME credits. This program complements C162: Continuum ® Test Your Knowledge: A Multiple-choice Question Review I, but covers independent topics. Upon Completion: Participants should be able to increase and refresh their knowledge of neuro-oncology and multiple sclerosis through presentation of common and not-so-common clinical problems, as well as learn to work through difficult clinical presentations both logically and successfully. Lecture/Faculty: }} Neuro-oncology Amy A. Pruitt, MD, Philadelphia, PA }} Multiple Sclerosis Stephen Krieger, MD, FAAN, New York, NY Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement, Professionalism Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

General Neurology Upon Completion: Participants should be able to identify the different disorders; adequately assess consultations at the psychiatry, pediatric neurology, and epilepsy wards; be able to avoid the pitfalls associated with antibody testing; and identify the appropriate tumors associated with the different syndromes. Lecture/Faculty: }} Neuropsychiatry and Encephalitis Josep O. Dalmau, MD, PhD, Barcelona, Spain }} Epilepsy and Encephalitis Maarten Jan Titulaer, MD, PhD, Rotterdam, Netherlands }} Brainstem Encephalitis and Myelitis Andrew McKeon, MD, Rochester, MN }} Difficult Cases and Clinical Pearls Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist Wednesday, April 26, 2017

3:30 p.m.–5:30 p.m.

C183 Neuroimaging for the General Neurologist II: Spine and Peripheral Nerve

Topic: General Neurology Director: Joshua P. Klein, MD, PhD, FANA, FAAN, Boston, MA

C182 Autoimmune Neurology II Advanced:

Program Description: This program is designed to increase clinician comfort and competence in reviewing neuroimaging studies of the spine and peripheral nerves to provide a practical and systematic approach that will allow for recognition of inflammatory, infectious, and neoplastic conditions.

Topic: General Neurology

This program complements C168: Neuroimaging for the General Neurologist I: Spine and Peripheral Nerve, but covers independent topics.

Wednesday, April 26, 2017

3:30 p.m.–5:30 p.m.

Autoimmune Encephalitis—At the Frontiers of Neuroscience

Director: Maarten Jan Titulaer, MD, PhD, Rotterdam, Netherlands Program Description: Recent years have shown many discoveries of new antibodies. These new antibodies have broadened the horizon of these diseases, bordering with psychiatry, pediatrics, intensive care medicine, and (chronic) epilepsy. Many physicians struggle to keep up with all the new developments. Faculty will cover the newest developments, discuss caveats at diagnosis, test results, and treatment decisions. This course will be more advanced than the Autoimmune Neurology I course, and expects some basic knowledge of antibodies and the related syndromes. Overlap is minimized, and physicians are encouraged to complete both courses. This program complements C167: Autoimmune Neurology I Basics and Beyond: Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes of the CNS and PNS, but covers independent topics. 62 2017 AAN Annual Meeting Early Look

Upon Completion: Participants should be able to systematically review imagesof the spine and detect inflammatory, infectious, andneoplastic abnormalities. Lecture/Faculty: }} Imaging of Spinal Infections and Inflammation Shamik Bhattacharyya, MD, Boston, MA }} Imaging of Spinal Tumors Jorg Dietrich, MD, PhD, Boston, MA Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

7:00 a.m.–9:00 a.m.

C187 Mitochondrial Disorders in Neurology Topic: General Neurology Director: Michio Hirano, MD, FAAN, New York, NY Program Description: Mitochondrial dysfunction accounts for an ever-increasing number of neurologic disorders (mitochondrial encephalomyopathies). Faculty will discuss basic concepts of mitochondrial biogenesis and the dual (and often overlapping) role of mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) in causing these frustratingly heterogeneous clinical disorders. The increasing application of new-generation exome sequencing is revealing novel pathogenic mechanisms and subverting traditional classifications of mitochondrial diseases. In practical terms, faculty will cover the impact of new scientific knowledge on the diagnostic approach to mitochondrial diseases and to emerging experimental therapeutic options. Upon Completion: Participants should be familiar with recent progress in mitochondrial genetics; gain a better understanding of the relationships, which are not always straightforward, between mutations in either genome (mtDNA or nDNA) and clinical presentations; learn useful clues to the correct diagnosis; glean ideas about pathogenesis (energy shortage, oxidative stress); and get a realistic understanding of palliative and experimental therapy. Lecture/Faculty: }} Mitochondrial Biology Eric A. Schon, PhD, New York, NY }} Mitochondrial Diseases Michio Hirano, MD, FAAN, New York, NY }} Treatment of Mitochondrial Diseases Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider Thursday, April 27, 2017

7:00 a.m.–9:00 a.m.

C189 Cognitive Psychology of Neurologic Errors: Why Do Neurologists Make Errors?

Topics: General Neurology; Research Methodology, Education, and History Director: Louis R. Caplan, MD, FAAN, Boston, MA Program Description: This course will be a case-based discussion of errors in diagnosis and management. Faculty will present neuromuscular, cerebrovascular, and cognitive-behavioral cases and discussion. $ = Additional Fee Required L = Leadership University

Upon Completion: Participants should be able to become aware of how they go about making neurological diagnoses, become aware of the main reasons that errors occur, and understand the systematic approach to neurological diagnosis and management. Lecture/Faculty: }} Neuromuscular Case: Errors in Diagnosis—What, Why, and How? Pushpa Narayanaswami, MBBS, MD, FAAN, Boston, MA }} Cognitive-behavioral Case and Discussion Daniel Press, MD, Winchester, MA }} Cerebrovascular Case: System of Diagnosis and Discussion Louis R. Caplan, MD, FAAN, Boston, MA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider Thursday, April 27, 2017

7:00 a.m.–9:00 a.m.

C190 Multiple Sclerosis Overview:

Basic and Translational Science

Topics: MS and CNS Inflammatory Disease; General Neurology Director: Michael K. Racke, MD, Columbus, OH See complete course description on page 91 » Thursday, April 27, 2017

1:00 p.m.–3:00 p.m.

C198 Functional Neurologic Disorders I:

Movement, Non-epileptic Seizures, and MS-like Disorders

Topic: General Neurology Director: Alberto J. Espay, MD, FAAN, Cincinnati, OH Program Description: Through an emphasis on case-based learning, this course will cover the clinician’s approach to the diagnosis and initial management of functional movement disorders, functional non-epiletic seizures, and multiple sclerosis-like disorders, including the approach to remove inappropriate medications to minimize iatrogenic harm and “undiagnose“ patients with previous diagnosis of epilepsy or multiple sclerosis. This program complements C211: Functional Neurologic Disorders II: Management, CBT, and Inpatient Therapeutic Strategies, but covers independent topics. Upon Completion: Participants should recognize the pearls and pitfalls in the diagnosis of the most common functional neurologic disorders and be in position Fast and easy registration · AAN.com/view/AM17 63

General Neurology

Thursday, April 27, 2017

Course Descriptions to apply strategies to minimize iatrogenic harm, correct misdiagnoses, and initiate a treatment plan. Lecture/Faculty: }} An Approach to Functional Movement Disorders Anthony E. Lang, MD, FAAN, Toronto, ON, Canada }} An Approach to Functional (Psychogenic Nonepileptic) Seizures W. Curt LaFrance, Jr., MD, MPH, FAAN, Providence, RI }} An Approach to Functional Disorders Misdiagnosed as Multiple Sclerosis Andrew Solomon, MD, Burlington, VT Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Thursday, April 27, 2017

1:00 p.m.–3:00 p.m.

C200 Therapy in Neurology I:

Multiple Sclerosis and Headache

Topic: General Neurology Director: David W. Dodick, MD, Phoenix, AZ Program Description: Refinement in diagnostic criteria for demyelinating diseases and headache disorders and advancement in therapies have improved the ability of clinicians to accurately diagnose these disorders in clinical practice and provide evidence-based treatments that improve patient outcomes. Through comprehensive overviews, faculty will discuss the application of diagnostic criteria and individualized therapy. This program complements C213: Therapy in Neurology II: Epilepsy and Neuro-oncology, C231: Therapy in Neurology III: Neuromuscular Disease and Neuro-infectious Disease, and C239: Therapy in Neurology IV: Movement Disorders and Cerebrovascular Disease, but covers independent topics. Upon Completion: Participants should be able to distinguish demyelinating diseases from mimics, identify common primary headache disorders, and select appropriate treatments based on evidence and disease severity. Lecture/Faculty: }} Multiple Sclerosis and Related Autoimmune CNS Disorders Dean M. Wingerchuk, MD, FAAN, Scottsdale, AZ }} Headache David W. Dodick, MD, Phoenix, AZ Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

64 2017 AAN Annual Meeting Early Look

General Neurology Thursday, April 27, 2017

1:00 p.m.–3:00 p.m.

C206 Neurologic Case Studies in Pregnancy I: Stroke and Headache

Topic: General Neurology Director: Mary Angela O’Neal, MD, Boston, MA Program Description: This case-based course demonstrates how experts in the field approach stroke and general neurologic problems in pregnancy. A case will be presented to one of the faculty members. The expert discussant will work through the case requesting imaging and necessary tests to decide on optimal management. The presenter will summarize the key points for the case, as well as the most recent information regarding the disorder. Cases will illustrate stroke and headache management in pregnancy. This program complements C219: Neurologic Case Studies in Pregnancy II: Epilepsy and Neuro-ophthalmology, but covers independent topics. Upon Completion: Participants should be able to understand the physiological changes in pregnancy which contribute to stroke; recommend safe imaging in pregnancy; understand the evaluation, management, and treatment of stroke; and understand and recommend safe options for treatment of headaches during pregnancy and postpartum. Lecture/Faculty: }} Case 1: Stroke in Pregnancy Steven K. Feske, MD, Boston, MA }} Take Home Points Steven K. Feske, MD, Boston, MA }} Case 2: Stroke in Pregnancy Aneesh B. Singhal, MD, FAAN, Boston, MA }} Take Home Points Aneesh B. Singhal, MD, FAAN, Boston, MA }} Case 1: Headache in Pregnancy Paul G. Mathew, MD, FAHS, FAAN, Boston, MA }} Take Home Points Paul G. Mathew, MD, FAHS, FAAN, Boston, MA }} Case 2: Headache in Pregnancy Mary Angela O’Neal, MD, Boston, MA }} Take Home Points Mary Angela O’Neal, MD, Boston, MA Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist

3:30 p.m.–5:30 p.m.

C211 Functional Neurologic Disorders II: Management, CBT, and Inpatient Therapeutic Strategies

Topic: General Neurology Director: Alberto J. Espay, MD, FAAN, Cincinnati, OH Program Description: Participants should be able to recognize and properly deliver the diagnosis of functional neurologic disorders, a crucial step in ensuring acceptance of the diagnosis and adherence and response to treatment. We will discuss cognitive behavioral therapy and other treatment modalities, in both outpatient and inpatient settings, including motor reprogramming and tremor retrainment, coordinated with the help of an interdisciplinary team to harness their potential in reducing burden of functional disability. This program complements C198: Functional Neurologic Disorders I: Movement, Non-epileptic Seizures, and MS-like Disorders, but covers independent topics. Upon Completion: Participants should be able to empathetically but assertively disclose the diagnosis of a functional neurologic disorder, appreciate the rationale for cognitive behavioral therapy, and coordinate the interdisciplinary collaboration between cognitive therapists, physiotherapists, and other allied health personnel in addressing functional symptoms and disability. Lecture/Faculty: }} The First Step in the Management of Functional Neurologic Disorders: Diagnostic Debriefing Alberto J. Espay, MD, FAAN, Cincinnati, OH }} Cognitive Behavioral Therapy (CBT) for Patients with Functional Neurologic Disorders Scott Ries, LISW-S, Cincinnati, OH }} Inpatient Therapeutic Strategies for Patients with Functional Neurologic Disorders Kathrin LaFaver, MD, Louisville, KY Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Thursday, April 27, 2017

3:30 p.m.–5:30 p.m.

C213 Therapy in Neurology II:

Epilepsy and Neuro-oncology

Topic: General Neurology Director: David W. Dodick, MD, Phoenix, AZ Program Description: There have been recent, rapid advances in medical and surgical options for patients with epilepsy and neuro-oncology. Faculty will facilitate a

$ = Additional Fee Required L = Leadership University

discussion of the evidence and experience-based implementation of current diagnostic modalities and best medical and surgical approaches to patients with epilepsy and central nervous system tumors. This program complements C200: Therapy in Neurology I: Multiple Sclerosis and Headache, C231: Therapy in Neurology III: Neuromuscular Disease and Neuro-infectious Disease, and C239: Therapy in Neurology IV: Movement Disorders and Cerebrovascular Disease, but covers independent topics. Upon Completion: Participants should be able to discuss recent guidelines for the use of available medications for epilepsy and status epilepticus; describe the newly available treatment options for epilepsy and their patientbased implementation in clinical practice; discuss the indications for inpatient epilepsy monitoring, the diagnostic evaluation of patients with refractory epilepsy, and the medical and surgical approaches; describe the diagnostic evaluation of patients with central nervous system malignancies and discuss the treatment approach to these patients. Lecture/Faculty: }} Epilepsy Joseph F. Drazkowski, MD, FAAN, Phoenix, AZ }} Neuro-oncology Alyx B. Porter, MD, Phoenix, AZ Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Intensive Care Specialist, Internist Thursday, April 27, 2017

3:30 p.m.–5:30 p.m.

C219 Neurologic Case Studies in Pregnancy II: Epilepsy and Neuro-ophthalmology

Topic: General Neurology Director: Mary Angela O’Neal, MD, Boston, MA Program Description: This case-based course demonstrates how experts in the field approach epilepsy and neuro-ophthalmology problems in pregnancy. A case will be presented to one of the faculty members who will have the same information as the audience. The expert discussant will work through the case requesting imaging and necessary tests to decide on optimal management. The presenter will summarize the key points for the case, as well as the most recent information regarding the disorder. This program complements C206: Neurologic Case Studies in Pregnancy I: Stroke and Headache, but covers independent topics. Upon Completion: Participants should be able to understand the physiological changes in pregnancy which affect epilepsy; recommend safe options for management and treatment of epilepsy during pregnancy; understand and recognize some of neuro-ophthalmology issues in pregnancy and postpartum.

Fast and easy registration · AAN.com/view/AM17 65

General Neurology

Thursday, April 27, 2017

Course Descriptions Lecture/Faculty: }} Case 1: Epilepsy and Pregnancy Kimford J. Meador, MD, FAAN, Palo Alto, CA }} Take Home Points Kimford J. Meador, MD, FAAN, Palo Alto, CA }} Case 2: Epilepsy and Pregnancy Page B. Pennell, MD, Boston, MA }} Take Home Points Page B. Pennell, MD, Boston, MA }} Case 1: Neuro-ophthalmology in Pregnancy Steven Galetta, MD, FAAN, New York, NY }} Take Home Points Steven Galetta, MD, FAAN, New York, NY }} Case 2: Neuro-ophthalmology in Pregnancy Faculty }} Take Home Points Faculty Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist Thursday, April 27, 2017

3:30 p.m.–5:30 p.m.

C221 Emerging Approaches to Biosensing for the

Diagnosis and Management of Neurological Disease

Topic: General Neurology Director: John David Hixson, MD, San Francisco, CA Program Description: Mobile technologies for detecting and storing physical variables relevant to neurologic disease are advancing at a rapid pace. The data collected through these devices promises to aid in both diagnosis and management. By focusing on the uses of wearable and mobile phone applications for a variety of neurologic conditions, faculty with facilitate a discussion about the potential applications, benefits, and drawbacks. Upon Completion: Participants should become familiar with the variety of wearable and mobile phone-based technologies that may provide value to neurologists and neurology patients. Additionally, participants should be able to recognize the potential benefits, as well as the challenges and pitfalls in this space. Lecture/Faculty: }} Emerging Approaches to Biosensing for the Diagnosis and Management of Neurological Disease John David Hixson, MD, San Francisco, CA Core Competencies: Medical Knowledge, Patient Care 66 2017 AAN Annual Meeting Early Look

General Neurology Teaching Style: Case-Based, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, NonNeurologist Friday, April 28, 2017

7:00 a.m.–9:00 a.m.

C222 The Global Burden of Neurologic Diseases Topics: Global Health; General Neurology Director: Jerome H. Chin, MD, PhD, MPH, FAAN, San Anselmo, CA See complete course description on page 68 » Friday, April 28, 2017

7:00 a.m.–9:00 a.m.

C227 Borderlands of Neurology and Internal Medicine: Chalk Talk

Topic: General Neurology Director: Martin A. Samuels, MD, MACP, FAAN, Boston, MA Program Description: A large swath of neurology consists of providing consultations to internists regarding neurological complications of general medical disease. Some examples of these areas in the borderlands between neurology and internal medicine are neurocardiology, neurohematology, neurorheumatology, neuroendocrinology, neurological infectious and inflammatory diseases, neurogastroenterology, neurohepatology, and neuro-oncology. This longstanding course is led by a neurologist who is also an internist and who has had a career-long interest in these important interface areas. The chalk talk is case based and will involve active involvement of participants in analyzing real patient examples of representative conditions. Upon Completion: Participants should be able to analyze a patient with a disorder in the interface between internal medicine and neurology and provide a cogent opinion to the consulting physician regarding the diagnosis and management of important neurological complications of general medical diseases. Lecture/Faculty: }} Borderlands of Neurology and Internal Medicine Martin A. Samuels, MD, MACP, FAAN, Boston, MA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

1:00 p.m.–3:00 p.m.

C231 Therapy in Neurology III:

Neuromuscular Disease and Neuro-infectious Disease

3:30 p.m.–5:30 p.m.

C239 Therapy in Neurology IV: Movement

Disorders and Cerebrovascular Disease

Topic: General Neurology Director: Madhu Soni, MD, Chicago, IL

Topic: General Neurology Director: Madhu Soni, MD, Chicago, IL Program Description: Advances in neurology have become commonplace, requiring both experienced and new academic and private practitioners to remain updated on novel therapeutics and evidence-based guidelines. This course will aim to review and update therapy for commonly encountered neurologic conditions with a specific focus on neuromuscular and neuro-infectious diseases. This program complements C200: Therapy in Neurology I: Multiple Sclerosis and Headache, C213: Therapy in Neurology II: Epilepsy and Neuro-oncology, and C239: Therapy in Neurology IV: Movement Disorders and Cerebrovascular Disease, but covers independent topics. Upon Completion: Participants should be able to discuss current treatments and evidence-based guidelines for common neuromuscular and neuroinfectious diseases. Lecture/Faculty: }} Therapy of Neuromuscular Disease Anthony A. Amato, MD, FAAN, Boston, MA }} Therapy of Neurological Infectious Diseases Karen L. Roos, MD, FAAN, Indianapolis, IN Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Friday, April 28, 2017

Friday, April 28, 2017

1:00 p.m.–3:00 p.m.

C237 Emergency Neurology I:

Evaluation of Coma, Meningitis, and Viral Encephalitis in the Emergency Room

Topics: Neuro Trauma, Critical Care, and Sports Neurology; General Neurology Director: Jose I. Suarez, MD, Cleveland, TX

Program Description: Advances in neurology occur frequently, requiring both experienced and new academic and private practitioners to remain updated on novel therapeutics and evidence-based guidelines. This course will aim to review and update therapy for commonly encountered neurologic conditions with a specific focus on movement disorders and cerebrovascular disease. This program complements C200: Therapy in Neurology I: Multiple Sclerosis and Headache, C213: Therapy in Neurology II: Epilepsy and Neuro-oncology, and C231: Therapy in Neurology III: Neuromuscular Disease and Neuro-infectious Disease, but covers independent topics. Upon Completion: Participants should be able to discuss current treatments and evidence-based guidelines for common movement disorders and cerebrovascular disease. Lecture/Faculty: }} Therapy of Movement Disorders Deborah Hall, MD, PhD, FAAN, Chicago, IL }} Therapy of Cerebrovascular Disease Pooja Khatri, MD, Cincinnati, OH Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Friday, April 28, 2017

3:30 p.m.–5:30 p.m.

C244 Emergency Neurology II:

Consultations in the General ICU

See complete course description on page 97 »

$ = Additional Fee Required L = Leadership University

Fast and easy registration · AAN.com/view/AM17 67

General Neurology

Friday, April 28, 2017

Course Descriptions GLOBAL HEALTH Friday, April 28, 2017

Global Health

HEADACHE 7:00 a.m.–9:00 a.m.

C222 The Global Burden of Neurologic Diseases Topics: Global Health; General Neurology Director: Jerome H. Chin, MD, PhD, MPH, FAAN, San Anselmo, CA Program Description: Neurologic diseases and infections represent approximately 10 percent of the global burden of disease. The incidence, prevalence, and risk factors for neurologic diseases and infections in different regions of the world are constantly changing due to epidemiologic transitions, demographic changes, and other factors. The faculty of this course will present and discuss up-to-date information on the global burden of neurologic diseases from the most recent reports of the Global Burden of Disease Study Collaborators, the WHO, and the CDC, as well as relevant systematic reviews, observational studies, and case series. Upon Completion: Participants should be able to discuss the importance of primary prevention to reducing the global burden of stroke, implement interventions to improve epilepsy care and treatment in resourcelimited regions, and identify the leading neurologic infections in different regions of the world. Lecture/Faculty: }} Epilepsy in Resource-limited Regions Mamta Bhushan Singh, MBBS, MD, DM, New Delhi, India }} Neurologic Infections: A Global Update Kiran Thakur, MD, New York, NY }} Global Epidemiology of Stroke Jerome H. Chin, MD, PhD, MPH, FAAN, San Anselmo, CA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

68 2017 AAN Annual Meeting Early Look

Saturday, April 22, 2017

C15

1:00 p.m.–3:00 p.m.

Practical Training in Injection Techniques in the Treatment of Headache Disorders Skills Workshop $ (registration required)

Topics: Headache; Pain and Palliative Care Director: Morris Levin, MD, FAAN, San Francisco, CA Program Description: This two-hour skills workshop will provide hands-on training in nerve blockade, including greater and lesser occipital nerves, supraorbital and supratrochlear nerves, and auriculotemporal nerves; posterior cervical trigger point injections with perhaps injection sites for TMD; and onabotulinum toxin injections using the FDA-approved protocol for chronic migraine. Upon Completion: Participants should be able to perform the key cranial nerve blocks used in the management of headache disorders, perform key trigger point injections used in the management of headache disorders, and perform onabotulinum toxin injections used in the treatment of chronic migraine. Lecture/Faculty: }} Breakout Session 3: Onabotulinum Toxin Injections Andrew M. Blumenfeld, MD, San Diego, CA }} Breakout Session 2: Trigger Point Injections Matthew S. Robbins, MD, Bronx, NY }} Breakout Session 1: Nerve Blocks Thomas N. Ward, MD, FAAN, Norwich, VT Core Competencies: Medical Knowledge, Patient Care Teaching Style: Interactive, Audience Participation, Hands on Practice CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

C34

1:00 p.m.–3:00 p.m.

Introduction to Primary Headache Disorders I: Migraine and Other Primary Headaches Including Tension-type, Hypnic, Primary Stabbing, and Nummular Headache Syndromes

Topic: Headache Director: Todd D. Rozen, MD, FAAN, Jacksonville, FL Program Description: Primary headache disorders are those that are not attributable to another underlying secondary condition like a vascular malformation or brain neoplasm. The most well recognized primary headache subtypes are migraine, cluster, and tension-type headache, but there are many more primary headache disorders listed in the International Headache Classification that neurologists should be aware of as they may encounter them in their clinical practice. This introductory course will focus on the primary headache syndromes and will delve into their epidemiology, clinical presentation, and treatment using case-based scenarios. The lectures in the present course will focus on migraine and tension-type headache, as well as lesser known primary headache conditions including hypnic headache, primary stabbing headache, and nummular headache. This program complements C52: Introduction to Primary Headache Disorders II: Trigeminal Autonomic Cephalalgias and Other Primary Headaches Including New Daily Persistent Headache, Cough, Exercise, and Primary Thunderclap Headaches, but covers independent topics.

Sunday, April 23, 2017

C52

3:30 p.m.–5:30 p.m.

Introduction to Primary Headache Disorders II: Trigeminal Autonomic Cephalalgias and Other Primary Headaches Including New Daily Persistent Headache, Cough, Exercise, and Primary Thunderclap Headaches

Topic: Headache Director: Todd D. Rozen, MD, FAAN, Jacksonville, FL Program Description: Primary headache disorders are those that are not attributable to another underlying secondary condition, like a vascular malformation or brain neoplasm. The most well-recognized primary headache subtypes are migraine, cluster, and tension-type headache, but there are many more primary headache disorders listed in the International Headache Classification that neurologists should be aware of as they may encounter them in their clinical practice. This introductory course will focus on the primary headache syndromes and will delve into their epidemiology, clinical presentation, and treatment using case-based scenarios. Faculty will focus on the trigeminal autonomic cephalalgias and lesser known headache conditions, including new daily persistent headache, cough headache, exercise headache, headache associated with sexual activity, and primary thunderclap headache. This program complements C34: Introduction to Primary Headache Disorders I: Migraine and Other Primary Headaches Including Tension-type, Hypnic, Primary Stabbing, and Nummular Headache Syndromes, but covers independent topics.

Upon Completion: Participants should be familiar with how to diagnose and treat various primary headache disorders and become familiar with the International Classification of Headache Disorders, 3rd edition (beta version), as well as updated evidence-based treatment guidelines for migraine and other primary headache disorders.

Upon Completion: Participants should be familiar with how to diagnose and treat various primary headache disorders; become familiar with the International Classification of Headache Disorders, 3rd edition (beta version); be able to define various subtypes of trigeminal autonomic cephalalgias; and identify specific treatment for these subtypes.

Lecture/Faculty: }} Migraine Headache Lawrence C. Newman, MD, FAAN, New York, NY }} Other Primary Headache Syndromes Deborah I. Friedman, MD, MPH, FAAN, Dallas, TX Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, NonNeurologist, Advanced Practice Provider

Lecture/Faculty: }} Other Primary Headache Syndromes Todd D. Rozen, MD, FAAN, Jacksonville, FL }} Trigeminal Autonomic Cephalalgias Christopher J. Boes, MD, FAAN, Rochester, MN Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

$ = Additional Fee Required L = Leadership University

Fast and easy registration · AAN.com/view/AM17 69

Global Health

Sunday, April 23, 2017

Course Descriptions Monday, April 24, 2017

6:00 p.m.–9:00 p.m.

C110 Case Studies:

Challenging Headache Cases

Topic: Headache Director: Kathleen B. Digre, MD, FAAN, Salt Lake City, UT Program Description: We learn the basics and guidelines on many headache diagnoses and treatments, but how do we apply this knowledge to real-life cases that we are challenged by in every day practice where the basics are not enough and even guidelines do not help us? This course is designed to challenge the attendee and the presenters as we work through complex headache cases—highlighting challenges to diagnosis, evaluation, interpretation, and treatment of complex cases. Faculty will highlight guidelines and best practice, with the assumption that attendees have had some basic headache background and are willing to grapple with complex issues in headache through discussion, sharing, and even debate. Cases will be posted ahead of time, with references and key points about the cases posted upon completion of the session. Upon Completion: Participants should be able to diagnose a variety of headache disorders often with confusing presentations, formulate treatment plans that can incorporate multi-disciplinary regimens, analyze drug treatment side effects as well as interactions in therapeutic options, recognize the importance of co-morbidities that contribute to complexity in headache diagnosis and treatment, and integrate these factors into a therapeutic plan. Lecture/Faculty: }} Cases for Discussion Kathleen B. Digre, MD, FAAN, Salt Lake City, UT Deborah I. Friedman, MD, MPH, FAAN, Dallas, TX Stephanie J. Nahas, MD, FAAN, Philadelphia, PA Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Interactive, Audience Participation CME Credits: 3 Recommended Audience: Trainee, General Neurologist, Advanced Practice Provider Tuesday, April 25, 2017

7:00 a.m.–9:00 a.m.

C119 Management of Migraine and Psychiatric Comorbidities

Topic: Headache Director: Mia T. Minen, MD, New York, NY Program Description: Migraine is one of the most common reasons for neurology referral. This diagnosis is frequently associated with psychiatric disorders, particularly depression and anxiety. Limited access to mental health 70 2017 AAN Annual Meeting Early Look

Headache services and patient reluctance to seek psychiatric care are among the barriers providers face. Neurologists’ recognition, diagnosis, and treatment of psychiatric conditions comorbid with migraine provides tremendous benefit to our patients and to our health care system. Faculty will provide an update on the various types of psychiatric conditions seen with migraine and provide tools for efficient in-office screening, and discuss treatment strategies, from the nuts and bolts of medication therapy to incorporating a non-pharmacologic approach. The program will conclude with case presentations led by headache specialists with expertise in behavioral health issues. Upon Completion: Participants will be familiar with the common psychiatric comorbidities related to migraine, such as anxiety, depression, bipolar disorder, PTSD, and sleep disorders; be able to discuss the various tools available to screen for these disorders during the course of the neurological evaluation; and be able to devise treatment regimens for psychiatric conditions, as well as understand the principles and benefit of non-pharmacologic therapeutic options. Lecture/Faculty: }} Epidemiology of the Psychiatric Comorbidities Associated with Migraine Mia T. Minen, MD, New York, NY }} Migraine and Psychiatric Comorbidities: Potential Mechanisms and Treatment Implications Gretchen E. Tietjen, MD, Toledo, OH }} Screening Tools for Psychiatric Comorbidity Elizabeth Seng, PhD, Bronx, NY }} Behavioral Treatment Options for Psychiatric Comorbidity in Migraine Elizabeth Seng, PhD, Bronx, NY }} Pharmacologic Treatment Options for the Psychiatric Comorbidities Noah Rosen, MD, Great Neck, NY }} Cases Noah Rosen, MD, Great Neck, NY Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

1:00 p.m.–3:00 p.m.

C131 Hot Topics in Headaches and Related

Disorders I: Migraine Pathophysiology, Brain Imaging, and Therapeutic Advances

Topic: Headache Director: Peter Goadsby, MD, PhD, San Francisco, CA Program Description: This program will address a range of issues relevant to clinical practice that are developing or emerged in recent years. Faculty will cover important changes in the understanding of migraine pathophysiology, explore the latest in brain imaging and how it can be used to classify the disorder, and cover the newest therapeutic advances to prepare physicians for what is to come in terms of novel treatments for migraine patients. This program complements C147: Hot Topics in Headaches and Related Disorders II, but covers independent topics. Upon Completion: Participants should be able to explain more completely to patients migraine pathophysiology, imaging data, and new treatments. Lecture/Faculty: }} Migraine Pathophysiology: What’s New? Andrew Charles, MD, Los Angeles, CA }} Brain Imaging in Migraine: An Update Todd J. Schwedt, MD, FAAN, Phoenix, AZ }} Therapeutic Advances in Migraine: What Can We Expect? Denise Elaine Chou, MD, New York, NY Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Child Neurologist Tuesday, April 25, 2017

3:30 p.m.–5:30 p.m.

C147 Hot Topics in Headaches and Related

Disorders II: Unusual Headaches, Childhood Headaches, and Obesity

Topic: Headache Director: Peter Goadsby, MD, PhD, San Francisco, CA Program Description: This program will address a range of issues relevant to clinical practice that are developing or emerged in recent years. Childhood headache will be discussed in the context of misdiagnosis and evolution of thinking in these disorders. Migraine and its link to obesity will be reviewed with the new data. The trigeminal autonomic cephalagias, particularly cluster headache, will be covered in terms of pathophysiology and new treatments, as will some more unusual headache disorders.

$ = Additional Fee Required L = Leadership University

This program complements C131: Hot Topics in Headaches and Related Disorders I, but covers independent topics. Upon Completion: Participants should be able to identify and manage childhood headache and trigeminal autonomic cephalalgias. Lecture/Faculty: }} Childhood Headache: A Growing Problem Amy Gelfand, MD, San Francisco, CA }} Migraine and Obesity: Links and Biomarkers Faculty }} An Update on Trigeminal Autonomic Cephalalgias and Other Unusual Headaches Peter Goadsby, MD, PhD, San Francisco, CA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider Wednesday, April 26, 2017

7:00 a.m.–9:00 a.m.

C149 Low and High Pressure Headache:

Clinical Presentation and Approach to Evaluation and Management

Topic: Headache Director: Kathleen B. Digre, MD, FAAN, Salt Lake City, UT Program Description: Headache is a common neurologic complaint, but when the headache is associated with either high or low pressure, a complicated headache picture begins to emerge. Faculty will review the clinical approach to headaches associated with low and high pressure, discuss clues to recognizing headaches associated with low and high pressure, review the evaluation and management of headaches using a case-based approach, guide the attendees through conundrums about the management of these disorders, and highlight principles of treatment. Attendees are encouraged to submit cases to the faculty that could be used for discussion. Upon Completion: Participants should be able to describe the approach to diagnosing headache associated with high and low pressure and understand treatment options. Lecture/Faculty: }} Understanding Pressure and Headache Relationships Deborah I. Friedman, MD, MPH, FAAN, Dallas, TX }} Basic Recognition/Evaluation of Low Pressure Headache Syndromes Kathleen B. Digre, MD, FAAN, Salt Lake City, UT }} Basic Recognition/Evaluation of High Pressure Headache Syndromes Deborah I. Friedman, MD, MPH, FAAN, Dallas, TX Fast and easy registration · AAN.com/view/AM17 71

Headache

Tuesday, April 25, 2017

Course Descriptions }} Case Discussions Kathleen B. Digre, MD, FAAN, Salt Lake City, UT Deborah I. Friedman, MD, MPH, FAAN, Dallas, TX Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Advanced Practice Provider Wednesday, April 26, 2017

1:00 p.m.–3:00 p.m.

C158 Comprehensive Migraine Education Program I: Diagnosis, Risk Factors, and Neurobiology

Topic: Headache Director: Gretchen E. Tietjen, MD, Toledo, OH Program Description: The Comprehensive Migraine Education Program (CMEP) was developed by the American Headache Society. The CMEP highlights epidemiologic data on the scope and distribution of migraine with an emphasis on chronic migraine, practical methods for diagnosing chronic migraine, and recent insights into the mechanisms of the disorder, setting the stage for improving treatment outcomes for this most disabling of headache disorders. The CMEP is designed to provide a comprehensive understanding of migraine with an emphasis on chronic migraine, as well as to better diagnose and treat these serious problems. This program complements C173: Comprehensive Migraine Education Program II: Behavioral and Psychological Aspects, Preventative Pharmacology, and Treatment Advances, but covers independent topics. Upon Completion: Participants should be able to apply criteria for the clinical diagnosis and differential diagnosis of chronic migraine and episodic migraine using diagnostic algorithms; recognize the scope, burden, and distribution of chronic migraine in the population as well as the risk factors that predispose to it; and describe emerging insights into the pathophysiology of chronic migraine. Lecture/Faculty: }} Diagnosis of Chronic Migraine Morris Levin, MD, FAAN, San Francisco, CA }} Risk Factors and Prognosis of Chronic Migraine Gretchen E. Tietjen, MD, Toledo, OH }} Neurobiology of Chronic Migraine Stewart J. Tepper, MD, Lebanon, NH Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist

72 2017 AAN Annual Meeting Early Look

Headache Wednesday, April 26, 2017

3:30 p.m.–5:30 p.m.

C173 Comprehensive Migraine Education

Program II: Behavioral and Psychological Aspects, Preventative Pharmacology, and Treatment Advances

Topic: Headache Director: Gretchen E. Tietjen, MD, Toledo, OH Program Description: The Comprehensive Migraine Education Program (CMEP) was developed by the American Headache Society. The CMEP highlights epidemiologic data on the scope and distribution of migraine with an emphasis on chronic migraine, practical methods for diagnosing chronic migraine, and recent insights into the mechanisms of the disorder, setting the stage for improving treatment outcomes for this most disabling of headache disorders. The CMEP is designed to provide a comprehensive understanding of migraine with an emphasis on chronic migraine, as well as to better diagnose and treat these serious problems. This program complements C158: Comprehensive Migraine Education Program I: Diagnosis, Risk Factors, and Neurobiology, but covers independent topics. Upon Completion: Participants should be able to apply criteria for the clinical diagnosis and differential diagnosis of chronic migraine and episodic migraine using diagnostic algorithms; recognize the scope, burden, and distribution of chronic migraine in the population as well as the risk factors that predispose to it; and describe emerging insights into the pathophysiology of chronic migraine. Lecture/Faculty: }} Behavioral and Psychological Aspects of Migraine Dawn C. Buse, PhD, Bronx, NY }} Preventive Pharmacology for Chronic Migraine Elizabeth Loder, MD, FACP, Boston, MA }} Advances in Acute Treatment of Chronic Migraine Gretchen E. Tietjen, MD, Toledo, OH Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist

7:00 a.m.–9:00 a.m.

C196 Emergency and Inpatient Management of Migraine and Other Headache Disorders

Topic: Headache Director: Stephanie J. Nahas, MD, FAAN, Philadelphia, PA Program Description: A combined case-based and didactic approach will illustrate empiric and evidence-based diagnosis and management strategies for patients presenting with headache in the urgent or inpatient setting. Topics to be covered include migraine, trigeminal autonomic cephalalgias, and secondary headaches, among others. Upon Completion: Participants should be able to discuss the diagnostic approach to patients with headache in the emergency department or hospital and explain the process and rationale for selecting therapy. Lecture/Faculty: }} Headache in the Emergency Department Stephanie J. Nahas, MD, FAAN, Philadelphia, PA William B. Young, MD, FAAN, Philadelphia, PA }} Inpatient Headache Medicine Stephanie J. Nahas, MD, FAAN, Philadelphia, PA William B. Young, MD, FAAN, Philadelphia, PA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

INFECTIOUS DISEASE Sunday, April 23, 2017

C27

7:00 a.m.–9:00 a.m.

Differential Diagnosis of Neurologic Infections

Topic: Infectious Disease Director: Marie Francisca Grill, MD, Phoenix, AZ Program Description: Differential diagnosis of patients with possible neurologic infections will be presented to discuss diagnostic considerations, imaging, cerebrospinal fluid interpretation, PCR testing and other microbiologic tests, as well as mimicking disorders. Specific topics will include cases highlighting coverage of encephalitis, meningitis, and myelitis. Upon Completion: Participants should be able to improve their ability to form a more precise differential diagnosis of possible neurologic infections, and to recognize specific laboratory tests and imaging findings that can guide the differential diagnosis accordingly. $ = Additional Fee Required L = Leadership University

Lecture/Faculty: }} Encephalitis Avindra Nath, MBBS, FAAN, Bethesda, MD }} Chronic Meningitis Israel Steiner, MD, Petach Tikva, Israel }} Myelitis Marie Francisca Grill, MD, Phoenix, AZ Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist Sunday, April 23, 2017

C39

1:00 p.m.–3:00 p.m.

So You’ve Diagnosed Your Patient with a Neuroinfectious Disease, Now What? Practical Pearls in the Treatment and Management of Neuroinfectious Diseases

Topic: Infectious Disease Director: Felicia Chow, MD, San Francisco, CA Program Description: Neurology providers are caring for an increasing number of patients with infections of the nervous system and associated neurological complications. In this case-based interactive course, an interdisciplinary panel of experts from both neurology and infectious diseases will share their approach to challenging neuroinfectious diseases cases. An emphasis will be placed on an up-to-date, evidence-based approach to complicated cases combined with onthe-ground experience from clinical experts in the field. Upon Completion: Participants will improve their skills in the evaluation and management of neuroinfectious diseases, with a focus on high-yield clinical pearls in advanced topics such as: Selection of antimicrobial therapy, CNS penetration and neurological toxicities of antimicrobial therapy, drug-drug interactions with frequently used medications in neurology, timing and duration of corticosteroid therapy for neurological infections, management of common complications of CNS infections (e.g., increased intracranial pressure), and utility of laboratories for monitoring response to therapy. Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Expert Panel CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist

Fast and easy registration · AAN.com/view/AM17 73

Headache

Thursday, April 27, 2017

Course Descriptions Monday, April 24, 2017

C67

7:00 a.m.–9:00 a.m.

Infections of the Nervous System I: Diagnostic Testing of Neurological Infections

Topic: Infectious Disease Director: Tracey Cho, MD, Boston, MA Program Description: This program will provide an overview of the laboratory and imaging studies available for timely and accurate diagnosis of a range of infections of the nervous system. Faculty will provide updates on the appropriate use of currently available tests, including sensitivity and specificity, as well as comment on emerging diagnostic modalities. Case discussions with audience questions will be encouraged. This program complements C82: Infections of the Nervous System II: Neuro-ID Emergencies and C96: Infections of the Nervous System III: Advanced Topics in Infectious Neurology, but covers independent topics. Upon Completion: Participants should be able to effectively order and interpret laboratory and imaging studies for timely and accurate diagnosis of infections of the nervous system. Lecture/Faculty: }} Diagnostic Laboratory Testing for CNS Infections Michael R. Wilson, MD, San Francisco, CA }} Diagnostic Imaging for CNS Infections Tracey Cho, MD, Boston, MA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist Monday, April 24, 2017

C82

1:00 p.m.–3:00 p.m.

Infections of the Nervous System II: Neuro-ID Emergencies

Topic: Infectious Disease Director: Tracey Cho, MD, Boston, MA Program Description: Infections of the nervous system can present acutely and cause permanent neurologic disability or death. Prompt diagnosis and appropriate treatment can mitigate the morbidity and mortality of acute CNS infections. Faculty will focus on acute meningitis and encephalitis, with an emphasis on diagnosis and management of these relatively common infectious syndromes. Syndromic approach to diagnosis and case discussions with audience questions will be encouraged.

74 2017 AAN Annual Meeting Early Look

Infectious Disease This program complements C67: Infections of the Nervous System I: Diagnostic Testing of Neurological Infections and C96: Infections of the Nervous System III: Advanced Topics in Infectious Neurology, but covers independent topics. Upon Completion: Participants should be able to recognize, differentiate, and manage common acute infections of the nervous system. Lecture/Faculty: }} Acute Meningitis Jennifer Lyons, MD, Boston, MA }} Encephalitis Arun Venkatesan, MD, PhD, Baltimore, MD Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider Monday, April 24, 2017

C96

3:30 p.m.–5:30 p.m.

Infections of the Nervous System III: Advanced Topics in Infectious Neurology

Topic: Infectious Disease Director: Tracey Cho, MD, Boston, MA Program Description: This program will provide an overview of advanced topics in infections of the central nervous system. Faculty will provide updates on the appropriate approach to diagnosis and management of a neurological Lyme disease and infectious causes of stroke. Case discussions with audience questions will be encouraged. This program complements C67: Infections of the Nervous System I: Diagnostic Testing of Neurological Infections and C82: Infections of the Nervous System II: Neuro-ID Emergencies, but covers independent topics. Upon Completion: Participants should be able to identify current diagnostic algorithms and treatment recommendations for a variety of advanced infections and infectious complications affecting the central nervous system. Lecture/Faculty: }} Infectious Causes of Stroke Kiran Thakur, MD, New York, NY }} Neuro-Lyme Update John J. Halperin, MD, FAAN, New York, NY Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider

Thursday, April 27, 2017

1:00 p.m.–3:00 p.m.

C208 A Case-based Approach to Acute

LEADERSHIP UNIVERSITY

CNS Infections

Director: Christina Marra, MD, FAAN, Seattle, WA Program Description: Central nervous system (CNS) infections are often neurological emergencies in which prompt diagnosis and treatment may mean the difference between good recovery and death or significant disability. Neurologists are often asked to make decisions about diagnosis and management of CNS infections. This course will begin with a systematic approach to diagnosis of acute CNS infections. This will be followed by case-based, interactive discussions of individual infections. Each case will be followed by an overview and update on the topic, including differential diagnosis, diagnostic studies, and antimicrobial therapy. Upon Completion: Participants should be able to apply a systematic approach to diagnosis and management of acute CNS infections, as well as increase their knowledge about specific infections and their treatment. Lecture/Faculty: }} Approach to Diagnosis of Acute CNS Infections Christina Marra, MD, FAAN, Seattle, WA }} Case Discussions Tracey Cho, MD, Boston, MA Christina Marra, MD, FAAN, Seattle, WA Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider

$ = Additional Fee Required L = Leadership University

Saturday, April 22, 2017

8:00 a.m.–5:00 p.m.

L Clerkship and Program Directors Leadership Academy (registration required)

Topic: Leadership Directors: Jaffar Khan, MD, FAAN, Atlanta, GA Rana R. Said, MD, Dallas, TX Joseph E. Safdieh, MD, FAAN, New York, NY Program Description: Our neurology clerkship and program directors are among our most important gatekeepers of our pipeline to careers in neurology. In many cases, these education leaders are responsible for the first contact with potential candidates for our future workforce in neurology. This course is designed to optimize the skill set of these influential leaders. Upon Completion: The objective of this program is to develop, enhance and strengthen the leadership attributes/skills/potential of our neurology clerkship and program directors. The program will provide the recipient with the opportunity to develop personal awareness, understand principles of leadership and enhance interpersonal skills as they relate to their role as leaders in education. Lecture/Faculty: }} Welcome/Faculty Introductions Jaffar Khan, MD, FAAN, Atlanta, GA }} AAN—History, Structure/Organization Jaffar Khan, MD, FAAN, Atlanta, GA }} Specific Leadership Qualities Jaffar Khan, MD, FAAN, Atlanta, GA Joseph E. Safdieh, MD, FAAN, New York, NY Rana R. Said, MD, Dallas, TX }} Principles, Qualities, and Responsibilities of Leadership Jaffar Khan, MD, FAAN, Atlanta, GA Joseph E. Safdieh, MD, FAAN, New York, NY Rana R. Said, MD, Dallas, TX }} Teamwork Jaffar Khan, MD, FAAN, Atlanta, GA Joseph E. Safdieh, MD, FAAN, New York, NY Rana R. Said, MD, Dallas, TX }} Strategic Thinking Jaffar Khan, MD, FAAN, Atlanta, GA Joseph E. Safdieh, MD, FAAN, New York, NY Rana R. Said, MD, Dallas, TX }} Negotiation Skills/Conflict Resolution Jaffar Khan, MD, FAAN, Atlanta, GA Joseph E. Safdieh, MD, FAAN, New York, NY Rana R. Said, MD, Dallas, TX Fast and easy registration · AAN.com/view/AM17 75

Infectious Disease

Topic: Infectious Disease

Course Descriptions }} Working Lunch Faculty }} The Most Important Tool in Your Black Bag: Gallup Strength Finders Julie Anderson, Stillwater, MN Keri Bischoff, Saint Paul, MN Teaching Style: Audience Participation CME Credits: 0 Recommended Audience: Clerkship and Program Directors Saturday, April 22, 2017

8:00 a.m.–5:00 p.m.

L Women in Leadership $ (registration required)

Topic: Leadership Directors: Orly Avitzur, MD, MBA, FAAN, Tarrytown, NY Janice M. Massey, MD, FAAN, Durham, NC Barbara L. Hoese, Minneapolis, MN Program Description: For more than two decades, over half of physicians and trainees in neurology have been women. Yet women still remain underrepresented in the top leadership positions in academic medical centers and large private practices. The number of women in top leadership positions has remained largely unchanged since the early 2000s. In a recent study published online in the Journal of American Medical Association Internal Medicine and referenced in the AAN’s Neurology Today, it was noted that women neurologists in academics make $44,000 less than their male counterparts. The ongoing challenges of women achieving equity in pay and opportunities is a leadership issue. To help develop and support women who have the capacity and desire to lead in academic or private sectors and in the field of neurology, the AAN is offering this course focusing on identifying and building women’s capacity to lead in both environments. Upon Completion: Participants will be able to develop and support women who have the capacity and desire to lead at higher levels in their institution or practice and in the field of neurology; through involvement of women Academy Fellows, provide role models for women; encourage women to embrace their own leadership capability; equip women to express their leadership voice and be heard (regardless of audience) on a variety of topics in their workplaces. Lecture/Faculty: }} The Call for Women to Lead •• What is Required of Leadership Today •• What Do We Know About Women Leaders in Neurology Today? •• What Are the Unique Challenges Women Face in Their Workplaces Today? Orly Avitzur, MD, MBA, FAAN, Tarrytown, NY Barbara L. Hoese, Minneapolis, MN Janice M. Massey, MD, FAAN, Durham, NC }} Leadership Styles – Does Gender Matter? •• The changing biases women (and others!) face today 76 2017 AAN Annual Meeting Early Look

Leadership University •• What would you do? yy Exploring Leadership Scenarios

•• Communication Styles yy Implicit biases impacting gender communications yy Negotiation considerations yy Having the “gender conversation”

rly Avitzur, MD, MBA, FAAN, Tarrytown, NY O Barbara L. Hoese, Minneapolis, MN Janice M. Massey, MD, FAAN, Durham, NC }} Focusing on Your Leadership Strengths and Experiences •• Who are you as an authentic leader? •• What are your strengths and how will you use them to lead? •• What is your leadership purpose? Orly Avitzur, MD, MBA, FAAN, Tarrytown, NY Barbara L. Hoese, Minneapolis, MN Janice M. Massey, MD, FAAN, Durham, NC }} Learning from Other Women Leaders: Mentors and Role Models (Panel Discussion) •• Stories on Career Paths, Value of Mentors and Role Models, Keeping Your Identity While Leading Others •• How to Find and Work With a Mentor Orly Avitzur, MD, MBA, FAAN, Tarrytown, NY Robin L. Brey, MD, FAAN, San Antonio, TX Barbara L. Hoese, Minneapolis, MN Janice M. Massey, MD, FAAN, Durham, NC Maisha T. Robinson, MD, MS, Jacksonville, FL Ann H. Tilton, MD, FAAN, New Orleans, LA Barbara G. Vickrey, MD, MPH, FAAN, New York, NY }} Leading Forward •• What Are Your Opportunities to Lead? •• Gaining Sponsorship Orly Avitzur, MD, MBA, FAAN, Tarrytown, NY Barbara L. Hoese, Minneapolis, MN Janice M. Massey, MD, FAAN, Durham, NC }} Focusing Your Leadership •• Finding Your Voice •• Committing to Your Leadership Development Orly Avitzur, MD, MBA, FAAN, Tarrytown, NY Barbara L. Hoese, Minneapolis, MN Janice M. Massey, MD, FAAN, Durham, NC Teaching Style: Interactive, Audience Participation CME Credits: 0 Recommended Audience: Women with Some Leadership Experience Who Seek to Prepare for Greater Leadership Roles in Their Careers

C47

1:00 p.m.–5:00 p.m.

L Gender Issues in Leadership

Topic: Leadership Directors: Lyell K. Jones, MD, FAAN, Rochester, MN Bert B. Vargas, MD, FAAN, Dallas, TX Maisha T. Robinson, MD, MS, Jacksonville, FL Barbara L. Hoese, Minneapolis, MN Program Description: While women make up half of the labor force—and over 50% of neurologists are women— they are still underrepresented in senior leadership roles in both private practice and academe. Women neurologists are still paid less than their male counterparts. Women represent approximately 17% of leadership positions in healthcare, and the number hasn’t changed in the past 15 years. What are the factors that are creating this imbalance? Interactive in nature, this program will offer a fresh look at unintended biases that may impede effective leadership equity through case studies and round table discussions. Finally, it will offer practical ideas for both men and women that can be rapidly implemented inthe workplace. Upon Completion: Participants should be able to learn effective leadership strategies displayed by both genders; decode communication styles so differences don’t lead to misunderstandings; for men: take away practical tips to use in creating a balanced workplace; for women: develop strategies to recognize and prepare for leadership opportunities; learn tips for mentoring the opposite gender; explore how to diffuse the discomfort of having the gender conversation. Lecture/Faculty: }} Gender Issues in Leadership •• Defining the problem and causes of gender issues in the workplace •• Latest Research on Leadership and Gender •• Why invest in leadership equity? Maisha T. Robinson, MD, MS, Jacksonville, FL }} Unintended Biases •• What are common unintended biases about the roles of women and men? •• Uncovering and changing beliefs Bert B. Vargas, MD, FAAN, Dallas, TX }} Interpersonal Communication Styles •• Common misperceptions in styles between genders •• Reading the room: what is said and not said •• Tips for navigating differences in style Barbara L. Hoese, Minneapolis, MN }} Developing Your Action Plan •• Where are the unintended biases in your organization? What can you do to close them? Lyell K. Jones, MD, FAAN, Rochester, MN Teaching Style: Interactive CME Credits: 0 Recommended Audience: Departmental and Practice Leaders Looking $ = Additional Fee Required L = Leadership University

for Ways to Provide or Create an Environment Where Leadership Opportunities are More Equitably Available Sunday, April 23, 2017

C48

1:00 p.m.–5:00 p.m.

L Leadership Challenges in Practice

Topics: Leadership; Practice, Policy, and Ethics Director: James C. Stevens, MD, FAAN, Fort Wayne, IN Program Description: With the issues facing today’s practicing neurologist, it is essential to develop the leadership skills needed to navigate these challenges. This program will address the concerns in the evolving health care environment and provide solutions to maintain steadfast leadership skills to keep your practice vibrant and successful. Topics will include: yy Relationship development and communication techniques to successfully negotiate with health care systems, insurers, and regulatory agencies yy Refining analytical skills to properly select and implement an economical and useful EHR system yy Properly implementing work flows and processes to increase new sources of revenue yy Increasing patient/provider satisfaction while meeting regulatory demands

Upon Completion: Participants should have a better understanding of how strong leadership skills can help mitigate the economic and regulatory demands of a practicing neurologist in the US health care system and ensure high-quality and rewarding care remains the top priority in an independent practice setting. Teaching Style: Interactive, Audience Participation CME Credits: 0 Recommended Audience: General Neurologist, Advanced Practice Provider Monday, April 24, 2017

C76

1:00 p.m.–3:00 p.m.

L Mentoring… Growing the Next Generation of Neurologist $ (registration required)

Topic: Leadership Director: Joanne L. Smikle, PhD, Ellicott City, MD Program Description: This informative, interactive session focuses on the competencies required to build strong developmental relationships. The session emphasizes the factors required to successfully mentor physicians from different settings and at different stages of practice. The presenter will explore the distinctions between coaching and mentoring, provide a framework for building a solid mentoring relationship, and offer approaches for maximizing the mentor/protègè relationship. Participants are encouraged to bring their questions and dilemmas related to mentoring as there will be many opportunities for large and small group discussions during the session. The session Fast and easy registration · AAN.com/view/AM17 77

Leadership University

Sunday, April 23, 2017

Course Descriptions is enhanced by short case studies that explore approaches to mentoring. Participants will also complete a short assessment that measures their mentoring aptitude. CME Credits: 0 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Monday, April 24, 2017

C88

1:00 p.m.–5:00 p.m.

L Improving Your Leadership Skills: A Practical Approach (registration required)

Topic: Leadership Directors: Terrence L. Cascino, MD, FAAN, Rochester, MN Ralph L. Sacco, MD, MS, FAHA, FAAN, Miami, FL Program Description: Leadership has been defined as “having a sound vision and convincing others to follow you.” This course will assist you in implementing the vision and offer practical tips and case examples on how to persuade others to follow. Course reading materials will be provided. Upon Completion: Attendees will learn to apply knowledge to roles as a leader in the hospital, community, state medical society, professional organizations, and political action. Lecture/Faculty: }} Characteristics of a Good Leader Terrence L. Cascino, MD, FAAN, Rochester, MN }} Planning 101 Terrence L. Cascino, MD, FAAN, Rochester, MN }} Change Management Ralph L. Sacco, MD, MS, FAHA, FAAN, Miami, FL }} Critical Conversations Terrence L. Cascino, MD, FAAN, Rochester, MN }} Secrets of Being an Effective AAN or Institutional Leader Ralph L. Sacco, MD, MS, FAHA, FAAN, Miami, FL }} Wrap Up Terrence L. Cascino, MD, FAAN, Rochester, MN Core Competencies: Interpersonal and Communication Skills, Professionalism Teaching Style: Didactic, Interactive, Audience Participation CME Credits: 3.5 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provide

78 2017 AAN Annual Meeting Early Look

Leadership University Tuesday, April 25, 2017

1:00 p.m.–5:00 p.m.

C133 L The Most Important Tool in Your Black Bag: Gallup StrengthsFinder™ Education Workshop $ (registration required) Topic: Leadership Directors: Keri Bischoff, Saint Paul, MN Julie Anderson, Stillwater, MN Program Description: A leader needs to know his strengths as a carpenter knows his tools, or a physician knows the instruments at her disposal.“ -Donald Clifton Back by popular demand, this is the foundation for all AAN Strengths learning. Consider joining us with members of your team for a deeper understanding of how you may work together more effectively. Gallup-certified consultants will share a language for understanding your unique strengths, which has powerful application for well being and happiness. Through customized exercises, materials, and conversations this interactive workshop encourages a new perspective through your own unique lens. Using the science behind the StrengthsFinder™ assessment we’ll discover your top five talent themes, and a positive language to leverage what’s right. We“ll share ways this approach can change the culture of your organization through engagement, which leads to increased productivity, patient satisfaction, and peer understanding. Gallup research reveals that in health care, relationships are key. How can we optimize communication skills? To patients, feelings are facts: How do you relate to others, and how do others experience you? Do you know? Online assessment required prior to workshop; access code provided. Prerequisite for the StrengthsFinder™ Advanced Workshop Upon Completion: Expect to acquire actionable, customized insight into your own unique strengths, leading to greater well being, as well as awareness of individual and team communication styles in personal and organizational contexts. Lecture/Faculty: }} Foundation of Gallup StrengthsFinderTM Philosophy Keri Bischoff, Saint Paul, MN }} Applying Strengths Personally and Professionally Julie Anderson, Stillwater, MN }} Organizational Application Keri Bischoff, Saint Paul, MN }} Communication, Strengths, and Misperceptions Julie Anderson, Stillwater, MN Teaching Style: Case-Based, Audience Participation CME Credits: 0 Recommended Audience: Trainee, General Neurologist, NonNeurologist, Advanced Practice Provider

1:00 p.m.–5:00 p.m.

C134 L Advanced Leadership Training: Life-after-the-Limelights

Topic: Leadership Director: Robert C. Griggs, MD, FAAN, Rochester, NY Program Description: A few neurologists are given leadership positions before they feel quite ready for them, but virtually all leaders—Academy Board Members, Officers, and Committee Chairs, as well as Department Chairs and other academic leaders conclude leadership positions and are relatively unprepared for the new leadership, but untitled, opportunities that they should accept and pursue. This interactive workshop is designed to bring together people who are at the mid-to-late-stages of their career to consider how one can shift gears and move into highly-productive, generative and creative activities when you no longer have or expect to have a “big“ job but have years of opportunities to continue as a practitioner, educator, or researcher. The format will include panel discussions with neurologists “whoby have been there“ as well as discussions among participants facilitator Richard Leider of “Life Reimagined.“ Topics and issues that will be considered include: Freelance mentoring; global opportunities; focusing on your mission; and supporting your passion. CME Credits: 0 Wednesday, April 26, 2017

1:00 p.m.–5:00 p.m.

C171 L The Most Important Tool in Your Black

Bag: Gallup StrengthFinders™ Assessment: Advanced Workshop $ (registration required)

Topic: Leadership Directors: Keri Bischoff, Saint Paul, MN Julie Anderson, Stillwater, MN Program Description: StrengthsFinder™ Advanced Workshop builds on the foundational learning in the introductory course and is designed for those who have completed the introductory course in 2016 or 2017. How can I improve my relationships professionally and socially? How can I contribute my strengths to team dynamics and performance? Learn to understand the practical and specific application of Strengths, and improve and maximize team productivity through interactive and guided discussions. A team-based approach is essential in all aspects of your profession: Clinical, education, and research. Written exercises, directed conversation, customized materials, and advanced StrengthsFinder™tools increase self-understanding and an appreciation for how you, uniquely, come at the world. We often use our own perceptions when we diagnose, describe, and discover: $ = Additional Fee Required L = Leadership University

What are yours? We see those around us through a lens of our own strength. This advanced workshop helps you look at yourself, and others, differently. This deeper understanding brings you to a more nuanced realization of how you come at the world, and how those around may approach the very same goals in very different ways. Assessment results must be provided prior to this Advanced Workshop. Prerequisite: StrengthsFinder™ Education Workshop Upon Completion: As a participant you will gain a better understanding of your strengths and a new perspective on those around you, including your patients, peers, and administrators. Both professional and socially you’ll develop a deeper understanding of how you come at the world, and how we can best contribute our strengths to unique team dynamics and performance. Lecture/Faculty: }} Advanced Gallup StrengthsFinder Understanding Julie Anderson, Stillwater, MN }} Application of Strengths and Values to Greater Selfawareness Keri Bischoff, Saint Paul, MN }} Best Practices for Strength-based Teams Julie Anderson, Stillwater, MN }} Effective Approaches to Research, Clinical, and Educational Settings Keri Bischoff, Saint Paul, MN Teaching Style: Case-Based, Interactive, Audience Participation CME Credits: 0 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist Thursday, April 27, 2017

1:00 p.m.–5:00 p.m.

C210 L Being A Resilient Leader:

How Do You Lead the Change?

Topic: Leadership Directors: Heidi B. Schwarz, MD, FAAN, Rochester, NY Jennifer Rose Molano, MD, FAAN, Cincinnati, OH Program Description: This four-hour, interactive program is designed to empower neurologists in leadership positions to increase engagement within one’s organization, clinic, or institution. Upon Completion: Understand burnout in neurology at the individual, work-unit, and national levels. Discuss challenges in promoting resiliency at one’s local organization, clinic, or institution. Identify strategies to promote improvements in the culture of one’s local organization, clinic, or institution. Core Competencies: Interpersonal and Communication Skills, Professionalism Fast and easy registration · AAN.com/view/AM17 79

Leadership University

Tuesday, April 25, 2017

Course Descriptions Teaching Style: Interactive, Audience Participation CME Credits: 0 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

Movement Disorders Sunday, April 23, 2017

C25

7:00 a.m.–9:00 a.m.

Cerebellar and Afferent Ataxias: Diagnosis and Management

Topic: Movement Disorders

MOVEMENT DISORDERS Saturday, April 22, 2017

8:00 a.m.–10:00 a.m.

Parkinson’s Disease Update

Topic: Movement Disorders Director: Melissa J. Nirenberg, MD, PhD, FAAN, New York, NY Program Description: This program will provide participants with a global overview of Parkinson’s disease, including the latest information about pathophysiology, genetic and environmental risk factors, biomarkers, and clinical phenomenology. Faculty will focus on the evidencebased management of motor symptoms, nonmotor symptoms, and complications of dopaminergic therapy, including the role of new and emerging medical and surgical treatments. Upon Completion: Participants should have a broad understanding of Parkinson’s disease, including pathophysiology, genetics, biomarkers, risk factors, motor and nonmotor symptoms, complications of dopaminergic therapy, and evidence-based medical and surgical therapies. Lecture/Faculty: }} Overview of Parkinson’s Disease: Part I Hubert H. Fernandez, MD, FAAN, Cleveland, OH }} Overview of Parkinson’s Disease: Part II Melissa J. Nirenberg, MD, PhD, FAAN, New York, NY Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Sunday, April 23, 2017

C24

7:00 a.m.–9:00 a.m.

Child Neurology: A Case-based Approach

Topics: Child Neurology and Developmental Neurology; Movement Disorders Director: Elaine C. Wirrell, MD, Rochester, MN See complete course description on page 41 »

80 2017 AAN Annual Meeting Early Look

Director: Massimo Pandolfo, MD, FAAN, Brussels, Belgium Program Description: Ataxia is the predominant manifestation of many acquired and inherited neurologic disorders affecting the cerebellum, its connections, and the afferent proprioceptive pathways. This course covers the phenomenology and etiologies of cerebellar and afferent ataxias and provides indications for a rational approach to diagnosis and management. Particular attention will be given to inherited ataxias and new developments in genetic testing. Through case presentations, faculty will discuss the diagnostic process and test result interpretation. Upon Completion: Participants should be familiar with the differential diagnoses and work-up, including genetic testing, of ataxias. Lecture/Faculty: }} The Dominant Spinocerebellar Ataxias Stefan M. Pulst, MD, FAAN, Salt Lake City, UT }} Recessive and X-linked Ataxias Massimo Pandolfo, MD, FAAN, Brussels, Belgium }} Case Presentations Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Sunday, April 23, 2017

C35

1:00 p.m.–3:00 p.m.

Deep Brain Stimulation I: Basic Principles and Programming in Movement Disorders

This program complements C53: Deep Brain Stimulation II: Advanced Management in Movement Disorders and Applications Beyond Movement Disorders, but covers independent topics. Upon Completion: Participants should be able to describe the rationale for the use of DBS and the patients for whom the treatment is most indicated and have a general understanding and appreciate the principles of initial DBS stimulator activation and programming. Lecture/Faculty: }} Overview of DBS, Current Indications, Patient Selection, Basics of Surgery Leonard Verhagen Metman, MD, PhD, Chicago, IL }} The Art and Science of Basic DBS Stimulation Programming (Focus PD and ET) Michael Pourfar, MD, New York, NY }} Cases/Questions/Discussion Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Nurse Practitioner, Registered Nurse, Advanced Practice Provider Sunday, April 23, 2017

C49

1:00 p.m.–5:30 p.m.

Clinical Uses of Botulinum Toxin for Dystonia Skills Workshop $ (registration required)

Topic: Movement Disorders Director: Diego Torres-Russotto, MD, Omaha, NE

Upon Completion: Participants should be able to list indications and contraindications for chemodenervation; select appropriate candidates for botulinum toxin injections in dystonia; recognize the phenomenology that leads to the development of an injection plan in patients; and review best practices for the establishment of a successful chemodenervation clinic. Lecture/Faculty: }} Dystonia Generalities Diego Torres-Russotto, MD, Omaha, NE }} Toxin Generalities Cynthia L. Comella, MD, FAAN, Chicago, IL }} Chemodenervation for Cervical Dystonia: Rationale, Muscle Selection, and Dosing Cynthia L. Comella, MD, FAAN, Chicago, IL }} Chemodenervation for Blepharospasm: Rationale, Muscle Selection, and Dosing Diego Torres-Russotto, MD, Omaha, NE }} Chemodenervation for Oromandibular and Lingual Dystonia: Rationale, Muscle Selection, and Dosing Pedro Gonzalez-Alegre, MD, Philadelphia, PA }} Chemodenervation for Limb Dystonia: Rationale, Muscle Selection, and Dosing Brad A. Racette, MD, FAAN, Saint Louis, MO }} How to Set Up a Successful Chemodenervation Clinic Diego Torres-Russotto, MD, Omaha, NE }} Interactive Injection Simulation: Cervical Injections Cynthia L. Comella, MD, FAAN, Chicago, IL }} Interactive Injection Simulation: Face Injections and Dilution Training Pedro Gonzalez-Alegre, MD, Philadelphia, PA }} Interactive Injection Simulation: Upper and Lower Limb Injections Brad A. Racette, MD, FAAN, Saint Louis, MO Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive, Practical Tips Through Case Reviews CME Credits: 4 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider

Program Description: Chemodenervation is one of the most useful treatments for dystonias. Faculty will cover all presentations of the disorder that could benefit from this treatment and the full gamut of indications where botulinum toxin injections could be helpful. The course will also provide training in how to perform the injections. Faculty will begin with presentations reviewing cervical, periocular, oromandibular, and limb dystonias, and the evidence for chemodenervation; and review how to set up a successful chemodenervation practice. During the second half, attendees will participate in interactive sessions covering injection tips, dilution training, injection videos, and practice on simulation systems. $ = Additional Fee Required L = Leadership University

Fast and easy registration · AAN.com/view/AM17 81

Movement Disorders

sessions, and those registering for the course are encouraged to participate in both sessions for a comprehensive overview of the topic. Part I will focus on basic DBS principles and programming issues in movement disorders. Part II will focus on more advanced DBS issues in movement disorders and also highlight DBS in nonmovement disorders conditions. These programs will include a casebased discussion highlighting patient candidacy and management of DBS, and will occur at the end each session.

Course Descriptions Sunday, April 23, 2017

C53

3:30 p.m.–5:30 p.m.

Deep Brain Stimulation II: Advanced Management in Movement Disorders and Applications Beyond Movement Disorders

Topic: Movement Disorders Director: Jill L. Ostrem, MD, San Francisco, CA Program Description: Deep brain stimulation is widely used to treat advanced, medicationresistant movement disorders, including essential tremor, Parkinson’s disease, and dystonia. An understanding of the DBS device, proper patient selection, and optimized postoperative management is essential to achieve successful outcomes with DBS, maximize patient benefits, and minimize adverse effects or complications. Each of these key issues will be discussed, with an emphasis on practical information for the clinician. This course has been divided into two sequential sessions, and those registering for the course are encouraged to participate in both Part I and Part II for a comprehensive overview of the topic. Part I will focus on patient candidacy and basic programming in movement disorders. Part II will cover more advanced DBS in movement disorders and evolving DBS indications beyond movement disorders. The program will include case-based discussion. This program complements C35: Deep Brain Stimulation Management I: Basic Principles and Programming in Movement Disorders, but covers independent topics. Upon Completion: Participants should be able to describe the rationale for the use of DBS and the patients for whom the treatment is most indicated, and have a general understanding and appreciate the principles of DBS programming, advanced patient management, and novel DBS indications. Lecture/Faculty: }} Advanced Management of PD, ET, Dystonia, and Troubleshooting Joohi Jimenez Shahed, MD, Houston, TX }} Novel and Emerging Uses of DBS: OCD, Tourette Syndrome, Depression, Alzheimer’s, and Epilepsy Michael S. Okun, MD, FAAN, Gainesville, FL }} Cases/ Discussion Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Nurse Practitioner, Nurse, Advanced Practice Provider

82 2017 AAN Annual Meeting Early Look

Movement Disorders Monday, April 24, 2017

C68

7:00 a.m.–9:00 a.m.

Approach to the Shaky Patient

Topic: Movement Disorders Director: Vicki Shanker, MD, New York, NY Program Description: Tremor is a common presentation in the neurologist’s office and may be normal or pathologic. Although phenomenologically there are several characteristic differences of the disease states that produce these tremors, parkinsonian tremor, essential tremor, and dystonic tremor are often confused, leading to early misdiagnosis and delay in care. Through didactic lecture and video clips, in addition to case-based presentations, faculty will review key distinguishing characteristics of common and uncommon disease entities that produce tremor and provide clinical pearls for diagnosis. This program is geared for general practitioners and trainees. Upon Completion: Participants should be able to recognize the clinical features of a parkinsonian tremor, essential tremor, and dystonic tremor as well as less common tremor conditions, and be able to apply clinical techniques to distinguish these disease entities in the office. Lecture/Faculty: }} Introduction in the Clinical and Diagnostic Approach to Tremor Vicki Shanker, MD, New York, NY }} Tremor in Parkinson’s Disease Andres Felipe Deik Acosta Madiedo, MD, Philadelphia, PA }} Tremor in Dystonia Andres Felipe Deik Acosta Madiedo, MD, Philadelphia, PA }} Tremor in Essential Tremor Vicki Shanker, MD, New York, NY }} Uncommon Tremors: Psychogenic and Beyond Vicki Shanker, MD, New York, NY Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic, Audience Participation, Video Review CME Credits: 2 Recommended Audience: Trainee, General Neurologist, NonNeurologist Monday, April 24, 2017

C83

1:00 p.m.–3:00 p.m.

Hot Topics and Controversies in Parkinson’s Disease

Topic: Movement Disorders Director: Melissa J. Nirenberg, MD, PhD, FAAN, New York, NY Program Description: This course will use an interactive format to address some of the most cutting-edge issues and controversies related to the diagnosis and management of Parkinson’s disease. Faculty will discuss and debate these issues based on the evidence-based literature. An

Upon Completion: Participants will understand how to approach and tackle some of the most important issues, controversies, and challenges in the diagnosis and management of Parkinson’s disease. Lecture/Faculty: }} Hot Topics and Controversies in Parkinson’s Disease Alberto J. Espay, MD, FAAN, Cincinnati, OH Melissa J. Nirenberg, MD, PhD, FAAN, New York, NY Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Monday, April 24, 2017

C97

3:30 p.m.–5:30 p.m.

The Dystonias: Diagnosis, Treatment, and Update on Causes

Topic: Movement Disorders Director: Daniel Tarsy, MD, FAAN, Boston, MA Program Description: Dystonia is one of the least understood and most often misdiagnosed movement disorders. Using video demonstrations, faculty will address the clinical spectrum and classification of the dystonias, current concepts regarding the underlying causes, strategies for diagnostic evaluation, and medical and surgical treatment strategies. Upon Completion: Participants should become familiar with the varied clinical manifestations of dystonia, the current classification of the dystonias, the current understanding of the etiology and pathogenesis of dystonia, and treatment options for dystonia. Lecture/Faculty: }} Clinical Features and Classification of the Dystonias Daniel Tarsy, MD, FAAN, Boston, MA }} The Medical and Surgical Treatment of Dystonia Samuel A. Frank, MD, Boston, MA }} Pathophysiology and Etiology of Dystonia Rachel J. Saunders-Pullman, MD, New York, NY Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Video Demonstrations CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist

$ = Additional Fee Required L = Leadership University

Monday, April 24, 2017

6:00 p.m.–9:00 p.m.

C106 Case Studies:

Unusual Movement Disorders

Topic: Movement Disorders Director: Kailash P. Bhatia, MD, FAAN, London, United Kingdom Program Description: This course has a long tradition of case presentations by both the faculty and members of the audience, highlighting diagnostic challenges. Participants are invited to bring interesting cases for presentation. These cases will be intermixed with cases from the faculty. Known diagnoses will be prioritized. The faculty will first emphasize an interactive discussion regarding visual recognition of the clinical phenomenology followed by a discussion of differential diagnoses, investigations, and management. Attendees hoping to present cases should contact Kailash Bhatia, MD, FAAN, at k.bhatia@ ucl.ac.uk to discuss the potential case presentation. Upon Completion: Participants should become familiar with unusual movement disorders and be able to formulate better differential diagnoses for them. Where relevant, participants should also be able to initiate appropriate diagnostic investigation and management of these disorders. Lecture/Faculty: }} Video Cases Kailash P. Bhatia, MD, FAAN, London, United Kingdom Alberto J. Espay, MD, FAAN, Cincinnati, OH Anthony E. Lang, MD, FAAN, Toronto, ON, Canada Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Audience Participation CME Credits: 3 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider Tuesday, April 25, 2017

7:00 a.m.–9:00 a.m.

C114 Therapy of Movement Disorders: A Case-based Approach

Topic: Movement Disorders Director: David E. Riley, MD, Cleveland, OH Program Description: This course is aimed at neurologists who wish to enhance their management skills for movement disorders. Faculty will focus on Parkinson’s disease, which is becoming ever more complex as we recognize an increasing variety of disease manifestations and complications. Faculty will present cases that demonstrate a wide spectrum of problems encountered, with a discussion of management options. Cases will address topics such as choice of initial therapy, management of motor complications associated with medications, and recognition and management of nonFast and easy registration · AAN.com/view/AM17 83

Movement Disorders

active learning format, including use of the audience response system, will allow participants to gain a deeper understanding of some of the most important issues, controversies, and challenges currently facing clinicians who treat patients with Parkinson’s disease.

Course Descriptions motor features of Parkinson’s disease and its treatment. The emphasis will be on practical therapeutic suggestions. In addition to Parkinson’s disease, faculty will use a similar case-based approach to present treatment alternatives for other selected common movement disorders. There will be ample room for questions; audience participation is encouraged. To discuss patients from your practice, please prepare a brief summary of the clinical problem, to accommodate as many questions as possible. Upon Completion: Participants should be able to identify common motor and nonmotor management challenges in Parkinson’s disease, apply a number of treatment options to solve common motor and nonmotor problems in Parkinson’s disease, and formulate a treatment plan for other selected movement disorders. Lecture/Faculty: }} 5 Case Presentations & Discussion Alberto J. Espay, MD, FAAN, Cincinnati, OH }} 5 Case Presentations & Discussion David E. Riley, MD, Cleveland, OH Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, NonNeurologist, Nurse, Physician’s Assistant, Advanced Practice Provider Tuesday, April 25, 2017

1:00 p.m.–3:00 p.m.

C125 Nonmotor Manifestations of Parkinson’s Disease I

Topic: Movement Disorders Director: Charles H. Adler, MD, PhD, FAAN, Scottsdale, AZ Program Description: This program will cover the nonmotor features that are now known to predate motor Parkinson’s disease (PD), as well as those that affect quality of life as PD progresses. PD is a systemic disorder and there will be discussion of the pathological basis for nonmotor features. Data will be presented showing which findings predate motor PD and how these may be used to identify individuals at higher risk for developing PD. This includes the evidence that patients with REM sleep behavior disorder are at high risk to develop PD. Methods to assess patients for nonmotor symptoms, including questionnaires and examination methods, will be discussed. As quality of life has been shown to be very impacted by nonmotor features of PD, this course will raise awareness of a topic that has not received nearly enough attention by PD and nonPD neurologists. This program complements C140: Nonmotor Manifestations of Parkinson’s Disease II, but covers independent topics. Upon Completion: Participants should be able to discuss prodromal Parkinson’s disease and identify nonmotor features of PD that predate motor signs and discuss methods for assessing nonmotor features including questionnaires and examination skills. 84 2017 AAN Annual Meeting Early Look

Movement Disorders Lecture/Faculty: }} Extranigral Pathology and Premotor Detection of Parkinson’s Disease Charles H. Adler, MD, PhD, FAAN, Scottsdale, AZ }} Diagnosis and Impact of Nonmotor Complications of Parkinson’s Disease Janis Miyasaki, MD, FAAN, Edmonton, AB, Canada Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, NonNeurologist, Advanced Practice Provider Tuesday, April 25, 2017

3:30 p.m.–5:30 p.m.

C140 Nonmotor Manifestations of Parkinson’s Disease II

Topic: Movement Disorders Director: Charles H. Adler, MD, PhD, FAAN, Scottsdale, AZ Program Description: This program will cover the nonmotor features of Parkinson’s disease that have a significant impact on quality of life including cognitive impairment, psychiatric, sleep, and autonomic symptoms and signs. Treatment options for the various nonmotor features will be discussed. As quality of life has been shown to be very impacted by nonmotor features of PD, this course will raise awareness of a topic that has not received nearly enough attention by PD and nonPD neurologists. This program complements C125: Nonmotor Manifestations of Parkinson’s Disease I, but covers independent topics. Upon Completion: Participants should be able to discuss methods for assessing cognitive, sleep, and autonomic symptoms and describe current treatment options for these nonmotor features of PD. Lecture/Faculty: }} Mild Cognitive Impairment, Dementia, and Psychiatric Jennifer G. Goldman, MD, MS, FAAN, Chicago, IL }} Sleep and Autonomic Complications in Parkinson’s Disease Stewart A. Factor, DO, FAAN, Atlanta, GA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, NonNeurologist, Advanced Practice Provider

7:00 a.m.–9:00 a.m.

C192 Paroxysmal Movement Disorders Topic: Movement Disorders Director: Kailash P. Bhatia, MD, FAAN, London, United Kingdom Program Description: Advances in identification of different forms of paroxysmal movement disorders and also molecular genetics have greatly impacted the practice of clinicians dealing with these conditions. Through presentations of video cases of common and rarer forms of acquired and genetic paroxysmal movement disorders the faculty will facilitate a discussion about differential diagnosis and laboratory evaluation. Each case will be followed by an overview and update on the topic. Upon Completion: Participants should be able to identify the different forms of paroxysmal movement disorders and be able to order appropriate investigations, whether they be imaging, biochemical, CSF examination, or genetics to arrive at the right diagnosis; and consider the appropriate drug or other management for each form of paroxysmal movement disorder. Lecture/Faculty: }} Primary Paroxysmal Dyskinesias Kailash P. Bhatia, MD, FAAN, London, United Kingdom }} Secondary Paroxysmal Dyskinesias Kapil D. Sethi, MD, FRCP (UK), FAAN, Augusta, GA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider Thursday, April 27, 2017

1:00 p.m.–3:00 p.m.

C203 Hyperkinetic Movement Disorders: Videodiagnosis and Treatment

Topic: Movement Disorders Director: Steven Frucht, MD, New York, NY Program Description: Hyperkinetic movement disorders present special challenges for the practicing clinician. Recent advances in genetics and expansion of the genotype phenotype relationship have made this area particularly challenging. Using a wide assortment of videos and case based format, this session will help prepare attendees to recognize and treat unusual hyperkinetic movement disorders. Upon Completion: Participants should be able to recognize, diagnose, and treat the broad spectrum of hyperkinetic movement disorder patients

$ = Additional Fee Required L = Leadership University

Lecture/Faculty: }} Chorea Steven Frucht, MD, New York, NY Pichet Termsarasab, MD, Bangkok, Thailand }} Dystonia Steven Frucht, MD, New York, NY Pichet Termsarasab, MD, Bangkok, Thailand }} Myoclonus Steven Frucht, MD, New York, NY Pichet Termsarasab, MD, Bangkok, Thailand }} Unusual Movement Disorders Steven Frucht, MD, New York, NY Pichet Termsarasab, MD, Bangkok, Thailand Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist Thursday, April 27, 2017

1:00 p.m.–3:00 p.m.

C209 Clinical Usefulness of Botulinum Toxin for Spasticity Skills Workshop $ (registration required) Topic: Movement Disorders Director: Allison Brashear, MD, MBA, FAAN, Winston Salem, NC Program Description: Chemodenervation is one of the most useful treatments for dystonias. However, most neurologists struggle to recognize all presentations of the disorder, or to understand the full gamut of indications where botulinum toxin injections could be helpful. Also, most physicians have not been trained to perform the injections. Faculty will begin with presentations reviewing cervical, periocular, oromandibular, and limb dystonias, and the evidence for chemodenervation; review how to set-up a successful chemodenervation practice; and lead interactive learning, providing first a session on tips for best injections, and a demonstration session with videos, and simulation systems. Upon Completion: Participants should be able to enlist indications and contraindications for chemodenervation; select appropriate candidates for botulinum toxin injections; recognize the phenomenology that leads tothe development of an injection plan in patients; and reviewbest practices for the establishment of a successful chemodenervation clinic. Lecture/Faculty: }} Spasticity in Pediatric Patients Ann H. Tilton, MD, FAAN, New Orleans, LA }} Anatomy in Spasticity Treatment: Ultrasound Katharine Alter, MD, Bethesda, MD }} Case-based Studies in Spasticity Treatment Allison Brashear, MD, MBA, FAAN, Winston Salem, NC Fast and easy registration · AAN.com/view/AM17 85

Movement Disorders

Thursday, April 27, 2017

Course Descriptions

Movement Disorders

Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement Teaching Style: Case-Based, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider

Friday, April 28, 2017

Thursday, April 27, 2017

Program Description: Parkinsonian disorders are common. Knowledge on how to diagnose and manage patients with parkinsonian disorders is important for clinicians dealing with adult patients, particularly elderly ones. We will present pitfalls in diagnosing common individuals and also discuss vignettes of patients with typical and atypical parkinsonian disorders. Participants will learn when to suspect patients have common parkinsonian disorders such as Parkinson disease or atypical parkinsonian disorders such as progressive supranuclear palsy, corticobasal degeneration, multiple system atrophy, and dementia with Lewy bodies. Participants will also learn the basics of how to manage patients with these disorders.

3:30 p.m.–5:30 p.m.

C216 Balance and Gait Disorders Topic: Movement Disorders Director: Bastiaan Roelof Bloem, MD, PhD, Nijmegen, Netherlands Program Description: Mobility is a prized ability. Disorders of balance and gait impair mobility, reduce independence, lead to falls and fall-related injuries, reduce quality of life, and are associated with reduced survival. Neurologists need to be able to recognize the clinical patterns of balance and gait disorders in order to diagnose and intervene effectively. Faculty will review the clinical exam of gait and balance and the latest classification for gait and balance disorders, then discuss video examples of various gait and balance disorders. Audience observations and questions about the video examples will be encouraged. Upon Completion: Participants should better appreciate the clinical importance of gait and balance disorders; gain techniques to improve their exam of gait and balance; learn to use the current classification of gait and balance disorders in a clinically useful manner; and learn to recognize several common gait and balance disorders. Lecture/Faculty: }} Clinical Assessment of Gait and Balance Disorders Bastiaan Roelof Bloem, MD, PhD, Nijmegen, Netherlands John G. Nutt, MD, FAAN, Portland, OR Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Geriatrician, Rehabilitation Specialist, Nursing Home Specialist

86 2017 AAN Annual Meeting Early Look

7:00 a.m.–9:00 a.m.

C223 Movement Disorders for the General

Neurologist I: Diagnosis and Management of Parkinsonian Disorders

Topic: Movement Disorders Director: Irene Litvan, MD, FAAN, La Jolla, CA

This program complements C232: Movement Disorders for the General Neurologist II: Tremor, Drug-induced Movement Disorders, RLS, and Ataxia and C240: Movement Disorders for the General Neurologist III: Chorea, Dystonia, Myoclonus, Stereotypes, and Tics, but covers independent topics. Upon Completion: Participants should become familiar with the differential diagnoses of common and uncommon parkinsonian disorders and how to manage patients with these disorders. Lecture/Faculty: }} Pitfalls in the Diagnosis of Parkinson’s Disease Stephen G. Reich, MD, FAAN, Baltimore, MD }} Lessons Learned from Patients Irene Litvan, MD, FAAN, La Jolla, CA }} Pearls for Management of Parkinsonian Disorders Michael S. Okun, MD, FAAN, Gainesville, FL Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, NonNeurologist

1:00 p.m.–3:00 p.m.

Friday, April 28, 2017

3:30 p.m.–5:30 p.m.

C232 Movement Disorders for the General

C240 Movement Disorders for the General

Topic: Movement Disorders

Neurologist II: Tremor, Drug-induced Movement Disorders, RLS, and Ataxia

Director: John C. Morgan, MD, PhD, Augusta, GA Program Description: This is part two of a basic overview of movement disorders for the non-expert. The field of movement disorders is highly reliant upon visual recognition and differentiation among abnormal movements and differential diagnosis of potential underlying etiologies. Our faculty will aim to help clinicians recognize various abnormal movements and provide an overview of common and uncommon etiologies of these movements. Faculty will use videos, provide pointers that help in differential diagnosis in clinical practice, and discuss appropriate investigations in a patient presenting with various movement disorders. Faculty will also briefly discuss appropriate treatment. This program complements C223: Movement Disorders for the General Neurologist I: Diagnosis and Management of Parkinsonian Disorders and C240: Movement Disorders for the General Neurologist III: Chorea, Dystonia, Myoclonus, Stereotypes, and Tics, but covers independent topics. Upon Completion: Participants should be able to recognize and classify the majority of common movement disorders and even some uncommon ones. They should be able to generate an appropriate differential diagnosis and initiate a cost-effective work-up. Participants should also be able to appropriately initiate symptomatic treatment for the major movement disorders discussed. Lecture/Faculty: }} Tremor and Drug-induced Movement Disorders Susan Fox, MD, Toronto, ON, Canada }} RLS and Ataxia Shyamal Mehta, MD, PhD, Phoenix, AZ Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, NonNeurologist

$ = Additional Fee Required L = Leadership University

Neurologist III: Chorea, Dystonia, Myoclonus, Stereotypes, and Tics

Director: John C. Morgan, MD, PhD, Augusta, GA Program Description: This is part three of a basic overview of movement disorders for the non-expert. The field of movement disorders is highly reliant upon visual recognition and differentiation among abnormal movements and differential diagnosis of potential underlying etiologies. Our faculty will aim to help clinicians recognize various abnormal movements and provide an overview of common and uncommon etiologies of these movements. Faculty will use videos, provide pointers that help in differential diagnosis in clinical practice, discuss appropriate investigations in a patient presenting with various movement disorders, and briefly discuss appropriate treatment. This program complements C223: Movement Disorders for the General Neurologist I: Diagnosis and Management of Parkinsonian Disorders and C232: Movement Disorders for the General Neurologist II: Tremor, Drug-induced Movement Disorders, RLS, and Ataxia, but covers independent topics. Upon Completion: Participants should be able to recognize and classify the majority of common movement disorders and even some uncommon ones. They should be able to generate an appropriate differential diagnosis and initiate a cost-effective work-up. Participants should also be able to appropriately initiate symptomatic treatment for the movement disorders discussed. Lecture/Faculty: }} Chorea and Dystonia Joohi Jimenez Shahed, MD, Houston, TX }} Myoclonus, Stereotypies, and Tics John C. Morgan, MD, PhD, Augusta, GA Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, NonNeurologist

Fast and easy registration · AAN.com/view/AM17 87

Movement Disorders

Friday, April 28, 2017

Course Descriptions MS AND CNS INFLAMMATORY DISEASE Saturday, April 22, 2017

8:00 a.m.–10:00 a.m.

Multiple Sclerosis Essentials

Topic: MS and CNS Inflammatory Disease Director: Stephen Krieger, MD, FAAN, New York, NY Program Description: Faculty will use a series of illustrative cases to bring participants up-to-date on current diagnosis and management of multiple sclerosis and other demyelinating disorders. Participants will be able to exercise their own judgment at multiple decision nodes as each case unfolds, and compare their choices with those of their peers and faculty. Cases have been carefully selected to represent real situations regularly encountered in the practice of two expert MS clinicians. Upon Completion: Participants should be familiar with current issues related to the diagnosis and treatment of patients with multiple sclerosis and related demyelinating disorders, and should recognize areas of both consensus and controversy in the field. Lecture/Faculty: }} Challenging Demyelinating Disease Cases Stephen Krieger, MD, FAAN, New York, NY Aaron E. Miller, MD, FAAN, New York, NY Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement Teaching Style: Case-Based, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Saturday, April 22, 2017

C11

10:30 a.m.–12:30 p.m.

Neuromyelitis Optica Spectrum Disorders

Topic: MS and CNS Inflammatory Disease Director: Dean M. Wingerchuk, MD, FAAN, Scottsdale, AZ Program Description: Neuromyelitis optica spectrum disorders (NMOSD) are a collection of clinical syndromes and neuroradiological accompaniments unified by their association with an autoantibody specific for the astrocytic water channel aquaporin-4 (AQP4). Recently revised diagnostic criteria for NMOSD, which include the classic transverse myelitis and optic neuritis attacks but also define additional brain, diencephalic, and brain stem syndromes, stratify the diagnosis based on whether AQP-IgG is detected or not. Faculty will present a state-of-theart review of NMOSD pathogenesis, diagnosis, AQP4-IgG assay interpretation, and the role of emerging autoantibodies associated 88 2017 AAN Annual Meeting Early Look

MS and CNS Inflammatory Disease with NMOSD clinical phenotypes (such as MOG-IgG) and summarize a practical approach to treatment and prevention of attacks. Case presentations will be used to illustrate key learning points during lectures and in a case-based discussion session. Upon Completion: Participants should be able to understand the clinical, neuroimaging, laboratory, and pathologic characteristics of NMOSD; compare the utility of AQP4-IgG assay methods; recognize clinical characteristics associated with MOG-IgG; be able to discuss elements of the newly revised NMOSD diagnostic criteria; and describe approaches to prevention and treatment of acute NMOSD attacks. Lecture/Faculty: }} NMOSD: Pathogenesis and Clinical Diagnosis Brian G. Weinshenker, MD, FAAN, Rochester, MN }} NMOSD: Current and Emerging Therapies and Strategies Dean M. Wingerchuk, MD, FAAN, Scottsdale, AZ }} Case-based Discussion Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Sunday, April 23, 2017

C36

1:00 p.m.–3:00 p.m.

Multiple Sclerosis Therapy: Disease-modifying Treatment I

Topic: MS and CNS Inflammatory Disease Director: Bruce A. C. Cree, MD, PhD, MCR, San Francisco, CA Program Description: Disease-modifying treatments in MS are one of the most rapidly evolving areas of therapeutic intervention in neurology. As new treatments become available, the options for patients, and their prescribing physicians, increases. Many of the newer therapies have complex risk: benefit profiles and require specialized expertise for safe and effective administration. Faculty will focus on therapeutic strategies and risk mitigation of currently available disease-modifying therapies, discuss proper use of these drugs and risk assessment, and use specific examples to cover the most frequent issues arising from MS treatment strategies. This program complements C54: Multiple Sclerosis Therapy: Disease-modifying Treatment II and C116: Multiple Sclerosis Therapy: Symptom Management, but covers independent topics. Upon Completion: Participants should be familiar with the indications and risks associated with approved disease-modifying agents in multiple sclerosis, and be better able to identify the appropriate patient populations for the newer agents.

Sunday, April 23, 2017

C54

3:30 p.m.–5:30 p.m.

Multiple Sclerosis Therapy: Disease-modifying Treatment II

Topic: MS and CNS Inflammatory Disease Director: Bruce A. C. Cree, MD, PhD, MCR, San Francisco, CA Program Description: Disease-modifying treatments in MS are one of the most rapidly evolving areas of therapeutic intervention in neurology. As new treatments become available, the options for patients, and their prescribing physicians, increases. Many of the newer therapies have complex risk: benefit profiles and require specialized expertise for safe and effective administration. Faculty will focus on therapeutic strategies and risk mitigation of currently available disease-modifying therapies, discuss proper use of these drugs and risk assessment, and use specific examples to cover the most frequent issues arising from MS treatment strategies. This program complements C36: Multiple Sclerosis Therapy: Disease-modifying Treatment I and C116: Multiple Sclerosis Therapy: Symptom Management, but covers independent topics. Upon Completion: Participants should be familiar with the indications and risks associated with approved disease-modifying agents in multiple sclerosis, and be better able to identify the appropriate patient populations for the newer agents. Lecture/Faculty: }} Risk Stratification and Mitigation Bruce A. C. Cree, MD, PhD, MCR, San Francisco, CA }} Emerging Therapies in MS: Slowing Progressive MS, Remyelination, Neural Protection, Neural Repair Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist

$ = Additional Fee Required L = Leadership University

Monday, April 24, 2017

C78

1:00 p.m.–3:00 p.m.

Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease I

Topics: MS and CNS Inflammatory Disease; General Neurology Director: Jeffrey Marc Gelfand, MD, MAS, San Francisco, CA Program Description: This course will provide a practical update on neuro-rheumatology—the neurological manifestations of systemic inflammatory and autoimmune syndromes—from an interdisciplinary faculty of neurologists and rheumatologists. Part I will review rheumatological diagnosis, physical examination techniques, and interpretation of laboratory studies; discuss neurological manifestations and treatment of Systemic Lupus Erythematosus, Sjogren’s Syndrome, Antiphospholipid Antibody Syndrome, Mixed Connective Tissue Disease, and Rheumatoid Arthritis; and review CNS Vasculitis and other vasculitides. Part II will review diagnosis and treatment of Neurosarcoidosis, Pachymeningitis and Behcet’s Disease; discuss Peripheral Nervous System Manifestations of Rheumatological Diseases; and conclude with an interdisciplinary case discussion with faculty highlighting how rheumatologists and neurologists approach differential diagnosis, treatment, and management. This program complements C91: Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease II, but covers independent topics. Upon Completion: Participants should become familiar with the differential diagnosis of neurological manifestations of systemic inflammatory, autoimmune, and rheumatological diseases; be able to identify common phenotypes associated with neurological organ system involvement of rheumatological syndromes; learn ways of distinguishing neurorheumatological diagnoses from other neuroinflammatory disorders; and develop practical approaches to treatment, care coordination, and health maintenance for neuro-rheumatological conditions. Lecture/Faculty: }} Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Laboratory Studies—Lessons for the Practicing Neurologist Eli Miloslavsky, MD, Boston, MA }} Systemic Lupus Erythematosus, Sjogren’s Disease, Antiphospholipid Antibody Syndrome, Mixed Connective Tissue Disease, and Rheumatoid Arthritis—Neurological Manifestations Shamik Bhattacharyya, MD, Boston, MA }} CNS Vasculitis and Mimics Rula Hajj-Ali, MD, Cleveland, OH Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider Fast and easy registration · AAN.com/view/AM17 89

MS and CNS Disease

Lecture/Faculty: }} Immunomodulation Versus Immunosuppression: Mechanism of Action of Multiple Sclerosis Drugs Scott S. Zamvil, MD, PhD, FAAN, San Francisco, CA }} Considering DMT: Escalation, Induction, Sequencing and Exit Strategy Timothy W. West, MD, Santa Barbara, CA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist

Course Descriptions Monday, April 24, 2017

C91

3:30 p.m.–5:30 p.m.

Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease II

Topic: MS and CNS Inflammatory Disease Director: Jeffrey Marc Gelfand, MD, MAS, San Francisco, CA Program Description: An interdisciplinary faculty of neurologists and rheumatologists will provide an update on neuro-rheumatology—the neurological manifestations of systemic inflammatory and autoimmune syndromes. Part I of this course will review rheumatological diagnosis, physical examination techniques, and interpretation of laboratory studies; discuss neurological manifestations and treatment of Systemic Lupus Erythematosus, Sjogren’s Syndrome, Antiphospholipid Antibody Syndrome, Mixed Connective Tissue Disease, and Rheumatoid Arthritis; and review CNS Vasculitis and other vasculitides. Part II will review diagnosis and treatment of Neurosarcoidosis, Pachymeningitis and Behcet’s Disease; discuss Peripheral Nervous System Manifestations of Rheumatological Diseases; and conclude with an interdisciplinary case discussion with faculty highlighting how rheumatologists and neurologists approach differential diagnosis, treatment, and management. This program complements C78: Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease I, but covers independent topics. Upon Completion: Participants should become familiar with the differential diagnosis of neurological manifestations of systemic inflammatory, autoimmune, and rheumatological diseases; be able to identify common phenotypes associated with neurological organ system involvement of rheumatological syndromes; learn ways of distinguishing neurorheumatological diagnoses from other neuroinflammatory disorders; and develop practical approaches to treatment, care coordination, and health maintenance for neuro-rheumatological conditions. Lecture/Faculty: }} Neurosarcoidosis, Pachymeningitis, Behcet’s Disease Jeffrey Marc Gelfand, MD, MAS, San Francisco, CA }} Peripheral Nervous System Manifestations of Rheumatological and Systemic Inflammatory Disease: Vasculitic Neuropathies, Small Fiber Neuropathies, Sensory Neuropathies Kelly G. Gwathmey, MD, Charlottesville, VA }} Case Discussions with Faculty Neurologists and Rheumatologists Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider

90 2017 AAN Annual Meeting Early Look

MS and CNS Inflammatory Disease Monday, April 24, 2017

6:00 p.m.–9:00 p.m.

C104 Case Studies: Multiple Sclerosis Topic: MS and CNS Inflammatory Disease Director: John Corboy, MD, FAAN, Denver, CO Program Description: Diagnostic and treatment issues in multiple sclerosis (MS) and related demyelinating disorders have become more complex, with multiple new treatment options. Through presentations of common and more challenging cases, faculty will facilitate a discussion on differential diagnosis, laboratory and MRI evaluation, ethical issues, and treatment of MS and related conditions. Each case will be followed by an overview and update on the topic. Upon Completion: Participants should be familiar with the differential diagnoses, work-up, and treatment of MS and related conditions, including interpretation of MRI studies for MS and other disorders that affect the brain and spinal cord. Lecture/Faculty: }} Cases Enrique Alvarez, MD, PhD, Aurora, CO John Corboy, MD, FAAN, Denver, CO Mary Alissa Willis, MD, Cleveland, OH Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 3 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist Tuesday, April 25, 2017

7:00 a.m.–9:00 a.m.

C116 Multiple Sclerosis Therapy: Symptom Management

Topic: MS and CNS Inflammatory Disease Director: Jonathan L. Carter, MD, Scottsdale, AZ Program Description: Symptom management in MS remains a very important determinant of quality of life in MS patients, even with the advent of increasing numbers of MS disease-modifying therapies. Symptoms of MS may be under-recognized and there are knowledge gaps among neurologists regarding management of these common symptoms. Faculty will review the management of common MS symptoms including spasticity, fatigue, gait disorders, bladder problems, bowel problems, and sexual dysfunction, and conclude with a panel discussion regarding management of these and other commonly encountered symptoms in MS patients.

Upon Completion: Participants should be able to diagnose and treat symptoms of fatigue, sleep disorders, spasticity, gait difficulties, bladder and bowel symptoms, and sexual dysfunction in MS patients. Lecture/Faculty: }} Management of Spasticity, Fatigue, and Sleep Disorders in MS Jonathan L. Carter, MD, Scottsdale, AZ }} Management of Ambulatory Dysfunction in MS Michelle Cameron, MD, Portland, OR }} Management of GU Dysfunction: When MS Hits Below the Belt Barbara S. Giesser, MD, FAAN, Los Angeles, CA }} Case-Based Panel Discussion: MS Symptom Management Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Tuesday, April 25, 2017

3:30 p.m.–5:30 p.m.

C142 Pediatric MS: Diagnosis and Treatment Topics: MS and CNS Inflammatory Disease; Child Neurology and Developmental Neurology Director: John W. Rose, MD, FAAN, Salt Lake City, UT Program Description: Pediatric demyelinating diseases are a multi-faceted group of disorders now being understood in greater depth. This program will focus on pediatric MS with attention to emerging demographic and clinical features of the disease. Faculty will stress the differentiation of MS from ADEM and NMO in pediatric patients, review the status of immunotherapies for children with demyelinating diseases, and present the particular MRI features of these demyelinating diseases in children. The program will integrate the new knowledge in the context of case-based exercises, and selected studied cases will be presented to illustrate current concepts in diagnosis, differential diagnosis, and therapy of pediatric multiple sclerosis. Upon Completion: Participants should know the clinical and MRI parameters of pediatric demyelinating diseases, understand diagnosis of pediatric MS and related disorders, differentiate pediatric demyelinating diseases, understand the current treatment options, know the emerging environmental factors, know the status of clinical trials in pediatric MS, and understand how to access continuing education/discussion specific for pediatric MS.

$ = Additional Fee Required L = Leadership University

Lecture/Faculty: }} Diagnosis of Pediatric MS Teri Schreiner, MD, MPH, Aurora, CO }} Treatment of Pediatric MS Emmanuelle Waubant, MD, FAAN, San Francisco, CA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Thursday, April 27, 2017

7:00 a.m.–9:00 a.m.

C190 Multiple Sclerosis Overview:

Basic and Translational Science

Topics: MS and CNS Inflammatory Disease; General Neurology Director: Michael K. Racke, MD, Columbus, OH Program Description: Improved management of multiple sclerosis (MS) would result from understanding of MS pathogenesis, risk factors, immune abnormalities, and mechanism of action of MS treatments, including understanding of complications that can result from those treatments. Faculty will discuss new understanding in MS pathogenesis and how immune interventions can alter disease pathogenesis for an improved clinical outcome, and the mechanism of action of current MS therapies. This program complements C201: Multiple Sclerosis Overview: Clinical Pearls and C214: Multiple Sclerosis Overview: Clinical Advances, but covers independent topics. Upon Completion: Participants should be able to identify steps in MS pathogenesis, treatments used in MS management, and how approved therapies affect the immune response and potential complications resulting from those interventions. Lecture/Faculty: }} MS Pathogenesis Olaf Stuve, MD, PhD, FAAN, Dallas, TX }} Mechanism of MS Therapies and Their Use Michael K. Racke, MD, Columbus, OH Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist

Fast and easy registration · AAN.com/view/AM17 91

MS and CNS Disease

This program complements C36: Multiple Sclerosis Therapy: Diseasemodifying Treatment I and C54: Multiple Sclerosis Therapy: Diseasemodifying Treatment II, but covers independent topics.

Course Descriptions Thursday, April 27, 2017

1:00 p.m.–3:00 p.m.

MS and CNS Inflammatory Disease Thursday, April 27, 2017

3:30 p.m.–5:30 p.m.

C201 Multiple Sclerosis Overview I:

C214 Multiple Sclerosis Overview II:

Topic: MS and CNS Inflammatory Disease

Clinical Pearls

Director: Myla Goldman, MD, Charlottesville, VA Program Description: The first step in treating the MS patient is making the correct diagnosis. To do so, one must understand the spectrum of presentations, such as first episode or MRI-only forms of MS (clinically isolated syndrome and radiologically isolated syndrome). Clinicians should also recognize alternative diagnoses or “MS mimics.“ MRI is an essential tool in the early stages of diagnosis and over the course of a patient’s care and management. Clinicians need to thoughtfully use MRI to monitor patients and guide decisions about when and if to change treatment. Faculty will review basic pathophysiology and risk factors in MS, common differential diagnostic considerations, clinical MRI tools and applications in the context of MS diagnosis and determination of treatment response. This program complements C190: Multiple Sclerosis Overview: Basic and Translational Science and C214: Multiple Sclerosis Overview: Clinical Advances, but covers independent topics. Upon Completion: Participants should be able to feel comfortable diagnosing MS and excluding clinically appropriate differential diagnoses, have increased confidence in using clinical MRI tools, and have a strategy for integrating this into their MS practice. Lecture/Faculty: }} MS Diagnosis and Classification Myla Goldman, MD, Charlottesville, VA }} MRI and MS: Is a Picture Worth a Thousand Words? Scott Douglas Newsome, DO, Baltimore, MD Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic CME Credits: 3 Recommended Audience: Trainee, General Neurologist, NonNeurologist, Advanced Practice Provider

92 2017 AAN Annual Meeting Early Look

Clinical Advances

Director: Scott Douglas Newsome, DO, Baltimore, MD Program Description: It is extremely important for clinicians treating MS to enhance their knowledge base about the changing landscape of the MS diseasemodifying therapies (DMTs). Making treatment decisions for an individual MS patient is a daunting task and the individualized patient benefit-risk assessment becomes increasingly difficult as new therapies emerge. Furthermore, if these therapies become available, clinicians need to have a full understanding of their benefit-risk profiles. Faculty will review the efficacy and safety profiles of current and late-stage emerging MS DMTs. It is equally challenging to define what constitutes optimal and suboptimal response to DMTs for an individual patient. Moreover, it is critical for clinicians to be able to recognize short-term clinical and paraclinical factors that may help identify patients at high risk for long-term disability. Faculty will review key considerations in MS clinical practice to address the above challenges in both didactic and case-based formats. This program complements C190: Multiple Sclerosis Overview: Basic and Translational Science and C201: Multiple Sclerosis Overview: Clinical Pearls, but covers independent topics. Upon Completion: Participants should feel more confident in prescribing and monitoring multiple sclerosis (MS) disease-modifying therapies (DMTs) as it relates to their efficacy and safety profiles along with develop a better understanding of key considerations in clinical practice. Participants will also become familiar with late-stage DMTs that have a strong potential of getting approved for use in MS. Participants should also be able to recognize what factors put an MS patient at risk for long-term disability and when to consider switching therapies. Lecture/Faculty: }} The Expanding Armamentarium of Multiple Sclerosis Therapeutics Scott Douglas Newsome, DO, Baltimore, MD }} Case-based Considerations in Clinical Practice for Multiple Sclerosis Myla Goldman, MD, Charlottesville, VA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

7:00 a.m.–9:00 a.m.

C224 Controversies in Multiple Sclerosis Therapy Topic: MS and CNS Inflammatory Disease Director: Riley Bove, MD, San Francisco, CA Program Description: Disease-modifying therapies for relapsing-remitting multiple sclerosis (RRMS) are considered to be most effective when started early in the course of the disease. Should patients with clinically and radiologically isolated syndromes be started on disease modifying therapy? Should MS patients with stable disease be trialed off of MS disease-modifying therapy and if so, under what circumstances? Should all MS patients with seropositivity for JC virus antibody discontinue natalizumab treatment? Should all patients with MS be treated with vitamin D supplementation? Definitive evidence-based criteria may remain uncertain, but faculty will discuss and debate the merits, the available evidence, and their own clinical experience that can assist participants in making these important treatment decisions. Upon Completion: Participants should be able to describe and discuss the relative pros and cons of a number of controversies in MS evaluation and therapy. Lecture/Faculty: }} All Patients with CIS and RIS Should Start MS Therapy Riley Bove, MD, San Francisco, CA }} All JCV Positive MS Patients Should Discontinue Natalizumab Therapy Faculty }} All Patients with MS Should Be Treated with Vitamin D Supplementation Ellen M. Mowry, MD, FAAN, Baltimore, MD }} Once Started, MS Therapies Should Be Continued for Life Ellen M. Mowry, MD, FAAN, Baltimore, MD Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist Friday, Apri l 28, 2017

1:00 p.m.–3:00 p.m.

C233 Multiple Sclerosis:

A Case-based Approach

Topic: MS and CNS Inflammatory Disease Director: Nancy L. Sicotte, MD, FAAN, Los Angeles, CA Program Description: This case-based course will cover important emerging concepts related to multiple sclerosis, which continues to be a diagnostic and management challenge to the clinician. Faculty will present a series of MS cases with focused questions using the audience response system to enhance the discussion of all issues pertinent to patient diagnosis and management. $ = Additional Fee Required L = Leadership University

Upon Completion: Participants should be familiar with the differential diagnosis, evaluation, and treatment of complex multiple sclerosis patients, including how to conceptualize the balance of risk and benefit of newer therapies in MS. Lecture/Faculty: }} Case 1: Diagnosis Marwa Kaisey, MD, Los Angeles, CA }} Case 2: Mimics and Variants Dean M. Wingerchuk, MD, FAAN, Scottsdale, AZ }} Case 3: Treatment Options Robert J. Fox, MD, FAAN, Cleveland, OH Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, NonNeurologist, Mid-Level Provider

NEURO TRAUMA, CRITICAL CARE, AND SPORTS NEUROLOGY Saturday, April 22, 2017

C14

10:30 a.m.–12:30 p.m.

Concussion: From Mechanisms to Management

Topic: Neuro Trauma, Critical Care, and Sports Neurology Director: David W. Dodick, MD, Phoenix, AZ Program Description: Advances in basic and clinical research has led to an enhanced understanding of the underlying biology of brain injury and improved management strategies. Faculty will facilitate a discussion on the pathogenesis of concussion and post-traumatic headache, and outline evaluation and management strategies that can be implemented in clinical practice in the acute, subacute, and chronic phases. This program complements C21: Concussion: Evaluation and Management in the Acute and Chronic Phases, but covers independent topics. Upon Completion: Participants should be able to describe the underlying pathogenesis of brain injury after concussion and the development of post-traumatic headache; discuss the mechanisms and biomarkers that may predict recovery or symptom/disease progression; and explain the evidencebased and optimal approach to the evaluation and management of concussion in the acute, subacute, and chronic phases. Lecture/Faculty: }} Concussion: From Biology to Biomarkers of Concussion and Recovery/Progression Faculty Fast and easy registration · AAN.com/view/AM17 93

MS and CNS Disease

Friday, April 28, 2017

Course Descriptions }} Pathophysiology and Management of Post-traumatic Headache David W. Dodick, MD, Phoenix, AZ Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Sports Medicine Physician, Advanced Practice Provider Saturday, April 22, 2017

C21

2:00 p.m.–4:00 p.m.

Concussion: Evaluation and Management in the Acute and Chronic Phases

Topic: Neuro Trauma, Critical Care, and Sports Neurology Director: David W. Dodick, MD, Phoenix, AZ Program Description: Faculty will provide an evidence-based update on the evaluation and management of athletes with sport-related concussion in the acute, subacute, and chronic phases. This program complements C14: Concussion: From Mechanisms to Management, but covers independent topics. Upon Completion: Participants should be able to diagnose concussion with high degree of accuracy and use clinical, imaging, cognitive, and vestibular evaluation tools to facilitate the diagnosis, prognosis, and management of concussion in all stages. Lecture/Faculty: }} Concussion Evaluation and Management: Pre-season, Sideline, and Office Amaal J. Starling, MD, Phoenix, AZ }} Concussion: Vestibular Evaluation and Treatment Jamie Bogle, PhD, Scottsdale, AZ }} Concussion: Cognitive Evaluation and Treatment Jennifer Voreis Wethe, PhD, Scottsdale, AZ Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

94 2017 AAN Annual Meeting Early Look

Neuro Trauma, Critical Care, and Sports Neurology Sunday, April 23, 2017

C32

7:00 a.m.–9:00 a.m.

Emergency Room Neuro-ophthalmology

Topics: Neuro-ophthalmology/Neuro-otology; Neuro Trauma, Critical Care, and Sports Neurology Director: Heather Moss, MD, PhD, FAAN, Chicago, IL See complete course description on page 109 » Monday, April 24, 2017

C70

7:00 a.m.–9:00 a.m.

Sports Neurology: Enhancing Athletic Performance

Topic: Neuro Trauma, Critical Care, and Sports Neurology Director: Kevin E. Crutchfield, MD, Baltimore, MD Program Description: As more neurologists become part of sports medicine teams, their impact on the athletes can be far more reaching than just managing persistent symptoms. Through didactics and case examples, faculty will engage the audience to enhance their knowledge regarding manageable factors that will enhance neurologic function and athletic performance. Upon Completion: Participants should be able to identify and modify commonly encountered factors that diminish neurologic and athletic performance. Lecture/Faculty: }} Peripheral Nerve and Overuse Injuries Brian W. Hainline, MD, FAAN, Indianapolis, IN }} Exertional Rhabdomyolysis: Current Questions and Controversies Francis O’Connor, MD, Bethesda, MD }} Elite Athletes with Neurologic Disorders Kevin E. Crutchfield, MD, Baltimore, MD }} Closing Remarks Kevin E. Crutchfield, MD, Baltimore, MD Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist

6:00 p.m.–9:00 p.m.

Tuesday, April 25, 2017

1:00 p.m.–3:00 p.m.

C108 Case Studies in the ICU

C126 Critical Care EEG Monitoring

Topic: Neuro Trauma, Critical Care, and Sports Neurology

Topics: Epilepsy/Clinical Neurophysiology (EEG); Neuro Trauma, Critical Care, and Sports Neurology

Director: Nicholas Joseph Silvestri, MD, Buffalo, NY Program Description: Neurologic complications in ICU patients often have a substantial negative impact on their outcome. Neurologists are being asked increasingly to evaluate patients in intensive care units. They are often called to assess unusual neurologic manifestations of other primary diseases, evaluate the consequences of critical care therapy, offer a prognosis, or determine brain death. Using a casebased approach, faculty will provide the core elements of modern neurologic critical care and suggested approach to the management of some of the most commonly encountered problems. Topics will include: approach to neurologic problems in the ICU, including failure to awaken after cardiac arrest; brain death; neuromuscular considerations in the ICU; difficulty-to-wean off artificial ventilation; and epilepsy, including status epilepticus. Interactions between faculty and participants will be encouraged. Upon Completion: Participants should have a comprehensive understanding of the general aspects of critical care of neurologic patients and common neurologic problems encountered in the ICU setting, be able to incorporate evidence-driven data into their recommendations, and be able to evaluate and treat common disorders in the ICU and provide an opinion regarding prognosis. Lecture/Faculty: }} Case Studies in Coma and Brain Death David M. Greer, MD, FAAN, New Haven, CT }} Case Studies in Epilepsy and Status Epilepticus Julie Roth, MD, Providence, RI }} Case Studies in Neuromuscular Disorders in the ICU Nicholas Joseph Silvestri, MD, Buffalo, NY Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement, Professionalism, Systems-Based Practice Teaching Style: Case-Based, Interactive CME Credits: 3 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist

$ = Additional Fee Required L = Leadership University

Director: Aatif M. Husain, MD, Durham, NC See complete course description on page 47 » Wednesday, April 26, 2017

7:00 a.m.–9:00 a.m.

C150 Neurological Intensive Care: The Essentials Topic: Neuro Trauma, Critical Care, and Sports Neurology Director: Alejandro A. Rabinstein, MD, FAAN, Rochester, MN Program Description: The practice of neurocritical care requires refined knowledge of brain pathophysiology and the semiological expressions of abnormal level of consciousness. The lectures in this session will provide in-depth reviews of essential topics for any neurologists caring for critically ill patients, including intracranial pressure, cerebral perfusion pressure, multimodality brain monitoring, and the assessment of coma. This program complements C159: Neurological Intensive Care II: From the Brain to the Muscles and C174: Neurological Intensive Care III: Vascular Diseases, but covers independent topics. Upon Completion: Participants should be able to discuss the factors that can affect intracranial pressure and cerebral perfusion pressure, list the indications and recognize the caveats of multimodality monitoring of cerebral function, and evaluate the clinical signs of different comatose states. Lecture/Faculty: }} Intracranial Pressure and Intracranial Hypertension William David Freeman, MD, FAAN, Jacksonville, FL }} Multi-modality Brain Monitoring: Indications and Caveats Paul M. Vespa, MD, FAAN, Los Angeles, CA }} Evaluation and Management of Acute Coma David M. Greer, MD, FAAN, New Haven, CT Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Nurse, Nurse Practitioner, Physician Assistant, Advanced Practice Provider

Fast and easy registration · AAN.com/view/AM17 95

Neuro Trauma

Monday, April 24, 2017

Course Descriptions Wednesday, April 26, 2017

1:00 p.m.–3:00 p.m.

C159 Neurological Intensive Care II: From the Brain to the Muscles

Topic: Neuro Trauma, Critical Care, and Sports Neurology Director: Alejandro A. Rabinstein, MD, FAAN, Rochester, MN Program Description: Neurologists working in the ICU can confront a great variety of acute diagnoses. The practice of neurocritical care demands wide knowledge on acute neurological conditions affecting the central and peripheral nervous system. This seminar will review updated and practical concepts on traumatic brain injury, neuromuscular respiratory failure, and refractory status epilepticus. This program complements C150: Neurological Intensive Care: The Essentials and C174: Neurological Intensive Care III: Vascular Diseases, but covers independent topics. Upon Completion: Participants should be able to identify the main secondary insults in patients with traumatic brain injury, recognize the signs of impending respiratory failure in acute neuromuscular patients, and discuss the most effective treatments for the control of refractory status epilepticus. Lecture/Faculty: }} Traumatic Brain Injury: Acute Management and Prognosis Kristine H. O’Phelan, MD, Miami, FL }} Neuromuscular Respiratory Failure Alejandro A. Rabinstein, MD, FAAN, Rochester, MN }} Refractory and Super-refractory Status Epilepticus Jan Claassen, MD, PhD, New York, NY Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Nurse, Advanced Practice Provider Wednesday, April 26, 2017

1:00 p.m.–3:00 p.m.

C170 Sports Concussion Skills Workshop I: Event Coverage Skills $ (registration required)

Topic: Neuro Trauma, Critical Care, and Sports Neurology Director: Vernon B. Williams, MD, Los Angeles, CA Program Description: Neurologists and those covering events with high risk of concussion require a unique skill set that can be demonstrated and practiced. The acute concussion occurs in an environment that represents a significant departure from office, emergency department, or hospital settings. This program will involve presentation of practical and immediately useful information through an “augmented reality”-like 96 2017 AAN Annual Meeting Early Look

Neuro Trauma, Critical Care, and Sports Neurology series of presentations. The program environment will mimic the actual sporting event environment. Presentations from faculty will be “augmented” by sound and high definition video-based examples of content. The aim of the program is to provide an interesting and authentic experience for participants as they develop and practice skills related to coverage of sporting events for concussion. This program complements C185: Sports Concussion Skills Workshop II: Office-based Skills, but covers independent topics. Upon Completion: Participants should be able to appropriately assess injured athletes relative to the issue of concussion. Participants should possess the ability to provide acute recommendations to athletes, trainers, coaches, parents, and other stakeholders in the acute sports-related concussion setting using practical skills. They should be aware of the unique aspects of “real-time” concussion assessment and integration into the athletic event environment. Lecture/Faculty: }} Emergency Action Plan Vernon B. Williams, MD, Los Angeles, CA }} Sideline Skills Ilan Jacob Danan, MD, Los Angeles, CA Tad Dean Seifert, MD, Louisville, KY }} Ringside Skills Anthony G. Alessi, MD, FAAN, Norwich, CT Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement, Professionalism Teaching Style: Case-Based, Didactic, Interactive, Audience Participation, Video Analysis CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Wednesday, April 26, 2017

3:30 p.m.–5:30 p.m.

C174 Neurological Intensive Care III: Vascular Diseases

Topic: Neuro Trauma, Critical Care, and Sports Neurology Director: Alejandro A. Rabinstein, MD, FAAN, Rochester, MN Program Description: Severe acute ischemic strokes and intracranial hemorrhages often require management in the ICU. Neurologists caring for these patients need to be prepared to identify and treat the complications that may occur in these cases. This session will review the most recent knowledge on the acute management of massive ischemic stroke, subarachnoid hemorrhage, and intracerebral hemorrhage. This program complements C150: Neurological Intensive Care: The Essentials and C159: Neurological Intensive Care II: From the Brain to the Muscles, but covers independent topics.

Lecture/Faculty: }} Critical Care Management of Acute Ischemic Stroke Wade S. Smith, MD, PhD, San Francisco, CA }} Neurocritical Care of Subarachanoid Hemorrhage Michael N. Diringer, MD, Saint Louis, MO }} Critical Care Management of Intracerebral Hemorrhage Jonathan Rosand, MD, Boston, MA Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Nurse, Advanced Practice Provider

the history and physical, interventional procedures, and key decisionmaking (specifically those related to rehabilitation recommendations, academic and athletic restrictions, monitored return to activity protocols, and/or retirement recommendations). Lecture/Faculty: }} Concussion-specific History and Examination Joel C. Morgenlander, MD, FAAN, Durham, NC }} Concussion-specific Interventions Vernon B. Williams, MD, Los Angeles, CA }} Concussion-specific Decision-making Jeffrey S. Kutcher, MD, FAAN, Brighton, MI Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement, Professionalism Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider Thursday, April 27, 2017

Wednesday, April 26, 2017

3:30 p.m.–5:30 p.m.

C185 Sports Concussion Skills Workshop II: Office-based Skills $ (registration required)

Topic: Neuro Trauma, Critical Care, and Sports Neurology Director: Vernon B. Williams, MD, Los Angeles, CA Program Description: The primary activities sports neurologists (and others) execute in clinic include the history and physical examination, interventional procedures, and decision-making. This program will focus on concussion-related skills in each domain. Skills required for a concussion-specific history and physical examination will be detailed. Skills required to perform common interventional procedures of benefit to concussed athletes will be discussed and demonstrated. Issues associated with development of concussion-specific decisionmaking skills will be presented. The ability to advise patients and other key stakeholders on issues related to benefit, need, or indication for symptom-specific rehabilitation is a decision-making skill. Other decision-making skills are related to academic accommodations, rest vs. exertion challenge and monitored return to play, and retirement from sport vs. continued participation. Video and case examples will be presented, as well as opportunities for participation from attendees. This program complements C170: Sports Concussion Skills Workshop I: Event Coverage Skills, but covers independent topics. Upon Completion: Participants should be able to use skills discussed, demonstrated, and practiced relative to the specific issue of office-based concussion management to provide best-practice level services to their patients. Participants should have learned and incorporated skills related to $ = Additional Fee Required L = Leadership University

1:00 p.m.–3:00 p.m.

C237 Emergency Neurology I:

Evaluation of Coma, Meningitis, and Viral Encephalitis in the Emergency Room

Topics: Neuro Trauma, Critical Care, and Sports Neurology; General Neurology Director: Jose I. Suarez, MD, Cleveland, TX Program Description: Advances in the treatment of neurologic emergencies have increased the complexity of their initial evaluation and impacted the way neurologists deal with them. Faculty will present discussions to highlight important issues such as high level of clinical suspicion, rapid and effective diagnosis and execution of treatment plans. All presentations will emphasize importance of appropriate therapeutic decisions carried out during the first few minutes of the initial encounter to prevent further neurologic injury. In Part I of this course, faculty will discuss coma and meningitis and encephalitis. This program complements C244: Emergency Neurology II: Consultations in the General ICU, but covers independent topics. Fast and easy registration · AAN.com/view/AM17 97

Neuro Trauma

Upon Completion: Participants should be able to discuss the indications for acute endovascular therapy and the options for management of reperfusion injury and ischemic cerebral edema; identify early and delayed complications of aneurysmal subarachnoid hemorrhage; and critically determine the best blood pressure target for treatment of hypertension after intracerebral hemorrhage.

Course Descriptions Upon Completion: Participants should be able to delineate the steps to follow to provide immediate evaluation and management of patients in coma in an organized fashion. In addition, participants should be able to recognize and initiate work up and management of patients presenting with suspected meningitis and encephalitis particularly in the current environment of emergent world pandemics. Lecture/Faculty: }} Coma Jose I. Suarez, MD, Cleveland, TX }} Meningitis and Encephalitis Barnett R. Nathan, MD, Charlottesville, VA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Friday, April 28, 2017

3:30 p.m.–5:30 p.m.

C244 Emergency Neurology II:

Consultations in the General ICU

Topics: Neuro Trauma, Critical Care, and Sports Neurology; Child Neurology and Developmental Neurology; General Neurology Director: Jose I. Suarez, MD, Cleveland, TX Program Description: Advances in the treatment of neurological emergencies have increased the complexity of their initial evaluation and impacted the way neurologists deal with them. Faculty will present discussions to highlight important issues such as high level of clinical suspicion, rapid and effective diagnosis, and execution of treatment plans. All presentations will emphasize importance of appropriate therapeutic decisions carried out during the first few minutes of the initial encounter to prevent further neurologic injury. In Part II of this course, faculty will discuss stroke in the cardiac surgery patient and status epilepticus in the non-neurological ICU. This program complements C237: Emergency Neurology I: Evaluation of Coma, Meningitis and Viral Encephalitis in the Emergency Room, but covers independent topics. Upon Completion: Participants should be able to delineate the steps to follow to provide immediate evaluation and management of cardiac surgery patients experiencing acute stroke (both ischemic and hemorrhagic) in an organized fashion. In addition, participants should be able to recognize and initiate work up and management of patients presenting with status epilepticus in the general ICU particularly in light of the increase in disease severity and complex surgical procedures including solid organ transplantation.

98 2017 AAN Annual Meeting Early Look

Neuromuscular and Clinical Neurophysiology (EMG) Lecture/Faculty: }} Acute Stroke in the Cardiac Surgery Patient Chethan Venkatasubba Rao, MD, Houston, TX }} Status Epilepticus in the General ICU Thomas P. Bleck, MD, FAAN, Chicago, IL Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

NEUROMUSCULAR AND CLINICAL NEUROPHYSIOLOGY (EMG) Saturday, April 22, 2017

C12

10:30 a.m.–12:30 p.m.

Neuromuscular Junction Disorders I: Myasthenia Gravis, Ocular and MuSK Myasthenia

Topic: Neuromuscular and Clinical Neurophysiology (EMG) Director: Laura Marie Tormoehlen, MD, Indianapolis, IN Program Description: Faculty will provide current perspectives on the diagnosis, pathogenesis, and care of patients with myasthenia gravis, ocular and MuSK myasthenia. Case presentations demonstrate a practical approach to identification, evaluation, and management of common and more challenging patients in the clinical setting. This program complements C19: Neuromuscular Junction Disorders II: Toxins, Lambert-Eaton Syndrome, and Less Common Disorders of Neuromuscular Transmission, but covers independent topics. Upon Completion: Participants should be familiar with the diagnosis and management of patients with myasthenia gravis and related disorders; learn to critically select therapies; and be able to distinguish myasthenia gravis, MuSK myasthenia, Lambert-Eaton syndrome, and recognize the less common disorders of neuromuscular transmission. Lecture/Faculty: }} What’s in the Diagnosis: Seropositive, MuSK and Seronegative Myasthenia Gravis Janice M. Massey, MD, FAAN, Durham, NC }} Evidence-based, Cost-effective, and New Developments Jeff Guptill, MD, Durham, NC Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist

C19

2:00 p.m.–4:00 p.m.

Neuromuscular Junction Disorders II: Toxins, Lambert-Eaton Syndrome and Less Common Disorders of Neuromuscular Transmission

Topic: Neuromuscular and Clinical Neurophysiology (EMG) Director: Laura Marie Tormoehlen, MD, Indianapolis, IN Program Description: Faculty will provide current perspectives on the diagnosis, pathogenesis, and care of patients with Lambert-Eaton and congenital myasthenic syndromes, as well as toxin-induced NMJ disorders. Case presentations demonstrate a practical approach to identification, evaluation, and management of common and more challenging patients in the clinical setting. This program complements C12: Neuromuscular Junction Disorders I: Myasthenia Gravis, Ocular, and MuSK Myasthenia, but covers independent topics. Upon Completion: Participants should be familiar with the diagnosis and management of patients with less common NMJ disorders; learn to critically select therapies; and be able to distinguish myasthenia gravis, MuSK myasthenia, Lambert-Eaton syndrome, and recognize the less common disorders of neuromuscular transmission. Lecture/Faculty: }} Toxins and Disorders of Neuromuscular Transmission Laura Marie Tormoehlen, MD, Indianapolis, IN }} Lambert-Eaton Syndrome and the Less Common Disorders of Neuromuscular Transmission Robert M. Pascuzzi, MD, FAAN, Indianapolis, IN Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist Sunday, April 23, 2017

C26

7:00 a.m.–9:00 a.m.

Clinical EMG I: Principles and Practice of NCS and Needle EMG

Topic: Neuromuscular and Clinical Neurophysiology (EMG) Director: Ruple S. Laughlin, MD, Rochester, MN Program Description: Accurate electrodiagnostic testing and interpretation is based on a solid understanding of functional nerve and muscle anatomy, physiology, and pathophysiology in addition to technical considerations. This course is the first in a three-part series of complementary courses aimed at enhancing the understanding and application of EMG to clinical practice. Clinical EMG

$ = Additional Fee Required L = Leadership University

I serves as the foundation for understanding the basics of nerve conduction studies and needle electromyography. Technical factors, pitfalls, and clues to pathophysiology will be highlighted throughout the course. This program complements C37: Clinical EMG II: Neuromuscular Junction Testing and Quantitative EMG, and C55: Clinical EMG III: Nerve Conduction Criteria and Electrodiagnostic Approaches, but covers independent topics. Upon Completion: Participants should be able to have a basic understanding into the origins and acquisition of compound muscle and sensory nerve action potentials and late responses, as well as how to use patterns offiring to assist in spontaneous and voluntary waveform recognition and interpretation. Lecture/Faculty: }} Nerve Conduction Studies: Origins, Acquisition, and Implications Ruple S. Laughlin, MD, Rochester, MN }} Needle Electromyography: Waveform Identification and Interpretation Devon I. Rubin, MD, FAAN, Jacksonville, FL Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Sunday, April 23, 2017

C37

1:00 p.m.–3:00 p.m.

Clinical EMG II: Neuromuscular Junction Testing and Quantitative EMG

Fast and easy registration · AAN.com/view/AM17 99

Neuromuscular

Saturday, April 22, 2017

Course Descriptions Lecture/Faculty: }} Electrodiagnostic Approach to Neuromuscular Junction Testing Vern C. Juel, MD, FAAN, Durham, NC }} Quantitative EMG Mark B. Bromberg, MD, PhD, FAAN, Salt Lake City, UT Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist Sunday, April 23, 2017

C55

3:30 p.m.–5:30 p.m.

Clinical EMG III: Nerve Conduction Criteria and Electrodiagnostic Approaches

Topic: Neuromuscular and Clinical Neurophysiology (EMG) Director: Mark B. Bromberg, MD, PhD, FAAN, Salt Lake City, UT Program Description: Accurate electrodiagnostic testing and interpretation is based on a solid understanding of functional nerve and muscle anatomy, physiology, and pathophysiology in addition to technical considerations. This course is the first in a three-part series of complementary courses aimed at enhancing the understanding and application of EMG to clinical practice. This program complements C26: Clinical EMG I: Principles and Practice of NCS and Needle EMG, and C37: Clinical EMG II: Neuromuscular Junction Testing and Quantitative EMG, but covers independent topics. Upon Completion: Participants should be able to have a basic understanding into the origins and acquisition of compound muscle and sensory nerve action potentials and late responses, as well as how to use patterns of firing to assist in spontaneous and voluntary waveform recognition and interpretation. Lecture/Faculty: }} Nerve Conduction Criteria for AIDP/CIDP Mark B. Bromberg, MD, PhD, FAAN, Salt Lake City, UT }} Electrodiagnostic Approach to Diagnosing ALS/MMN Mark B. Bromberg, MD, PhD, FAAN, Salt Lake City, UT }} Myopathies: Diagnostic Guidance and Correlations from EMG/NCS Laurie Gutmann, MD, FAAN, Iowa City, IA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist

100 2017 AAN Annual Meeting Early Look

Neuromuscular and Clinical Neurophysiology (EMG) Monday, April 24, 2017

C69

7:00 a.m.–9:00 a.m.

Therapy of Neuromuscular Disease: ALS, Inflammatory Neuropathies and Myopathies, and Myasthenia Gravis

Topic: Neuromuscular and Clinical Neurophysiology (EMG) Director: Michael D. Weiss, MD, FAAN, Seattle, WA Program Description: Many neuromuscular diseases are immune-mediated and are treatable and potentially curable. Regrettably, diseases like amyotrophic lateral sclerosis (ALS) are not, but even patients with ALS can see substantial improvements in quality of life and survival with proper therapy. Faculty will provide up-to-date and concise guidelines for the management of ALS, inflammatory neuropathies and myopathies, and myasthenia gravis. Upon Completion: Participants should be familiar with the current management of ALS, inflammatory neuropathies and myopathies, and myasthenia gravis. Lecture/Faculty: }} Treatment of Amyotrophic Lateral Sclerosis Michael D. Weiss, MD, FAAN, Seattle, WA }} Treatment of Inflammatory Neuropathies Michael D. Weiss, MD, FAAN, Seattle, WA }} Treatment of Myasthenia Gravis Anthony A. Amato, MD, FAAN, Boston, MA }} Treatment of Inflammatory Myopathies Anthony A. Amato, MD, FAAN, Boston, MA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist Monday, April 24, 2017

C84

1:00 p.m.–3:00 p.m.

Clinical Approach to Muscle Disease I: Muscle Disorders and Rhabdomyolysis

This program complements C98: Clinical Approach to Muscle Disease II: Polymyositis and Muscle Pathology, but covers independent topics. Upon Completion: Participants should be able to recognize the various clinical patterns associated with myopathies that will help narrow down the differential diagnosis and judiciously reach a final diagnosis. Participants would learn about the role of muscle pathology in diagnosis of inherited and acquired muscle diseases. The participants will understand the role of autoimmune myositis associated and myositis specific autoantibodies in managing myositis patients. Participants will be able to understand the various causes of rhabdomyolysis and how to approach patients with rhabdomyolysis. Lecture/Faculty: }} Approach to Muscle Disorders Namita Goyal, MD, Orange, CA }} Approach to Rhabdomyolysis Andrew Mammen, MD, PhD, Baltimore, MD Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist Monday, April 24, 2017

C98

3:30 p.m.–5:30 p.m.

Clinical Approach to Muscle Disease II: Inflammatory Myopathies and Muscle Pathology

Topic: Neuromuscular and Clinical Neurophysiology (EMG) Director: Tahseen Mozaffar, MD, FAAN, Orange, CA Program Description: Patterns of recognition for various inherited and acquired muscle diseases are important to accurately diagnose and minimize testing. It also helps to judiciously select testing modality. Furthermore, the role of muscle pathology has changed in the diagnosis of muscle disorders, especially inherited muscle disorders. Role of autoimmune myositis specific and associated antibodies has modified the way we approach inflammatory muscle disorders. Through presentations of common and more challenging cases, faculty will facilitate a discussion with the audience of differential diagnosis and laboratory evaluation. Each case will be followed by an overview and update on the topic. This program complements C84: Clinical Approach to Muscle Disease I: Muscle Disorders and Rhabdomyolysis, but covers independent topics. Upon Completion: Participants should be able to recognize the various clinical patterns associated with myopathies that will help narrow down

$ = Additional Fee Required L = Leadership University

the differential diagnosis and judiciously reach a final diagnosis. Participants would learn about the role of muscle pathology in diagnosis of inherited and acquired muscle diseases. The participants will understand the role of autoimmune myositis associated and myositis specific autoantibodies in managing myositis patients. Participants will be able to understand the various causes of rhabdomyolysis and how to approach patients with rhabdomyolysis. Lecture/Faculty: }} Unicorns, Dragons, Polymyositis, and Other Mythological Beasts: The Truth About Polymyositis Tahseen Mozaffar, MD, FAAN, Orange, CA }} Role of Muscle Biopsy in Muscle Disorders Margherita Milone, MD, Rochester, MN Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist Monday, April 24, 2017

6:00 p.m.–9:00 p.m.

C107 Case Studies: Unusual Diagnostic and Management of Cases in Neuromuscular Disease

Topic: Neuromuscular and Clinical Neurophysiology (EMG) Director: Anne M. Connolly, MD, Saint Louis, MO Program Description: The practice of neuromuscular medicine has been impacted by recent advances in immunology, molecular biology, and genetics. Through the presentation of both common disorders with unusual diagnostic or management issues, as well as rarer and more challenging cases, faculty will facilitate a discussion of diagnosis, laboratory workup, and treatment of a wide array of neuromuscular conditions. Each case will include an overview and an update on the particular clinical entity, including evolving concepts and approaches to therapy. Upon Completion: Participants should be familiar with the differential diagnosis, evaluation, treatment, and management of common and uncommon neuromuscular disorders, and gain an enhanced awareness of rare or unusual neuromuscular phenotypes. Lecture/Faculty: }} Unusual Case Studies in Neuromuscular Disorders Muhammad Al-Lozi, MD, Saint Louis, MO Anne M. Connolly, MD, Saint Louis, MO P. James B. Dyck, MD, FAAN, Rochester, MN Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Interactive, Audience Participation CME Credits: 3 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist Fast and easy registration · AAN.com/view/AM17 101

Neuromuscular

the audience of differential diagnosis and laboratory evaluation. Each case will be followed by an overview and update on the topic.

Course Descriptions Tuesday, April 25, 2017

7:00 a.m.–9:00 a.m.

C120 Mastering EMG Waveform Recognition Skills in Just Two Hours!

Topic: Neuromuscular and Clinical Neurophysiology (EMG) Director: Devon I. Rubin, MD, FAAN, Jacksonville, FL Program Description: Interpretation of EMG studies relies on the ability to accurately identify and interpret normal and abnormal spontaneous activity and changes in motor unit potentials (MUP) that occur in neuromuscular diseases. Mastering accurate and efficient EMG waveform identification requires learning skills of pattern recognition and auditory semi-quantitation. Once these skills are learned, EMG diagnostic efficiency and accuracy can be enhanced with appropriate practice. This interactive session will teach attendees methods used to identify EMG waveforms using an interactive, audience participation approach. Attendees will learn and practice the methods of auditory pattern recognition and semi-quantitation with focus on MUP recruitment, as well as recognition of other MUP parameters including stability, phases, and duration. Examples of spontaneous EMG waveforms and MUP abnormalities will be shown through case examples to test waveform recognition skills. Upon Completion: Participants should be able to demonstrate the ability to recognize the auditory firing patterns of EMG waveforms; understand the significance of abnormal recruitment changes in motor unit potential in diseases; recognize morphologic MUP changes according to the temporal course of a neuromuscular disease; learn to identify common and uncommon abnormal spontaneous EMG waveforms; and correlate EMG abnormalities with underlying neuromuscular diseases. Lecture/Faculty: }} You Make the Call! Interactive Audience Quiz of Unknown EMG Waveforms Devon I. Rubin, MD, FAAN, Jacksonville, FL Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist

Neuromuscular and Clinical Neurophysiology (EMG) Tuesday, April 25, 2017

1:00 p.m.–3:00 p.m.

C121 Small Fiber Neuropathies: Sensory, Autonomic, and Both I: Focus on Autonomic Nervous System

Topic: Neuromuscular and Clinical Neurophysiology (EMG) Director: Christopher H. Gibbons, MD, FAAN, Boston, MA Program Description: Small fiber and autonomic neuropathies are common but often unrecognized conditions that affect the peripheral, somatic, and autonomic nervous systems. Through the presentation of didactic material and cases of varying complexity, faculty will facilitate a discussion of the pathophysiology, differential diagnosis, diagnostic evaluation, and therapy of these conditions. Part I will focus more heavily on conditions that impact the autonomic nervous system; Part II will focus more heavily on conditions that impact the somatic or sensory nervous system. Both parts will discuss conditions that may impact the sensory and autonomic small fibers simultaneously. This program complements C136: Small Fiber Neuropathies: Sensory, Autonomic, and Both II: Focus on Sensory Nervous System, but covers independent topics. Upon Completion: Participants should become familiar with the pathophysiology, semiology, differential diagnosis, diagnostic approaches (including skin biopsy and autonomic testing), laboratory evaluation, and treatment of small fiber somatic and autonomic neuropathies. Lecture/Faculty: }} Case Studies of Peripheral Autonomic Neuropathies Roy L. Freeman, MD, Boston, MA }} Evaluation of Autonomic Function Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist Tuesday, April 25, 2017

1:00 p.m.–5:30 p.m.

C135 Neuromuscular Ultrasound Skills Workshop $ (registration required)

Topic: Neuromuscular and Clinical Neurophysiology (EMG) Director: Craig M. Zaidman, MD, Saint Louis, MO Program Description: This skills workshop will introduce participants to the field of neuromuscular ultrasound (NMUS) and cover the basic principles of ultrasonography and current applications. NMUS techniques will be presented through both video and live demonstration sessions. Participants will also have the opportunity to gain limited hands-on 102 2017 AAN Annual Meeting Early Look

Upon Completion: Participants should be able to understand the basic principles of neuromuscular ultrasonography, including its advantages and limitations, and the role of ultrasound in the diagnosis of entrapment neuropathies; become familiar with the techniques required to use ultrasound in the guidance of neuromuscular procedures, and the methods required to use muscle ultrasound; and learn to integrate electrodiagnostic and sonographic information through case presentations. Lecture/Faculty: }} Introduction and Orientation to Neuromuscular Ultrasound Craig M. Zaidman, MD, Saint Louis, MO }} Breakout I: Upper Extremity Ultrasound Bob Bucelli, MD, PhD, Saint Louis, MO }} Breakout II: Ultrasound Guided Procedures/Diaphragmatic EMG Jeffrey Strommen, MD, Rochester, MN }} Breakout III: Brachial Plexus and Muscle Craig M. Zaidman, MD, Saint Louis, MO }} Breakout IV: Lower Extremity Ultrasound Andrea Boon, MD, Rochester, MN Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic, Case-Based, Interactive, Audience Participation CME Credits: 4 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist Tuesday, April 25, 2017

3:30 p.m.–5:30 p.m.

C136 Small Fiber Neuropathies:

Sensory, Autonomic, and Both II: Focus on Sensory Nervous System

Upon Completion: Participants should become familiar with the pathophysiology, semiology, differential diagnosis, diagnostic approaches (including skin biopsy and autonomic testing), laboratory evaluation, and treatment of small fiber somatic and autonomic neuropathies. Lecture/Faculty: }} Case Studies in Peripheral Neuropathy Christopher H. Gibbons, MD, FAAN, Boston, MA }} Neuropathic Pain—Mechanisms Guide Treatment Ralf Baron, MD, Kiel, Germany Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist Wednesday, April 26, 2017

1:00 p.m.–3:00 p.m.

C164 Evaluation and Management of Autonomic

Disorders I: Autonomic Testing, Failure, and Peripheral Neuropathies

Topic: Neuromuscular and Clinical Neurophysiology (EMG) Director: Amanda C. Peltier, MD, MS, Nashville, TN Program Description: Availability of noninvasive autonomic testing is expanding neurologic practice in the diagnosis and management of disorders of the autonomic nervous system. Faculty will provide a clinical overview of autonomic tests, and clinical approaches to common autonomic disorders and their diagnosis. This program complements C180: Evaluation and Management of Autonomic Disorders II: Diagnostic Approach and Treatments for Dysautonomia, but covers independent topics. Upon Completion: Participants should be able to improve their ability to formulate a differential diagnosis, organize a work-up, and a treatment plan for patients with autonomic dysfunction. Lecture/Faculty: }} Autonomic Testing: Where Is the Lesion Wolfgang Singer, MD, Rochester, MN }} Autonomic Failure: MSA, PD, and Beyond Horacio C. Kaufmann, MD, FAAN, New York, NY }} Autonomic Peripheral Neuropathies Roy L. Freeman, MD, Boston, MA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider

Fast and easy registration · AAN.com/view/AM17 103

Neuromuscular

experience with ultrasound systems under the guidance of a faculty member. Specific information will be presented on the role of NMUS in the diagnosis and management of entrapment neuropathies, and its use in guided procedures and in the diagnosis of muscular disorders.

Course Descriptions Wednesday, April 26, 2017

1:00 p.m.–5:30 p.m.

C172 EMG Skills Workshop: Basic $ (registration required)

Topic: Neuromuscular and Clinical Neurophysiology (EMG) Director: Ezgi Tiryaki, MD, Minneapolis, MN Program Description: The program consists of four sessions covering: motor nerve conduction studies; sensory nerve conduction studies; nerve conduction techniques such as repetitive nerve stimulation, F waves, and H reflexes; and needle EMG. In small, hands-on group sessions, faculty will first demonstrate and then supervise attendees performing these techniques. The presentations will also cover the clinical utility and technical pitfalls of these techniques. Attendees rotate through each of the sessions. Participants should be familiar with basic electrodiagnostic skills for the evaluation of common neuromuscular problems. The course is designed for practicing neurologists who wish to update basic skills in these important techniques and residents in training who either are rotating or have rotated through the EMG lab in their training program. Upon Completion: Participants should be able to describe fundamentals of nerve conduction and needle examination; list electrodiagnostic approaches to common problems encountered in the EMG laboratory; and recognize common technical pitfalls and artifacts. Lecture/Faculty: }} Needle EMG Cynthia Bodkin, MD, Indianapolis, IN }} Sensory Nerve Conduction Studies Holli Ann Horak, MD, FAAN, Tucson, AZ }} Motor Nerve Conduction Studies Jun Kimura, MD, FAAN, Iowa City, IA }} Repetitive Stimulation and Late Responses Faculty Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement, Systems-Based Practice Teaching Style: Interactive CME Credits: 4 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, EMG Technologist

Neuromuscular and Clinical Neurophysiology (EMG) Wednesday, April 26, 2017

3:30 p.m.–5:30 p.m.

C180 Evaluation and Management of Autonomic Disorders II: Diagnostic Approach and Treatments for Dysautonomia

Topic: Neuromuscular and Clinical Neurophysiology (EMG) Director: Amanda C. Peltier, MD, MS, Nashville, TN Program Description: Discrimination between structural and functional autonomic disorders and the treatment of both is expanding neurologic practice and management. Faculty will provide and overview of common functional autonomic disorders typically encountered and clinical approaches to treatment for symptoms of autonomic disorders. This program complements C164: Evaluation and Management of Autonomic Disorders I: Autonomic Testing, Failure, and Peripheral Neuropathies, but covers independent topics. Upon Completion: Participants should be able to improve their ability to formulate a differential diagnosis for functional autonomic disorders and a treatment plan for patients with common varieties of autonomic dysfunction. Lecture/Faculty: }} Diagnostic Approach to the Patient with Dysautonomia William P. Cheshire, Jr., MD, FAAN, Jacksonville, FL }} Treatments for Autonomic Failure and Dysautonomia Amanda C. Peltier, MD, MS, Nashville, TN Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist Thursday, April 27, 2017

7:00 a.m.–9:00 a.m.

C193 Peripheral Neuropathy I:

Anatomical Basis and Acquired Demyelinating Neuropathies

Topic: Neuromuscular and Clinical Neurophysiology (EMG) Director: Michael E. Shy, MD, Iowa City, IA Program Description: Peripheral neuropathies (PN) ultimately affect almost 10 percent of the population. New diagnostic and management options make rational therapies for PN increasingly possible. However, the high cost of certain diagnostic tests and therapies, along with the complexities involved in choosing which tests and treatments to initiate, complicate the management of patients with PN. The Peripheral Nerve Society (PNS) and AAN Neuromuscular Section will present three two-hour courses devoted to the diagnosis and management of these disorders. Faculty will provide an overview of the peripheral nervous system, including a pathological overview of PN, and review the diagnosis and management of acquired immune-based ceuropathies, including Guillain Barre syndrome and CIDP.

104 2017 AAN Annual Meeting Early Look

Upon Completion: Participants should be able to understand the anatomical basis and pathological consequences of peripheral neuropathies, distinguish between acquired and inherited peripheral neuropathies, and use a rational, evidence-based approach to treat acquired immunologically based peripheral neuropathies. Lecture/Faculty: }} Peripheral Neuropathy—Overview of Anatomy and Pathology Steven Scherer, MD, Philadelphia, PA }} Diagnosis and Treatment of Acquired Demyelinating Neuropathies Richard A. Lewis, MD, FAAN, Los Angeles, CA }} Questions and Answers/Case Presentations Richard A. Lewis, MD, FAAN, Los Angeles, CA Steven Scherer, MD, Philadelphia, PA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist Thursday, April 27, 2017

1:00 p.m.–3:00 p.m.

C204 Peripheral Neuropathy II:

Diabetic and Inherited Neuropathies

Topic: Neuromuscular and Clinical Neurophysiology (EMG) Director: Michael E. Shy, MD, Iowa City, IA Program Description: Peripheral neuropathies (PN) ultimately affect almost 10 percent of the population. New diagnostic and management options make rational therapies for PN increasingly possible. However, the high cost of certain diagnostic tests and therapies along with the complexities involved in choosing which tests and treatments to initiate complicate the management of patients with PN. The Peripheral Nerve Society (PNS) and Neuromuscular Section of the AAN will present three two-hour courses devoted to the diagnosis and management of these disorders. Faculty will review approaches and management issues for patients with inherited neuropathies, as well as approaches and management issues for the various forms of diabetic neuropathy. This program complements C193: Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies and C217: Peripheral Neuropathy III: Genetic Testing and Next Generation Sequencing, but covers independent topics. Upon Completion: Participants should be able to determine whether a neuropathy is likely to be genetically based; identify the likely genetic causes

$ = Additional Fee Required L = Leadership University

of a genetic neuropathy; become familiar with current and future management approaches in different genetic causes of inherited neuropathy; identify the distinct forms of diabetic neuropathy; determine whether a neuropathy is likely to be related to diabetes; and obtain a rational, evidence-based approach to treating diabetic neuropathies. Lecture/Faculty: }} Diabetic Neuropathies A. Gordon Smith, MD, FAAN, Salt Lake City, UT }} Inherited Neuropathies Michael E. Shy, MD, Iowa City, IA }} Questions and Answers/Case Presentations A. Gordon Smith, MD, FAAN, Salt Lake City, UT Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Thursday, April 27, 2017

3:30 p.m.–5:30 p.m.

C217 Peripheral Neuropathy III: Genetic Testing and Next Generation Sequencing

Topic: Neuromuscular and Clinical Neurophysiology (EMG) Director: Michael E. Shy, MD, Iowa City, IA Program Description: Next generation sequencing testing is making a genetic diagnosis increasingly available and affordable for patients with inherited neuropathies. However, it is increasingly confusing and complex in deciding what genetic testing to perform and how to interpret the results. The Peripheral Nerve Society (PNS) and Neuromuscular Section of the AAN will present this two-hour course to address these issues. Expert faculty with extensive experience in ordering and interpreting genetic testing for CMT will review strategies for ordering and interpreting test results, as well as discuss the current state and future of next generation testing for patients with inherited neuropathies and related disorders. This program complements C193: Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies and C204: Peripheral Neuropathy II: Diabetic and Inherited Neuropathies, but covers independent topics. Upon Completion: Participants should be able to determine when to consider ordering genetic testing for patients with neuropathy; determine when testing is positive or negative and have an approach of what to do when results are inconclusive; and understand the different forms of next generation sequencing and the strengths and weaknesses of these forms.

Fast and easy registration · AAN.com/view/AM17 105

Neuromuscular

This program complements C204: Peripheral Neuropathy II: Diabetic and Inherited Neuropathies and C217: Peripheral Neuropathy III: Genetic Testing and Next Generation Sequencing, but covers independent topics.

Course Descriptions Lecture/Faculty: }} Interpreting Genetic Testing Results in Patients with Inherited Neuropathies Shawna Feely, Iowa City, IA }} Interpretation and Usage of Next Generation Sequencing: The Future Faculty }} Questions and Answers/Case Presentations Shawna Feely, Iowa City, IA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

NEURO-ONCOLOGY Sunday, April 23, 2017

C38

1:00 p.m.–3:00 p.m.

Case Studies: Neurologic Consultations in Cancer Patients I

Topic: Neuro-oncology Director: Amy A. Pruitt, MD, Philadelphia, PA Program Description: Faculty will discuss 10-12 cases representing such problems as stroke in a cancer patient, complications of new immune checkpoint inhibitors, acute mental status changes in transplant recipients, primary CNS lymphoma and its mimics, and neurologic problems of cancer survivors such as chemobrain, secondary neoplasms, and infections. Some cases will address the evolving role of palliative care consultation in the management of these patients. This program complements C56: Case Studies: Neurologic Consultations in Cancer Patients II, but covers independent topics. Upon Completion: Participants should be able to evaluate causes of stroke in cancer patients and explain appropriate anticoagulation strategies, recognize the many variations of presentation of primary CNS lymphoma, recognize and treat novel neurologic complications in patients receiving immune checkpoint inhibitors, recognize toxicities of drugs used in hematopoietic cell transplantation, and perform a thorough screen for neurologic issues in long-term survivors of CNS cancer treatment. Lecture/Faculty: }} Case Studies Jaishri Blakeley, MD, Baltimore, MD Amy A. Pruitt, MD, Philadelphia, PA David Schiff, MD, FAAN, Charlottesville, VA Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care 106 2017 AAN Annual Meeting Early Look

Neuro-oncology Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist Sunday, April 23, 2017

C56

3:30 p.m.–5:30 p.m.

Case Studies: Neurologic Consultations in Cancer Patients II

Topic: Neuro-oncology Director: Patrick Y. Wen, MD, FAAN, Boston, MA Program Description: Neurologists are often called upon to weigh in on management issues related to patients with brain tumors or systemic cancer. They must recognize syndromes that predate cancer diagnosis, complications of therapy, and sequelae. The program will be divided into three sessions using cases to illustrate 1) the current management and new WHO classification of gliomas, 2) the diagnosis and management of metastatic complications of cancer, and 3) recent developments in the diagnosis and management of paraneoplastic neurologic syndromes. These presentations will be followed by a fourth session involving a tumor board format to discuss cases of interest. This program complements C38: Case Studies: Neurologic Consultations in Cancer Patients I, but covers independent topics. Upon Completion: Participants should be able to understand the current diagnosis, classification, and management of gliomas; the diagnosis and management of the common metastatic complications of cancer; and the diagnosis and management of paraneoplastic syndromes of the nervous system. Lecture/Faculty: }} Update on WHO Classification and Treatment of Gliomas Patrick Y. Wen, MD, FAAN, Boston, MA }} Diagnosis and Management of Metastatic Complications of Cancer David Schiff, MD, FAAN, Charlottesville, VA }} Diagnosis and Management of Paraneoplastic Syndromes Josep O. Dalmau, MD, PhD, Barcelona, Spain }} Tumor Board Case Studies Amy A. Pruitt, MD, Philadelphia, PA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider

C66

7:00 a.m.–9:00 a.m.

Neuro-oncologic Emergencies

Topic: Neuro-oncology Director: Nimish A. Mohile, MD, Rochester, NY Program Description: Neuro-oncology encompasses several emergent conditions that require immediate recognition and therapeutic management in order to preserve and improve patient outcomes. Faculty will present cases involving the most common and critical neuro-oncologic emergencies and describe the optimal diagnostic approach, therapies, and prognosis. Six clinical scenarios will be presented, each discussing clinical presentation, differential diagnosis, therapeutic management, and patient outcomes. Faculty will present cases of cancer patients who present with myelopathy, cauda equina syndrome, acute encephalopathy, increased intracranial pressure, stroke, and new neurologic symptoms in bone marrow transplant patients. For each case, faculty will discuss a broad differential diagnosis with an emphasis on the most emergent conditions and treatments. Upon Completion: Participants should become familiar with evidence-based emergent management of metastatic epidural spinal cord compression, be familiar with identification and management of increased intracranial pressure in brain tumor patients, develop a differential diagnosis for acute mental status changes in a cancer patient, understand the possible differentials for new neurologic complications in bone marrow transplant patients, and understand the management of acute stroke in cancer patients. Lecture/Faculty: }} Metastatic Epidural Spinal Cord Compression Julie E. Hammack, MD, FAAN, Rochester, MN }} Cauda Equina Syndromes Julie E. Hammack, MD, FAAN, Rochester, MN }} Increased Intracranial Pressure Julie E. Hammack, MD, FAAN, Rochester, MN }} Acute Encephalopathy Nimish A. Mohile, MD, Rochester, NY }} Stroke in a Cancer Patient Nimish A. Mohile, MD, Rochester, NY }} Acute Neurologic Symptoms in a Bone Marrow Transplant Patient Nimish A. Mohile, MD, Rochester, NY Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider

$ = Additional Fee Required L = Leadership University

Tuesday, April 25, 2017

7:00 a.m.–9:00 a.m.

C117 The Palliative Care Guide in Neurology:

Best Practice Guidelines in Communication, Symptom Management, and End of Life Care of Patients with Brain Tumors and Other Life Limiting Neurological Disorders

Topics: Neuro-oncology; Pain and Palliative Care Director: Tobias Walbert, MD, PhD, Detroit, MI Program Description: This program is intended to teach neurologists the broad principles of palliative care, with a focus on how to apply those principles in the practice with brain tumor patients as well as other life limiting neurological disorders. Faculty will cover an introduction to the history and goals of palliative care, distinction of palliative care from hospice care, communicating with the patient and the patient’s family (how to disclose bad news and how to provide honest, yet compassionate, information), understanding the concept of quality of life, fostering trust and avoiding perceptions by the patient of abandonment, and how to initiate advance care planning. The principles will focus on neuro-oncology patients as well as other patients with life limiting neurological disorders. Special attention will be given to practical decision-making, symptom management, and advance care planning. Upon Completion: Participants should be able to communicate a serious diagnosis to a patient in an honest yet compassionate manner, identify the key components of palliative care and hospice, discuss end-of-life issues with patients and assist them in developing advance directives, and manage the palliative care needs of a patient with brain tumors. Lecture/Faculty: }} Palliative Care and Neurology: Why Does it Matter, How Does It Affect Our Patients and Their Families, and Why Should We Care? What Is the Role of Advance Care Planning in Neurology? Tobias Walbert, MD, PhD, Detroit, MI }} Know How: Symptom Management and Communication Skills for the Neurologist Alan C. Carver, MD, New York, NY Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

Fast and easy registration · AAN.com/view/AM17 107

Neuro-oncology

Monday, April 24, 2017

Course Descriptions Thursday, April 27, 2017

7:00 a.m.–9:00 a.m.

C194 Basic Principles of Brain Tumors: For Practice and for Certification

Topic: Neuro-oncology Director: Erin M. Dunbar, MD, Atlanta, GA Program Description: This course is high-yield for the initial boards and MOC exams. This course concisely reviews primary brain tumors, including the new 2016 WHO Classifications, evidenced-based multidisciplinary treatment, symptom management, neuro-oncology emergencies, genetic syndromes, and scenarios for referral. Upon Completion: Participants should be able to improve their skills, outcomes, and confidence in the management of these tumors with this high-impact review for those taking their initial boards and/or their maintenance of certification (MOC). Lecture/Faculty: }} 2016 WHO CNS Tumor Classification Updates and Genetic Syndromes Pearls John W. Henson, MD, FAAN, Atlanta, GA }} Neurosurgical and Radiation-oncology Management Jeffrey Weinberg, MD, Houston, TX }} Neuro-oncology and Symptom Management Erin M. Dunbar, MD, Atlanta, GA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Thursday, April 27, 2017

3:30 p.m.–5:30 p.m.

C218 Cutting Edge Neuro-oncology— Understanding Current Trends

Topic: Neuro-oncology Director: Maciej M. Mrugala, MD, Seattle, WA Program Description: This program will aim to teach general neurologist and neurooncologist about most recent developments in the field of neurooncology. The first talk will cover new experimental therapies showing promise such as polio virus and immunotherapies using checkpoint inhibitors, among others. Patients are frequently asking about these therapies, and critical overview of the data for the practicing clinician will be provided. The second talk will address molecular diagnostics in primary brain tumors. This is an area of active research and many of the molecular markers recently discovered have clinical utility. Practical information about ordering

108 2017 AAN Annual Meeting Early Look

Neuro-ophthalmology/Neuro-otology different molecular panels and how to interpret them will be provided. In the third talk we will cover novel surgical techniques being already used or in stages of advanced development, in therapy for primary and metastatic brain tumors. We will emphasize information important for clinicians when advising patients about pros and cons of each therapeutic approach. Upon Completion: Participants should be able to identify novel developments in the field of neuro-oncology with emphasis on molecular testing, and new emerging therapies. Lecture/Faculty: }} Evolving New Therapies in Neuro-oncology—What a Neurologist Should Know Maciej M. Mrugala, MD, Seattle, WA }} Understanding Molecular Testing in Brain Tumors—How Clinically Useful It Really is Seema Nagpal, MD, Stanford, CA }} Deciphering Technical Novelties in Surgical Therapy for Brain Tumors—What Is Coming and How to Advise the Patients? Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Neuro-oncologist

NEURO-OPHTHALMOLOGY/NEUROOTOLOGY Saturday, April 22, 2017

C22

2:00 p.m.–4:00 p.m.

It’s a Bird, It’s a Plane, It’s… The Doctor Who Cured my Benign Paroxysmal Positional Vertigo

Topic: Neuro-ophthalmology/Neuro-otology Director: Kevin A. Kerber, MD, Ann Arbor, MI Program Description: How often does a neurologist have the opportunity to cure a patient of disabling symptoms during an office visit? The answer is actually quite often, if you see patients with dizziness. In this program, we will discuss the positional test and canalith repositioning for benign paroxysmal positional vertigo. Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist

C32

7:00 a.m.–9:00 a.m.

Emergency Room Neuro-ophthalmology

Topics: Neuro-ophthalmology/Neuro-otology; Neuro Trauma, Critical Care, and Sports Neurology Director: Heather Moss, MD, PhD, FAAN, Chicago, IL Program Description: In the patient with acute visual loss, diplopia, and extra-eye movements, it is important to recognize certain entities as a timely diagnosis improves chances of a favorable outcome. Faculty will highlight such neuro-ophthalmic emergencies, focusing on examination techniques, evaluation, and management. Didactic lectures, case examples, and open discussion with the faculty will provide participants with both basic knowledge and updates on current controversies. Upon Completion: Participants should be familiar with the clinical features and initial management of neuro-ophthalmic conditions that present in the emergency department, including giant cell arteritis, pituitary apoplexy, aneurysmal third nerve palsy, cerebral venous thrombosis, arterial dissection, and brainstem ocular motor disorders. Lecture/Faculty: }} Approaching the Patient with Vision Loss Heather Moss, MD, PhD, FAAN, Chicago, IL }} Examining the Ocular Fundus and Interpreting What You See Beau Benjamin Bruce, MD, Atlanta, GA }} Discussion and Cases Faculty }} Approaching the Patient with Diplopia and Extra Eye Movements Heather Moss, MD, PhD, FAAN, Chicago, IL }} Interpreting and Diagnosing Extra Eye Movements Eric R. Eggenberger, DO, FAAN, East Lansing, MI }} Discussion and Cases Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider

$ = Additional Fee Required L = Leadership University

Sunday, April 23, 2017

C50

1:00 p.m.–5:30 p.m.

Neuro-ophthalmology and Neurovestibular Exam Lab Skills Workshop $ (registration required)

Topic: Neuro-ophthalmology/Neuro-otology Director: John Pula, MD, Chicago, IL Program Description: This is a hands-on mini-lab to convey neuro-ophthalmology and neurootology examination skills. The lab consists of stations to address individual components of the exam, including visual acuity (near and Snellen acuity), color vision, fields (confrontation and Amsler grid including techniques to diagnose functional patients), pupils (RAPD and anisocoria), ocular alignment (prism cover, general prism use, red Maddox rod), assessment of pursuits and saccades, nystagmus examination (Frenzel lens), ophthalmoscopy (direct and panoptic ophthalmoscopes), assessment of the vestibular ocular reflex (head thrust and ophthalmoscopy), Hallpike testing, and repositioning treatments. Participants will visit each station for individualized instruction and troubleshooting with an expert on these essential examination skills. Upon Completion: Participants should understand the techniques used in performing the neuro-ophthalmic and neurovestibular exams, including afferent, pupil, efferent, and vestibular components. Lecture/Faculty: }} Slit Lamp Examination (Anterior Chamber, Retina, and 3D View of Optic Nerve) Gregory P. Van Stavern, MD, Saint Louis, MO }} Visual Field Testing (Amsler Grid, Functional Vision Loss) Christopher Glisson, DO, Grand Rapids, MI }} Acuity and Color Vision (Near Acuity, Functional Vision Loss, Dyschromatopsia) Eric R. Eggenberger, DO, FAAN, East Lansing, MI John Pula, MD, Chicago, IL }} Neurovestibular Examination (VOR Gain and Suppression, DixHallpike Test, Canalith Repositioning Treatment) Jorge C. Kattah, MD, FAAN, Peoria, IL Kevin A. Kerber, MD, Ann Arbor, MI }} Ocular Motility (Alignment, Ductions, Prisms, Red-Maddox Rod) Faculty }} Ophthalmoscopy: An Important Skill for All Neurologists Kathleen B. Digre, MD, FAAN, Salt Lake City, UT Heather Moss, MD, PhD, FAAN, Chicago, IL }} Pupil Examination (Anisocoria, RAPD) Wayne T. Cornblath, MD, FAAN, Ann Arbor, MI Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement, Systems-Based Practice Teaching Style: Interactive CME Credits: 4 Recommended Audience: Trainee, General Neurologist

Fast and easy registration · AAN.com/view/AM17 109

Neuro-ophthalmology

Sunday, April 23, 2017

Course Descriptions Monday, April 24, 2017

C86

1:00 p.m.–3:00 p.m.

Neuro-otology I: The Common Peripheral Vestibular Disorders

Topic: Neuro-ophthalmology/Neuro-otology Director: Kevin A. Kerber, MD, Ann Arbor, MI Program Description: This program will provide attendees with detailed information about the approach to the history and physical in patients with dizziness, and specifically regarding the three most common peripheral vestibular disorders: vestibular neuritis, Meniere’s disease, and benign paroxysmal positional vertigo. A solid understanding of these common peripheral vestibular disorders is critical to the neurologist who evaluates patients with dizziness. Evidence-based diagnosis and management will be discussed when applicable. This program complements C100: Neuro-otology II: Diagnosis and Treatment of Nuanced Causes of Dizziness, but covers independent topics. Upon Completion: Participants should be familiar with the key aspects of the history and examination for dizziness presentations, and particularly regarding the three most common peripheral vestibular disorders. Lecture/Faculty: }} Approach to the History and Examination in Dizziness Patients Kevin A. Kerber, MD, Ann Arbor, MI }} Vestibular Neuritis Terry D. Fife, MD, FAAN, Phoenix, AZ }} Meniere’s Disease Faculty }} Benign Paroxysmal Positional Vertigo (Posterior Canal) Kevin A. Kerber, MD, Ann Arbor, MI Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist Monday, April 24, 2017

3:30 p.m.–5:30 p.m.

C100 Neuro-otology II:

Diagnosis and Treatment of Nuanced Causes of Dizziness

Topic: Neuro-ophthalmology/Neuro-otology Director: Kevin A. Kerber, MD, Ann Arbor, MI Program Description: Building on clinical topics from Neuro-otology I, this program will cover more nuanced variants of benign paroxysmal positional vertigo,

110 2017 AAN Annual Meeting Early Look

Neuro-ophthalmology/Neuro-otology dizziness-stroke presentations, and vestibular migraine. The program will conclude with case studies and a question and answer session. Evidence-based management will be discussed when applicable. This program complements C86: Neuro-otology I: The Common Peripheral Vestibular Disorders, but covers independent topics. Upon Completion: Participants should be familiar with the key elements needed to identify the variants of benign paroxysmal positional vertigo, strokecausing dizziness, and vestibular migraine. Lecture/Faculty: }} Horizontal Canal BPPV and Atypical Positional Vertigo Terry D. Fife, MD, FAAN, Phoenix, AZ }} Stroke and Dizziness Kevin A. Kerber, MD, Ann Arbor, MI }} Vestibular Migraine Robert W. Baloh, MD, FAAN, Los Angeles, CA }} Case Presentations / Questions and Answers Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, NonNeurologist Tuesday, April 25, 2017

7:00 a.m.–9:00 a.m.

C118 Nystagmus and Saccadic Intrusions Made Simple

Topic: Neuro-ophthalmology/Neuro-otology Director: Janet C. Rucker, MD, New York, NY Program Description: Accurate identification of abnormal spontaneous eye movements, such as nystagmus and saccadic intrusions, is critical to proper neurological localization and diagnosis. The focus of this course will be on enhancing accurate identification via pattern recognition of abnormal eye movements that disrupt steady fixation and degrade vision. Through video presentations of ocular oscillations and ample case presentations, faculty will present the clinical features, localization, prognosis, and diagnostic implications of each eye movement. Upon Completion: Participants should be able to accurately identify nystagmus and saccadic intrusion patterns and to discuss the localization of each eye movement and common causative etiologies. Lecture/Faculty: }} Introduction to Nystagmus and Saccadic Intrusions Janet C. Rucker, MD, New York, NY }} Nystagmus Marc Dinkin, MD, New York, NY

Tuesday, April 25, 2017

1:00 p.m.–3:00 p.m.

C129 Pediatric Neuro-ophthalmology Update Topics: Neuro-ophthalmology/Neuro-otology; Child Neurology and Developmental Neurology Director: Christopher Glisson, DO, Grand Rapids, MI Program Description: This course will review pediatric neuro-ophthalmic topics including optic neuropathies in childhood (with a focus on optic neuritis and its relationship to MS), pediatric eye movement disorders, and causes of optic disc swelling. Knowledge will be transferred by various formats, including lecture, case-based discussion, and audience participation. Upon Completion: Participants should be able to demonstrate familiarity with afferent neuro-ophthalmic disorders in children (including optic neuritis, optic disc edema and vision loss), be knowledgable concerning the common efferent neuro-ophthalmic disorders that affect children (including diplopia, third/fourth/sixth nerve palsies, and other eye movement abnormalities), and review the relevant neuro-ophthalmic manifestations of systemic disease in the pediatric population. Lecture/Faculty: }} The Pediatric Neuro-ophthalmic Examination Christopher Glisson, DO, Grand Rapids, MI }} Optic Disc Swelling in Childhood Melissa W. Ko, MD, FAAN, Jamesville, NY }} Pediatric Optic Neuritis (KEYNOTE) Grant Liu, MD, FAAN, Philadelphia, PA }} Nystagmus and Nystagmoid Eye Movements Faculty }} Pediatric 3rd, 4th, and 6th Nerve Palsies Grant Liu, MD, FAAN, Philadelphia, PA }} Neuro-ophthalmic Manifestations of Systemic Disease Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist

$ = Additional Fee Required L = Leadership University

Wednesday, April 26, 2017

7:00 a.m.–9:00 a.m.

C151 Neuro-ophthalmology I:

Visual Loss, Optic Neuropathies, and Papilledema

Topic: Neuro-ophthalmology/Neuro-otology Director: Nancy J. Newman, MD, FAAN, Atlanta, GA Program Description: This is part I of a three-part comprehensive review of clinical neuro-ophthalmology designed to be a stand-alone course; however, attendees are strongly encouraged to attend all three parts. Numerous case presentations will be followed by related short reviews. Topics specifically addressed in part I include the differential diagnosis of visual loss, the examination of the ocular fundus, optic neuropathies, and papilledema, with cases addressing a large number of clinical problems. Practical clinical and management issues will be emphasized. This course is designed to enhance interaction between participants and faculty. This program complements C160: Neuro-ophthalmology II: Optic Neuritis, Visual Fields, and Anisocoria and C175: Neuroophthalmology III: Diplopia, Ocular Motility Disorders, and Nystagmus, but covers independent topics. Upon Completion: Participants should become familiar with the diagnosis, evaluation, and treatment of common afferent neuro-ophthalmic problems. Lecture/Faculty: }} Case 1 Valerie Biousse, MD, Atlanta, GA }} Visual Loss Nancy J. Newman, MD, FAAN, Atlanta, GA }} Case 2 Valerie Biousse, MD, Atlanta, GA }} Optic Neuropathies Nancy J. Newman, MD, FAAN, Atlanta, GA }} Case 3 Valerie Biousse, MD, Atlanta, GA }} Papilledema Valerie Biousse, MD, Atlanta, GA }} Case 4 Valerie Biousse, MD, Atlanta, GA }} Case 5 Nancy J. Newman, MD, FAAN, Atlanta, GA Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement, Professionalism, Systems-Based Practice Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist Fast and easy registration · AAN.com/view/AM17 111

Neuro-ophthalmology

}} Saccadic Intrusions Janet C. Rucker, MD, New York, NY }} Self-test and Cases Steven Galetta, MD, FAAN, New York, NY Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist

Course Descriptions Wednesday, April 26, 2017

1:00 p.m.–3:00 p.m.

C160 Neuro-ophthalmology II:

Optic Neuritis, Visual Fields, and Anisocoria

Topic: Neuro-ophthalmology/Neuro-otology Director: Nancy J. Newman, MD, FAAN, Atlanta, GA Program Description: This is part II of a three-part comprehensive review of clinical neuro-ophthalmology designed to be a stand-alone course; however, attendees are strongly encouraged to attend all three parts. Numerous case presentations will be followed by related short reviews. Topics specifically addressed in part II include assorted important neuro-ophthalmic topics such as optic neuritis, visual field defects, anisocoria and third nerve palsy, with cases addressing a large number of clinical problems. Practical clinical and management issues will be emphasized. This course is designed to enhance interaction between participants and faculty. This program complements C151: Neuro-ophthalmology I:Visual Loss, Optic Neuropathies, and Papilledema and C175: Neuroophthalmology III: Diplopia, Ocular Motility Disorders, and Nystagmus, but covers independent topics. Upon Completion: Participants should become familiar with the diagnosis, evaluation, and treatment of common afferent and efferent neuro-ophthalmic problems. Lecture/Faculty: }} Case 1 Nancy J. Newman, MD, FAAN, Atlanta, GA }} Management of Optic Neuritis Steven Galetta, MD, FAAN, New York, NY }} Case 2 Nancy J. Newman, MD, FAAN, Atlanta, GA }} Visual Fields Nancy J. Newman, MD, FAAN, Atlanta, GA }} Case 3 and Discussion Valerie Biousse, MD, Atlanta, GA }} Case 4 Valerie Biousse, MD, Atlanta, GA }} Anisocoria Steven Galetta, MD, FAAN, New York, NY }} Case 5 Valerie Biousse, MD, Atlanta, GA }} Case 6 Nancy J. Newman, MD, FAAN, Atlanta, GA Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement, Professionalism, Systems-Based Practice Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist 112 2017 AAN Annual Meeting Early Look

Neuro-ophthalmology/Neuro-otology Wednesday, April 26, 2017

3:30 p.m.–5:30 p.m.

C175 Neuro-ophthalmology III:

Diplopia, Ocular Motility Disorders, and Nystagmus

Topic: Neuro-ophthalmology/Neuro-otology Director: Nancy J. Newman, MD, FAAN, Atlanta, GA Program Description: This is part III of a three-part comprehensive review of clinical neuroophthalmology. This course is designed to be a stand-alone course; however, attendees are strongly encouraged to attend all three parts. Numerous case presentations will be followed by related short reviews. Topics specifically addressed in part III include diplopia from a wide variety of causes including muscle, neuromuscular junction, and cranial nerve, and internuclear and supranuclear disorders as well as nystagmus, with cases addressing a large number of clinical problems. Practical clinical and management issues will be emphasized. This course is designed to enhance interaction between participants and faculty. This program complements C151: Neuro-ophthalmology I: Visual Loss, Optic Neuropathies, and Papilledema and C160: Neuroophthalmology II: Optic Neuritis, Visual Fields, and Anisocoria, but covers independent topics. Upon Completion: Participants should become familiar with the diagnosis, evaluation, and treatment of common efferent neuro-ophthalmic problems. Lecture/Faculty: }} Case 1 Valerie Biousse, MD, Atlanta, GA }} Those Other Causes of Diplopia Nancy J. Newman, MD, FAAN, Atlanta, GA }} Case 2 Valerie Biousse, MD, Atlanta, GA }} Supranuclear and Internuclear Ocular Motility Disorders Steven Galetta, MD, FAAN, New York, NY }} Case 3 Valerie Biousse, MD, Atlanta, GA }} Nystagmus Steven Galetta, MD, FAAN, New York, NY }} Case 4 Nancy J. Newman, MD, FAAN, Atlanta, GA }} Assorted Cases Valerie Biousse, MD, Atlanta, GA Nancy J. Newman, MD, FAAN, Atlanta, GA Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement, Professionalism, Systems-Based Practice Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist

7:00 a.m.–9:00 a.m.

C191 A Case-Based Approach to

Neuro-ophthalmology: What Went Wrong?

Topic: Neuro-ophthalmology/Neuro-otology Director: Nancy J. Newman, MD, FAAN, Atlanta, GA Program Description: Diagnostic error is the leading cause of death in the USA. One of the main causes of diagnostic error is thinking bias and inadequate diagnostic skills. Neuro-ophthalmologic cases are particularly prone to diagnostic and management errors because of its complexity and because many neurologic emergencies present with neuroophthalmologic complaints. In this course, numerous neuroophthalmologic cases involving both the visual afferent and efferent systems will be presented in which something “went wrong” during diagnosis or management. Practical clinical and management issues will be emphasized. This course is designed to enhance interaction between participants and faculty. Upon Completion: Participants should be able to correctly diagnose and manage clinical cases involving both afferent and efferent neuro-ophthalmological symptoms and signs. Lecture/Faculty: }} Case Presentations and Discussion Valerie Biousse, MD, Atlanta, GA Nancy J. Newman, MD, FAAN, Atlanta, GA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist Thursday, April 27, 2017

1:00 p.m.–3:00 p.m.

C202 Higher Cortical Visual Disorders: Case-based Review

Topics: Neuro-ophthalmology/Neuro-otology; Aging, Dementia, Cognitive, and Behavioral Neurology Director: Sashank Prasad, MD, Boston, MA Program Description: This course will review important neurologic disorders of higher visual processing. The diagnosis of these fascinating conditions can be challenging and is often delayed. In these patients, routine evaluations of visual function may not readily yield a diagnosis; it is important to conduct a refined examination of visual functions in order to correctly localize and identify the problem. After reviewing the organization of visual processing networks in the brain, faculty will illustrate specific disorders by using videos that depict patients describing their symptoms followed by focused examinations highlighting their visual processing abnormalities. Topics covered $ = Additional Fee Required L = Leadership University

will include Anton syndrome, apperceptive visual agnosia, hemiachromatopsia, alexia without agraphia, Riddoch syndrome, Balint syndrome, prosopagnosia, Charles Bonnet syndrome, and Lhermitte“s peduncular hallucinosis. Discussion of each syndrome, its localization, and recent scientific insights from modern investigations of these disorders will follow each case. Upon Completion: Participants should be able to gain familiarity with the diagnosis, localization, management, and neuroscientific understanding of disorders of visual processing. Lecture/Faculty: }} Introduction to Cortical Visual Disorders Sashank Prasad, MD, Boston, MA }} Anton Syndrome Faculty }} Visual Agnosia Faculty }} Hemi-achromatopsia Faculty }} Alexia Without Agraphia Faculty }} Riddoch Syndrome Faculty }} Balint Syndrome Faculty }} Prosopagnosia Faculty }} Charles Bonnet syndrome Faculty }} Lhermitte’s Peduncular Hallucinosis Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Psychologist, Neuropsychologist, Psychiatrist, Advanced Practice Provider Thursday, April 27, 2017

3:30 p.m.–5:30 p.m.

C215 Canalith Repositioning for Benign Paroxysmal Positional Vertigo

Topic: Neuro-ophthalmology/Neuro-otology Director: Terry D. Fife, MD, FAAN, Phoenix, AZ Program Description: Benign paroxysmal positional vertigo (BPPV) is the most common cause of vertigo. Canalith repositioning procedure is an established effective treatment for BPPV. Faculty will review the mechanisms that underlie the symptoms and the nystagmus of BPPV, how to examine for positional nystagmus and determine from that which ear and which semicircular canal is affected by BPPV, and demonstrate and provide videos of treatment of BPPV with canalith repositioning for Fast and easy registration · AAN.com/view/AM17 113

Neuro-ophthalmology

Thursday, April 27, 2017

Course Descriptions `each of the common forms of BPPV. Successful treatment of BPPV is both cost-effective and rewarding to the patient and clinician. The over-arching goal of this program is to make practicing neurologists comfortable with successfully performing the canalith repositioning procedure in the office or hospital setting. Upon Completion: Participants should be familiar with the causes and clinical features of BPPV including the features of the characteristic positional nystagmus of BPPV and how to lateralize to the affected ear and semicircular canal and be comfortable treating the common form of BPPV (posterior canal) using canalith repositioning and be familiar with the treatment for the less common variants of BPPV. Lecture/Faculty: }} Incidence, History, and Differential Diagnosis of BPPV Kristen K. Steenerson, MD, Scottsdale, AZ }} Mechanisms of BPPV Kamala Saha, MD, Phoenix, AZ }} Examination Manuevers and Nystagmus of BPPV Terry D. Fife, MD, FAAN, Phoenix, AZ Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic, Demonstrations CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist Friday, April 28, 2017

7:00 a.m.–9:00 a.m.

C230 Eye Movement Disorders:

A Systematic Approach to the Evaluation of Diplopia

Topic: Neuro-ophthalmology/Neuro-otology Director: Janet C. Rucker, MD, New York, NY Program Description: Correct localization is the primary objective in the evaluation of diplopia. Faculty will present a systematic approach to localizing diplopia, including basic and advanced concepts and diagnostically challenging cases. Interactive video-based case examples presented as unknowns will facilitate audience discussion and immediate application of new skills to diagnose diplopia localizing to extraocular muscle, neuromuscular junction, cranial nerve, nuclear, and supranuclear locations. Topic discussions will include pearls, pitfalls, and pathognomonic signs in localization. Upon Completion: Participants should be able to localize diplopia via utilization of basic and advanced examination skills and to recognize the wide-range of clinical diagnoses of patients with diplopia via participation in evaluating diagnostically challenging case presentations. Lecture/Faculty: }} Exam Skills Marc Dinkin, MD, New York, NY 114 2017 AAN Annual Meeting Early Look

Neuro-ophthalmology/Neuro-otology }} Supranuclear Causes of Diplopia Janet C. Rucker, MD, New York, NY }} Cranial Nerve Dysfunction Marc Dinkin, MD, New York, NY }} Neuromuscular Junction Janet C. Rucker, MD, New York, NY }} Orbital Causes of Diplopia Marc Dinkin, MD, New York, NY }} Cases Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist Friday, April 28, 2017

3:30 p.m.–5:30 p.m.

C245 Now You See It, Now You Know It—

Pathognomonic Neuro-ophthalmology Findings

Topic: Neuro-ophthalmology/Neuro-otology Director: Wayne T. Cornblath, MD, FAAN, Ann Arbor, MI Program Description: This program consists of images and videos of pathognomonic neuroophthalmology examination features (i.e., opsoclonus, blepharospasm, Kayser-Fleischer rings) that are presented as an unknown with the audience using the audience response system to choose the correct diagnosis. This is followed by one or two slides of additional information and other examples of the condition. The format is designed to show the pathognomonic feature of a large number of different diseases so participants can quickly and accurately make the correct diagnosis. Upon Completion: Participants should be able to recognize neuro-ophthalmology findings that are encountered in general neurology practice and quickly arrive at the correct diagnosis. Lecture/Faculty: }} Now You See It, Now You Know It—Pathognomonic Neuroophthalmology Findings Wayne T. Cornblath, MD, FAAN, Ann Arbor, MI Eric R. Eggenberger, DO, FAAN, East Lansing, MI Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider

NEURO-REHABILITATION

Monday, April 24, 2017

Topics: Neuro-rehabilitation; Pain and Palliative Care

Common Spine Disorders I: Evaluation

Topics: Neuro-rehabilitation; Pain and Palliative Care Director: J. D. Bartleson, MD, FAAN, Rochester, MN Program Description: Neurologists should play a primary role in evaluating patients with spine and/or limb pain because of our ability to detect the presence of spinal cord, spinal nerve, and cauda equina injury. Many neurologists are uncomfortable evaluating patients with spine and limb pain and interpreting spine imaging studies because of a lack of training and a paucity of instructional courses at neurology meetings. Faculty will describe important aspects of the history and neurological and musculoskeletal examination of patients with common spine disorders and cover the use of neurophysiologic testing in the diagnosis of spine and limb pain. Spine MRI is the most important diagnostic study in the evaluation of patients with spine disorders. An experienced spine radiologist will instruct attendees when to obtain and how to interpret spine MRI, emphasizing correlation of imaging findings with the patient’s clinical presentation. This course will focus on common spine disorders, mostly due to spondylosis. This program complements C95: Common Spine Disorders II: Treatment, but covers independent topics. Upon Completion: Participants will be better able to diagnose common spine disorders using clinical skills. Participants will also learn when to obtain and how to interpret spine MRI. Lecture/Faculty: }} The History and Neurological Examination of Spine Disorders Ligia Viorela Onofrei, MD, Salt Lake City, UT }} Spine Neuroimaging Timothy Maus, MD, Rochester, MN Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

Common Spine Disorders II: Treatment

Director: J. D. Bartleson, MD, FAAN, Rochester, MN Program Description: The natural history of most common acute spine disorders is one of improvement. Treatment for common acute and chronic spine disorders is available and effective. Treatment of the patient with spine and limb pain can be gratifying. However, many treatment modalities, including surgery, are used prematurely and excessively. Faculty will describe the treatments that are appropriate for acute and chronic axial spine pain, radiculopathy, spondylotic myelopathy, and cauda equina syndrome. Injections for diagnostic and especially therapeutic purposes are commonly utilized in the care of patients with spine disorders. An experienced interventional radiologist will describe the common needle procedures that are used to help diagnose and treat patients with spine and limb pain, including facet blocks, epidural injections, and discography. This program complements C81: Common Spine Disorders I: Evaluation, but covers independent topics. Upon Completion: Participants will be able to treat patients with common spine disorders. This includes use of medications, physical treatments, and surgery in some patients. Participants will also learn when to refer patients with spine and/or limb pain for epidural injections, facet blocks, and discography and the risks and benefits of these procedures. Lecture/Faculty: }} Treatment of Common Spine Disorders J. D. Bartleson, MD, FAAN, Rochester, MN }} Interventional Spine Procedures Timothy Maus, MD, Rochester, MN Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Tuesday, April 25, 2017

1:00 p.m.–3:00 p.m.

C123 Myelopathies I:

Inflammatory and Vascular Etiologies

Fast and easy registration · AAN.com/view/AM17 115

Neuro-ophthalmology

C81

1:00 p.m.–3:00 p.m.

C95

3:30 p.m.–5:30 p.m.

Course Descriptions treatment. Rapid scientific advances have enhanced and broadened our understanding of a wide spectrum of these disorders. This course will cover recognition, classification, diagnostic investigation, and management of myelopathies. Faculty will discuss vascular myelopathies, inflammatory and immune-mediated myelopathies, metabolic and toxic myelopathies, and the diagnostic approach to these syndromes. Case-based learning points will be used and will focus on practical clinical information and a comprehensive update on recent developments. This program complements C138: Myelopathies II: Symptom Management and Rehabilitation, but cover independent topics. Upon Completion: Participants should be able to recognize the wide spectrum of myelopathies and develop a practical and systematic approach toward the investigation and management of these disorders; and be aware of the recent advances related to spinal dural arteriovenous fistulas, neuromyelitis optica, multiple sclerosis and other autoimmune disorders, copper deficiency, and other metabolic and toxic disorders. Lecture/Faculty: }} Transverse Myelitis Benjamin M. Greenberg, MD, FAAN, Dallas, TX }} Vascular Myelopathies Philippe Gailloud, MD, Baltimore, MD }} Hereditary Myelopathies Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Tuesday, April 25, 2017

3:30 p.m.–5:30 p.m.

C138 Myelopathies II:

Symptom Management and Rehabilitation

Topic: Neuro-rehabilitation Director: Benjamin M. Greenberg, MD, FAAN, Dallas, TX Program Description: Spinal cord disorders are frequently encountered by both general and subspecialty neurologists. They are potentially devastating, but treatable, conditions that require prompt recognition, testing, and treatment. Rapid scientific advances have enhanced and broadened our understanding of a wide spectrum of these disorders. This course will cover recognition, classification, diagnostic investigation, and management of myelopathies. Case-based learning points will be used and will focus on practical clinical information and a comprehensive update on recent developments. This program complements C123: Myelopathies I: Inflammatory and Vascular Etiologies, but covers independent topics.

116 2017 AAN Annual Meeting Early Look

Neuro-rehabilitation Upon Completion: Participants should be familiar with the wide spectrum of myelopathies and develop a practical and systematic approach toward the investigation and management of these disorders. Symptom management, including approaches to gait evaluation, and rehabilitation will be explored. Lecture/Faculty: }} Evaluation and Management of Gait Disorders Karen McCain, DPT, Dallas, TX }} Evaluation and Management of Neurogenic Bladder Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Wednesday, April 26, 2017

7:00 a.m.–9:00 a.m.

C156 Rehabilitation in Neurology Topic: Neuro-rehabilitation Director: Karunesh Ganguly, MD, PhD, San Francisco, CA Program Description: Neurologic rehabilitation is a dynamic process through which patients optimize physical, cognitive, and social functions. It is a patientcentered, multidisciplinary endeavor involving neurologists and a wide range of providers. The ultimate objectives are to renew or maintain independence, participation, and quality of life despite the impairments. Over the past two decades, growing evidence supports specific approaches to neurologic rehabilitation. Rehabilitation is also the translation of basic and clinical neuroscience research to maximize mechanisms of neural reorganization and compensation. Faculty will use the examples of post-stroke care, as well as the care of patients with TBI, to highlight the role of neurologists in rehabilitation, as well as highlight future directions and emerging technologies that promise to revolutionize neurologic rehabilitation. Upon Completion: Participants should be able to develop a greater understanding of the multidisciplinary care of patients with disability from neurologic diseases, as well as develop understanding of the current research for improving care. Lecture/Faculty: }} Mild-moderate TBI: Clinical Recommendations to Optimize Neurobehavioral Function Faculty }} Stroke Rehabilitation Update Gary M. Abrams, MD, FAAN, San Francisco, CA }} Neurotechnology for Rehabilitation Karunesh Ganguly, MD, PhD, San Francisco, CA

Wednesday, April 26, 2017

7:00 a.m.–9:00 a.m.

C157 Lumbar Radiculopathy, Lumbar Spinal

Stenosis, Low Back Pain, and Failed Back Syndrome

Topics: Pain and Palliative Care; Neuro-rehabilitation Director: Ligia Viorela Onofrei, MD, Salt Lake City, UT See complete course description on page 119 » Thursday, April 27, 2017

1:00 p.m.–3:00 p.m.

C207 Severe TBI: From ICU to Rehabilitation Topics: Neuro-rehabilitation; Aging, Dementia, Cognitive, and Behavioral Neurology; Neuro Trauma, Critical Care, and Sports Neurology Director: Holly E. Hinson, MD, MCR, Portland, OR Program Description: Traumatic brain injury (TBI) is one of the most common, disabling neurologic disorders; one to two percent of the US population lives with disability from TBI. Severe TBI presents a number of difficult clinical and research challenges in diagnosis and treatment, including early diagnosis and management to limit secondary injury and prognosis. This course will focus on severe TBI from acute treatment in the ICU to rehabilitation of severe brain injury. Faculty will discuss the mechanisms of brain damage after TBI, with emphasis on secondary brain injury, as well as best practices for acute management; prognostication after severe TBI; present the latest structural and functional neuroimaging methods including diffusion tensor imaging; describe emerging research in biomarkers with an emphasis on neuroinflammation; and address current controversies of diagnosis and treatment. Upon Completion: Participants should be familiar with the variety of mechanisms and pathophysiologic events associated with TBI and how to minimize secondary brain injury with up-to-date acute management procedures emphasizing relevant guidelines; and be comfortable using scoring systems and imaging techniques to aid in prognostication after severe TBI. Lecture/Faculty: }} Managing Severe TBI in the ICU Holly E. Hinson, MD, MCR, Portland, OR }} Imaging in Severe TBI Brian Edlow, MD, Boston, MA $ = Additional Fee Required L = Leadership University

}} Pharmacological and Rehabilitative Approaches to Neurological Sequelae of TBI David L. Brody, MD, PhD, Saint Louis, MO Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Friday, April 28, 2017

1:00 p.m.–3:00 p.m.

C235 Neck Pain, Cervical Spinal Stenosis,

Cervical Radiculopathy, and Cervical Spondylotic Myelopathy

Topics: Neuro-rehabilitation; Pain and Palliative Care Director: John W. Engstrom, MD, FAAN, San Francisco, CA Program Description: Neck pain is a very common reason outpatients seek the opinion of a neurologist. This program is designed to improve the competence of neurology care providers in the management of common cervical spine disorders, skills not commonly taught in depth to neurology residents during training. Presenters will use a combination of case presentations and didactic teaching to engage the audience. Upon Completion: Participants should be able to use with facility “red flags” to identify patients at risk for a serious cause of neck pain, know how to follow the course of nerve roots on spine imaging to understand the common causes of radiculopathy, know how to assess cervical spinal stenosis for clinical relevance to the patient’s symptoms, and be able to develop a rational plan for conservative or surgical care of cervical spondylotic myelopathy-including recognition of possible mimics of cervical myelopathy. Lecture/Faculty: }} Initial Evaluation and Managment of Neck Pain Jeffrey Ralph, MD, San Francisco, CA }} Cervical Spinal Stenosis John W. Engstrom, MD, FAAN, San Francisco, CA }} Cervical Radiculopathy Jeffrey Ralph, MD, San Francisco, CA }} Cervical Spondylotic Myelopathy John W. Engstrom, MD, FAAN, San Francisco, CA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

Fast and easy registration · AAN.com/view/AM17 117

Neuro-rehabilitation

Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

Course Descriptions PAIN AND PALLIATIVE CARE Saturday, April 22, 2017

C15

1:00 p.m.–3:00 p.m.

Practical Training in Injection Techniques in the Treatment of Headache Disorders Skills Workshop $ (registration required)

Topics: Headache; Pain and Palliative Care Director: Morris Levin, MD, FAAN, San Francisco, CA See complete course description on page 68 » Monday, April 24, 2017

C81

1:00 p.m.–3:00 p.m.

Common Spine Disorders I: Evaluation

Topics: Neuro-rehabilitation; Pain and Palliative Care Director: J. D. Bartleson, MD, FAAN, Rochester, MN See complete course description on page 115 » Monday, April 24, 2017

C95

3:30 p.m.–5:30 p.m.

Common Spine Disorders II: Treatment

Topics: Neuro-rehabilitation; Pain and Palliative Care Director: J. D. Bartleson, MD, FAAN, Rochester, MN See complete course description on page 115 » Tuesday, April 25, 2017

7:00 a.m.–9:00 a.m.

C117 The Palliative Care Guide in Neurology:

Best Practice Guidelines in Communication, Symptom Management, and End of Life Care of Patients with Brain Tumors and Other Life Limiting Neurological Disorders

Topics: Neuro-oncology; Pain and Palliative Care Director: Tobias Walbert, MD, PhD, Detroit, MI See complete course description on page 107 »

118 2017 AAN Annual Meeting Early Look

Pain and Palliative Care Tuesday, April 25, 2017

3:30 p.m.–5:30 p.m.

C143 Non-Neuro-oncology: Case-based Palliative Care Throughout the Continuum of Disease

Topics: Pain and Palliative Care; Practice, Policy, and Ethics Director: Maisha T. Robinson, MD, MS, Jacksonville, FL Program Description: Palliative care is important in neurologic practice as the trajectory of many neurologic illnesses is progressive and incurable. Recent national platforms have underscored the need for physicians to be knowledgeable about and competent in basic palliative care. Through the use of personal anecdotes, case presentations, and examples in the literature, faculty will provide strategies to effectively incorporate palliative care into routine neurologic practice from the time of diagnosis throughout the disease course. Upon Completion: Participants should be able to incorporate basic palliative care principles into their practice, understand when to consult specialty palliative care, and recognize when patients may need to be transitioned to hospice care. Lecture/Faculty: }} Introducing the Idea of Palliative Care from the Time of Diagnosis Maisha T. Robinson, MD, MS, Jacksonville, FL }} Putting Palliative Care into Practice: Symptom Assessment and Management from Day One Alan C. Carver, MD, New York, NY }} Discussing Prognosis at the Time of Diagnosis Janis Miyasaki, MD, FAAN, Edmonton, AB, Canada }} Using Cases to Put it in to Practice Alan C. Carver, MD, New York, NY Janis Miyasaki, MD, FAAN, Edmonton, AB, Canada Maisha T. Robinson, MD, MS, Jacksonville, FL Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

7:00 a.m.–9:00 a.m.

C157 Lumbar Radiculopathy, Lumbar Spinal Stenosis, Low Back Pain, and Failed Back Syndrome

Topics: Pain and Palliative Care; Neuro-rehabilitation Director: Ligia Viorela Onofrei, MD, Salt Lake City, UT Program Description: Spine conditions are exceedingly common. Neurologists are frequently asked to evaluate and treat patients with low back and lower limb pain that could be due to radiculopathy or cauda equina compression. Faculty will address the indications and timing for obtaining imaging and further diagnostic tests, discuss the treatments available and the evidence behind them, and discuss surgical options and indications for and against surgery. For many spine conditions, the evidence base for evaluating and treating patients is weak at best. Thus, in many situations, there is no one right answer for how to care for the patient with a spine disorder. This interactive program will use the audience response system to present cases that attendees will be asked to evaluate and treat. In addition, we will discuss the role of opioid analgesics in the treatment of acute and chronic pain. Upon Completion: Participants will be familiar with evidenced-based recommendations for diagnostic testing and treatment of common lumbar spine disorders, including when to obtain advanced imaging, when and what kind of spine injections to order, the appropriate use of opioid analgesics for acute and chronic low back and radicular lower limb pain, and when to recommend lumbar spine surgery. Lecture/Faculty: }} Case Presentations and Case Discussion Ligia Viorela Onofrei, MD, Salt Lake City, UT }} Opioid Analgesic Therapy vs Alternatives for Acute and Chronic Low Back and Radicular Lower Limb Pain Gary M. Franklin, MD, MPH, FAAN, Seattle, WA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Individuals With Low Back Pain, Advanced Practice Provider

$ = Additional Fee Required L = Leadership University

Wednesday, April 26, 2017

1:00 p.m.–3:00 p.m.

C169 Core Concepts in Pain Management I: Refractory Neuropathic Pain— Practical Pharmacologics, Advances in Neuromodulation, and a Balanced Look at Cannabinoids

Topic: Pain and Palliative Care Director: James C. Watson, MD, Rochester, MN Program Description: Neuropathic pain is challenging to treat and frustrating to caregivers and patients when first-line agents are insufficient. This program is structured to be clinically relevant to non-pain specialists, with multidisciplinary faculty focusing on the treatment of refractory neuropathic pain. Topics will include the role of non-first-line neuropathic pain adjuvants, NMDA antagonists, topicals, opioids, and cognitive behavioral treatments. Faculty will discuss the evolving role of neuromodulation for refractory neuropathic pain with new technologies and target sites. Because the accessibility of medical cannabinoids continues to grow, faculty will also discuss the facts and fiction behind cannabinoids in the treatment of neuropathic pain. This program complements C184: Core Concepts in Pain Management II: Safe Opioid Prescribing—Practical Considerations, Unintended Consequences, and Legal Issues, but covers independent topics. Upon Completion: Participants should be familiar with multimodal treatment options for the treatment of refractory neuropathic pain and in what situations their use may be appropriate. Lecture/Faculty: }} Refractory Neuropathic Pain—Mitigating First-line Treatment Failures and Implementing Multimodal Treatments James C. Watson, MD, Rochester, MN }} Neuromodulation—Evolving Technologies, Targets, and Uses Jason Eldrige, MD, Rochester, MN }} Cannabinoids: Fact or Fiction—A Balanced Look at Cannabinoid Usage for Neuropathic Pain Jacob Strand, MD, Rochester, MN Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic, Multidisciplinary CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

Fast and easy registration · AAN.com/view/AM17 119

Pain

Wednesday, April 26, 2017

Course Descriptions Wednesday, April 26, 2017

3:30 p.m.–5:30 p.m.

Pain and Palliative Care Friday, April 28, 2017

1:00 p.m.–3:00 p.m.

C184 Core Concepts in Pain Management

C235 Neck Pain, Cervical Spinal Stenosis,

Topic: Pain and Palliative Care

Topics: Neuro-rehabilitation; Pain and Palliative Care

II: Safe Opioid Prescribing—Practical Considerations, Unintended Consequences, and Legal Issues

Director: James C. Watson, MD, Rochester, MN Program Description: Chronic opioid therapy (COT) is becoming increasingly common in the treatment of chronic non-cancer pain. In neurology practice it is most often used in the treatment of chronic peripheral or central neuropathic pain, musculoskeletal pain in patients with limited mobility from neurologic deficits, headache, or restless legs syndrome. This session will address safe opioid prescribing and monitoring. It will include discussion on patient selection, risk factors for chronic opioid therapy as well as for aberrant use, misuse, abuse, or diversion. Opioid selection and side effects will be covered including emerging evidence of unintended metabolic consequences of chronic opioid therapy such as hypogonadism and osteoporosis. Opioid induced hyperalgesia and its clinical implications will be discussed. The session will conclude with a discussion of legal implications of opioid prescribing by a physician defense attorney. This program complements C169: Core Concepts in Pain Management I: Refractory Neuropathic Pain—Practical Pharmacologics, Advances in Neuromodulation, and a Balanced Look at Cannabinoids, but covers independent topics. Upon Completion: Participants should be able to understand the role of opioids in the treatment of refractory neuropathic pain, opioid selection, risks, monitoring, and legal issues involved in their usage. Lecture/Faculty: }} Opioids: Pharmacology, Indications, Patient Selection, and Appropriate Use Jason Eldrige, MD, Rochester, MN }} Mitigating Unintended Opioid Consequences—Safe Prescribing, Adverse Effects (Including HypothalamicPituitary-Gonadal/Adrenal, Bone, and OIH), and Monitoring James C. Watson, MD, Rochester, MN }} Legal Issues in Opioid Prescribing Joanne Martin, JD, Rochester, MN Core Competency: Medical Knowledge Teaching Style: Didactic, Multidisciplinary CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

120 2017 AAN Annual Meeting Early Look

Cervical Radiculopathy, and Cervical Spondylotic Myelopathy

Director: John W. Engstrom, MD, FAAN, San Francisco, CA See complete course description on page 117 »

PRACTICE, POLICY, AND ETHICS Saturday, April 22, 2017

C10

10:30 a.m.–12:30 p.m.

Making Sure You Get Paid Under the New Health Care Laws

Topic: Practice, Policy, and Ethics Director: Gregory J. Esper, MD, MBA, FAAN, Atlanta, GA Program Description: Health care legislative and regulatory changes are occurring at an astounding rate, and this threatens the viability of practice for private practice and academic neurologists. We aim to describe these changes and to help neurologists respond to them in pragmatic and effective ways that will help to ensure practice viability for as long as possible. Upon Completion: Participants should become familiar with the legislative and regulatory changes that have been made, understand the possible effect on their clinical practices, and use pragmatic tools the AAN is developing to respond appropriately. Lecture/Faculty: }} MACRA Overview and AAN Response Gregory J. Esper, MD, MBA, FAAN, Atlanta, GA }} Strategies for MACRA: Documentation and Population Management Eric M. Cheng, MD, MS, FAAN, Los Angeles, CA }} Using Axon Registry for Quality Reporting Lyell K. Jones, MD, FAAN, Rochester, MN Core Competency: Practice-Based Learning and Improvement Teaching Style: Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Practice Administrator, Advanced Practice Provider

C17

2:00 p.m.–4:00 p.m.

How Is Your Patient Really Doing? Patient Reported Scales, Tools and Shared Decision Making

Topic: Practice, Policy, and Ethics Director: Anant Shenoy, MD, Springfield, MA Program Description: There is growing interest in using patient reported outcomes to improve patient care and to drive practice improvement for neurologists. This course will discuss the strengths and limitations of various patient scales and tools including PROMIS, Neuro QOL, and the NIH Tool Box. Participants will learn why it is important for neurologists to use these tools, and faculty will explore strategies to integrate these tools into everyday practice. Shared decision-making will also be reviewed. Upon Completion: Participants should be able to understand the strengths and limitations of various patient scales and tools including PROMIS, Neuro QOL, and NIH Tool Box; understand why it is important for a neurologist to collect this data; and understand strategies to implement these scales in everyday practice. Participants will also understand shared decision-making with patients. Lecture/Faculty: }} How Is Your Patient Really Doing? Patient Reported Scales and Tools Lisa M. Shulman, MD, FAAN, Baltimore, MD }} Shared Decision-making Tools Anna D. Hohler, MD, FAAN, Boston, MA }} Presentation of Quality and Safety Award Anant Shenoy, MD, Springfield, MA Core Competency: Patient Care Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Other Care Team Members, Advanced Practice Provider Sunday, April 23, 2017

C31

7:00 a.m.–9:00 a.m.

Advanced Neurologic Coding

Topics: Practice, Policy, and Ethics; General Neurology Director: Peter D. Donofrio, MD, FAAN, Nashville, TN Program Description: This program will cover the topics of advanced E&M coding (billing for time, counseling and coordination of care, transitional care, and chronic care management), advanced coding for electrophysiologic testing, and coding for infusions.

$ = Additional Fee Required L = Leadership University

Upon Completion: Participants should be able to bill for codes not commonly used to bill for outpatient and inpatient visits; gain a better understanding of electrophysiologic codes and how and when to use them; and understand the proper way to bill for infusions and/or oversee those in their clinical setting who perform infusions. Lecture/Faculty: }} Advanced Evaluation and Management (E&M) Coding Peter D. Donofrio, MD, FAAN, Nashville, TN }} Advanced Coding for Neurophysiologic Testing Neil A. Busis, MD, FAAN, Pittsburgh, PA }} Coding for Infusions Christine Mann, Hamburg, NY Core Competencies: Medical Knowledge, Patient Care, SystemsBased Practice Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Sunday, April 23, 2017

C45

1:00 p.m.–3:00 p.m.

Navigating the World of Mobile Health

Topic: Practice, Policy, and Ethics Director: Eric Anderson, MD, PhD, Gulfport, FL Program Description: Have you ever heard the terms “mobile health (mHealth),“ “digital health,“ or “wearables“? Have you ever had a patient who wanted you to review the data they collected on their smartphone or other device? Have you ever recommended an medical app to a patient? Faculty will take you on a visual journey through the evolving landscape of mobile health. This guided interactive discussion will highlight what you need to know about how medical apps are being increasingly used by both patients and physicians and how these can be incorporated into current practice. Several demos of relevant medical apps will be performed. Other concerns including the amount of evidence that exists for the use of medical apps, HIPAA, and security issues will also be discussed. Lecture/Faculty: }} Navigating the World of Mobile Health Eric Anderson, MD, PhD, Gulfport, FL Core Competencies: Patient Care, Practice-Based Learning and Improvement, Systems-Based Practice Teaching Style: Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist

Fast and easy registration · AAN.com/view/AM17 121

Pain

Saturday, April 22, 2017

Course Descriptions Sunday, April 23, 2017

C48

1:00 p.m.–5:00 p.m.

L Leadership Challenges in Practice

Topics: Leadership; Practice, Policy, and Ethics Director: James C. Stevens, MD, FAAN, Fort Wayne, IN See complete course description on page 77 » Monday, April 24, 2017

C64

7:00 a.m.–9:00 a.m.

ICD-10-CM: How to Optimize for Accurate Diagnosis and Reimbursement

Topic: Practice, Policy, and Ethics Director: Jeffrey R. Buchhalter, MD, FAAN, Calgary, AB, Canada Program Description: On October 1, 2015, the ICD-10-CM code set became required for all transactions involving reimbursement from the Center for Medicare and Medicaid Services, as well as for other third-party payers. A one-year grace period was granted that allowed full reimbursement for using the correct code family without full specificity. Presenters will use a case-based approach focusing on practical aspects of ICD-10 including optimizing coding specificity for common neurologic disorders (e.g. stroke, epilepsy, headache), how codes relate to valuebased reimbursement and MACRA, and how more accurate coding results in fewer denials. Upon Completion: Participants should be able to code common neurologic disorders to the highest degree of specificity to reflect the severity of illness, know the codes for several of the most commonly encountered disorders seen by neurologists, understand how coding plays an essential role in value-based reimbursement, and avoid and respond to denials for services rendered. Lecture/Faculty: }} ICD-10-CM Basics: Value-based Purchasing and Case Presentations Jeffrey R. Buchhalter, MD, FAAN, Calgary, AB, Canada }} Optimal ICD-10 Coding of Common Neurological Disorders Korwyn Williams, MD, PhD, Phoenix, AZ }} How to Avoid and Respond to Denials David A. Evans, MBA, Dallas, TX Core Competencies: Medical Knowledge, Practice-Based Learning and Improvement Teaching Style: Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Practice Manager, Billing Specialist, Nurse Practitioner, Advanced Practice Provider

122 2017 AAN Annual Meeting Early Look

Practice, Policy, and Ethics Monday, April 24, 2017

C87

1:00 p.m.–3:00 p.m.

How to Run a Practice: Business Strategies for Neurology Private Practices, Academic Centers, and the Future

Topic: Practice, Policy, and Ethics Director: Brad C. Klein, MD, MBA, FAAN, Willow Grove, PA Program Description: Neurology practices struggle for survival due to higher overhead and shrinking reimbursements for cognitive specialists. Higher malpractice premiums and office expenses, lower payments per patient, the rising cost of compliance with government regulations, and time-consuming insurance documentation requirements are the trend. Overlooking the true cost of services and procedures can result in financial drains to neurologic practice and unexpected losses. Faculty will give an overview of basic financial tools and how to apply sound business strategies to neurology practice issues. Faculty will cover the critical processes necessary to quantitatively evaluate a practice’s income and expenses, particularly in-depth analysis of revenue cycle and practice efficiencies. Faculty will also cover the steps involved in determination if expansion of services and/or providers will result in sustainable financial growth, avoidance of internal fraud, and strategic planning for future financial models, such as accountable care organizations. Upon Completion: Participants should be able to understand practice revenues, expenses, and cash flow; identify revenue cycle problems; establish and use key performance indicators for their practices; enhance work flow to maintain fiscal health; use benchmarking to enhance their practice; know and address basic legal issues in setting up and running a practice; understand how to choose and use technology at point of care; evaluate the economics of outsourcing versus providing in-house services; use financial analysis to determine if technology and other capital investments will provide a return on investment; know how to determine which payers are creating an administrative drain on their practices; identify possible fraud internally within the practice; and understand how to evaluate and implement new financial reimbursement and risk-sharing management models such as accountable care organizations. Lecture/Faculty: }} Understanding Your Revenues, Expenses, and Benchmarks to Increase Your Income Gregory J. Esper, MD, MBA, FAAN, Atlanta, GA }} Revenue Cycle Management: How to Make Money in Your Practice and Be a Doctor Brad C. Klein, MD, MBA, FAAN, Willow Grove, PA Core Competencies: Interpersonal and Communication Skills, Patient Care, Practice-Based Learning and Improvement Teaching Style: Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Administrator

3:30 p.m.–5:30 p.m.

C102 Business Strategies for Payer Negotiations and/or How to Go off the Grid

Topic: Practice, Policy, and Ethics Director: Brad C. Klein, MD, MBA, FAAN, Willow Grove, PA Program Description: Neurologists struggle to spend the necessary amount of time to provide high quality care for patients. Despite limited data to support neurology quality metrics or appropriate cost saving measures, government and commercial payer intervention in the physicianpatient relationship continues to expand. Efforts to work under ever-increasing demands and requirements may be unsustainable for many neurologists, raising serious questions of viability in maintaining a traditional practice model. Faculty will provide a framework to evaluate and negotiate current payer relationships and, if collaboration is not possible, how to assess and develop alternate practice models that could remove dependency on payers for payments and maintain the physician-patient relationship. Upon Completion: Participants should be able to develop an advanced understanding of their practice’s clinical revenues; develop a comprehensive and critical assessment of the value of each payer; build a sensitivity analysis to project potential financial implications of leaving a payer if needed; understand potential steps in negotiations; and recognize and manage unfavorable payer contract clauses in participation agreements. Participants should also be able to understand specific challenges related to leaving government payers such as Medicare. Lastly, participants should be able to learn additional skillsets to help transition to a cash practice as well as strategies and techniques to grow, maintain, and succeed in caring for patients unencumbered by insurance contracts. Lecture/Faculty: }} Negotiating with Payers Brad C. Klein, MD, MBA, FAAN, Willow Grove, PA }} Transitioning Without Payers—Where to Begin Daryl Story, MD, Norwalk, CT }} Growing a Successful Practice without Payers Faculty Core Competency: Practice-Based Learning and Improvement Teaching Style: Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist

$ = Additional Fee Required L = Leadership University

Tuesday, April 25, 2017

3:30 p.m.–5:30 p.m.

C143 Non-Neuro-oncology:

Case-based Palliative Care Throughout the Continuum of Disease

Topics: Pain and Palliative Care; Practice, Policy, and Ethics Director: Maisha T. Robinson, MD, MS, Jacksonville, FL See complete course description onpage 118 » Tuesday, April 25, 2017

3:30 p.m.–5:30 p.m.

C145 Hot Topics in Neurologic Practice: Managing the Patient Experience in 2017 and Beyond

Topics: Practice, Policy, and Ethics; General Neurology; Research Methodology, Education, and History Director: Richard J. Caselli, MD, FAAN, Scottsdale, AZ Program Description: Patients’ experience of their care matters to all clinicians and increasingly to third-party payers. This program will review regulatory aspects that impact reimbursement, factors which bias patient experience outcomes, provider-specific strategies for improvement, and organizational strategies for managing the patient experience. Upon Completion: Participants should be able to understand the impact of HCAHPS, CGCAHPS, and other regulatory measures on reimbursement; identify complexities of care embedded with a practice mix that may bias patient satisfaction outcomes; learn effective strategies for providerspecific improvement; and acquire a basic approach to managing the patient experience at the organizational level. Lecture/Faculty: }} CAHPS and Related Requirements Jodie Cunningham, South Bend, IN }} Merging Patient Experience Data, Outcomes Research, and Practice Cornelius Thiels, DO, Rochester, MN }} Provider-specific Strategies for Improvement Thomas Howell, MD, Rochester, MN }} Organizational Management of the Patient Experience Richard J. Caselli, MD, FAAN, Scottsdale, AZ Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Didactic, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

Fast and easy registration · AAN.com/view/AM17 123

Practice/Policy/Ethics

Monday, April 24, 2017

Course Descriptions Wednesday, April 26, 2017

1:00 p.m.–3:00 p.m.

C161 Bedside Evidence-based Medicine:

How to Find and Deconstruct Articles in Order to Take Care of Patients I

Topic: Practice, Policy, and Ethics Director: Gary S. Gronseth, MD, FAAN, Kansas City, KS Program Description: Faculty will de-mystify EBM concepts and equip participants with the knowledge and tools needed to translate evidence (a published article, a research presentation) into action (a specific intervention). Rather than relying on traditional didactic presentations, faculty will emphasize small group problem-solving using the peer instruction model. Participants should plan on attending both Part I and Part II and bring a laptop with Microsoft Excel, a USB flash drive, and wireless capability; a tablet, such as an iPad, will not be sufficient. This program complements C176: Bedside Evidence-based Medicine: How to Find and Deconstruct Articles in Order to Take Care of Patients II, but covers independent topics. Upon Completion: Participants will understand the principles of evidence-based medicine and critical review, and how these apply to the bedside practice of neurology; be able to deconstruct published articles addressing therapeutic questions, assess their accuracy and rigor, and make appropriate evidence-based clinical decisions; dramatically reduce their susceptibility to being misled by bias and the misuse of statistical procedures; and feel comfortable developing, investigating, and publishing the findings of their own clinical research questions. Lecture/Faculty: }} Introduction and Developing Evidence-answerable Questions Melissa Armstrong, MD, MSc, FAAN, Gainesville, FL Michael Glantz, MD, FAAN, Hershey, PA Gary S. Gronseth, MD, FAAN, Kansas City, KS Steven R. Messé, MD, FAAN, FAHA, Philadelphia, PA Tamara M. Pringsheim, MD, Calgary, AB, Canada }} Efficiently Finding Evidence Faculty }} Selecting the Best Evidence Faculty Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

124 2017 AAN Annual Meeting Early Look

Practice, Policy, and Ethics Wednesday, April 26, 2017

1:00 p.m.–3:00 p.m.

C165 Clinical Neurology for

Advanced Practice Providers I

Topic: Practice, Policy, and Ethics Director: Jessica Erfan, PA-C, Austin, TX Program Description: The role of advanced practice providers (APP) in the care of neurologic patients is increasingly critical. Through building a foundation of neuroimaging knowledge and reviewing the clinical features and diagnostic work-up of stroke patients, the APP will be able to directly apply this knowledge to the neurologic practice. Clinical cases will be discussed. This program complements C181: Clinical Neurology for Advanced Practice Providers II, but covers independent topics. Upon Completion: Participants should be able to build a basic foundation for using and interpreting neuroimaging, and have clinical knowledge of the diagnosis and evaluation of a stroke patient. Lecture/Faculty: }} Neuroimaging 101 Ryan Hakimi, DO, Greenville, SC }} Strokes: Classification, Intervention, Prevention Jessica Erfan, PA-C, Austin, TX Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Non-Neurologist, Nurse Practitioner, Physician Assistant, Clinical Nurse Specialist, Advanced Practice Provider Wednesday, April 26, 2017

3:30 p.m.–5:30 p.m.

C176 Bedside Evidence-based Medicine:

How to Find and Deconstruct Articles in Order to Take Care of Patients II

Upon Completion: Participants will understand the principles of evidence-based medicine and critical review, and how these apply to the bedside practice of neurology; be able to deconstruct published articles addressing therapeutic questions, assess their accuracy and rigor, and make appropriate evidence-based clinical decisions; dramatically reduce their susceptibility to being misled by bias and the misuse of statistical procedures; and feel comfortable developing, investigating, and publishing the findings of their own clinical research questions. Lecture/Faculty: }} The Risk of Bias Melissa Armstrong, MD, MSc, FAAN, Gainesville, FL Michael Glantz, MD, FAAN, Hershey, PA Gary S. Gronseth, MD, FAAN, Kansas City, KS Steven R. Messé, MD, FAAN, FAHA, Philadelphia, PA Tamara M. Pringsheim, MD, Calgary, AB, Canada }} Interpreting Effects and Evidence Synthesis Faculty }} Making Decisions: More Than Evidence Faculty Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Wednesday, April 26, 2017

3:30 p.m.–5:30 p.m.

C181 Clinical Neurology for

Advanced Practice Providers II

Topic: Practice, Policy, and Ethics Director: Jessica Erfan, PA-C, Austin, TX Program Description: The role of advanced practice providers (APPs) in the care of neurologic patients is increasingly critical. Identifying the red flags of headaches presenting as neurologic emergencies will result in appropriate and timely treatment. Clinical cases will be reviewed in each topic. Through a review of the clinical features and evaluation of multiple sclerosis, the APP will be able to directly apply this knowledge to their neurologic practice. This program complements C165: Clinical Neurology for Advanced Practice Providers I, but covers independent topics. Upon Completion: Participants should identify red flags for patients presenting with headache and become familiar with the differential diagnoses and workup. Participants should become familiar with the evaluation and management of patients with multiple sclerosis. $ = Additional Fee Required L = Leadership University

Lecture/Faculty: }} What Makes a Headache a Neurologic Emergency? Calli Leighann Cook, Atlanta, GA }} An Update in Multiple Sclerosis Bryan D. Walker, PA, Cary, NC Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Non-Neurologist, Nurse Practitioner, Physician Assistant, Clinical Nurse Specialist, Advanced Practice Provider

RESEARCH METHODOLOGY, EDUCATION, AND HISTORY Saturday, April 22, 2017

8:00 a.m.–12:00 p.m.

Resident Basic Science I: Neuroanatomy—All the Lesions

Topic: Research Methodology, Education, and History Director: Zachary N. London, MD, FAAN, Ann Arbor, MI Program Description: This course will present an organized and succinct overview of neuroanatomy. The course will employ a lesion-based approach to functional anatomy of the central and peripheral nervous system, reflecting the importance of neuroanatomic localization as the foundation of clinical neurology. This program complements C16: Resident Basic Science II: Neuropathology and C46: Resident Basic Science III: Neuropharmacology, but covers independent topics. Upon Completion: Participants should be able to name and recognize clinically relevant structures in the brain, brainstem, cerebellum, spinal cord, and peripheral nervous system, and understand the classic clinical features of a lesion in each of these structures. Lecture/Faculty: }} The Brain Sashank Prasad, MD, Boston, MA }} The Brainstem Raymond Price, MD, Philadelphia, PA }} The Cerebellum and Spinal Cord Praveen Dayalu, MD, Ann Arbor, MI }} The Peripheral Nervous System Zachary N. London, MD, FAAN, Ann Arbor, MI Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic CME Credits: 3.5 Recommended Audience: Trainee, Advanced Practice Provider Fast and easy registration · AAN.com/view/AM17 125

Practice/Policy/Ethics

This program complements C161: Bedside Evidence-based Medicine: How to Find and Deconstruct Articles in Order to Take Care of Patients I, but covers independent topics.

Course Descriptions Saturday, April 22, 2017

8:00 a.m.–5:00 p.m.

Early Career Research Training Symposium: A Roadmap to Academic Success for Residents and Fellows (registration required)

Topic: Research Methodology, Education, and History Directors: Myla Goldman, MD, Charlottesville, VA Peter K. Todd, MD, PhD, Ann Arbor, MI Program Description: This program will provide information to early-stage neurologists (senior residents, fellows, instructors, and junior faculty in their first two years) who are embarking on an academic career in neurologic research (clinical, basic, or translational) with a focus on acquiring a career development award. Didactic lectures and small group sessions will focus on preparing for competitive grant submissions to the NIH, major foundations, and the American Brain Foundation, as well as core principles of publishing impactful reports, academic career development, and productive mentor-mentee relationships. Attendees will receive information critical to their transition from residency, fellowship, and early faculty to investigative independence in academic neurology. In order to facilitate the mentoring sessions, attendees are asked to identify their interest in basic or clinical research and their specific area of interests for research. Upon Completion: Participants should gain essential information about the core components of a successful K award application and other mentored career development grants, developing and maintaining productive mentor-mentee relationships, guidelines for development of a successful research career (finding the right question), strategies for successful scientific writing, and suggestions for addressing the competing demands that are common at the start of an academic career. This also serves as a valuable networking opportunity with fellow junior academic neurologists and leaders in the field. Lecture/Faculty: }} Keynote Talk: Keys to Success in Academic Neurology Merit E. Cudkowicz, MD, MSC, Boston, MA }} A K-23 Success Story Brian Edlow, MD, Boston, MA }} A K-08 Success Story Audrey C. Brumback, MD, PhD, San Francisco, CA }} A Non-K Pathway Success Story Vikram Khurana, MD, PhD, Boston, MA }} K Awardee Panel Discussion Audrey C. Brumback, MD, PhD, San Francisco, CA Kathryn A. Davis, MD, Swarthmore, PA Brian Edlow, MD, Boston, MA Vikram Khurana, MD, PhD, Boston, MA }} NIH Research in Neurology: The Benefit for Our Patients and For a Fulfilling Career Walter J. Koroshetz, MD, FAAN, Bethesda, MD

126 2017 AAN Annual Meeting Early Look

Research Methodology, Education, and History }} Grant Application Kisses of Death Faculty }} Working Lunch: Keys to Successful Publishing in Academic Neurology Journals Robert A. Gross, MD, PhD, FAAN, Rochester, NY Clifford B. Saper, MD, PhD, FAAN, Boston, MA }} How to Work Successfully with Your Chair David J. Fink, MD, FAAN, Ann Arbor, MI }} Chair Panel Discussion Allison Brashear, MD, MBA, FAAN, Winston Salem, NC Merit E. Cudkowicz, MD, MSC, Boston, MA David J. Fink, MD, FAAN, Ann Arbor, MI Clifford B. Saper, MD, PhD, FAAN, Boston, MA }} Breakout Session #1 Faculty }} Breakout Session #2 Faculty Core Competency: Medical Knowledge Teaching Style: Didactic, Interactive, Audience Participation, Small Groups CME Credits: 7.5 Recommended Audience: Trainee, Clinician Scientist Applying for Mentored Career Development Award, R-25 Recipient, Clinical Research Training Scholar Saturday, April 22, 2017

C16

1:00 p.m.–5:00 p.m.

Resident Basic Science II: Neuropathology

Topic: Research Methodology, Education, and History Director: J. Clay Goodman, MD, FAAN, Houston, TX Program Description: Neuropathology is a rapidly and continuously evolving discipline encompassing basic, translational, and clinical neuroscience. A thorough understanding of the basics of neuropathology permits much deeper insight into mechanisms and manifestations of neurologic disease and provides a basis for more complete understanding of neuroimaging and laboratory studies. Faculty will provide a fast-paced, visually oriented overview of central nervous system neuropathology including tumors, demyelinating diseases, infections, cerebrovascular disease, toxic/metabolic conditions, neurotrauma, and neurodegenerative disease. The images shown during the program will be contained in the slide and written syllabi which will also contain substantial supplementary material. This program complements C5: Resident Basic Science I: Neuroanatomy—All the Lesions and C46: Resident Basic Science III: Neuropharmacology, but covers independent topics. Upon Completion: Participants should be able to recognize common gross, histological, and molecular features of central nervous system disorders, and be able to understand cellular and gross neuropathology in relationship to neurologic disease mechanisms, diagnosis, progression, laboratory studies, imaging, and therapeutic opportunities.

Sunday, April 23, 2017

C43

1:00 p.m.–3:00 p.m.

Introduction to Clinical Research and Methods

Topic: Research Methodology, Education, and History Director: Deborah Hall, MD, PhD, FAAN, Chicago, IL Program Description: The complex building of current clinical research continues to stand on three methodological pillars: the clinical trial, the cohort study, and the case-control study. These three methods, along with their combinations and modifications, enable us to investigate any possible cause-effect relationship across biological, personal, or social factors or events, symptoms, diseases, or conditions, and treatments, procedures, or interventions. This program provides a brief introduction to the three methods with emphasis on their complementarities and their relative strengths and weaknesses. Upon Completion: Participants should have a better understanding of how evidence is generated and disseminated in clinical neurology; improve their ability to design, conduct, and interpret studies; and improve their ability to write and read scientific papers and grant applications. Lecture/Faculty: }} Introduction to Study Design/Case-Control Studies Deborah Hall, MD, PhD, FAAN, Chicago, IL }} Cohort Studies Alexander Pantelyat, MD, Baltimore, MD }} Clinical Trial Design Gary S. Gronseth, MD, FAAN, Kansas City, KS }} Introduction to Biostatistics Faculty Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Professionalism Teaching Style: Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee $ = Additional Fee Required L = Leadership University

Sunday, April 23, 2017

C46

1:00 p.m.–5:00 p.m.

Resident Basic Science III: Neuropharmacology

Topic: Research Methodology, Education, and History Director: James W. M. Owens, Jr., MD, PhD, Seattle, WA Program Description: Neurology now has an “embarrassment of riches” when it comes to pharmacological treatment. As our understanding of the basic neurobiology of disease progresses, this pharmacopeia continues to expand and to involve novel agents. Faculty will review basic pharmacological principles important for medication selection as well as facilitate an expanded understanding of the treatment of epilepsy, Parkinson’s disease, and sleep disorders. Presentations will include discussion of drug targets and mechanisms punctuated by illustrative cases. This program complements C5: Resident Basic Science I: Neuroanatomy—All the Lesions and C16: Resident Basic Science II: Neuropathology, but covers independent topics. Upon Completion: Participants should be able to discuss basic pharmacological concepts relevant to the clinical practice of neurology as well as an approach to medication selection for patients with epilepsy, Parkinson’s disease, and sleep disorders based on an understanding of pharmacological mechanisms of action and pharmacokinetcs. Lecture/Faculty: }} Overview of Neuropharmacology James W. M. Owens, Jr., MD, PhD, Seattle, WA }} Treatment of Parkinson’s Disease Joohi Jimenez Shahed, MD, Houston, TX }} Treatment of Epilepsy Atul Maheshwari, MD, Houston, TX }} Treatment of Sleep Disorders Matt T. Bianchi, MD, PhD, Boston, MA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 3.5 Recommended Audience: Trainee, General Neurologist, NonNeurologist, Advanced Practice Provider

Research

Lecture/Faculty: }} Increased Intracranial Pressure, Tumors, and Vascular Disease J. Clay Goodman, MD, FAAN, Houston, TX }} Demyelinating, Toxic/Metabolic, Traumatic, and Infectious Disorders J. Clay Goodman, MD, FAAN, Houston, TX }} Neurodegenerative Disorders Matthew D. Cykowski, MD, Houston, TX Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic CME Credits: 3.5 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

Fast and easy registration · AAN.com/view/AM17 127

Course Descriptions Sunday, April 23, 2017

C60

3:30 p.m.–5:30 p.m.

Precision Neurology: The Promise and Perils of Personalized Medicine in the Genomic Era

Topics: Research Methodology, Education, and History; General Neurology Director: Peter K. Todd, MD, PhD, Ann Arbor, MI Program Description: Addressing the rapidly developing area of Precision Medicine, this two-hour symposium will discuss the potential power and pitfalls of next generation genetic testing for people with and at risk for neurological disorders and how these technologies are already influencing our understanding of neurological disease. The first part of the symposium will address the broad question of what impact next gen sequencing (NGS) has on personalized medicine and genomics in neurological practice, both now and going forward. The second half of the session will address how genetic background influences genetic and sporadic neurological disease and how these background effects are broadening our comprehension of genotype/ phenotype relationships. Upon Completion: Participants will be aware of the different types of genetic testing tools available for clinical and research purposes, when to get these tests, and what to do with the information when they have it. They will also gain a greater understanding of how these tools might be used in the future for people with both genetically based neurological disorders and common neurological diseases. They will also learn about how disclosure of genetic results impacts patients and about how somatic mutations and repeat expansion contribute to the burden of neurological disease. Lecture/Faculty: }} What REVEAL and MedSeq Tell Us About the Future of Precision Medicine Faculty }} Genetic Variance and Risk in Complex Neurological Disorders Faculty }} We Are the 99%: How Non-exonic Sequences and Repeats Cause Neurological Disease Peter K. Todd, MD, PhD, Ann Arbor, MI }} Somatic Mutations in Neural Development and Neurological Disease Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist

128 2017 AAN Annual Meeting Early Look

Research Methodology, Education, and History Monday, April 24, 2017

C74

7:00 a.m.–9:00 a.m.

Annual A.B. Baker Program: Focus on Professionalism

Topic: Research Methodology, Education, and History Director: Laurie Gutmann, MD, FAAN, Iowa City, IA Program Description: The symposium will address the concept of professionalism as it relates throughout one’s medical career from matriculation as a medical student to a seasoned physician. Upon Completion: Participants should be able to define professionalism; identify its importance at all stages of career development; and describe mechanisms by which lapses in professionalism may be remediated. Lecture/Faculty: }} Professionalism Pedagogy and the Conspicuous Curriculum William P. Cheshire, Jr., MD, FAAN, Jacksonville, FL }} Intrinsic and Extrinsic Sources of Professionalism Daniel G. Larriviere, MD, JD, FAAN, New Orleans, LA }} Presentation of the 2017 A.B. Baker Award for Lifetime Achievement in Neurologic Education to Harold P. Adams, Jr., MD, FAAN Laurie Gutmann, MD, FAAN, Iowa City, IA }} Keynote: The Importance of Teaching Neurology to NonNeurologists Harold P. Adams, Jr., MD, FAAN, Iowa City, IA Core Competencies: Interpersonal and Communication Skills, Practice-Based Learning and Improvement, Professionalism Teaching Style: Case-Based, Didactic, Interactive CME Credits: 2 Recommended Audience: Educator Monday, April 24, 2017

C75

12:00 p.m.–5:30 p.m.

Clerkship and Program Directors Conference: Wellness and Burnout During Training

Topic: Research Methodology, Education, and History Director: Jaffar Khan, MD, FAAN, Atlanta, GA Program Description: Neurology is the only medical specialty that has one of the highest rates of burnout and the lowest rates of work-life balance. Through this course, participants will review the current state of burnout in neurology with an emphasis on our trainees, both residents and medical students. Participants will explore the potential impact of burnout on the neurology pipeline and implications for the future workforce in neurology. Clerkship and program directors will gain the knowledge to identify the signs and symptoms of burning out and develop strategies for its mitigation and for the promotion of wellness.

Lecture/Faculty: }} Working Lunch Faculty }} State of Wellness/Burnout in Neurology Neil A. Busis, MD, FAAN, Pittsburgh, PA }} Signs and Symptoms of Burnout and Improving Wellness Faculty }} Promoting Wellness Among Our Trainees: Starting the Conversation Patrick S. Reynolds, MD, Winston Salem, NC }} Program Director Breakout Session I A: Milestones Lyell K. Jones, MD, FAAN, Rochester, MN }} Program Director Breakout Session I B: Career Development for Program Directors Zachary N. London, MD, FAAN, Ann Arbor, MI }} Clerkship Directors: Introduction to ReBoot Camp Joseph E. Safdieh, MD, FAAN, New York, NY }} Clerkship Director Breakout Session I A: Curriculum Development Ralph F. Józefowicz, MD, FAAN, Rochester, NY }} Clerkship Director Breakout Session I B: Blended Learning Joseph E. Safdieh, MD, FAAN, New York, NY }} Clerkship Director Breakout Session II B: Faculty Development Charlene Gamaldo, MD, FAAN, Baltimore, MD }} Clerkship Director Breakout Session II A: Assessment of Student Clinical Skills Ann N. Poncelet, MD, San Francisco, CA }} Program Director Breakout Session II A: Dealing with a Troubled Resident Patrick S. Reynolds, MD, Winston Salem, NC }} Program Director Breakout Session II B: Barriers to Effective Implementation of a Residency Curriculum David Lee Gordon, MD, FAHA, FAAN, Oklahoma City, OK }} Clerkship Directors: Debrief Joseph E. Safdieh, MD, FAAN, New York, NY Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Practice-Based Learning and Improvement, Professionalism Teaching Style: Case-Based, Didactic, Interactive CME Credits: 5.5 Recommended Audience: Trainee, Clerkship and Program Director

Monday, April 24, 2017

C85

1:00 p.m.–3:00 p.m.

Boston City Hospital: The Cradle of American Neurology Part I

Topics: General Neurology; Research Methodology, Education, and History Director: Steven A. Sparr, MD, FAAN, Bronx, NY See complete course description on page 56 » Monday, April 24, 2017

C93

3:30 p.m.–5:30 p.m.

Boston City Hospital: The Cradle of American Neurology Part II

Topics: General Neurology; Research Methodology, Education, and History Director: Steven A. Sparr, MD, FAAN, Bronx, NY See complete course description on page 57 » Tuesday, April 25, 2017

1:00 p.m.–3:00 p.m.

C130 Eponymous Women in Neurology I Topic: Research Methodology, Education, and History Director: Stephen G. Reich, MD, FAAN, Baltimore, MD Program Description: A method commonly used to study the history of medicine is the biographical approach; this is sometimes referred to as the “great man approach,“ tracing history from one dominant leader to another. But, this neglects the many “great women“ who have also made important contributions. Many of these “great men“ live on by the diseases and signs they described which bear their name. Eponymous woman have received less attention and many neurologists are unable to name a single disease or sign described by a woman and are unaware that many commonly used eponyms are attributed to women. This course will highlight women who live on eponymously in neurology. The disease or signs they described will be reviewed along with a biographical sketch of each. This program complements C146: Eponymous Women in Neurology II, but covers independent topics. Upon Completion: Participants should be able to recognize the important contributions of selected women to neurology and have a better understanding of the disease or signs they described; and be familiar with the lives of eponymous women in neurology as well other contributions by these women which are not preserved eponymously. Lecture/Faculty: }} The Mary Walker Effect: Mary Broadfoot Walker Christopher J. Boes, MD, FAAN, Rochester, MN }} Dèjerine-Klumpke Syndrome: Augusta Dèjerine-Klumpke Jennifer McKinney, MD, Columbus, OH

$ = Additional Fee Required L = Leadership University

Fast and easy registration · AAN.com/view/AM17 129

Research

Upon Completion: At the conclusion of this course, the participants will be able to describe the current state of burnout in the field of neurology, the signs and symptoms of burnout among our trainees, and strategies to mitigate burnout and promote wellness.

Course Descriptions }} The Roussy-Lèvy Syndrome: Gabrielle Lèvy Peter J. Koehler, MD, PhD, FAAN, Heerlen, Netherlands }} Louis-Bar Syndrome (Ataxia Telangiectasia): Denise LouisBar Elizabeth A. Coon, MD, Rochester, MN Core Competency: Medical Knowledge Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Tuesday, April 25, 2017

1:00 p.m.–3:00 p.m.

Research Methodology, Education, and History Tuesday, April 25, 2017

3:30 p.m.–5:30 p.m.

C145 Hot Topics in Neurologic Practice: Managing the Patient Experience in 2017 and Beyond

C132 Developing the Treatments of Tomorrow I:

Tuesday, April 25, 2017

Topic: Research Methodology, Education, and History

Taking Molecules from Lab to Human

Director: Amy R. Brooks-Kayal, MD, FAAN, Aurora, CO Program Description: This program will provide an overview to a general audience of neurologists and researchers on the initial navigation of novel treatments for neurological disease, going from discoveries in the lab to initial studies in human subjects. Specific examples will be used to illustrate the challenges that occur during the course of drug development. A companion session will cover the challenges beyond initial studies in healthy subjects. This program complements C148: Developing the Treatments of Tomorrow II: Clinical Trials in Neurology, but covers independent topics. Upon Completion: Participants should have an increased understanding of the steps involved in drug discovery and development up to the initial studies in healthy subjects, and will have been introduced to strategies for increasing success in later development. Lecture/Faculty: }} Discovery of Novel Therapeutic Agents for CNS Disorders: Target Selection and Discovery Process Peter Lansbury, Cambridge, MA }} Entry of Novel Therapeutic Agents into Man Jang-Ho John Cha, MD, PhD, Cambridge, MA }} Beyond Small Molecules: Developing Biologic Therapies Gary Starling, PhD, Palo Alto, CA }} Increasing Translational Success: Why Do Drugs Fail in Clinical Trials and What Can Be Done to Increase the Rate of Success Shai Silberberg, PhD, Bethesda, MD Core Competencies: Medical Knowledge, Systems-Based Practice Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist 130 2017 AAN Annual Meeting Early Look

3:30 p.m.–5:30 p.m.

C146 Eponymous Women in Neurology II Director: Stephen G. Reich, MD, FAAN, Baltimore, MD Program Description: A method commonly used to study the history of medicine is the biographical approach; this is sometimes referred to as the “great man approach,“ tracing history from one dominant leader to another. But, this neglects the many “great women“ who have also made important contributions. Many of these “great men“ live on by the diseases and signs they described which bear their name. Eponymous woman have received less attention and many neurologists are unable to name a single disease or sign described by a woman and are unaware that many commonly used eponyms are attributed to women. This course will highlight women who live on eponymously in neurology. The disease or signs they described will be reviewed along with a biographical sketch of each. This program complements C130: Eponymous Women in Neurology I, but covers independent topics. Upon Completion: Participants should be able to recognize the important contributions of selected women to neurology and have a better understanding of the disease or signs they described; and be familiar with the lives of eponymous women in neurology as well other contributions by these women which are not preserved eponymously. Lecture/Faculty: }} The Dix-Hallpike Maneuver: Margaret Dix Douglas J. Lanska, MD, FAAN, Tomah, WI }} Canavan Disease: Myrtelle May Canavan Lenora Moore Lehwald, MD, Columbus, OH }} Hurler Syndrome: Gertrud Hurler Margie A. Ream, MD, PhD, Columbus, OH }} Frey Syndrome (Gustatory Sweating): Lucja Frey Stephen G. Reich, MD, FAAN, Baltimore, MD

Tuesday, April 25, 2017

3:30 p.m.–5:30 p.m.

C148 Developing the Treatments of Tomorrow II: Clinical Trials in Neurology

Topic: Research Methodology, Education, and History Director: Jeffrey Marc Gelfand, MD, MAS, San Francisco, CA Program Description: This program will provide an overview and update of the science of clinical trials for practicing neurologists, researchers, and trainees. Clinical trials are the bedrock of evidence-based neurology and one of the greatest methodological innovations of modern medicine. Academic, industry, and regulatory representatives will provide an overview of clinical trials, discuss approaches to optimize success, review advances in trial design and implementation, and address statistical and regulatory considerations. Faculty will also facilitate a discussion with the attendees. A companion session will address the preclinical drug development pipeline, translation of research breakthroughs to the clinic, and first-in-human studies. This program complements C132: Developing the Treatments of Tomorrow I: Taking Molecules from Lab to Human, but covers independent topics. Upon Completion: Participants should be able to understand differences between early and late stage clinical trials and their role in the drug development pipeline, assess the strengths and weaknesses of various clinical trial designs, use appropriate statistical approaches, and understand regulatory issues. Lecture/Faculty: }} Introduction: Clinical Trials in the Drug Development Pipeline Faculty }} Considerations for Early and Late Stage Trials Faculty }} Innovations in Clinical Trial Design and Implementation Jeffrey Marc Gelfand, MD, MAS, San Francisco, CA }} Statistical Considerations for Designing and Interpreting Clinical Trials Faculty }} Regulatory Considerations for Clinical Trials in Neurology Faculty Core Competencies: Medical Knowledge, Systems-Based Practice Teaching Style: Case-Based, Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

$ = Additional Fee Required L = Leadership University

Wednesday, April 26, 2017

1:00 p.m.–3:00 p.m.

C163 An Introduction to Research in Medical Education

Topic: Research Methodology, Education, and History Director: Stuart Lubarsky, MD, Montreal, QC, Canada Program Description: Research in medical education is a dynamic, rapidly growing field of inquiry that aims to investigate and inform all aspects of teaching, learning, assessment, clinical performance, and patient care in medicine. Informed by disciplines as diverse as education, psychology, sociology, epidemiology, statistics, measurement, anthropology, rhetoric, and knowledge translation, it is a domain of scholarship whose findings are currently disseminated through numerous journals, texts, and academic conferences. The goal of this colloquium is to explore the process of transforming ideas and problems drawn from medical education contexts and experiences into researchable questions, of situating these ideas and problems within a conceptual or theoretical framework, and of choosing a research approach (quantitative or qualitative) that is most appropriate to the purpose of the study. Upon Completion: Participants should be able to describe the purposes of medical education research; transform an idea or problem in medical education into a researchable question; situate ideas and problems in medical education within appropriate theoretical or conceptual frameworks; and select the appropriate research methodology (qualitative or quantitative) for addressing ideas and problems in medical education. Lecture/Faculty: }} Transforming Ideas and Problems into Researchable Questions Stuart Lubarsky, MD, Montreal, QC, Canada }} Research Methods 1: Qualitative Methodologies Aliki Thomas, PhD, Montreal, QC, Canada }} Research Methods 2: Quantitative Methodologies Meredith Young, PhD, Montreal, QC, Canada }} Small Group Activity: Devise a Research Question and Select an Appropriate Research Method Faculty }} Whole Group Discussion: Reporting and Feedback Faculty Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement, Professionalism, Systems-Based Practice Teaching Style: Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Medical Educator

Fast and easy registration · AAN.com/view/AM17 131

Research

Core Competency: Medical Knowledge Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

Course Descriptions Thursday, April 27, 2017

7:00 a.m.–9:00 a.m.

C189 Cognitive Psychology of Neurologic Errors: Why Do Neurologists Make Errors?

Topics: General Neurology; Research Methodology, Education, and History Director: Louis R. Caplan, MD, FAAN, Boston, MA See complete course description on page 63 »

SLEEP Sunday, April 23, 2017

C23

7:00 a.m.–9:00 a.m.

Using Sleep Medicine to Help Solve Difficult Neurologic Cases

Topics: Sleep; General Neurology Director: Bradley V. Vaughn, MD, FAAN, Chapel Hill, NC Program Description: Sleep and circadian rhythm disorders are frequently encountered in general neurology practice. The neurologist is in a critical position to provide diagnostic and treatment input for patients with sleep and circadian rhythm disorders. This course will discuss common neurologic disorders associated with sleep and circadian disturbances, differential diagnoses of sleep disorders, and identification of sleep disorders caused by or related to neurologic disorders. The interaction of circadian rhythm, sleep disorders and neurologic disorders is frequent, requiring the neurologist to understand presentation, pathophysiology, and treatment. The case discussions will highlight advances in key clinical areas of sleep medicine, including identification of underlying insomnia, hypersomnia, sleep disordered breathing, and RLS in patients with common disorders such as headache, stroke, MS, epilepsy, and neurodegenerative disorders. Application to practice will include easily accessible testing techniques, nonpharmacological and pharmacological interventions coding, and documentation of various clinical presentations. Upon Completion: Participants should be able to understand the importance of sleep in the generation of neurologic symptoms, be able to ask appropriate questions to identify patients with neurologic disorders who have sleep issues, and apply basic principles of sleep medicine to patients with neurologic complaints. Lecture/Faculty: }} Introduction to Cases and Format Bradley V. Vaughn, MD, FAAN, Chapel Hill, NC }} “I Can’t Sleep” Epilepsy and Daily Headache Bradley V. Vaughn, MD, FAAN, Chapel Hill, NC }} The Sleepy Patient with Neuromuscular Disease Michael H. Silber, MB, ChB, FAAN, Rochester, MN 132 2017 AAN Annual Meeting Early Look

Sleep }} MS and Never Rested Bradley V. Vaughn, MD, FAAN, Chapel Hill, NC }} Out of Step—Parkinsonism Michael H. Silber, MB, ChB, FAAN, Rochester, MN }} Wrap Up and Discussion of Cases Faculty Core Competencies: Medical Knowledge, Patient Care, PracticeBased Learning and Improvement Teaching Style: Case-Based, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Sleep Specialist, Advanced Practice Provider Monday, April 24, 2017

C71

7:00 a.m.–9:00 a.m.

Hot Topics in Sleep Neurology

Topic: Sleep Director: Erik Kent St. Louis, MD, FAAN, Rochester, MN Program Description: Understanding of the purposes of sleep for brain and general health, and the ability to diagnose and treat sleep disturbances and disorders, has advanced significantly in recent years. To optimize quality of life and improve neurological functioning in their patients, neurologists should be familiar with advances in the understanding of sleep, especially in neurologic sleep medicine. Faculty will review the bidirectional relationships between sleep and neurodegeneration; diagnosis, prognostic counseling, and treatment options for patients with REM sleep behavior disorder; diagnosis and recent advances in the management of restless legs syndrome, and the diagnosis and treatment of chronic insomnia. Upon Completion: Participants should be able to understand evolving evidence regarding the bidirectional associations between sleep, sleep disorders, and neurodegeneration; understand evolving diagnostic standards, the strong prognostic association with synucleinopathies, and treatment approaches in patients with REM sleep behavior disorder; use diagnostic standards and treatment approaches to chronic insomnia; and determine best therapies for patients with restless legs syndrome, including those with augmentation. Lecture/Faculty: }} REM Sleep Behavior Disorder: Recent Advances in Diagnosis and Treatment Erik Kent St. Louis, MD, FAAN, Rochester, MN }} Sleep and Neurodegeneration: A State of the Art Review Yo-El Ju, MD, Saint Louis, MO }} Dreaming of Somnolence: An Update in Insomnia Management Michael J. Howell, MD, FAAN, Minneapolis, MN }} Restless Legs Syndrome: Evolving Understanding and Treatments LynnMarie Trotti, MD, Atlanta, GA

Tuesday, April 25, 2017

1:00 p.m.–3:00 p.m.

C128 Sleep Apnea and Related Disorders Over the Lifecycle: What Neurologists Need to Know

Topic: Sleep

Director: Michael J. Howell, MD, FAAN, Minneapolis, MN Program Description: By the time an individual lives to 78 they will have spent 26 years in a state of purposeful unconsciousness with decreased ventilatory responses. These changes in brainstem function represent a respiratory “stress test“ and various pathologies can result in sleepdisordered breathing. The etiologies, and thus management, of sleep apnea, hypoventilation, and related conditions evolve over a lifetime. But regardless of whether these pathologies are due to obesity, hypertrophic tonsils/adenoids, brain stem pathology, or commonly prescribed analgesic medications, sleep disordered breathing has neurobehavioral and cerebrovascular consequences. Faculty will provide clinically relevant, up-to-date summaries of these fascinating conditions, including an overview of sleep disordered breathing across the lifecycle, a discussion of normal age-related changes in sleep-related respiratory physiology, and a review of the challenges and opportunities in diagnosing and treating sleep apnea and related disorders. Upon Completion: Participants should be able to identify the neurologic conditions commonly associated with obstructive sleep apnea and sleep-related hypoventilation, and be able to explain the treatment options. Lecture/Faculty: }} Sleep-related Breathing Disorders from Tots to Teens Faculty }} To Breathe or To Sleep? Sleep Apnea and Related Disorders in Adults Michael J. Howell, MD, FAAN, Minneapolis, MN Core Competencies: Medical Knowledge, Patient Care Teaching Style: Didactic CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist

$ = Additional Fee Required L = Leadership University

Tuesday, April 25, 2017

3:30 p.m.–5:30 p.m.

C144 Approaching the Management of Common Sleep Disorders: Case-based Review for the Non-sleep Specialist

Topic: Sleep

Director: Charlene Gamaldo, MD, FAAN, Baltimore, MD Program Description: Faculty will feature interactive format for presenting new trends and updates on the evaluation, treatment, and ongoing management considerations of sleep conditions commonly encountered in the general neurology practice. Neurologists frequently encounter patients who report disturbed sleep. Upon Completion: Participants should be able to update their knowledge of management strategies, diagnostic tools, and therapeutic options for common sleep disorders (insomnia, RLS, insufficient sleep, sleep apnea, etc.). Lecture/Faculty: }} Sleep-wake Confusion, Somnambulism, and a Lost Paradox: Parasomnia Cases for the Neurologist Michael J. Howell, MD, FAAN, Minneapolis, MN }} Narcolepsy and Hypersomnia Cases for the General Neurologist LynnMarie Trotti, MD, Atlanta, GA }} Your Sleepless Patient: Clinical Considerations for Non-sleep Specialists Treating Patients with Insomnia Charlene Gamaldo, MD, FAAN, Baltimore, MD Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist Wednesday, April 26, 2017

1:00 p.m.–3:00 p.m.

C166 Circadian Rhythm Disorders: Implications for Neurology

Topic: Sleep

Director: Phyllis C. Zee, MD, PhD, Chicago, IL Program Description: The circadian timing system is ubiquitous to nearly all organisms, from single cells to humans. The discovery of the molecular mechanisms underlying the generation of circadian rhythms, and the finding that these circadian clock genes are expressed throughout the central nervous system, and in most peripheral tissues, has expanded our view of the role of circadian rhythms in health and neurologic disease. Circadian based sleep disturbances are an important feature of many neurological disorders. Through presentation on the biology of circadian rhythm regulation, impact of circadian dysregulation in aging and neurodegeneration, and common as well as challenging cases of circadian rhythm sleep disorders, faculty will discuss evaluation, diagnostic tools, and treatment approaches for circadian disorders. Fast and easy registration · AAN.com/view/AM17 133

Sleep

Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

Course Descriptions Upon Completion: Participants should be able to acquire knowledge of the state of the science in circadian rhythm regulation, become familiar with the impact of circadian dysregulation on the expression of neurological disease and clinical outcomes, apply circadian based diagnostic tools and treatment approaches, and get an update on new breakthroughs in this field. Lecture/Faculty: }} Circadian Rhythms: Implications for Health and Disease Phyllis C. Zee, MD, PhD, Chicago, IL }} Circadian Rhythm Disorders: Update on Diagnosis and Treatment Sabra M. Abbott, MD, PhD, Chicago, IL }} Circadian Disorders in Aging and Neurodegeneration Aleksandar Videnovic, MD, MSc, FAAN, Boston, MA Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider Thursday, April 27, 2017

7:00 a.m.–9:00 a.m.

C197 Interpreting Sleep Study Procedure(s),

Data, and Reports: What the Non-sleep Specialist Needs to Know

Topic: Sleep Director: Charlene Gamaldo, MD, FAAN, Baltimore, MD Program Description: Neurologists increasingly order sleep studies, which requires familiarity with the type of studies available and when and how to order specialized studies. The objective of this course is to review the type of procedures currently available for the evaluation and management of sleep disorders, focusing specifically on those sleep conditions commonly encountered by neurologic patients. Faculty will discuss the interpretation of sleep tests, including in-laboratory polysomnography, portable sleep studies, multiple sleep latency tests, actigraphy, and other specialized sleep testing for patients with various sleep complaints. Faculty will focus on indications for sleep testing; interpretation of tests; and key electrographic findings in major sleep disorders encountered in neurology practice, including sleep apnea, narcolepsy, movement disorders of sleep, and complex nocturnal behaviors. An interactive platform will be used, with examples of sleep recordings to help illustrate and reinforce the important concepts in sleep neurology. Upon Completion: Participants should be able to gain familiarity with the rationale for polysomnography in the assessment and evaluation of patients with hypersomnia, insomnia, and abnormal nocturnal behaviors and movements; select appropriate sleep studies in the investigation of key sleep disorders; become familiar with the key electrographic 134 2017 AAN Annual Meeting Early Look

Sleep criteria for sleep apnea, narcolepsy, motor disorders of sleep, and parasomnias; describe and differentiate among the key sleeprelated respiratory disorders, parasomnias, and sleep-related movement disorders likely to be encountered by a neurologist; enhance competency in the interpretation of the polysomnography and multiple sleep latency testing in the evaluation of narcolepsy and become familiar with the use of actigraphy in the monitoring of sleep-wake schedule disorders; strengthen clinical skills in the recognition and classification of abnormal behaviors and movements during the night through polysomnographic examples highlighting unique semiology; and appreciate some of the criteria listed in the International Classification of Sleep Disorders, the American Academy of Sleep Medicine (AASM) Manual for the Scoring of Sleep in the diagnosis of key sleep disorders including sleep apnea, narcolepsy, motor disorders of sleep, and parasomnias. Lecture/Faculty: }} Your Sleepless Patient: Making Sense of the Procedural and Wearable Options Charlene Gamaldo, MD, FAAN, Baltimore, MD }} Central Hypersomnia and REM Behavioral Sleep Disorder: Making Sense of the Sleep Study Reports Rachel Marie E. Salas, MD, Baltimore, MD }} Sleep Apnea Assessment: Tools, Tricks, and Tips Douglas B. Kirsch, MD, FAAN, Charlotte, NC Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist

7:00 a.m.–9:00 a.m.

C226 How to Integrate Sleep Medicine

into Your Child Neurology Practice

Topics: Sleep; Child Neurology and Developmental Neurology Director: Suresh Kotagal, MD, FAAN, Rochester, MN Program Description: Between 20-40 percent of childhood neurologic disorders are associated with altered sleep-wake function. The incorporation of sleep medicine concepts into the child neurology practice enhances clinical outcomes and the quality of life of our patients. The course faculty are experienced child neurologists and sleep specialists. They will focus on enhancing the sleep-related knowledge-base and discuss sleep management strategies relevant to pediatric neurology practitioners. Upon Completion: Participants should be able to understand components of a sleepfocused history and examination and become aware of the utility and limitations of common sleep laboratory diagnostic procedures; appreciate the bi-directional relationship between sleep and epilepsy; understand how enhancing sleep can improve the quality of life in neurodevelopmental disorders such as autism; and learn about how improving sleep impacts childhood headache syndromes. Lecture/Faculty: }} Clinical and Sleep Laboratory Assessment Suresh Kotagal, MD, FAAN, Rochester, MN }} Transforming Research into Practice: Sleep in Neurodevelopmental Disabilities Faculty }} Epilepsy and Sleep—Common Bedfellows Sanjeev V. Kothare, MD, FAAN, New York, NY }} The Relationship Between Headache and Sleep Sejal V. Jain, MD, Tucson, AZ Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Non-Neurologist, Advanced Practice Provider

$ = Additional Fee Required L = Leadership University

Friday, April 28, 2017

1:00 p.m.–3:00 p.m.

C234 Sleep for the Practicing Neurologist I:

Is it Narcolepsy or Something Else? Diagnostic and Management Challenges in the Central Disorders of Hypersomnolence

Topic: Sleep Director: Michael J. Howell, MD, FAAN, Minneapolis, MN Program Description: Patients with brain disease frequently describe excessive daytime sleepiness. Because of this neurologists are often asked to investigate and manage the central disorders of hypersomnolence such as: Narcolepsy Types 1 and 2, idiopathic hypersomnia, and Kleine-Levin Syndrome. These treatable conditions are challenging to both clinicians and patients. Faculty will provide a clinically relevant, up-to-date review on the identification and management of patients with central disorders of hypersomnolence; discuss narcolepsy, its unique presentation, pathophysiology, and treatments; and discuss the other central disorder of hypersomnolence. These conditions, which include idiopathic hypersomnia, are difficult to diagnose and treat with currently employed diagnostic and therapeutic tools. This program complements C242: Sleep for the Practicing Neurologist II: Night Fighting: sleep Related Hypermotor Epilepsy, Sleepwalking, and Dream Enactment, but covers independent topics. Upon Completion: Participants should be able to recognize the features of narcolepsy that distinguish it from other central disorders of hypersomnolence; be able to recognize the limitations of the multiple sleep latency test, the most commonly employed laboratory measure of sleepiness; and leave with new insights on the etiology of these conditions, as well as understand the directions researchers are taking towards the development of novel therapies. Lecture/Faculty: }} Stuck in the Revolving Door: Challenges in Narcolepsy Logan D. Schneider, MD, Redwood City, CA }} Stuck in the MSLT: Challenges in Diagnosing and Treating the Other Central Disorders of Hypersomnolence LynnMarie Trotti, MD, Atlanta, GA Core Competency: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider

Fast and easy registration · AAN.com/view/AM17 135

Sleep

Friday, April 28, 2017

Course Descriptions Friday, April 28, 2017

3:30 p.m.–5:30 p.m.

C242 Sleep for the Practicing Neurologist II:

Night Fighting: Sleep Related Hypermotor Epilepsy, Sleepwalking, and Dream Enactment

Topic: Sleep Director: Michael J. Howell, MD, FAAN, Minneapolis, MN Program Description: There have been numerous discoveries related to parasomnias over the last several years. These insights and developments include the potential role of REM sleep behavior disorder (RBD) as a biomarker in the development of disease modifying therapies, a new approach to understanding sleepwalking and other disorders of arousal from NREM sleep, as well as new diagnostic criteria for Sleep Related Hypermotor Epilepsy (previously known as Nocturnal Frontal Lobe Epilepsy). Faculty will provide an up-to-date review of these fascinating disorders using video as well as other media to illustrate the features and diversity of these conditions. This program complements C234: Sleep for the Practicing Neurologists I: Is it Narcolepsy or Something Else? Diagnostic and Management Challenges in the Central Disorders of Hypersomnolence, but covers independent topics. Upon Completion: Participants will be familiar with the new diagnostic criteria of sleeprelated hypermotor epilepsy and have new insights on the etiology of this challenging seizure disorder. Additionally, attendees will have new treatment options for the management of patients with NREM parasomnias and be able to provide new hope for RBD patients worried about developing Parkinson’s disease. Lecture/Faculty: }} Sleep-related Hypermotor Epilepsy—Not Just a New Name: Novel Insights for a Fascinating Disorder Milena Pavlova, MD, Boston, MA }} Disorders of Arousal and Dream Enactment: Exploring the World of NREM and REM Parasomnias Michael J. Howell, MD, FAAN, Minneapolis, MN Core Competencies: Medical Knowledge, Patient Care Teaching Style: Case-Based, Didactic, Interactive, Audience Participation CME Credits: 2 Recommended Audience: Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider

136 2017 AAN Annual Meeting Early Look

Sleep

Frontiers in Child Neurology: Cultivating Careers, Networking, and Exploring a Neurologic Disorder Through a Lifespan—Focus on MS Sunday, April 23

12:30 p.m.-6:00 p.m. Continuing the success of 2016, the 2017 program will focus on presenting the latest science and therapies in pediatric to adult multiple sclerosis. The focus will be on similarities and contrasts of pediatric versus adult MS and then highlight the numerous new therapies. This is a unique forum for attendees to engage with experts about pursuing a career in child neurology, sharing knowledge, and networking with new and familiar colleagues.

Highlights

Careers in Child Neurology Luncheon— Ask the Experts Co-chairs: Ann H. Tilton, MD, FAAN, and Rujuta Bhatt, MD Medical students and residents who are considering a career as a child neurologist will get a unique opportunity to meet with the experts and have their questions answered.

Neuroscience in the Clinic: Neurologic Disorder Through a Lifespan—Focus on MS Coordinators: Shafali Jeste, MD, and Rebecca K. Lehman, MD This session will combine scientific research with clinical application and bring them together in context regarding pediatric and adult MS and the new exciting therapies on the horizon.

$ = Additional Fee Required L = Leadership University

Networking Reception The program will conclude with a wine and cheese reception allowing attendees an opportunity to talk with presenters and network.

Fast and easy registration · AAN.com/view/AM17 137

Experience Unique Opportunities for Students, Residents, and Fellows The AAN Annual Meeting offers a unique experience for students, residents, and fellows with boundless opportunities to get exposure to a variety of interests and career disciplines, and network with leading neurologists and neurology professionals from around the world.

Registration

Volunteer Opportunities

FREE for Medical Students

Serve as a program monitor or a workshop volunteer and receive gratis registration. See page 149 » for full details.

Annual Meeting registration is FREE to medical students, graduate students, and PhD candidates who present a student ID card or are AAN members. Sign up for an AAN complimentary student membership at AAN.com/view/membership.

Only $245 for Junior Residents and Junior Fellows Annual Meeting registration is only $245 (a more than $800 savings from nonmember neurologist registration!) before the March 30, 2017, early registration deadline. Gold Registration—Upgrade to Gold Registration to receive a copy of Annual Meeting On Demand. Skills Workshops, Maintenance of Certification Exam Preparation Course, Improving Your Leadership Skills: A Practical Approach, Women in Leadership, Leadership Effectiveness for Clerkship and Program Directors Academy, Early Career Research Training Symposium, The Most Important Tool in Your Black Bag: Gallup StrengthsFinder™ Assessment Courses, and Mentoring…Growing the Next Generation of Neurologist are not included in the Annual Meeting registration price. These courses require pre-registration, may have a separate registration fee, and are subject to closure due to reaching maximum capacity.

138 2017 AAN Annual Meeting Early Look

2O17 Medical Student, Residents, and Fellows Annual Meeting Page Visit AAN.com/view/StudentsR&F for specific, up-to-date information highlighting all events and opportunities of interest to Students, Residents, and Fellows.

Mark Your Calendar!

Faculty & Trainee Reception Monday, April 24

6:00 p.m.–9:00 p.m. }} Network with your peers and share ideas }} Award presentations }} Institution posters: Find information about residency programs, on pursuing fellowships and/or careers in neurology academics, research, or practice }} Exhibits: Explore exhibits by private practice groups and recruiters/ headhunters regarding job opportunities

Letâ&#x20AC;&#x2122;s All Commit To Outsmarting Brain Disease. Help us in our commitment to Outsmart Brain Disease. Please join the American Brain Foundation at our Commitment to Cures event. Your donations will help us fund the best and brightest scientific minds in the crucial research to cure brain disease. By examining the whole brain, we get the whole picture. Because we believe itâ&#x20AC;&#x2122;s all connected. So a cure for one disease could be a cure for others.

Commitment to Cures Boston | April 26, 2017

Join us at our event and stop by our booth and learn how you can help. To learn more about the launch of our new funding platform in Spring 2017, visit www.americanbrainfoundation.org

Preliminary Scientific Schedule The AAN Annual Meeting brings together a diverse group of scientists from around the globe and from a wide range of specialties and subspecialties to present and discuss the very latest science in the world of neurology. The 2017 Scientific Program reflects this vast neurology spectrum. You’ll find everything from the latest updates on diagnostic and treatment techniques to prevention strategies throughout the meeting’s more than 2,800+ platform and poster presentations. Note: All below dates, times, and program information are tentative. The full scientific program will be available in February 2017.

Saturday, April 22 5:00 p.m.–6:30 p.m. Hot Topics Plenary Session

Sunday, April 23 8:00 a.m.–9:00 a.m. “Best of” Session 8:30 a.m.–5:30 p.m. Poster Session I 9:15 a.m.–12:00 p.m.

Presidential Plenary Session 1:00 p.m.–3:00 p.m. Scientific Platform Sessions Neuroscience in the Clinic: Neurobiology and Treatment of Disorders of Language and Action 3:30 p.m.–5:30 p.m. Scientific Platform Sessions Neuroscience in the Clinic: Child Neurology: Neurologic Disorder Through a Lifespan—A Focus on MS

Monday, April 24 8:00 a.m.–9:00 a.m. “Best of” Session 8:30 a.m.–7:00 p.m. Poster Session II

9:15 a.m.–11:30 a.m. Contemporary Clinical Issues Plenary Session 1:00 p.m.–3:00 p.m. Scientific Platform Sessions Neuroscience in the Clinic: Cutting Edge Concussion Data from the NCAA-DoD Grand Alliance 3:30 p.m.–5:30 p.m. Scientific Platform Sessions Invited Science Session

Tuesday, April 25 8:00 a.m.–9:00 a.m. “Best of” Session 8:30 a.m.–7:00 p.m. Poster Session III

9:15 a.m.–11:30 a.m. Clinical Trials Plenary Session

140 2017 AAN Annual Meeting Early Look

1:00 p.m.–3:00 p.m. Scientific Platform Sessions Invited Science Session Neuroscience in the Clinic: Zika Virus: The Global Outbreak of a Neurotropic Virus 3:30 p.m.–5:30 p.m. Scientific Platform Sessions

Wednesday, April 26 8:00 a.m.–9:00 a.m. “Best of” Session 8:30 a.m.–7:00 p.m. Poster Session IV

9:15 a.m.–11:30 a.m. Frontiers in Neuroscience Plenary Session 1:00 p.m.–3:00 p.m. Scientific Platform Sessions Neuroscience in the Clinic: Stress and Neurologic Diseases: Effects Through the Neuroendocrine System 3:30 p.m.–5:30 p.m. Scientific Platform Sessions Neuroscience in the Clinic: Functional Recovery in Neurology and Neuroscience

Thursday, April 27 8:00 a.m.–9:00 a.m. “Best of” Session 8:30 a.m.–7:00 p.m. Poster Session V

9:15 a.m.–11:30 a.m. Controversies in Neurology Plenary Session 1:00 p.m.–3:00 p.m. Scientific Platform Sessions 3:30 p.m.–5:30 p.m. Scientific Platform Sessions Neuroscience in the Clinic: Novel Therapeutic Targets in Critical Care Neurology: Intracerebral and Intraventricular Hemorrhage

Friday, April 28 8:00 a.m.–9:00 a.m. “Best of” Session 8:30 a.m.–5:30 p.m. Poster Session VI 9:15 a.m.–11:30 a.m. Neurology Year in Review Plenary Session 1:00 p.m.–3:00 p.m. Scientific Platform Sessions Neuroscience in the Clinic: Afferent and Efferent Visual Pathway Manifestations of Neurodegenerative Diseases: Implications for Diagnosis and Treatment 3:30 p.m.–5:30 p.m. Scientific Platform Sessions

Fast and easy registration · AAN.com/view/AM17 141

Connect at Social Events There’s no better way to combine an evening of great fun and entertainment with unparalleled networking than to experience the Opening Party, Closing Party Happy Hour—or both. Whether you attend the Annual Meeting at the beginning or the end, these exciting social events are not-to-be-missed.

Opening Party

Exhibit Hall Opening Lunch

Sunday, April 23, 6:00 p.m.–10:00 p.m.

Sunday, April 23, 11:30 a.m.–1:30 p.m.

Neurobowl® 6:00 p.m.–8:00 p.m.

Attend the opening lunch to mingle with fellow attendees and preview the latest products and services available in the neurologic industry. A New England style lunch will be served. The exhibits will be open at this time.

This popular event hosted by AAN former president Thomas R. Swift, MD, FAAN, is one of the Annual Meeting’s premier happenings. Neurobowl showcases the best and brightest in neurology competing for the coveted Neurobowl trophy in an entertaining game-show format.

Run/Walk for Brain Research Tuesday, April 25, 6:30 a.m.–8:30 a.m. Support research in neurology and join us for a 5k run or one-mile walk along the scenic Boston waterfront. Both occasional and seasoned runners, as well as walkers, will enjoy this beautiful event for a good cause. All proceeds will go to help support brain research. The race is open to all meeting attendees and their families. Water and refreshments will be available following the race. The registration fee is $50. Bus service to and from the race site will be provided. For registration and details, visit AAN.com/view/RunWalk or contact Andrew Halverson at ahalverson@aan.com or (612) 928-6117.

Closing Party Happy Hour Friday, April 28, 5:30 p.m.–7:00 p.m.

Trinity Irish Dance Company 8:30 p.m.–9:15 p.m. Billed as “everything you expect but nothing you imagine,” Trinity Irish Dance Company quickly dispels whatever notions you may have about Irish dance. The company dazzles audiences with harddriving percussive power, lightning-fast agility, aerial grace, and the awe-inspiring precision of its dancers that led them to win an unprecedented 17 World Championships for the US and appearances in feature films by Disney, DreamWorks, Touchstone, and Universal and on the Tonight Show.

Live DJ and Dancing: 9:15 p.m.–10:00 p.m. Get down with friends and colleagues to some of the most memorable dance tunes spanning the past six decades.

142 2017 AAN Annual Meeting Early Look

Celebrate the end of a great meeting at a special early-evening happy hour event! Enjoy drinks, games, and socializing with colleagues, and swing out to your favorite jazz standards with a live performance by NEUROJAZZ, a four-piece ensemble led by AAN member Phillip Pearl, MD, FAAN. Each registered meeting attendee will receive one free ticket to this event. Guest tickets are available through registration for $50.

Reunion/In Conjunction With Meetings Reconnect with your peers and program directors, and network with your fellow alumni at various department reunion meetings occurring throughout the Annual Meeting. These In Conjunction With (ICW) Meetings, formerly known as Affiliate Meetings, are designed for functions that include Annual Meeting attendees but are not planned by or sponsored by the AAN. If your department is interested in hosting its alumni meeting during the 2017 Annual Meeting, reserve your meeting today at AAN.com/view/ICW or by contacting Grace Henderson at ICW@aan.com or (612) 928-6103.

CLOSING PARTY! DON’T MISS THE

Friday, April 28

•

5:30 p.m.–7:00 p.m.

Celebrate the end of a great meeting at a special early-evening happy hour event! • Enjoy drinks, games, and socializing with colleagues • Swing out to your favorite jazz standards with a live performance by NEURO JAZZ, a four-piece ensemble led by AAN member Phillip Pearl, MD, FAAN • Make plans to explore beautiful, historic Boston afterwards

Enhance your Annual Meeting experience with Annual Meeting On Demand. There is no better place than the AAN Annual Meeting for a high-quality educational experience in neurology. With the robust offering of concurrent courses available during the meeting, it is impossible to attend every one. Annual Meeting On Demand delivers captured content from the Annual Meeting to your doorstep so that you can experience all that the meeting has to offer. Annual Meeting On Demand is a CME accredited comprehensive digital library with more than 500 hours1 of presentations from the 2017 AAN Annual Meeting including syllabi for 200+ programs. Features of Annual Meeting On Demand include: • Online access to content within 24 hours of live presentations. • Integrated online CME testing. • An advanced search engine that delivers a direct link to the specific presentations and slides containing your search terms. • Downloadable PDFs of presentation slides and syllabi summaries. • Downloadable MP3 files provide the option of listening to any (or all) lectures while driving, traveling, or any occasion where audio is most convenient. • A complimentary portable hard drive2 for offline viewing when internet is not available. 1

Specific presentations within a session may not be available or may be audio only if the presenter has confidential patient information or otherwise declines to be recorded. Hard drive does not include all the functionality available online, such as Advanced Search, MP3/PDF Downloads, Bookmarks, Recently Viewed and CME testing.

144 2017 AAN Annual Meeting Early Look

Annual Meeting Attendee Pricing: Gold Registration Upgrade to gold registration and receive all sessions at the meeting* as well as access to Annual Meeting On Demand. With so many concurrent sessions, Gold Registration is the best value for attendees who want to experience the full value of the meeting. * Skills Workshops, Neurology MOC Prep Course, Improving your Leadership Skills: A Practical Approach, Women in Leadership, Leadership Effectiveness for Clerkship and Program Directors Academy, Early Career Research Training Symposium, The Most Important Tool in Your Black Bag: Gallup StrengthsFinder™ Assessment Courses, and Mentoring…Growing the Next Generation of Neurologist are not included in the Annual Meeting registration price. These courses require pre-registration, may have a separate registration fee, and are subject to closure due to reaching maximum capacity.

Gold Registration BEFORE March 30, 2017

AFTER March 30, 2017

STUDENTS

$199

SENIOR & HONORARY

$399

JUNIOR

$444

$534

NON-NEUROLOGIST MEMBER

$619

$769

MEMBER

$1,119

$1,379

NONMEMBER

$1,819

$2,259

Select Gold Registration when you register for the meeting!

Syllabi USB Upgrade! All attendees will receive complimentary online access to all Annual Meeting Syllabi for one year. Upgrade to a Syllabi On Demand USB drive for permanent use. Syllabi On Demand is a quick reference tool with summaries for 200+ programs from the 2017 Annual Meeting. Order Online: AAN.com/view/Register

Not attending the 2017 Annual Meeting? You can still pre-order On Demand products prior to the meeting and receive a special discount. Learn more by calling or visiting online. Order Online: AANonDemand.com/PreMeeting Order by Phone: (800) 501-2303 or (818) 844-3299 Pre-meeting discounts expire April 21, 2017.

Syllabi USB Pricing Syllabi On Demand (USB upgrade)

MEMBER, SENIOR, & HONORARY

$39

NONMEMBER

$59

JUNIOR AND NONNEUROLOGIST MEMBER

$29

Non-Attendee Pricing Annual Meeting On Demand

Syllabi On Demand

MEMBER, SENIOR, & HONORARY

$649

$199

NONMEMBER

$949

$299

JUNIOR AND NONNEUROLOGIST MEMBER

$199

$99

Fast and easy registration · AAN.com/view/AM17 145

We’re Making It Easier to Bring the Entire Family! We’re making it easier than ever to bring the entire family to the totally customizable Annual Meeting! You’ll have more opportunities to take in your favorite sessions, attend to the family, and still have time to explore beautiful, historic Boston. z Enjoy the enhanced mothers room with a quiet, comfortable family lounge and changing stations z Discover a variety of child care options available throughout Boston— check with your hotel concierge for details

z Explore beautiful, historic Boston and take in family-friendly fun like the New England Aquarium, IMAX Theatres, Children’s Theater, Science Museum, Franklin Park Zoo, and more—visit familyfriendlyboston.com for more ideas

AAN.com/view/AM17

General Information Accreditation/CME/Core Competencies Accreditation

The American Academy of Neurology Institute (AANI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation

The American Academy of Neurology Institute designates this live activity for a maximum of (*) AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. * See individual program descriptions in this booklet for the maximum number of credits per program.

CME/Participation Records

AANI has mechanisms in place to record, and when authorized by the participating physician, verify participation in the CME activity. To receive CME for the Annual Meeting live program, participants must: (1) have their badge printed on site and be verified as eligible for credit; (2) attend the program(s); and (3) submit the evaluation form for the program(s). CME is given only when all three steps are completed. AAN member CME and participation transcripts are available approximately four to six weeks following the close of the meeting via the AAN’s NeuroTracker™ at AAN.com/view/NeuroTracker. Nonmembers’ CME credits and participation transcripts will be sent automatically via email.

ABPN Statement

The American Board of Psychiatry and Neurology has reviewed the AAN Annual Meeting and has approved this product as a part of a comprehensive lifelong learning program which is mandated by the ABMS as a necessary component of maintenance of certification.

Core Competencies

The AANI develops its activities/educational interventions in the context of the desirable physician attributes; specifically, of the Accreditation Council for Graduate Medical Education (ACGME) Core Competencies which include: }} Patient Care }} Medical Knowledge }} Interpersonal and Communication Skills }} Practice-Based Learning and Improvement }} Professionalism }} Systems-Based Practice For more information on the definitions of the ACGME core competencies, please consult the following webpage: ACGME.org . Once again, the Annual Meeting CME offerings, at the program and lecture level, are identified according to these competencies. Through identifying individual programs by competencies, attendees can easily identify and attend programs that meet each core competency.

AMA CME Definition/Educational Content of Certified CME The AMA HOD and the Council on Medical Education have defined continuing medical education as follows: CME consists of educational activities which serve to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public, or the profession. The content of CME is the body of knowledge and skills generally recognized and accepted by the profession as within the basic medical sciences, the discipline of clinical medicine and the provision of health care to the public. (HOD policy #300.988) Certified CME is defined as: 1. Nonpromotional learning activities certified for credit prior to the activity by an organization authorized by the credit system owner, or 2. Nonpromotional learning activities for which the credit system owner directly awards credit Accredited CME providers may certify nonclinical subjects (e.g., office management, patient-physician communications, faculty development) for AMA PRA Category 1 Credit™ as long as these are appropriate to a physician audience and benefit the profession, patient care, or public health. CME activities may describe or explain complementary and alternative health care practices. As with any CME activity, these need to include discussion of the existing level of scientific evidence that supports the practices. However, education that advocates specific alternative therapies or teaches how to perform associated procedures, without scientific evidence or general acceptance among the profession that supports their efficacy and safety, cannot be certified for AMA PRA Category 1 Credit™.

Content Validation The AANI, as an ACCME accredited provider, is responsible for validating the clinical content of CME activities that it provides. Specifically, 1. All the recommendations involving clinical medicine in a CME activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. 2. All scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

Fast and easy registration · AAN.com/view/AM17 147

General Information Disclaimers/Disclosures Disclaimer The primary purpose of the Annual Meeting is to meet the educational needs of its members and address practice gaps by providing practiceoriented and scientifically based educational activities that will maintain and advance competence and performance in the field of neurology. A diversity of opinions exists in the medical field and the views of the Annual Meeting faculty do not represent those of the AAN/ AANI or constitute endorsement by the AAN/AANI. The AAN/AANI disclaims any and all liability for the claims that may result from the use or nonuse of information, publications, therapies, and/or services discussed at the Annual Meeting. The activities conducted and content distributed at the Annual Meeting are for educational purposes only and do not constitute standard of care or substitute for professional medical advice, diagnosis, or treatment. In all cases, the selected course of action should be considered by the treating provider in the context of treating the individual patient. Use of the content provided is voluntary. The AAN/AANI provide this information on an â&#x20AC;&#x153;as isâ&#x20AC;? basis and makes no warranty, expressed or implied, regarding the information. The AAN/AANI specifically disclaim any warranties of merchantability or fitness for a particular use or purpose. The AAN/ AANI assume no responsibility for any injury or damage to persons or property arising out of or related to any use of this information or for any errors or omissions. Attendee assumes any and all liability associated with attendance/participation at the Annual Meeting.

Relationship Disclosure and Conflict of Interest Resolution According to AANI and ACCME policies, everyone who is in a position to control the content of an education activity must disclose financial relationships with any commercial interest to the provider. An individual who refuses to disclose relevant financial relationships is disqualified from being a planning committee member, a teacher, or an author of CME, and cannot have control of, or responsibility for, the development, management, presentation or evaluation of the CME activity. In addition, the AANI must implement a mechanism to identify and resolve all conflicts of interest prior to the education activity being delivered to learners. The resolution of conflict is handled by the Education and Science Committees. Disclosures for everyone in the position to control Annual Meeting content can be found on the AAN Annual Meeting website. In addition, education and science faculty disclosures can also be found in the syllabi, slides, handouts, and/or are given verbally from the podium.

Unlabeled Use Disclosure The AANI requires all Annual Meeting presenters to disclose if a therapy/product is not labeled for the use being discussed or if the therapy/product is still investigational. Unlabeled use disclosures can be found in the program materials.

148 2017 AAN Annual Meeting Early Look

Continued

Grants Some Annual Meeting education and scientific programs are supported in part by educational grants from commercial entities. Disclosure of the educational grant is done through acknowledgment statements on the program materials, signs outside of the room, and verbally from the podium. Although educational grants are received, all programs are developed and implemented solely by the Education Committee and Science Committee. The terms, conditions, and purposes of the commercial support are documented in a written agreement between the AANI and commercial supporter. The AAN uses grant funds to support and enhance existing, as well as new, education programs.

Services Luggage Check No luggage check is available at The Boston Convention and Exhibition Center (BCEC). Check with your concierge at your hotel to make your arrangements.

Transportation Due to the proximity of the hotels to The Boston Convention and Exhibition Center, the AAN will provide shuttle service for select hotels. The housing website indicates whether a hotel is walkable or in the shuttle zone. Please use this information when making your housing selection.

Wireless Connection Wireless Internet hotspots will be available at The Boston Convention and Exhibition Center.

First Aid Station A First Aid station is located on the lobby level of The Boston Convention and Exhibition Center. The station is staffed by licensed medical professionals and fully equipped with supplies, including automatic external defibrillators (AED). The station is operational throughout the duration of the Annual Meeting.

Prayer Room A prayer room will be available in the Convention Center for attendees looking for a quiet space for thought, reflection, and prayer.

Child Care Information A variety of child care options are available in Boston. Check with the concierge at your hotel on or before your arrival to make your arrangements.

Mothers Room A private room will be available for nursing mothers and others with sensitive personal health needs. Please note that this room will not be staffed.

Guidelines Photography and Recording of Programs The AAN strictly prohibits all unauthorized photography (flash, digital, or otherwise), audio and/or video recording during the Annual Meeting. Equipment will be confiscated. Photography is allowed only in the Poster Sessions.

Consent to Use of Images All portions of the Annual Meeting may be photographed, videotaped, or recorded for future rebroadcast, distribution, promotion, or other commercial purpose. By attending the Annual Meeting you are consenting to being recorded, photographed, and videotaped without acknowledgment, payment or remuneration of any kind. Any recordings, photographs, or videos of any nature are the sole property of AAN and its successors and assignees.

Cell Phones

Monday, April 24, the Neuromuscular Ultrasound Skills Workshop on Tuesday, April 25, the EMG Skills Workshop: Basic on Wednesday, April 26, and the Clinical Uses of Botulinum Toxin for Spasticity Workshop on Thursday, April 27. Skills workshop subjects will receive a waived meeting registration and workshop fee as well as payment of $40 per noninvasive session and $60 per invasive session. Space is available on a first-come, first-served basis for current Junior and Student AAN members. For more information, contact Laurie Dixon at ldixon@aan.com or (612) 928-6154.

Weather/Attire April brings spring-like temperatures to Boston. Temperatures usually range from 37 degrees to 54 degrees Fahrenheit. The AAN promotes business casual attire for the duration of the Annual Meeting. Consider bringing a light jacket or sweater to Annual Meeting activities since meeting room temperatures and personal comfort levels vary.

The AAN requests that attendees turn cellular phones and pagers to vibrate mode upon entering all Annual Meeting programs.

Language The official language of the Annual Meeting is English. No simultaneous translation is available.

No Smoking The Boston Convention and Exhibition Center is a nonsmoking facility. For the health and comfort of everyone, smoking is prohibited at Annual Meeting functions, which include all education and scientific activities and social functions.

Press Room Only authorized media may use the Press Room at the Annual Meeting. Journalists must check in at the Press Room and provide proper credentials. For more information, contact Michelle Uher at muher@aan.com or (612) 928-6120.

Volunteer Opportunities Education and Scientific Program Monitors Monitors are needed for all education program offerings and scientific platform sessions to assist directors, faculty, session co-chairs, and staff as required. The AAN will give discounts to registration fees as well as grant CME credit for the monitored program. Space is available on a first-come, first-served basis for current Junior and Student AAN members. For an application form or more information, contact Laurie Dixon at ldixon@aan.com or (612) 928-6154.

Skills Workshop Volunteers Volunteers are needed to participate in the Clinical Uses of Botulinum Toxin for Dystonia Workshop on Sunday, April 23, the Neurophysiologic Intraoperative Monitoring Skills Workshop on

Fast and easy registration Âˇ AAN.com/view/AM17 149

Hotels and Amenities Hotel Name / Address

Lowest Rates* (SGL / DBL)

Distance to Convention Center

High Speed Internet Number of Access Per Day Restaurants

Aloft Boston Seaport Hotel 401-403 D Street

$283.00 / $283.00

1 Block

No Charge

Boston Courtyard Downtown 275 Tremont Street

$289.00 / $289.00

1.4 Miles

No Charge

Boston Park Plaza Hotel 50 Park Plaza at Arlington Street

$295.00 / $295.00

1.6 Miles

$11.99

Boston Marriott Long Wharf 296 State Street

$369.00 / $369.00

1.3 Miles

$16.95

Colonnade Hotel 120 Huntington Avenue

$329.00 / $329.00

2.3 Miles

No Charge

DoubleTree by Hilton - Boston Downtown 821 Washington Street

$289.00 / $289.00

1.4 Miles

$9.95

Element Boston Seaport 391-395 D Street

$293.00 / $293.00

2 Blocks

No Charge

Embassy Suites Boston at Logan Airport 207 Porter Street

$234.00 / $234.00

3.4 Miles

No Charge

Fairmont Copley Plaza 138 St. James Avenue

$337.00 / $337.00

2 Miles

$11.00

Four Seasons Hotel Boston 200 Boylston Street

$405.00 / $405.00

1.4 Miles

No Charge

Hilton Boston Back Bay 40 Dalton Street

$285.00 / $285.00

2.6 Miles

$14.95

Hilton Boston Downtown / Faneuil Hall 89 Broad Street

$315.00 / $315.00

1.1 Miles

$15.99

Hilton Boston Logan Airport 1 Hotel Drive

$289.00 / $289.00

3.5 Miles

$6.95

Hotel Commonwealth 500 Commonwealth Avenue

$329.00 / $329.00

3 Miles

No Charge

Hyatt Regency Boston One Avenue de Lafayette

$290.00 / $290.00

1.1 Miles

No Charge

InterContinental Boston 510 Atlantic Avenue

$344.00 / $344.00

8 Blocks

$12.95

Langham Hotel 250 Franklin Street

$343.00 / $343.00

1 Mile

No Charge

Lenox Hotel 61 Exeter Street at Boylston

$299.00 / $299.00

2 Miles

No Charge

Liberty Hotel Boston 215 Charles Street

$369.00 / $369.00

2.1 Miles

No Charge

Marriott Copley Place 110 Huntington Avenue

$292.00 / $292.00

2.1 Miles

$12.95

Midtown Hotel 220 Huntington Avenue

$179.00 / $179.00

2.5 Miles

No Charge

*Lowest available rate shown. Availability in that room category may be limited; other room categories may be available at a higher rate.

150 2017 AAN Annual Meeting Early Look

Ch els ea St

Meridian St

Ha no ve rS t

No rth ern

BS t 1s tS t

7t h

Headquarter Hotel

E 1st St

Massport Haul Rd

Hotel

Farragut Rd

Br oa dw ay

William J Day Blvd

M as Su sp m or t H a m er St Drydock Ave

By pa ss

24 St

Marginal Rd

y lon Co Old

Convention Center

E Broadway

e Av

Hotel Name / Address

Co ng res s

Bo st on

Travel er St

L Street

Unio Mald n Park St en S t St y n ba Al

Se ap or tB lvd

W ay

Av e

Co ng re ss St

St ree t

Kne elan dS t

Dorchester Ave

Ha rr is on

Linc oln St

Su mm er St

St re et

Av e Co lu m bu s

Ave de Lafa yett e

Pa pp as

Tr em on tS t

Tre mo nt S t

Av e

Hu nt in gt on

t eS e as v rch ic A Pu lant At

Essex St

Harr ison Ave

Sorr ow D r

2 Mi les O ut

g way S t

Boston Convention and Exhibition Center 415 Summer St, Boston, MA 02210

13 17

Hem en

Park Dr

Bro ad S t

St lin nk Fra

W4 th S t

d or nc Co

Pa rke rS t

Sch ool

1 Mile O ut

e Av

am th al W

n to ew N

St State

Hera ld St

n to ng hi as W

e Av ut m aw h S

t tS on em Tr

Cou rt St

Jo hn F

e Rd urfac rald S zge Fit

t yS kele Ber

am dh De

Av e

3 7

Cr os sS t

St arl Pe

z Park Pl

EB erk ele y

M as sa ch us et ts

ut Waln

St rles Cha Boylston St

St on rd

St ress Cong

Joy St

Charles St

t nS ngto Arli

Westla nd Ave

St don ren Cla

Belvid ere St

St con Bea

St uth tmo Dar

Ru gg les

St yth Fors

way Fen

St don ren Cla

n St lsto Boy

on Dalt

t ter S Exe

Charlesgate

on St Mt Vern t St stnu Che

t nS lsto Boy ve es A am St J t rt S a Stu

Pinckney St

Bowdoin St

Cambridge St

t yS kele Ber

Ave etts hus sac Mas

C New

Longfellow Bridge

Dr row Sor St on c a Be St gh u o r rlbo Ma Ave alth nwe mo Com t yS bur New

Merr ima c St

Atlantic Ave

ay W ey

Blo ss o

To ma ha wk Dr

Ha rb or

St St ay ew us a C

Lom asn

Se rvi ce Rd

Com me rcia lS t

Nash

St re et

Lowest Rates* (SGL / DBL)

Distance to Convention Center

High Speed Internet Number of Access Per Day Restaurants

Omni Parker House 60 School Street

$259.00 / $259.00

1.2 Miles

No Charge

Renaissance Boston Waterfront Hotel 606 Congress Street

$303.00 / $303.00

4 Blocks

$16.95

Seaport Boston Hotel One Seaport Lane

$316.00 / $316.00

3 Blocks

No Charge

Sheraton Boston Hotel 39 Dalton Street

$280.00 / $280.00

2.5 Miles

$9.95

Westin Boston Waterfront 425 Summer Street

$325.00 / $325.00

Less Than 1 Block

$12.95

Westin Copley Place Boston Hotel 10 Huntington Avenue

$303.00 / $303.00

2.1 Miles

$14.95

Wyndham Boston Beacon Hill 5 Blossom Street

$299.00 / $299.00

2 Miles

No Charge

tel Driv e Ho

Ri ve rD am

St ton ing ash NW

Ch ar les

Po rte rS t

Fast and easy registration Â· AAN.com/view/AM17 151

Hotel and Reservations Why Book a Hotel Room Through the AAN? Booking your room through the official AAN housing company assures you are getting a room at the hotel that best fits your needs. You are also helping the AAN maintain consistent and competitive registration fees. The reason is simple. When a city is selected as the site for the AAN Annual Meeting, contracts are signed with several hotels reserving a specific number of rooms to be available for meeting attendees. If these rooms are not sold, the AAN is liable financially. Penalties incurred affect the overall costs of the Annual Meeting and what the AAN charges for registration, exhibit space, and other services. Discounted hotel rates are available until March 8, 2017, or until the block is filled. After this date, reservations are subject to availability. Hotel fees will be posted and charged in American dollars.

Save on Hotel Reservations Take advantage of the AAN’s special hotel rates to make your trip more affordable. Annual Meeting hotel reservations are processed by Convention Management Resources (CMR).

AAN Online Hotel Reservations

Telephone Reservations

AAN.com/view/BookHotel The AAN makes it easy and convenient to book your hotel rooms for the 69th Annual Meeting. Booking online allows you to: }} Take advantage of the AAN’s special hotel rates }} View room descriptions, photos, and availability }} Access maps of hotel proximity to Annual Meeting locations

All correspondence, questions, and inquiries should be directed to CMR at: Phone: US/Canada (800) 676-4226 International (415) 979-2283

Hours: Credit card reservations only Monday–Friday 6:00 a.m.–6:00 p.m. PT

Deposits }} All hotels require a credit card guarantee of $300 (US dollars) per room and $500 (US dollars) per suite. Deposits will be credited towards your first night’s room and tax. }} No hotel reservation will be processed without a credit card guarantee. }} Deposits are refundable up to seven days prior to arrival, after which there will be no refunds. }} Credit cards will be charged for one night’s room and tax if you fail to arrive on the confirmed date of arrival or if you fail to cancel your reservation at least seven days prior to arrival.

Confirmations, Changes, and Cancellations }} You will receive your hotel confirmation from CMR. This is the only confirmation you will receive. }} Please check your arrival and departure dates on the confirmation carefully. }} After March 8, 2017, contact CMR to book a room. After this date, however, rooms are subject to availability. Note: Some hotels may charge a penalty for changes made to your departure date after you have checked in.

152 2017 AAN Annual Meeting Early Look

Group Accommodations Deadline: March 8, 2017

Blocks of 10 or more sleeping rooms are considered a group. Email your written request to aanam.cmrushelp.com and you will be contacted by an AAN Housing Consultant.

Additional Tax/Assessments }} Rates do not include the 15% hotel tax. }} An $8 per night assessment fee is included to offset the expense of the meeting.

Travel Information Save with Annual Meeting Travel Reservation Through Travel Agency

Direct Through Airlines

The official travel agency for the Annual Meeting is ATC Travel Management. For 2%–10% discounted airline tickets to the Annual Meeting, contact them at: Phone: (800) 458-9383 Email: reservations@atcmeetings.com Hours: Monday–Friday, 8:30 a.m.–7:00 p.m. ET Closed weekends and holidays

You may also contact your preferred airline directly. You must reference the AAN Annual Meeting and provide the appropriate airline discount codes listed below.

A $33 service fee will be assessed per ticket for reservations made via phone.

Travel Website

Airline Delta United

Discount Code NMPBD ZVM8 820754

Phone Number Website (800) 328-1111 Delta.com (800) 521-4041 United.com

For travel forms and information updates, visit the AAN Annual Meeting website at AAN.com/view/AM17.

Travel Tips Travel Documents/Passports and Entry Requirements

Luggage

Non-US visitors must have valid travel documents/passports to enter Boston to provide proof of their citizenship. Document requirements vary depending on your country of origin, citizenship, the reason for your visit, and the length of your stay, and may include passport or a birth certificate, photo ID, and/or a visa.

Restrictions for carry-on baggage and weight and size limits for checked baggage are different for international flights than for domestic flights. Be sure to check with your individual carrier as to weight and measurement restrictions and associated costs for overages.

For more information, or to request a Letter of Announcement for the 2017 Annual Meeting, visit AAN.com/view/AMinfo.

Measurements

Logan International Airport The Boston, MA, area is served by the Logan International Airport. The airport is approximately three miles from The Boston Convention and Exhibition Center.

Currency Boston’s currency is the US dollar; currency exchange is available at banks and kiosks throughout the city and at the airport. Cash machines/ATMs are available in most banks, hotels, and shopping centers. For denominations under one dollar, the currency is coins.

Customs and Immigration From an international point of arrival, upon arriving in Boston, you will be required to go through a US Customs and Border Protection (CBP) inspection. Before you land, your flight crew will distribute an Immigration and Customs Declaration Form for you to complete; forms are also available at the airport upon your arrival. You will need to present this form, along with your passport, visa (if any), and return tickets to the CBP officer.

Health Insurance

Boston uses the United States customary system for weights and measurements. If you choose to drive in Boston be aware the speed limits are posted in miles per hour.

Medication If you are entering Boston with prescription drugs and syringes: keep the medication in its original, labeled container; include medical certificate with syringes showing they are for medical use and have them declared to US Customs officials; bring an extra prescription in case your medication is lost and/or to attest to your need to take such prescriptions; and carry the generic name of prescription medicines.

Mobile Phone Service Contact your service provider directly to inquire if service is available and/or the applicable rates.

Time Zone Boston is in the Eastern Time Zone. In April it will be the same time as New York, one hour ahead of Chicago, three hours ahead of Los Angeles, five hours behind London, and 13 hours behind Tokyo. For more information, visit AAN.com/view/AMinfo.

Be sure to check with your health insurance provider about policy coverage away from home—particularly if you’re insured by an HMO and/or Medicare/Medicaid.

Fast and easy registration · AAN.com/view/AM17 153

69th Annual Meeting Committee Members Meeting Management Committee

Bruce I. Ovbiagele, MD, MSc, FAAN

Eric Klawiter, MD

Stefan M. Pulst, MD, FAAN, Chair

Joseph E. Safdieh, MD, FAAN

Claudia F. Lucchinetti, MD, FAAN

Carlayne E. Jackson, MD, FAAN, Co-chair

Rana R. Said, MD

Randolph S. Marshall, MD, FAAN

Brenda Banwell, MD, FAAN

Lori A. Schuh, MD, FAAN

Massimo Pandolfo, MD, FAAN

Allison Brashear, MD, MBA, FAAN

Joseph I. Sirven, MD, FAAN

Adolfo Ramirez Zamora, MD

Neil A. Busis, MD, FAAN

Madhu Soni, MD

Jessica Robinson Papp, MD, FAAN Guy A. Rouleau, MD, PhD

Terrence L. Cascino, MD, FAAN

Ralph L. Sacco, MD, MS, FAHA, FAAN

Lisa M. DeAngelis, MD, FAAN

Conference Subcommittee

John W. Engstrom, MD, FAAN

Joseph I. Sirven, MD, FAAN, Chair

Mill Etienne, MD, MPH, FAAN

Erika Fullwood Augustine, MD, FAAN

Jori Fleisher, MD, MSCE

David W. Dodick, MD

Jonathan P. Hosey, MD, FAAN

Pierre Fayad, MD, FAAN, FAHA

Ralph F. Jรณzefowicz, MD, FAAN

Terry D. Fife, MD, FAAN

Jose G. Merino, MD, MPhil, FAAN

Susan Fox, MD

Jennifer Rose Molano, MD, FAAN

Na Tosha N. Gatson, MD, PhD

John C. Morris, MD, FAAN

Jonathan Graff-Radford, MD

Medical Economics and Management Committee

Timothy A. Pedley, MD, FAAN

Laurie Gutmann, MD, FAAN

Orly Avitzur, MD, MBA, FAAN, Chair

Ronald C. Petersen, PhD, MD

Stephen Krieger, MD, FAAN

Maisha T. Robinson, MD, MS

Constantine Moschonas, MD

Gregory J. Esper, MD, MBA, FAAN, Vice Chair

Ralph L. Sacco, MD, MS, FAHA, FAAN

Maciej M. Mrugala, MD

Heidi B. Schwarz, MD, FAAN

Paola Sandroni, MD, PhD, FAAN

Bruce Sigsbee, MD, FAAN

Heidi B. Schwarz, MD, FAAN

Joseph I. Sirven, MD, FAAN

A. Gordon Smith, MD, FAAN

Andrew J. Westwood, MD

Bert B. Vargas, MD, FAAN

Education Committee A. Gordon Smith, MD, FAAN, Chair Laurie Gutmann, MD, FAAN, Vice Chair Allen J. Aksamit, Jr., MD, FAAN Robert D. Brown, Jr., MD, FAAN Bruce A. C. Cree, MD, PhD, MCR Barry M. Czeisler, MD, MS Jessica Erfan, PA-C Blair Ford, MD, FAAN Jennifer G. Goldman, MD, MS, FAAN J. Clay Goodman, MD, FAAN Jaffar Khan, MD, FAAN Kerry H. Levin, MD, FAAN Steven L. Lewis, MD, FAAN Janis Miyasaki, MD, FAAN 154 2017 AAN Annual Meeting Early Look

Science Committee

Michael E. Shy, MD Mark H. Tuszynski, MD, PhD, FAAN Barbara G. Vickrey, MD, MPH, FAAN Aleksandar Videnovic, MD, MSc, FAAN Ryan R. Walsh, MD, PhD, FAAN

Stuart B. Black, MD, FAAN Brian Callaghan, MD Bruce H. Cohen, MD, FAAN David A. Evans, MBA Terry D. Fife, MD, FAAN Elaine C. Jones, MD, FAAN Lyell K. Jones, MD, FAAN Joel M. Kaufman, MD, FAAN

Lisa M. DeAngelis, MD, FAAN, Chair

Robert M. Kropp, MD, FAAN

Natalia S. Rost, MD, FAAN, Vice Chair

Constantine Moschonas, MD

Karen Hsiao Ashe, MD, PhD

John Ney, MD, MPH

Gregory K. Bergey, MD, FAAN

Jason J. Sico, MD

Edward H. Bertram, MD, FAAN Terrence L. Cascino, MD, FAAN Jose E. Cavazos, MD, PhD, FAAN Paul M. George, MD, PhD, MSE Peter Goadsby, MD, PhD Robert C. Griggs, MD, FAAN Deborah Hall, MD, PhD Joseph Jankovic, MD, FAAN Shafali Jeste, MD Petra Kaufmann, MD, FAAN

Practice Committee Heidi B. Schwarz, MD, FAAN, Chair Eric Anderson, MD, PhD, Vice Chair Wayne E. Anderson, MD, FAAN Carmel Armon, MD, FAAN Jay T. Barnes, MBA Sarah M. Benish, MD, FAAN Jeffrey R. Buchhalter, MD, FAAN Mandi Sue Counters, NP

Jason B. Diamond, MD, MPH Richard M. Dubinsky, MD, FAAN, MPH Miriam L. Freimer, MD Joseph V. Fritz, PhD Raghav Govindarajan, MD Mark Gudesblatt, MD Cynthia L. Harden, MD Anna D. Hohler, MD, FAAN Irene L. Katzan, MD Mark Keegan, MD Pushpa Narayanaswami, MBBS, MD, FAAN Don B. Smith, MD, FAAN Roderick C. Spears, MD Jonathan B. Strober, MD Raissa Villanueva, MD David Z. Wang, DO, FAAN, FAHA

Meeting Information and Contacts Hotel Reservation Deadline: March 8, 2017

Early Registration Deadline: March 30, 2017

Registration, Hotel, and Travel Reservations: AAN.com/view/AM17

Annual Meeting Oversight Catherine M. Rydell, CAE Chief Executive Officer/Executive Director, AAN, AAN Institute Christine E. Phelps Deputy Executive Director, AAN Institute Kris Fridgen Senior Director, Education, Science, and Conferences Senior Director, Corporate Relations Kevin Heinz Director, Annual Meeting and Conferences

Education Program

education@aan.com Amy Nostdahl Senior Education Manager, Annual Meeting and Conferences

Meeting Registration and Housing Phone: US/Canada (800) 676-4226 International (415) 979-2283 Hours:

Monday–Friday 6:00 a.m.–6:00 p.m. PT

Online: aanam.cmrushelp.com

Travel Reservation Services ATC Travel Management Phone: (800) 458-9383 Hours: Monday–Friday, 8:30 a.m.–7:00 p.m. EST Closed weekends and holidays

In Conjunction With Events/Logistics Grace Henderson Administrative Assistant, Annual Meeting and Conferences

Brain Health Fair

Wendy Vokaty Manager, Special Events

Exhibits Gretchen Liedl Manager, Exhibits and Sponsorship

Sales and Sponsorship Andrew Halverson Senior Manager, Industry Sales

Compliance Issues Susan Rodmyre Senior Director, Education

Ashley Hubbard Senior Education Specialist, Annual Meeting and Conferences

John Hutchins Asociate General Council

Science Program

Lucy Persaud Samaroo Senior Manager, Undergraduate/Graduate Education

science@aan.com Erin Jackson Senior Science Manager, Annual Meeting and Conferences

Resident and Student Activities

Practice and Public Policy Issues

Nate Kosher Senior Science Administrator, Annual Meeting and Conferences

advocacy@aan.com Jason Kopinski, CAE Deputy Executive Director, AAN Chief Health Policy Officer

Registration

For direct email and phone contacts, please contact Member Services at:

aanam.cmrushelp.com Laurie Dixon Senior Administrator, Registration and Logistics

Housing Julie Ratzloff Manager, Housing and Special Events 156 2017 AAN Annual Meeting Early Look

memberservices@aan.com Toll Free: (800) 879-1960 or International: (612) 928-6000

Build your leadership skills to take your career to the next level! This year’s expanded leadership course offerings have something for everyone, at every career stage.

Women in Leadership Directors: Janice M. Massey, MD, FAAN; Orly Avitzur, MD, MBA, FAAN; Barbara L. Hoese, President, Pentecore Coaching

Saturday, April 22, 2017 • 8:00 a.m.–5:00 p.m.

Clerkship and Program Directors Leadership Academy Directors: Jaffar Khan, MD, FAAN; Joseph E. Safdieh, MD, FAAN; Rana R. Said, MD

Saturday, April 22, 2017 • 8:00 a.m.–5:00 p.m.

Gender Issues in Leadership Directors: Barbara L. Hoese, President, Pentecore Coaching; Lyell K. Jones, MD, FAAN; Bert B. Vargas, MD, FAAN; Maisha T. Robinson, MD, MS

Sunday, April 23, 2017 • 1:00 p.m.–5:00 p.m.

Leadership Challenges in Practice Director: James C. Stevens, MD, FAAN

Sunday, April 23, 2017 • 1:00 p.m.–5:00 p.m.

Mentoring…Growing the Next Generation of Neurologist Director: Joanne L. Smikle, PhD

Monday, April 24, 2017 • 1:00 p.m.–3:00 p.m.

Improving Your Leadership Skills: A Practical Approach Directors: Ralph L. Sacco, MD, MS, FAHA, FAAN; Terrence L. Cascino, MD, FAAN

Monday, April 24, 2017 • 1:00 p.m.–5:00 p.m.

The Most Important Tool in Your Black Bag: Gallup StrengthsFinderTM Education Workshop Directors: Keri Bischoff and Julie Anderson, Gallup-certified Strengths Consultants

Tuesday, April 25, 2017 • 1:00 p.m.–5:00 p.m.

Advanced Leadership Training: Life-after-the-Limelights Director: Robert C. Griggs, MD, FAAN

Tuesday, April 25, 2017 • 1:00 p.m.–5:00 p.m.

The Most Important Tool in Your Black Bag: Gallup StrengthFindersTM Assessment: Advanced Workshop Directors: Keri Bischoff and Julie Anderson, Gallup-certified Strengths Consultants

Wednesday, April 26, 2017 • 1:00 p.m.–5:00 p.m.

Being A Resilient Leader: How Do You Lead the Change Directors: Heidi B. Schwarz, MD, FAAN; Jennifer Rose Molano, MD, FAAN

Thursday, April 27, 2017 • 1:00 p.m.–5:00 p.m.

For more information, visit AAN.com/view/17AMLeader.

PAID Permit No. 3840 Twin Cities, MN

201 Chicago Avenue Minneapolis, MN 55415

2O17 AAN Annual Meeting Early Look

Non-Profit Org. US Postage

Future AAN Annual Meeting Dates and Locations 71st AAN Annual Meeting

72nd AAN Annual Meeting

Los Angeles, CA April 21–28, 2018

Philadelphia, PA May 4–11, 2019

Toronto, Ontario, Canada April 25–May 2, 2020

AAN Member Services: (800) 879-1960

Use #AANAM and follow the AAN

AMERICAN ACADEMY OF NEUROLOGY

70th AAN Annual Meeting